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Abstract 
A multi-sited ethnography of patient and public involvement in epilepsy 
research.  
Contemporary health policy and funding bodies are placing increasing emphasis on patient 
and public involvement (PPI) in healthcare and health research, advocating PPI in all stages 
of the research process. Currently, however, there is limited empirical evidence critiquing 
different approaches to PPI or exploring its associated benefits and challenges. Without this 
information researchers and patient/public representatives cannot make informed 
decisions about best practice. 
The principal aim of this thesis was to generate a detailed understanding of the 
implementation of PPI in health research. To accomplish this broad aim, I focused on a 
specific health condition, epilepsy, and the research structures underlying health research 
in the UK, namely, research networks. I achieved this using a multi-sited, ethnographic 
approach, incorporating multiple qualitative data collection methods, including 47 
interviews, 35 observations, fieldnotes and document analysis.  
My in-depth thematic analysis of the data found that PPI is conceptualised in terms of 
‘meaningful’ and ‘tokenistic’ involvement by those engaged in the process, rather than how 
it is depicted in the current models of involvement. Having first explored these terms I 
identified five components that can help to ensure that PPI is meaningful and not 
tokenistic. Having compared and contrasted multiple approaches to PPI I conclude that 
there is not one single ‘best approach’ for implementing PPI. Rather, to achieve high 
‘quality’ PPI there is a need to incorporate seven methodological factors that overarch 
approaches and ensure that there is an alignment of approach and purpose. 
Both the professionals and the patient/ public representatives within my research appeared 
to be highly aware of the moral and political motivations of PPI, but were primarily 
motivated by pragmatic or consequentialist reasons. Professionals were motivated almost 
exclusively by the goal of improving the applicability or relevance of the research. This goal 
was important for representatives too but they were also motivated by a range of personal 
reasons, including the wish to feel they were making a difference; the opportunity to learn 
about epilepsy and epilepsy research; and the opportunity to interact with others. The 
perceived benefits of PPI were also identified and discussed in depth, and appeared to be 
largely congruent with those reported in the literature. However, my work has identified 
some challenges and barriers around PPI that have not previously been explored including: 
adverse emotional effects; organisational practicalities; concerns about 
‘representativeness’ and ‘tokenism’; the ‘blurring’ of roles and the erosion of patient-
clinician boundaries. 
I conclude by recommending that there should be an increased focus on appropriate, 
‘meaningful’, involvement rather than endeavouring to implement PPI in all stages of the 
research process, as currently advocated in policy documents. The insights into the 
challenges of PPI that my work has provided will allow them to be addressed from the 
outset, improving the PPI experience and consequently the likelihood of PPI being 
successfully implemented. 
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Introduction 
This thesis is the product of a PhD studentship based at the University of Liverpool within 
the Department of Public Health and Policy, funded by the North West Hub for Trial 
Methodology Research. With a Health Psychology background, a passion for qualitative 
research and an avid interest in the research question I undertook this challenge. Its 
purpose was to further current understanding of, and provide recommendations about, the 
process of patient and public involvement (PPI) in health research, by emphasising the 
experiences of those involved in the process and how they interpret these experiences. In 
this short introduction I contextualise the questions addressed in this thesis and outline the 
information given in the following chapters to provide a framework and guide for this 
thesis.  
Contextualising this thesis  
Government policy now advocates that patients and the public must be involved in all 
stages of the research process (DH, 2006). This commitment to PPI in health research is 
reflected by the range of UK government funding bodies that now require researchers to 
specify how they are going to involve PPI representatives in their proposed research, 
without which information research funding may be declined (2002).  
This stance on PPI arises in part from the moral belief that involvement in health care and 
health care research is a citizen’s right within a democratic society (Howe, MacDonald, 
Barrett, & Little, 2006). This view has been reinforced by the development of activist groups 
and the social pressure they have generated has helped to establish the rights of the 
individual in policy and practice (see Section 1.5). Consequently, PPI is often considered, 
prima facie, good beyond question (Dyer, 2004; Florin & Dixon, 2004) and at this level: 
“being in favour of better public consultation or more user involvement is rather like being 
against sin: at a rhetorical level, it is hard to find disagreement” (Harrison & Mort, 1998, 
p.66). 
As the culture of PPI in research has developed so too has the need to understand the 
impact of PPI on the research process. Consequently there has been a proliferation of 
literature discussing PPI that alludes to its possible benefits to the research process (see 
Section 1.6). However, very little of this literature is based in empirical evidence; the 
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majority of papers are theoretical or based on anecdotal evidence (see Section 1.6). While 
little is known about the impacts of PPI on the research process there is even less evidence 
about the effect of PPI on those involved in the process. Compounding this, the context 
specific nature of PPI also means that it is difficult to compare across approaches and, 
therefore, there is limited information for professionals trying to make decisions about how 
to integrate PPI into their research and the potential pitfalls of which they need to be 
aware.  
Aims and objectives  
The principal aim of this thesis was: To generate a detailed understanding of patient and 
public involvement in health research. To accomplish this broad aim I chose to focus on a 
specific health condition, epilepsy, and the research structures underlying health research 
in the UK, namely research networks. In order to achieve this, I identified four specific 
objectives: 
1. To describe how PPI was implemented within the specific context of the newly 
established UK Epilepsy Research Network (UKERN), and research linked to this 
network. 
2. To compare and contrast the theoretical underpinnings of PPI with its practical 
application in this context. 
3. To describe the experiences of the representatives and professionals involved in 
the PPI process, including their perceptions of the benefits and challenges of PPI. 
4. To compare different approaches of implementing PPI, by contrasting the 
experiences of the professionals and representatives across the different research 
sites.  
Clarifying terms  
In Chapter 1 I describe the debate within the literature regarding the labels and definitions 
surrounding patient and public involvement and explain my choice of terminology (see 
Section 1.3). However, it is important to briefly define these terms here. I use the term 
patient to refer specifically to those who have experienced disease or illness first-hand 
(Caron-Flinterman, Broerse, & Bunders, 2005). The term public is used to describe all 
individuals associated with the use of health care, including people who use health and 
social services, informal carers, parents/guardians, and organisations that represent people 
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who use services (Staley, 2009). When not specifically denoting one of these two groups, I 
use the term representative(s) as an abbreviation of patient and public representative(s).  
I use the label professional to describe anyone involved in the research process in a non-
representative role for example: clinical academics including doctors and nurses; non-
clinical academic researchers; and administrators. Although those involved in research may 
inhabit several roles and some representatives are also professionals, the distinction 
between representative and professional is necessary here in order to designate their roles 
within the context of this research. Lastly, I define involvement as: “doing research with or 
by the public, rather than to, about, or for the public” (INVOLVE, 2012b,p.6). 
Overview of this thesis 
This thesis is divided into seven chapters covering: background and literature review; 
methodological considerations; results and discussion. I will now give a synopsis of each of 
the chapters.  
Chapter 1, Background and literature review is presented in two parts. The first draws on a 
general review of the literature to describe the political and moral drivers for PPI, situating 
it in its historical context. The second presents the findings of a structured literature review 
into the current evidence base surrounding the impacts of PPI on the research process and 
those involved in it.  
Chapter 2, Methodological considerations answers the questions: why focus on epilepsy 
research and why focus on the UKERN? While accounting for my hermeneutic 
phenomenological stance, it explains the multi-sited ethnographic method that I used to 
address the research aims. Methodological considerations such as the data analysis 
process, ethical considerations and the process of PPI that was undertaken as part of this 
thesis are also detailed.  
Chapter 3, How PPI is operationalised, explores the nature of the PPI process in each of the 
four main research sites. Particular attention is given to the site specific motivations for and 
decision making processes around PPI, thus starting to address research objective 1 and 
providing the context for the following three chapters. In the discussion section of this 
chapter I conclude that there are three key factors that influence the professionals 
approach to PPI.  
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Chapter 4, Professionals’ experience and perceptions of PPI, starts by addressing the 
professionals’ motivation for engaging in PPI, focusing on their understanding of the 
purpose and benefits. The majority of these benefits are associated with improving the 
research process to increase how ‘useful’ or ‘relevant’ it is. It then goes on to discuss the 
challenges that professionals experienced, including issues around ‘tokenism’, 
‘representativeness’, time commitments, disruptions to their academic roles and general 
worries about getting PPI right.  
Chapter 5, Representative experiences and perceptions of PPI, shifts the focus to the 
representatives and their understanding of ‘meaningful’ involvement, looking in depth at 
their motivations for involvement and understanding of the potential benefits of PPI. It 
pays particular attention to the importance the PPI facilitator and how confident the 
representatives are to contribute in group settings, highlighting six main challenges that 
representatives experienced. 
Chapter 6, Further consideration of key findings about process and perceptions, draws 
together information from the three results chapters to conceptualise ‘meaningful’ 
involvement, present a new ‘typology’ of PPI and identify the strengths and limitations of 
the different PPI approaches adopted within the four main research sites. 
Chapter 7, Discussion, brings together the findings from the results chapters in order to 
compare and contrast representatives and professionals experiences of PPI; and to draw 
out the main findings. It focus is on issues around: motivations for PPI, meaningful 
involvement, differences across approaches to PPI, benefits and challenges of PPI and 
makes clear recommendations about the implementation of PPI in policy and practice. The 
chapter also addresses some limitations of my thesis and evaluates the choice to use a 
multi-sited ethnography in this context.  
 
  
1 
 
Chapter 1. Background and literature review 
1. 1 Introduction 
In the last two decades there has been a significant drive to increase the involvement of 
patients in health research (Andejeski et al., 2002), with an emphasis on patients actively 
contributing to the research process beyond their role as research subjects (Oliver et al., 
2008). Over time this initiative has become formalised into policy; for example, the 
Department of Health Research Governance guidance stipulates that patient involvement 
should exist at every stage of the research process (DH, 2005). In this two part introduction 
I first examine what is meant by patient and public involvement (PPI) and situate it in its 
historical and political context as established by a broad review of the literature. Secondly I 
describe the findings of a structured literature review that focused on the empirical 
evidence around the impacts of PPI, highlighting a number of gaps in this literature.  
1.2 Part one: PPI’s historical and political context  
In this part of my literature review, I define who is included in the phrase ‘patient and 
public’ and then explore the meaning of ‘involvement’. I then go on to describe the moral 
and political drivers for involvement, as identified in my general review of the literature. 
This includes both an account of relevant public activist groups and the resulting policy 
documents. Examining the background and development of PPI is important as it has a 
direct relationship to the current knowledge base and practice of PPI. 
1.3 Who is meant by ‘patient’ and ‘public’?  
There is considerable debate within the literature regarding the definition and labelling of 
patient and public involvement. For example, the labels ‘patient’, ‘consumer’, ‘service user’, 
‘lay’, ‘public’ and ‘client’ have all been applied to the individuals consulted and involved in 
health research (Bastian, 1994). Each label carries multiple, often overlapping, definitions 
within the literature. Depending on the chosen term and the chosen definition, the 
individuals included or excluded vary (see Table 1). 
Bastian (1994) proposed that this question about labels is: “not just an argument about 
words, but about ways of seeing and portraying people and their relationship with the 
health care system” (p.11) or, more specifically in the present context, with health research. 
2 
 
Coinciding with this statement, each of the labels has multiple definitions (see Table 1) and 
invokes a range of connotations and ideological positions (Bastian, 1994; Boote, Telford, & 
Cooper, 2002). For example, some people are apprehensive about using the term ‘patient’ 
as they feel it reflects someone in a traditionally passive position with an inferior status, 
with implications of dependency and unquestioning compliance, none of which are 
compatible with active involvement (Herxheimer & Goodare, 1999; Hibbert, Bissell, & 
Ward, 2002). The terms ‘user’, ‘consumer’ and ‘public’ are the most interchangeable as 
they tend to be the most inclusive (see Table 1). However it has been argued that ‘user’ 
invokes overtones of drug misuse (Herxheimer & Goodare, 1999; Hibbert, Bissell, & Ward, 
2002), and ‘consumer’ is heavily linked with the notion of a commercial relationship, 
implying that the medical system is a commodity to be bought, which does not sit easily 
within a publically funded health care system such as that in the UK (Bastian, 1994; Boote, 
Telford, & Cooper, 2002). 
In my studies and in writing this thesis, I have chosen to adopt the phrase ‘patient and 
public’, taking the most widely accepted and inclusive definition of the word ‘public’. This 
encompasses all individuals associated with the use of health care, including people who 
use health and social services, informal carers, parents/guardians, and organisations that 
represent people who use services (Staley, 2009). In conjunction with this, the word 
‘patient’ will be used to refer specifically to those who have experienced disease or illness 
first-hand (Caron-Flinterman, Broerse, & Bunders, 2005). Although the phrase ‘patient and 
public’ is not universally accepted, I chose this terminology for three main reasons. Firstly it 
is the most inclusive label, while still placing emphasis on the individual with ill-health. 
Secondly, it is the description used in current UK policy documents. Thirdly, it the most 
acceptable terminology to both clinicians and the public (Boote, Baird, & Beecroft, 2010; 
Dickens & Picchioni, 2011). It is important to note that the terms ‘patient’ and ‘public’ are 
being used to denote roles in a specific situation, not categories of people and it is usual for 
an individual to fulfil many roles (Herxheimer & Goodare, 1999). 
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Table 1: Labels and their definitions used in the PPI literature  
Author(s) Definition  
Public  
Staley (2009b, p.13) 
 
- Patients and potential patients 
- Informal carers 
- Parents/guardians 
- People who use health and social care services  
- Disabled people 
- Members of the public who are potential recipients of health promotion    
programmes, public health programmes and social service interventions  
- Groups asking for research because they believe they have been exposed 
to potentially harmful substances or products  
- Organisations that represent people who use services.  
 
Oliver et al. (2008, 
p.73) 
 
People whose primary interest in health-care is their own health or that of 
their family, as users of services or carers; and people representing these 
groups though community organizations, networks, or campaigning self-help 
groups.  
Consumer 
Andejeski et al. 
(2002, p.380) 
 
Breast cancer survivors with advocacy experience and the support of a 
constituency. 
 
Boote, Telford, & 
Cooper (2002, 
p.214)  
 
People who receive, or who have the potential to receive, health care... In this 
interpretation, consumers have been allocated to one of three groups: 
individuals, local groups and (inter)national consumer organisations.  
 
Oliver et al.(2001, 
p.19) 
 
The term consumer refers to people whose primary interest in health-care is 
their own health or that of their family, as past, current and potential 
patients, users of services or carers, and people representing any of these 
groups though community organizations, networks, or campaigning and self-
help groups. 
Patient 
Caron-Flinterman, 
Broerse, & Bunders 
(2005, p.2575) 
 
The term ’patients’ indicates everyone who has personally experienced 
diseases or illnesses.  
 
Williamson (1998, 
p.1374) 
 
Patients are people in clinical relationships with doctors or other healthcare 
professionals.  
 
Herxheimer & 
Goodare (1999, p.3) 
The people that come to health professionals with an illness or a symptom, 
for advice and treatment.  
Lay 
Ross et al. (2005, 
p.269) 
 
Lay’ because it was seen to encompass involvement through life experience, 
and be inclusive of service users, carers, patients, clients and citizens. 
 
Charles & DeMaio 
(1993, p.883) 
A common way of differentiating lay from non-lay individuals is to distinguish 
between providers and non-providers.  
Client 
 Herxheimer & 
Goodare (1999, p.4) 
A person using the services of a professional person. 
User 
Herxheimer & 
Goodare (1999, p.4) 
This is a neutral catch-all term for all those who use or have used any health 
service, public or private, and is easily extended to include potential users 
too- that’s everybody. 
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1.4 What is ‘involvement’? 
Involving patient and public representatives 1 in health research is seen as: “doing research 
with or by the public, rather than to, about, or for the public” (INVOLVE, 2012b,p.6). 
Regardless of the method of involvement a key component is that there is an active, 
genuine partnership between the researchers and the representatives (Boote, Barber, & 
Cooper, 2006; Caron-Flinterman, Broerse, & Bunders, 2005; Rhodes et al., 2002; 
Williamson, 2001). As PPI requires working with a diversity of perspectives in varying 
contexts for differing purposes, it has been argued that there cannot be a ‘one size fits all 
approach’ (Ross et al., 2005). PPI is often perceived as a continuum from no involvement 
through to research which representatives initiate, undertake and control themselves 
(Beresford, 2005). The number of component levels or categories within this continuum is 
variable dependent on the model.  
1.4.1 Models of involvement  
An early model of involvement was Arnstein’s (1969) Ladder of Citizen Participation. 
Arnstein developed the typology in the context of citizen involvement in urban renewal 
projects. Nevertheless, she stated that the underlying issues, and consequently the 
framework, could be applied to any situation where people who traditionally have little 
power or influence are trying to make others listen and respond to their views. The model 
equates the level of power the individuals have over determining the end product of any 
enterprise with their level of involvement. This is represented in the form of a ladder, with 
each of the eight rungs signifying the degree of influence and power the representatives 
have (see Error! Reference source not found.). The bottom two rungs, Manipulation and 
herapy, are considered by Arnstein to equate to non-participation, as at these levels 
professionals do not seek input from representatives, but rather want to teach, cure or 
bring the representatives to their world view under the guise of involvement. The next 
three levels, Informing, Consultation and Placation, encompass methods by which 
representatives have an opportunity to get their opinions across but have no control over 
whether or not they are subsequently addressed; and so are labelled within the model as 
Degrees of Tokenism. The final three rungs, Partnership, Delegation of Power and Citizens 
                                                          
1
 Hereon, when not specifically referring to one of these two groups, public and patient 
representative(s) will be referred to simply as ‘representative(s)’.  
5 
 
Control are the only levels where Arnstein believed that PPI representatives have a degree 
of Citizen Power and consequently at least some ability to decide the outcome. 
Figure 1: Arnstein’s (1969, p.217) ladder of citizen engagement  
 
Multiple models of PPI have been developed in health research based on Arnstein’s (1969) 
ladder of participation. The most quoted model of involvement is that by Boote, Telford 
and Cooper (2002) which they describe as ‘levels of consumer involvement’. Their 
conceptualisation identifies three categories: Consultation, Collaboration and Consumer 
control (see Error! Reference source not found.).  
Figure 2: Boote et al. (2002, p.224) levels of consumer involvement in health research  
 
Consultation includes types of involvement that allow the researcher to obtain 
representatives’ views. At this level what the representatives say can be influential, but 
they have no power to ensure the researcher acts on their views (Boote, Telford, & Cooper, 
2002). Consultation is largely focused around feedback, for example, asking representatives 
to review research protocols, participant information sheets and drafts of published papers. 
This form of involvement is valued as it can be implemented at all stages of the research 
process using a variety of methods and on a range of scales; for example, drawing on the 
views of a small group of representatives through a focus group or a large group through 
administration of a questionnaire (Williamson, 2001).  
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The Collaboration level is less stringently defined but is typified by an on-going partnership 
between researchers and representatives in the research process. In collaborative research, 
representatives have more ownership of the research and can, at least in theory, contribute 
more directly to the form and direction it takes, for example, by sitting on steering groups. 
Consumer controlled research is where the representatives hold the power and researchers 
are brought in as facilitators, with the representatives designing, implementing and 
disseminating the research. This three level model of involvement became popular as a 
conceptual framework in health research when it was adopted by INVOLVE, the national 
patient and public involvement association (Staley, 2009).  
In general, other current models of PPI are variations of the ‘levels of consumer 
involvement’ model. For example, Minogue et al. (2005) proposed that there are five 
categories of involvement: consultation; collaboration or partnership; user-commissioned; 
user-controlled or user-led; and user disseminated. Oliver et al.’s (2008) model subdivides 
the researcher’s degree of engagement in the process in conjunction with the 
representatives’ level of participation, resulting in an eight-dimensional framework. In 
contrast, Williamson (2001) argued that there are in fact only two types of involvement, 
Consultation and Partnership. Williamson drew on the same definition of consultation as 
Boote, Telford and Cooper (2002), then combined user control and collaboration under the 
label of partnership.  
A central theme running though all of these frameworks is Arnstein’s (1969) argument that 
power over outcome is equivalent to level of involvement. It is now starting to be 
acknowledged in the literature that using this hierarchical criterion of power to denote 
involvement is an over-simplification. In reality, power does not account for all the 
dimensions of involvement that might be important, for example, the value of the process 
of involvement itself or the outcomes of PPI (O'Donnell & Entwistle, 2004; Tritter & 
McCallum, 2006). Tritter (2009) criticises these models of involvement for: “assuming that 
power is finite and that ceding power to one or other parties diminishes the power of the 
other rather than considering that there are different kinds of power and knowledge and 
that partnership and collaboration can bring about a better outcome” (p.279). He goes on 
to argue that, in addition to issues around framing PPI as a struggle for power, most of the 
current models do not account for the diversity of people involved or the importance of 
process as well as outcomes. Building on this, his model of PPI (see Figure 3) conceptualises 
PPI based on three components: firstly, whether the representatives have an explicit role 
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(‘direct’ involvement) in the decision making process, or professionals gather 
representatives’ views and then make the decisions (‘indirect’ involvement); secondly, 
whether representatives are acting as sole agents (‘individual’ involvement) or as part of a 
group (‘collective’ involvement); and thirdly, whether representatives help to shape the 
‘agenda’ (are ‘proactive’) or work to a pre-existing agenda (are ‘reactive’).  
Figure 3: Tritter (2009) ‘A model of involvement’ 
 
While Tritter’s module of PPI is useful in exploring different components of PPI and 
expanding the conceptualisation of what involvement is, he does not explain how this 
model was developed - and I would argue that it is still implicit within his model that power 
over outcome is a key defining characteristic of involvement. 
Gibson, Britten and Lynch (2012) argue that the current models of PPI fail to take into 
account the cultural, political and social dynamics of involvement. They suggest that 
emphasis should be placed on how the interaction of different types of expertise can allow 
for new information to be discovered. How this interaction happens, they argue, is 
dependent on four dimensions which result in new ‘knowledge spaces’. They view the four 
dimensions as points on a continuum which may move over time and are interdependent 
(see Figure 4).    
Figure 4: Gibson et al. (2012) a Four dimensional view of knowledge spaces 
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Each of the four dimensions (monism/pluralism, instrumental/expressive, strong 
public/weak public, conservation/change) draws on different theoretical constructs that are 
used to describe and position that dimension. Thus, these authors suggest that current PPI 
methods lead to situations where professional forms of knowledge are more highly valued 
than the ‘experiential knowledge’ that representatives may possess, and that 
representatives may not have the cultural knowledge required to get their opinions across. 
In such a situation of ‘monism’ only the professionals’ view is taken into account; in 
contrast ‘pluralism’ allows for an equal mix of views to be recognised. The authors maintain 
that PPI can function either to achieve specific aims and goals (‘instrumental’) or be 
orientated towards understanding and interpreting representatives’ perceptions and 
experiences as a whole (‘expressive’). There are situations where representatives have the 
ability to influence decision-making (‘strong public’) and those where the issues may be 
discussed but they have little chance of influence (‘weak public’). Lastly, these first three 
dimensions operate in a situational context where there may be the need to maintain the 
current processes (‘conservation’) or the ability to implement systematic and deliberate 
change (‘change’).  
The framework is presented as a tool for reflection on current practice and as a means for 
developing new ways of thinking about involvement. It takes into account the tensions and 
contractions involved in PPI. It also allows for PPI to be viewed as on a continuum rather 
than as a series of dichotomies as proposed by Tritter’s (2009) model. It is in essence 
however, like the others, a heavily theoretically based model.  
From my literature review I perceive that the prevailing use of derivatives of Arnstein’s 
model of involvement and the continuing use of power as the primary criterion for defining 
levels of involvement has limited the ability of researchers to evaluate and make 
comparisons between the different methods of involvement as, by default, research which 
takes a consultative approach will be considered inferior to a collaborative or 
representative led project. The absence of comparative studies and agreed criteria by 
which to assess PPI means it is not possible to state whether one method of involvement is 
superior than another (Barber, Boote, & Cooper, 2007), preventing researchers and 
representatives alike from making informed decisions. Each method is logically associated 
with different potential advantages and disadvantages. For example, if representatives are 
involved in designing a study or act as members of funding panels their input might have a 
substantial influence on the choice of outcome measures or the research process as a 
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whole (Tritter & McCallum, 2006). However, projects that are led by representatives will be 
heavily reliant on those representatives having a certain level of interpersonal and 
professional skills, potentially reducing the number of people capable of being included, 
which, it could be argued, goes against the principles of PPI as a democratic and 
representative process (see Section 1.5). In comparison, consultative approaches can 
involve a broader range of individuals but are more reliant on professional researchers 
making best use of the information generated. It is important therefore that the method of 
involvement matches the needs and expectations of all involved (Barber, Boote, & Cooper, 
2007; Tritter & McCallum, 2006). 
1.5 Evolution of PPI in health research  
The justifications for PPI in health research fall under two main categories, the ‘political and 
moral’ and ‘pragmatic or consequentialist’ (O'Donnell & Entwistle, 2004; Telford, Beverley, 
Cooper, & Boote, 2002; Ward et al., 2009). As the drivers for PPI in the UK have their basis 
more in notions of policy and morality (Boote, Telford, & Cooper, 2002) this will be 
discussed first, followed by the more recent focus on the pragmatic justifications (see 
Section 1.6).  
There are three broad political and moral drivers of PPI. Whilst these drivers will be 
presented separately to allow each to be discussed in depth, they are intrinsically linked. 
The first is the underpinning moral and ethical position linked to the belief that involvement 
in health care and health care research is a citizen’s right within a democratic society 
(Howe, MacDonald, Barrett, & Little, 2006). The second to be discussed is the development 
of activist groups and how the social pressure they generated helped to establish the rights 
of the individual in relation to policy and practice. The third driver, political developments 
as reflected in policy documents, will be explored to demonstrate how policy has 
responded to, and in turn, enabled activist groups to develop PPI. 
1.5.1 Ethical and moral underpinnings  
The moral and ethical arguments for PPI in research flow from the belief that individuals 
whose lives and bodies may be affected by research should have a say into what and how 
research is undertaken (Bastian, 1998; Boote, Telford, & Cooper, 2002; Caron-Flinterman, 
Broerse, & Bunders, 2005; Staley, 2009b). In a democratic society, involvement in health 
research is considered a right of the public, especially in relation to publicly funded 
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research and a publicly funded health service wherein representatives can be seen as 
stakeholders (Dyer, 2004; Florin & Dixon, 2004; Ward et al., 2009). Bastian (1998) also 
suggests that the ethical validation of PPI addresses ideas of community responsibility, 
social justice and accountability.  
Harrison and Mort (1998) argue that at this moral level it is hard to disagree with the 
principle of involvement, suggesting that: “being in favour of better public consultation or 
more user involvement is rather like being against sin: at a rhetorical level, it is hard to find 
disagreement” (p.66). This was also highlighted by Arnstein (1969) who typified the concept 
by stating: “the idea of citizen participation is a little like eating spinach: no one is against it 
in principle because it is good for you” (p.216). Consequently, PPI is often considered, prima 
facie, good beyond question (Dyer, 2004; Florin & Dixon, 2004). These right-based 
arguments have been used to advocate for PPI in research (O'Donnell & Entwistle, 2004) 
and as such PPI may be seen as a goal in and of itself (Bastian, 1994). Despite the 
importance of this ethical stance, advocates of PPI are cautioned against stating the moral 
case as the sole justification of PPI in research, as this may not be enough to motivate 
mainstream researchers to involve representatives in their work (Beresford, 2005).  
It has been proposed that the moral and ethical stance of any culture both feeds into and is 
generated by its government’s policies (Shore & Wright, 1997). This seems particularly 
evident in the development of PPI. The following sections describe how public activism 
drove the development of health policies that, combined with the moral arguments, were 
among the main drivers for PPI in health research.  
1.5.2 Development of public activism 
“A social movement does not imply one great monolithic structure or a single 
interest group: it is made up of many parallel, and not necessarily concerted, actions 
in a community, and it should indeed ‘move’ and seek to create social change. Some 
of the key characteristics of a social movement are that there are some beliefs that 
are generalized throughout and that the movement remains politically alive, 
renewing itself and passing on its beliefs and heritage to new generations of 
activists.” (Bastian, 1998, p.14) 
Bastian’s (1998) multi-level and historically developing process of social change is reflected 
in the many different activist movements that have been regarded as the impetus for PPI. 
The lessons learnt by one group trying to change policy and society are cross-fertilised and 
used by other groups until the combined pressure from all the groups leads to overarching 
change. Most of the literature situates the advent of PPI in the social movements in the late 
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20th century. Each of these can trace their lineage back to the freedom movements at the 
turn of the 18th century when increased literacy and the political acknowledgment of the 
rights of the individual led to more cohesive and sustained activism, for example, the 
abolition of slavery and the independence movements of European colonies (Bastian, 
1998). The industrialisation of Western Europe in the late 18th early 19th century is also 
regarded as a key time point in the history of activism in general, as the consequent start of 
Trade Union activism for workers’ conditions of employment and health and safety in the 
work place demonstrated the efficiency of powerful and effective advocacy (Webster, 
1990).  
The feminist, civil rights, consumerist, acquired immune deficiency syndrome (AIDS) and 
disability movements of the late 1960s and early 1970s have all been credited as the origin 
of more recent advances in PPI (Bastian, 1998; Beresford, 2005; Fisher, 2002; Frankham, 
2009; Lupton, 1997). However, my review of the literature suggests that claims for their 
role in stimulating PPI are often vague and unclear. Many authors state that these 
movements were the catalysts for PPI, without supporting or justifying this claim. This is 
especially true with regard to the link between the feminist movement and PPI. Adopting 
Bastian’s (1998) view on the need for many overlapping social pressures to result in social 
change, I maintain the argument that the current focus on PPI results from a combination 
of the philosophies and activities of these movements.  
The feminist and civil rights movements are credited with shaping: “a generation’s 
consciousness of the role that gender, race, ethnicity and class play in constructing 
knowledge and legitimating ‘knowers’” (Brisolara, 1998, p.26). Feminists were the first 
group of researchers to focus on the importance of ‘unalienated knowledge’, placing the 
person and their subjective view of their own experience at the centre of the research 
process (Morris, 1992). This shift away from an ‘objective’, medical model to a more 
person-centred approach resulted in the development of new research paradigms and 
methods (Keith, 1992) and contributed to creating a society that was more amenable to the 
importance of different types of knowledge. In addition, the feminist movement in the 
1960s and the research it generated began to challenge medical professional values, and 
more critically, its professional claim to medical expertise (Coulter & Fitzpatrick, 2000).  
The principles of consumerism also started to penetrate the health care system in the 
1970s, providing an additional range of challenges to the dominant medical model (Coulter 
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& Fitzpatrick, 2000). Pickstone (2000) reported that consumerism was driven by the 
emphasis in the 1960s on choice of lifestyle, especially in relation to sexual behaviour and 
reproduction. Consumerism was actively encouraged in the 1970s by popular medical 
journalism, private health companies, pharmaceutical companies and leisure companies 
(Pickstone, 2000). The consumerist model of health is based on the principle that health 
care should be considered a commodity to be bought and sold (Lupton, 1997). Within this 
model, medical practitioners are seen as competitive providers of their medical expertise. If 
they are overpriced or provide an unsatisfactory service, the patient will chose an 
alternative provider. The theory was that if this model was applied to health care it would 
facilitate increased quality, consumer choice and optimal pricing (Lupton, 1997). 
Consumerism emphasises choice, responsibility and empowerment of the patient and 
promotes the view that the power between health care providers and patients should be 
more evenly distributed (Ward et al., 2009). At the centre of this model is the assumption 
that the modern patient has greater access to information, is more open to challenging 
clinician authority and is as capable of navigating a consumerist health system as they are in 
other aspects of their lives (Goode et al., 2004; Harrison & Moran, 2000). It has been 
suggested that the consumerist movement also allowed some patient groups to evolve into 
consumer groups who could actively lobby for services and research that they deemed 
important (Pickstone, 2000). 
It is highlighted in the literature that there is an underlining conflict between a consumerist 
health model and a publicly funded health service, such as the one in the UK (Newman & 
Vidler, 2006). Given that in this situation no one can ever be a ‘real’ consumer since they 
are not paying directly for the service, they may be an unwilling consumer, or medically 
incapable of making a competent decision. Even putting these factors aside, patients may 
have no choice over their healthcare provider due to an absence of ‘real’ competition for 
most services (Calnan & Gabe, 2001; Harrison & Moran, 2000; Newman & Vidler, 2006). 
The question of whether or not patients and practitioners really expect or want the medical 
system to function in a similar fashion to a commercial business or whether it has its own 
separate place in British society has also been repeatedly raised (Harrison & Moran, 2000; 
Newman & Vidler, 2006; Rhodes & Nocon, 1998).  
The development of consumerism within health care provision has been mirrored by a 
similar, if slightly delayed rise in the idea of consumerism in health research (Henderson & 
Peterson, 2002; Hill, 2007) leading to the emergence of the 'research consumer' (Ward et 
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al., 2009). As with health care, consumerism in research has turned research into a 
competitive commodity that has to be responsive to consumer needs. However, the 
underpinning notions of choice within the consumerism model beg similar questions in 
relation to research as in relation to those raised in health care (Ward et al., 2009). 
Whilst the consumerist model of health care provision and health research has not gained 
full acceptance in the UK, in order to respond to societal demands, improve services and 
increase patient satisfaction, the health profession has had to reconceptualise what it 
means to be a patient and renegotiate issues of power (Coulter & Fitzpatrick, 2000; 
Harrison & Moran, 2000; Newman & Vidler, 2006). Consequently consumerism maybe 
considered one of the main influences on health and health research policy (Crinson, 1998). 
In the 1970s AIDS activists developed creative, flamboyant campaign techniques instead of 
following the established rules of lobbying (Sepkowitz, 2001; Williamson, 2001). These 
methods ranged from wearing red ribbons, drug buyers’ clubs and telephone ‘zaps’ (the 
jamming of switchboards) through to aggressive civil disobedience. These activists raised 
questions as to whether AIDS funding was being apportioned appropriately; consequently 
the USA’s Institute of Medicine recommended broader public input into decisions about the 
allotment of research funds (Sepkowitz, 2001). In addition, perceived government inactivity 
and delay with regards to prevention or treatments resulted in AIDS groups self-funding 
research designed to impact on policy, treatment and testing of new drugs via clinical trials. 
Subsequently gay men had unprecedented oversight and input into AIDS research, leading 
AIDS campaigners to be viewed as one of the original, successful models of PPI in health 
research (Bastian, 1994; Berridge, 2000). This success subsequently influenced the 
approach of many other patient groups including those for patients with breast cancer, 
Parkinson’s disease and Alzheimer’s disease (Andejeski et al., 2002; Berridge, 2000; 
Sepkowitz, 2001).  
While the late 1960s and early 1970s saw the politicisation of disability activists (Barnes, 
2003), a key turning point for PPI was the redefinition of disability in 1976 by the UK Union 
of the Physically Impaired Against Segregation (UPIAS). This group made a significant 
distinction between physical impairment and the ‘disability’ caused by social context, 
stipulating that physical impairment was the medically defined condition that an individual 
has, and that: “disability is something imposed on top of our impairments by the way we are 
unnecessarily isolated and excluded from full participation in society” (UPIAS, 1975, p.14). 
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This social-political interpretation is described as the ‘social model of disability’ and 
resulted in the growth of emancipatory and participatory research, with its followers 
emphasising the importance of sharing control of the research process with the people who 
are the most influenced by it (Frankham, 2009).  
The underlying principles of the social model of disability and emancipatory research 
methods connect many subordinate or minority groups who can argue that their 
positioning in society is not just a consequence of their sexuality, ethnicity, mental health or 
medical condition, but rather of how others are conditioned to respond to them and how 
social policy impacts on them (Frankham, 2009; Lewis, 2004). This argument has shifted the 
focus of attention away from individual deficits and onto social structures and how these 
need to be adapted to enable the proper participation of disabled people in society (Oliver, 
1992). In addition, the increased emphasis on valuing experiential knowledge, combined 
with the improved lobbying techniques developed by AIDS campaigners at a time when the 
medical profession was reassessing the role of the patient as a consumer, resulted in the 
acknowledgment of the importance of a patient and public focused health service and the 
need to have PPI in health research (Beresford, 2005; Fisher, 2002; Frankham, 2009). In 
recent years, social activist pressures have become more unified with the development of 
groups such as INVOLVE. INVOLVE is a national advisory group members of which describe 
themselves as: “specialists in public participation; bringing institutions, communities and 
citizens together to discuss, decide and reshape the things that matter to them. INVOLVE 
makes a practical difference to democracy by delivering, researching and promoting high 
quality public participation processes” (INVOLVE, 2012a). This arguably allows for a more 
cohesive and sustained pressure on issues related to PPI than is achieved from the 
disparate efforts of individual activist groups.  
The PPI agenda was given considerable momentum as a result of evidence of serious 
clinical and service failings in the NHS, highlighted by a number of high-profile inquiries, 
including those relating to: Bristol Royal Infirmary, Dr Shipman, Maidstone and Tunbridge 
Wells Hospital, Alder Hey Children’s Hospital and the Mid Staffordshire NHS Foundation 
Trust (Ocloo & Fulop, 2011). Some of these inquiries involved specific individuals - such as 
the Shipman inquiry, which investigated the activities of the general practitioner, Dr Harold 
Shipman, who it is believed to have murdered at least 215 of his patients between 1974 
and 1998 (Baker, 2004). Others, such as the Alder Hey inquiry, explored NHS institutional 
practises around the unauthorised removal, retention, and disposal of human tissue. These 
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inquiries were frequently fought for by patients harmed by patient safety incidents and 
their families; and the conclusion from them was that active PPI is vital to ensure similar 
failings do not happen again (Ocloo & Fulop, 2011). For example, the Bristol inquiry into the 
high mortality rate of babies undergoing heart surgery at the Bristol Royal Infirmary urged 
doctors to include patients as active participants in their own care to help ensure patient 
safety, reduce complaints and litigation, encouraging patient self-reliance, quality 
improvements and ‘accountability‘ (Coulter & Dunn, 2002). The Mid-Staffordshire review 
into substandard care and staff failings at two hospitals in Mid-Staffordshire between 
January 2005 and March 2009, identified six key recommendations for improving services 
focused on PPI, emphasising the importance of responsive ‘real time’ data collection 
surrounding complaint procedures. The argument was made that patient experience 
information can demonstrate that even when an organisation is performing well overall, 
more detailed feedback about patients’ experiences may demonstrate that some wards, 
departments or services are underperforming (Thome, 2009). Smith (1998b) highlighted 
how these very public ‘dramas’ held the attention of both members of the public and 
medical staff in a way that policy documents did not, affecting the trust between patients 
and doctors and acting as a catalyst for the development of PPI in the UK health system. 
In response to the varied and sustained social pressure for inclusion, the British 
government started to incorporate PPI into its policies. The following section describes how 
these policies have changed and developed over the last 30 years, but are still considered 
to be lacking in detail and not fully justified.  
1.5.3 Development of UK policy on PPI 
The Griffiths Report (DH, 1983) is credited with being the first UK health policy document to 
address PPI, albeit in a rudimentary form (Boote, Telford, & Cooper, 2002). This report 
resulted in general managers being appointed at each level of the NHS. Part of their role 
was to assess patient/consumer satisfaction with services and be responsive to the 
feedback they received (Calnan & Gabe, 2001). Before this there had been little or no 
emphasis on patients’ perspectives or levels of satisfaction. Instead, the NHS was run by 
teams of practitioners with doctors and nurses sharing managerial responsibilities 
(Kelleher, Gabe, & Williams, 1994). The perception of the public as consumers was 
solidified by the 1989 White Paper ‘Working for Patients’ which resulted in the introduction 
of an ‘internal market’ within the NHS (DH, 1989; Flynn, 1991). This separated service 
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providers from Commissioners and is recognised as attempting to introduce a degree of 
customer choice (Rhodes & Nocon, 1998). Patient satisfaction surveys were seen as 
legitimising managers’ claims that they understood the needs of the patients. However, the 
content of the surveys was often considered superficial (Calnan & Gabe, 2001). 
The consumerism paradigm was still evident as a underlying force in the early 1990s, as 
reflected in the ‘Patient’s Charter’ (DH, 1991) and ‘Local Voices’ (DH, 1992) policy 
documents. The Patient’s Charter was intended to make the health service more responsive 
to the needs of its consumers by informing them of their rights and the level of service they 
could expect (Florin & Dixon, 2004; Rhodes & Nocon, 1998). The types of rights identified in 
the document included admission to hospital within two years of being put on a waiting list, 
detailed information about local health services and the right for all complaints be followed 
up and dealt with appropriately (Calnan & Gabe, 2001). The Local Voices document 
encouraged managers to consult with their local populations when making purchasing 
decisions (Calnan & Gabe, 2001; Rhodes & Nocon, 1998) and was perceived to give official 
government support for involving the public in NHS processes (Harrison & Mort, 1998). 
Rhodes and Nocon (1998) highlighted that these two documents are often confused with 
each other, but the key difference is that the Patient’s Charter was about rights for people 
at the point of interaction with the NHS, whereas Local Voices addressed PPI in a much 
wider context. A consistent criticism of the policies set out in both documents was that they 
did not have to be enforced and there was no statutory obligation to pursue them, so they 
were often not implemented. They were also perceived as mechanisms by which to 
monitor levels of service rather than as means of addressing patient priorities (Calnan & 
Gabe, 2001; Rhodes & Nocon, 1998). In addition, the Patient’s Charter targets were 
considered to be ambiguous and ineffective, and resulted in more power being given to 
managers rather than to patients (Boote, Telford, & Cooper, 2002; Calnan & Gabe, 2001).  
Newman and Vidler (2006) argued that when New Labour came into power in 1997 and 
issued the White Paper ‘The New NHS: Modern, Dependable’ (DH, 1997) there was a return 
to a more paternalistic approach in health policy. It has been suggested (Boote, Telford, & 
Cooper, 2002; Rhodes & Nocon, 1998) that this was a calculated strategy to reassure health 
professionals at a time of great job uncertainty brought about by the ‘internal market’, and 
to address more pressing concerns for public accountability. While the White Paper 
referred to the value of PPI, it did not discuss how and why it should be addressed. The 
importance of PPI was re-emphasised later with the document ‘A first Class service: Quality 
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in the new NHS’ (DH, 2000) which highlighted the need to engage the public in an active 
relationship with professionals in all areas of the NHS. The emphasis was now on 
partnership and cooperation as opposed to consumerism in relation to PPI (Calnan & Gabe, 
2001). 
In terms of health research policy more specifically, PPI in research was first acknowledged 
as important in 1991 with the launch of the NHS Research and Development strategy 
(Boote, Telford, & Cooper, 2002), an agenda that become increasingly important. 
Thompson (2010) identified three key policy documents that specifically referred to and 
proposed development of public involvement in research: ‘Patient and Public Involvement 
in the NHS’ (DH, 1999), ‘The Research Governance Framework for Health and Social Care’ 
(DH, 2005) and ‘Best Research for Best Health’ (DH, 2006). The 'Patient and Public 
Involvement in the NHS’ (DH, 1999), document stated that:  
“Research and development (R&D) in the NHS needs to focus on what is important 
for patients and users. To achieve this patients and service users need to be involved 
at all stages of the R&D process [my emphasis].” (DH, 1999,p.20)  
While this was a substantial policy development for the promotion of PPI, the rationale 
informing this directive was unclear, as were ways in which the public might be involved in 
the research and development process (Thompson, 2010). Subsequently this was expanded 
upon in ‘The Research Governance Framework for Health and Social Care’ (DH,2005) and 
‘Best Research for Best Health’ (DH, 2006), the latter of which specified that:  
“… patients and the public must be involved in all stages [my emphasis] of the 
research process: Priority setting, Defining research outcomes, Selecting research 
methodology, Patient recruitment, Interpretation of findings, Dissemination of 
results.” (DH, 2006, p.34)  
The ‘Best Research for Best Health’ report (DH, 2006) also provided a brief rationale for 
public involvement in research, stating that it increased the applicability, relevance and 
reliability of research. However, the report gave no evidence to support these claims and 
like ‘The Research Governance Framework for Health and Social Care’ (DH,2005) has been 
criticised for not providing a specific definition of PPI (Fudge, Wolfe, & McKevitt, 2008; 
Thompson, 2010). The reports also heavily focused on PPI as a quality issue, failing to 
address the multiple motivations for PPI (Fudge, Wolfe, & McKevitt, 2008). Despite these 
limitations, it is now government policy that researchers involve representatives in all 
stages of the research process. This commitment to PPI in research is reflected in the range 
of government funding bodies that now require researchers to specify how they are going 
to involve representatives in their proposed research, without which information, research 
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funding maybe be declined (Boote, Telford, & Cooper, 2002). Thus, it is now politically and 
financially wise for researchers to engage in PPI, irrespective of the moral or practical 
motivations (Telford, Beverley, Cooper, & Boote, 2002; Ward et al., 2009). 
1.6 Part two: focused literature review of PPI impacts 
While the impetus for PPI stems from the political and moral drivers discussed, it is now 
acknowledged that there is a necessity for a meaningful evidence base around the 
consequentialist aspects of PPI (Beresford, 2005; Boote, Telford, & Cooper, 2002). This 
evidence is needed to allow for a critical assessment of the costs and benefits of PPI to the 
research process, to facilitate best practice and to motivate researchers who are more 
resistant to implementing PPI (O'Donnell & Entwistle, 2004). In order to establish what 
empirical evidence is available regarding the impacts, costs and benefits of PPI on the 
research process and those involved, I conducted a second more focused review of the 
literature. Before outlining the findings of this review, I will briefly describe how it was 
conducted.  
As explained in 1.5.2 INVOLVE is a government funded organisation: “to support active 
public involvement in NHS, public health and social care research”(INVOLVE, 2012a). In 2010 
INVOLVE had established an online library of 175 references, articles and reports that look 
at the impact, nature and extent of public involvement in research (INVOLVE, 2010). This 
detailed library was the starting point for my focused literature review. I combined the 
INVOLVE references with database searches, reference and author tracking, and using all 
possible labels of PPI, I generated a master list of 229 references. As a substantial amount 
of information on PPI is published in reputable grey literature (Rummery, 2009; Telford & 
Faulkner, 2004), these references did not just include peer reviewed articles. Although my 
review was not a systematic review in the ‘pure’ sense, it was structured and extensive. 
Once this master list had been generated I developed a strategy for determining the 
relevance of the references, to establish which should be included in my review. The forty 
most cited references were selected (taking into account their year of publication), to 
ensure that the most influential references were addressed. I also included 19 literature 
reviews as their findings represented a much larger evidence base. References that were 
based on primary evidence sources, focused on health research networks or the 
experiences of those involved were deemed particularly relevant and were also 
included. Consequently 63 articles were selected to be explored and summarised, to 
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examine the current evidence of the impact of PPI in health research. Using Nelson et al’s 
(2011) approach as a guide, I paid particular attention to the focus of each paper, the main 
findings, strengths and limitations (see Appendix 1). I updated the literature review in 
November 2012 with the aid of INVOLVE’S updated bibliography (INVOLVE, 2012c) and 
additional literature searching. This resulted in a final master list of 266 references with 74 
references included in the review (see Appendix 1).  
Despite the extensive literature discussing PPI, I found there to be extremely limited 
empirical evidence to support claims of its impacts. The majority of the papers were 
theoretical or based on anecdotal evidence. This same observation was repeatedly 
reported in the PPI review articles (Boote, Telford, & Cooper, 2002; Minogue et al., 2005; 
O'Donnell & Entwistle, 2004; Oliver et al., 2008; Staley, 2009b). Overall however, the same 
claims of PPI impacts are consistently reported within the literature (Staley, 2009) and can 
be placed into three discrete categories: impact on the research process, impact on the 
professionals and impact on the representatives. Each of these will be discussed in turn in 
this section. When discussing the potential effects of PPI it is necessary to be mindful that 
some aspects of implementing PPI maybe context and condition specific, for example, 
issues surrounding involving someone in a wheel chair may differ to those of involving 
someone who has had a stroke.  
1.6.1 Effects on the research process  
Trying to unpick the limited evidence about how PPI can influence the research process is 
difficult as many of the arguments are overlapping and vague. Improved relevance, 
credibility and acceptability appear to be the most commonly listed benefits (Caron-
Flinterman, Broerse, & Bunders, 2007; Elberse, Caron-Flinterman, & Broerse, 2011; Fisher, 
2002; O'Donnell & Entwistle, 2004; Popay & Williams, 1996; Rhodes et al., 2002; Wright et 
al., 2007; Staley, 2009a). The experiential knowledge that representatives contribute gives 
credence to their ability to make judgment calls on how relevant the purpose and 
outcomes of a research project are to the targeted population. This is believed to increase 
the project’s usability to both its participants and the wider research community. This 
perceived usability in turn gives the research increased credibility and acceptability, making 
it more likely to influence practice and improve healthcare (Oliver et al., 2008). While this 
intuitively makes sense, there is limited evidence to support these claims. It can be argued 
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that at this conceptual level just the perceived presence or endorsement from patients and 
the public might have a similar result to actual involvement. 
There are more tangible ways in which PPI may positively impact on the quality of research 
design and, in turn, its relevance. It has been suggested that PPI can improve the clarity of 
participant information, removing jargon and making it more salient to potential 
participants (Boote, Baird, & Beecroft, 2010; Hanley et al., 2001; Minogue et al., 2005). 
Representatives’ knowledge can improve outcome measures in terms of quality, usability 
and applicability (Boote, Baird, & Beecroft, 2010; Faulkner & Thomas, 2002; Fisher, 2002; 
Rhodes et al., 2002; Staley, 2009b). PPI can facilitate more representative sampling as it can 
facilitate access to ‘hard to reach’ populations though PPI networks (Coupland & Maher, 
2005). An additional benefit is the potential to increase recruitment; this is particularly 
significant for clinical trials that, historically have cited failure to recruit as a primary reason 
for non-completion (Iliffe, McGrath, & Mitchell, 2011; McDonald et al., 2006; Watson & 
Torgerson, 2006; Wyatt et al., 2008). However, evidence of increased recruitment is largely 
anecdotal as it is difficult to measure. It has also been suggested that PPI can expedite 
ethical approval and data collection, shortening the time frame of the research (Coupland & 
Maher, 2005; Elliott, Watson, & Harries, 2002; Wight et al., 2006). Lastly, PPI is claimed to 
broaden opportunities for dissemination, increasing the impact of the research (Wight et 
al., 2006; Wyatt et al., 2008; Staley, 2009a). Therefore PPI is regarded as having a potential 
to benefit all stages of the research process. However, some researchers have expressed 
concerns that PPI will negatively impact the relevance of research as they feel 
representatives may not have a holistic perspective and, being partisan, may not be able to 
judge the importance of a project (Caron-Flinterman, 2005; O'Donnell & Entwistle, 2004).  
Reporting of negative impacts of PPI on the research processes are limited and are mostly 
described as barriers or challenges to implementing PPI rather than negative impacts on 
research (Simpson & House, 2002). I submit that this gap in the literature is due to a 
combination of a general lack of evaluation of PPI and the political environment in which 
this type of research takes place. Added cost, time and complexity of PPI are the main 
barriers to its implementation reported in the literature (Boote, Baird, & Sutton, 2011; 
Trivedi & Wykes, 2002). Room hire, training, additional administration, time and travel 
reimbursement are all potential costs of PPI that are often not taken into account during 
resource allocation (Mitton et al., 2009). This is compounded by the fact that researchers 
are encouraged to implement PPI at the application stage which means funding for PPI, at 
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least in the early stages of a project, is likely to be limited. Administration, recruitment, 
training and support of representatives all require time and resources commitments that 
are not part of the traditional research process. Also representatives might have difficulties 
working within the traditionally tight academic and funding body timeframes and structures 
as a result of other commitments or their health condition (Elliott, Watson, & Harries, 2002; 
Mitton et al., 2009; Rhodes et al., 2002; Wright et al., 2007). Time and cost constraints, 
combined with the additional complexity of working with another stakeholder group, could 
act as deterrents for researchers considering involving patients and the public. They are not 
however, implicitly detrimental to research design and outcomes.  
1.6.2 Effects on representatives  
Only a handful of the papers reviewed provided empirical evidence on the effect of being 
involved in research on the representatives. The majority of impacts are focused around a 
positive change in representatives’ self-perception (Newell & South, 2009). Representatives 
report increased confidence in their own capabilities and influence, feeling valued, 
improved self-esteem and an overall sense of well-being as outcomes of their roles 
(Minogue et al., 2005; Newell & South, 2009). They also value gaining knowledge of their 
condition and the research process, alongside new skills and experiences (Minogue et al., 
2005; Newell & South, 2009; O'Donnell & Entwistle, 2004; Rhodes et al., 2002). 
Additionally, the opportunity to interact with other people with a similar condition not only 
provides them with a chance to exchange information but also to establish new forms of 
peer support (Minogue et al., 2005; Rhodes et al., 2002). Analogous with other research in 
this area, research on the effect of PPI on representatives was focused on the positive 
aspects of involvement rather than the challenges. Rummery (2009), however, suggests 
that some representatives found increased information on their condition elevated their 
anxiety levels and Newell and South (2009) highlighted that some representatives had 
concerns about the perceived level of responsibility PPI brought. It is evident from this that 
there is a need for further research to understand the experience of PPI on representatives.  
1.6.3 Effects on professionals  
While there is limited evidence about the effects of PPI on the research process and the 
representatives there is even less on the effect on the professionals2 (Staley, 2009b). This is 
                                                          
2
 I use the term ‘professional’ to encompass anyone who is involved in the research process not as a 
patient or public representative. 
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surprising as it is professionals who implement and facilitate PPI and without their support, 
PPI is unlikely to occur.  
Some professionals have been found to appreciate the PPI process as an opportunity to 
interact with representatives outside of their normal clinical roles. This different form of 
interaction has been found to help researchers learn about the culture of their participants 
(Elberse, Caron-Flinterman, & Broerse, 2011), increase their social awareness of local 
communities (Newell & South, 2009), connect to the ‘real world’ (Lindenmeyer et al., 2007), 
develop conflict resolution systems and skills, and result in a more positive attitude towards 
their patients (Coupland & Maher, 2005).  
Coupland and Maher (2005) recognise both the benefits and challenges to professionals of 
the ‘blurring’ of clinician-patient, researcher-participant roles that PPI can bring. This 
blurring provides new opportunities for learning and developing systems, but can be 
disconcerting for the individuals involved. Some professionals feel that by placing increasing 
emphasis on representatives’ knowledge that there is a shift in research ownership away 
from the professional (Faulkner & Thomas, 2002). Professionals have identified concerns 
about ‘who’ they should involve, the abilities of the representatives and how to involve 
them. The ‘who’ questions are not just focused on labels and breadth of experience (see 
Section 1.3) but how to ensure that representatives are ‘representative’ of the target group 
(Entwistle, Sowden, & Watt, 1998; Entwistle et al., 1998; Rhodes et al., 2002). Caron-
Flinteman (2005) identified eight key concerns that researchers may have about involving 
representatives: 
“Lack essential knowledge about research issues and procedures; do not speak nor 
understand scientific language, are unable to put their own questions and demands 
into a scientific context; have unrealistic expectations of scientific research; are 
strongly influenced by the media; are unable to abstract from their own individual 
situation; have difficulty to think in long-term targets; and/or are only interested in 
subjects concerning care or social issues.” (p. 254) 
Paradoxically, representatives about whom professionals do not have such concerns may 
be considered atypical of the general population and therefore not truly ‘representative’ 
(Lindenmeyer et al., 2007).  
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1.7 Summary 
My review of the literature suggests that PPI in health research was originally driven by 
activist groups and government policies. Combined with the strong moral and ethical 
arguments and guidelines from funding bodies, PPI is becoming mandatory in health 
research. However, there is currently little in-depth empirical evidence on the impact of PPI 
and the evidence that is available appears to be limited as it often overlooks negative or 
challenging aspects of PPI.  
I conclude there is a need for comparative studies across different approaches to PPI 
involvement to help researchers make informed decisions and to provide insights into the 
effects of PPI on research. There is also a need to better understand the experiences of the 
people involved in PPI, both professionals and representatives. This would allow potential 
challenges to be addressed from the outset, improving the PPI experience and 
consequently the likelihood of PPI being successfully implemented. Also, PPI might be more 
appropriately facilitated if the different groups had the opportunity to understand their 
counterparts’ perspectives so that they gain an insight into each other’s mindsets and the 
constraints they each operate under. My research aimed to address some of these issues by 
developing a detailed understanding of PPI involvement within the context of health 
research, with a focus on a specific condition, epilepsy. Chapter 2, Methodological 
considerations, more explicitly states my research aims and objectives, describing and 
justify the process I undertook to achieve them.  
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Chapter 2. Methodological considerations 
2.1 Introduction   
Through exploring the literature as discussed in Chapter 1 I reached the conclusion that a 
more in-depth understanding of the PPI process was needed. The purpose of this chapter is 
to describe the multi-sited ethnographic approach that I adopted to achieve this. To 
provide a framework for the project, I focused on a specific health condition, epilepsy, and 
a particular research context, the recently established ‘UK Epilepsy Research Network’ 
(UKERN) and two trials hosted by it.  
In this chapter I first describe the research aims and epistemological stance that underpins 
this research. Building from this I explain my decision to use a multi-sited ethnographic 
approach, focusing on the specific methods used, including details of site selection, data 
collection and how ethical considerations were addressed. Within this I also provide some 
pertinent information about epilepsy research to place my findings in context. Lastly I 
discuss how the principles of PPI were incorporated into this research, to ensure that it was 
directly informed and guided by the views of representatives.  
2.2 Research aims and objectives 
The principal aim of this thesis is: To generate a detailed understanding of patient and 
public involvement in health research. To accomplish this broad aim I chose to focus on a 
specific health condition, epilepsy, and the research structures underlying health research 
in the UK, namely research networks. In order to achieve this, I identified four specific 
objectives: 
1. To describe how PPI was implemented within the specific context of the UK 
Epilepsy Research Network (UKERN) and research linked to this network. 
2. To compare and contrast the theoretical underpinnings of PPI with its practical 
application in this context. 
3. To describe the experiences of the representatives and professionals involved in 
the PPI process, including their perceptions of the benefits and challenges of PPI. 
4. To compare different approaches of implementing PPI, by contrasting the 
experiences of the professionals and representatives across the different research 
sites.  
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2.3 Theoretical orientations 
It is accepted in qualitative research that an investigator’s theoretical beliefs about the 
nature of reality shape how they see the world, linking the researcher to a bundle of 
assumptions and practices that they utilise when choosing and implementing methods of 
inquiry (Crotty, 1998; Denzin & Lincoln, 2011). To fully explain my choice of methods I am 
first going to describe my views on the nature of ‘knowledge’ and my relationship to it.  
Through my Undergraduate and Master’s degrees I had a developed a basic understanding 
of different theoretical orientations. In order to gain both a more nuanced and broader 
understanding of different qualitative methodological approaches and methods, in the first 
six months of my PhD I completed the University of Liverpool’s module ‘Epistemological 
and Methodological approaches to Qualitative Research in Medicine’. This postgraduate 
module explored ontology, epistemology, methods and methodical approaches in the 
context of the Social Sciences. It explored the strengths and limitations of different 
theoretical orientations and placed them in their historical context. Starting with ‘historical 
perspectives on science, rationality and method: the empiricist perspective’ the course 
detailed the development of qualitative research, exploring topics such as: Positivism, 
Phenomenology, Ethnomethodology, Symbolic Interactionism, Social Constructionism and 
the implications of Postmodernism. Independently I explored additional theoretical 
orientations such as Critical Realism (Bygstad & Munkvold, 2011) and Pragmatism 
(Cameron, 2011). Table 2 summarises the key elements in each of these orientations. As 
these orientations all take a postmodernist view I did not perceive them all as discrete 
positions. Rather I viewed them as overlapping; it is where they place emphasis and focus 
that distinguishes them from each other. Given this overlap, my selection of chosen 
orientation was made at a more intuitive level, in terms of which seemed to me to suit my 
purpose; rather than through a structured process of weighing the advantages and 
disadvantages of each in this context. I concluded that Social Constructionism and 
Phenomenology offered theoretical orientations which best aligned with my research into 
the process, experience and context of PPI (see Section 2.2). 
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Table 2: Summary of potential theoretical orientations 
Theoretical Orientation  Summary  
Phenomenology Concerned with understanding and describing how things are 
subjectively experienced and interpreted by those involved 
(Denscome, 2007).   
Ethnomethodology Focuses on how members ‘do’ social life, aiming to document 
how they construct and sustain social objects (Denzin & Lincoln, 
2011). 
Symbolic Interactionism Biased on three premises (Flick, 2009a):  
I. how we act towards ‘things’  depend on the meaning 
we ascribe them 
II. meanings are derived from social interactions between 
people  
III. these meanings are adjusted though an interpretive 
process  
Social constructionism  Stipulates that knowledge is not found or discovered but made. 
We develop concepts, models and schemas to make sense of 
experience, continually testing these constructions in the light of 
new information and experiences (Denzin & Lincoln, 2011).  
Critical Realism Underlined by the beliefs that (Bygstad & Munkvold, 2011): 
I. the ‘real world’ exists independent of our knowledge of 
it.  
II. we then interpret this reality 
III. some interpretations reflect reality better than others; 
there are logical ways to assess the validity of the 
interpretation  
Pragmatism Importance is placed on the ‘practical’ rather than the ‘abstract’.  
The value of any theory can only by judged by how well it can be 
applied in relation to practical needs and how well it functions in 
practice (Denscome, 2007).   
 
From a Social Constructionist perspective, knowledge is based against a backdrop of shared 
understandings, practices, experiences and language (Schwandt, 2000). Social reality is seen 
as inter-subjective, constructed between people through shared language, history and 
culture (Berger & Luckmann, 1991); therefore what exists or represents ‘reality’ is what we 
perceive to exist (Burr, 2001; Green & Thorogood, 2004). Explanations offered by social 
constructionism are often framed in terms of the dynamics of social interaction, with 
emphasis placed on process and context rather than structures (Burr, 2001). As PPI is 
context specific, and my research aimed to focus on the ‘processes’ of PPI, social 
constructionism seemed, initially to fit my purpose. However, one of the key assumptions 
within social constructionist approaches is that knowledge cannot be separated from socio-
linguistic practices. Consequently language and how it is used to construct reality is a key 
component within social constructionist research (Burr, 2001; Gergen, 1996; Nightingale & 
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Cromby, 1999). My research was not aimed specifically at focusing on how language is used 
to construct the ‘reality’ of the PPI process, but rather at exploring participants’ experiences 
and perceptions of their ‘subjective’ PPI experience. On reflection I considered this to be 
best encapsulated within a more phenomenological perspective.  
Hermeneutic Phenomenology is part of the broader theoretical stance known as 
‘Interpretivism’. Interpretivism comes from the philosophical belief that what distinguishes 
social actions from the biological, physical and chemical ones is that social actions are 
inherently meaningful (Crotty, 1998). It therefore follows that in order for a person to be 
able to understand the meaning of a social action, they must first be able to place the 
action in the context of the system of meaning in which it occurs (Schwandt, 2000). 
‘Phenomenology’ and ‘Hermeneutics’ are broad theoretical perspectives within 
Interpretivism. While they share the core principle of ‘meaningfulness’, how this meaning 
or knowledge is seen to be generated varies between the two (Crotty, 1998; Schwandt, 
2000).  
Phenomenology is the study of the world as it is experienced before it is categorised or 
reflected on (Van Manen, 1997). From a phenomenological perspective the world or ‘life-
world’ is not the same as the physical ‘world’. It is the set of relationships, practices, rules 
and language with commonly understood and shared meanings that people acquire as a 
result of being part of a particular culture (Leonard, 1994). Phenomenologists argue that we 
depend on these shared meanings in order to function, but for the majority of the time the 
‘world’ is so all-consuming that we are oblivious to its components, and they only appear to 
us in a conscious way when they are disrupted or analysed (Leonard, 1994). 
Phenomenologists further argue that if people can put aside or bracket their own learnt 
understanding of a phenomenon and actively look at it, original or enhanced 
understandings of the meaning of everyday experiences will emerge (Husserl, 1970; Smith, 
1998a). Phenomenology focuses on the very nature or ‘essence’ of an experience and aims 
to establish what differentiates and defines that experience as unique from others (Crotty, 
1998; Laverty, 2008). It does this by systematically revealing and describing the internal 
meaning structures of ‘lived’ experience (Schwandt, 2000).  
The hermeneutic perspective, also referred to as ‘hermeneutic phenomenology’, overlaps 
with the phenomenological approach in that it too looks at life-worlds and how meaning is 
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interpreted and constructed between individuals in the context of a shared culture. While 
hermeneutics is also interested in the ‘essence’ of a phenomenon, it places additional 
emphases on the importance of cultural ‘texts’, bringing in for consideration elements such 
as written communication, arts and music, in addition to verbal communication, to aid 
interpretation of meaning (Laverty, 2008). The fundamental difference between 
hermeneutic and phenomenological perspectives is that hermeneutics stipulates that it is 
not possible for a person to put aside their own understandings when looking at an 
experience; to describe something is to interpret it through a set of established biases 
(Schwandt, 2000). Researchers therefore need to be aware of their own preconceptions 
and cultural norms in order to account for these interpretive influences (Laverty, 2008).  
From the hermeneutic perspective objectivity in relation to the meaning of a lived 
experience does not come from a decontextualized neutral position. Instead, skills, 
practices and meanings are objective in the sense of being shared and therefore verifiable, 
both within the researcher’s own world and that of the research participants (Leonard, 
1994). To achieve this level of ‘objective’ meaning, researchers use a process called the 
hermeneutic circle which moves between interpretations of the parts of a phenomenon 
under study and the whole (Chadderton, 1994).  
The premise of the circle is that by systematically exploring the whole, new insights and an 
increased depth of understanding of the phenomenon will be produced. This information is 
then used to examine the sub-components of the phenomenon, in turn resulting in new 
understandings that need to be re-explored in terms of the whole (Leonard, 1994). This 
cyclic process has no clear termination point and is dependent on the researcher deciding 
when they have reached the point of ‘optimal understanding’. Gadamer (2004) argued that 
while it is difficult to predict or justify the exact point at which optimal understanding has 
been achieved ‘everyone knows it when it happens’. In order to follow a hermeneutic 
process the researcher must be self-reflective, while staying true to the data, honouring the 
lived experience of the participants without venerating it (Laverty, 2008). 
In this research I maintain a hermeneutic phenomenological perspective. In order to 
achieve the research aims I will describe and interpret the ‘life-world’ of those involved in 
PPI. This will be achieved by mediating between the internal worlds of the participants and 
my own reflections on the meanings of these worlds. While these reflections were 
corroborated through working with others, I recognise that my own belief structures 
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impacted on the data collected and on my interpretations of that data. In order to clarify 
potential biases arising from my own experiences and establish transparency regarding my 
interpretations I needed to be continually reflexive and explicit about my positioning 
(Creswell, 2007). 
2.3.1 My initial positioning  
While it is impossible to be value free or to attain ‘objectivity’, by being reflexive and open 
about our own identity and its potential impact on the research, a level of distance can be 
established between the researcher and the data. This is seen as a key component of 
qualitative research (Green & Thorogood, 2004). My reflections on conducting this research 
are touched on briefly in latter parts of this chapter and addressed in the discussion. 
However, I have been aware since I first applied for this PhD that there was one component 
of my identity that I would have to be continually mindful of, as it had the potential to 
affect the research and it had contributed to my motivation for doing this PhD.  
From the age of six I have been recognised as having the specific learning disorder, dyslexia. 
My parents’ response to mine and my older sister’s dyslexia was to become active 
members (Head and Secretary) of the local Dyslexia Association and have been referred to 
as ‘Parents with Elbows’. They are strong believers in fighting for support and maintain that 
if people accept that they have no power in a situation, then they have none. This is an 
attitude that I have absorbed over the years and have repeatedly put into practice since I 
took responsibility for establishing my own learning support at university. Eighteen years of 
interacting with a collection of professionals in a rigid educational system has left me with 
the belief that while professionals hold a breadth of knowledge and collective experience 
that is invaluable, the individual with the condition has a substantial amount of information 
and experience which those who have not experienced the condition have no direct access 
to. I believe that combining the two sets of knowledge will result in better outcomes for the 
people involved than relying solely on only one perspective. Consequently while having no 
particular understanding of the best method(s) for implementing PPI, or the specific 
benefits and challenges, I started from a value position that people with epilepsy and their 
families should be involved in epilepsy research; and that, if done well, PPI can increase the 
quality of research and also have a positive impact on those involved.  
Also influencing my beliefs and potentially balancing my experience of the ‘patient’ position 
is that fact that prior to starting this research I worked as a research assistant for four years 
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within a university. Adopting a similar ethos to that embraced by PPI, the research team of 
which I was a part felt that as the research was about university students, then university 
students should be involved in the research process as more than just participants. This aim 
was not always realised, despite most of the research team supporting it. This experience, I 
believe, gave me insight into the difficulties encountered by individuals whose role is to 
coordinate and implement research and a partial understanding of some of the systems 
and constraints they are working under.  
2.4 Ethnography and multi-sited ethnography  
Ethnographic methodologies derive from the principle that knowledge is constructed. 
Consequently these methodologies are in tune with my hermeneutic phenomenological 
underpinning (Van Manen, 1997). Ethnography is considered an appropriate design when 
research is aiming to: “describe how cultural groups work and explore the beliefs, language, 
behaviours and issues such as power, resistance and dominance” (Creswell, 2007, p. 70). 
They are also considered useful when developing an understanding of complex 
relationships from multiple perspectives (Kendall et al., 2009; Long, Hunter, & Van der 
Geest, 2008). Consequently an ethnographic approach addresses both my epistemological 
position and the research objectives, providing a vehicle for looking in-depth at the 
potentially disparate perspectives surrounding PPI.  
Savage (2000) places the origins of ethnography within social anthropology, which 
traditionally explored small ‘non-western’ communities which were considered to have 
discrete, culturally specific, practices and beliefs. In the early 1920s ethnography helped 
anthropologists to facilitate a shift from reliance on secondary data sources to researchers 
having personal experience of the cultures that they investigated (Risjord, 2000). Sociology 
has always been closely linked to anthropology but traditionally focused on western, urban 
settings and mainly drew on quantitative methodologies (Falzon, 2009). Sociologists 
working at the University of Chicago (or the ‘Chicago School’ as it is known) from the 1920s 
to the 1950s developed an approach to studying western culture that overlapped with that 
being developed in anthropology (Hammersley & Atkinson, 2007). This advocated the 
importance of fieldwork and the use of empirical data to build theoretical models and 
developing ethnography as its core mythological approach (Falzon, 2009). British and 
French sociology and psychology, however, persisted in the positivist tradition, favouring 
quantitative, experimental and deductive methods (Gallo, 2009). This largely continued 
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until the socio-political movements of the 1960s (civil rights, gay rights and feminism- see 
Section 1.5.2) put pressure on the social sciences to address issues of representation, 
power and ethics. This resulted in a multidisciplinary movement promoting the use of 
qualitative approaches, particularly ethnography (Hammersley & Atkinson, 2007; Falzon, 
2009). One reason that ethnography was ‘imported’ into so many different disciplines was 
because, fundamentally, ethnography is the study of culture, which is not just core to 
anthropology but many other disciplines as well (Flick, 2009a; Patton, 2002). Consequently 
ethnography is no longer purely the domain of anthropologists and the Chicago School, but 
has been adopted by a range of disciplines including but not limited to: sociology, 
psychology, applied educational research, organisational studies, human geography, 
programme evaluation, and business studies (Hammersley & Atkinson, 2007; Falzon, 2009; 
Patton, 2002).  
Brewer (2000) and Hammersley (1992) emphasise that both across and within disciplines 
there are different ‘schools’ of thought surrounding ethnography. Across these schools 
there are consistencies and these are what I draw upon. The defining characteristic of 
traditional ethnography is participant observation, with the researcher participating in the 
daily lives and events being studied over an extended period of time (Hammersley & 
Atkinson, 2003). Other defining characteristics of ethnographic research include using 
multiple methods of data collection, placing emphasis on context, reflectivity and a focus 
on what people do, as well as what they say they do (Savage, 2000; Tedlock, 2000). One 
advantage of ethnography is that it draws on the strengths of each of the types of data 
collection utilised while in turn compensating for some of their weaknesses. For example, 
semi structured interviews used as a single strategy (see Section 2.6.2), which would have 
been the alternative methodology in this case, have the advantage that they supply in-
depth information about participants’ views and experiences. They allow participants the 
chance to expand their ideas and explain their views, while giving the researcher access to 
accounts about settings and events that they may not be able to observe themselves 
(Denscome, 2007; Hammersley, 2006). However, a disadvantage of this approach is that 
interview data is removed from the experiential context in which the experience took place 
and analysis can only be based on what participants ‘said’ or ‘think’ happened. By using 
interviews in conjunction with participant observation (see Section 2.6.1) it is possible to 
see the interlinking between different aspects of the culture under study: looking at the 
wider processes, relationships, connections and interdependency of the actors in the 
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setting rather than looking at one person’s perspective in isolation.  In addition, by 
spending an extended period of time with the participants during the observation process 
the researcher can establish rapport and trust with the participants, which in turn can 
facilitate honest, uninhibited discussion during the interviews. This allows for disclosure of 
information that might not be obtained during an interview where the interviewee has 
limited or no prior relationship with the researcher.  
The ethnographic approach is underlined by the assumption that accessing beliefs and 
behaviours in the context in which they occur will aid understanding and provide a holistic 
perspective (Patton, 2002). Ethnographers therefore place importance on exploring the 
meanings of social interactions, as opposed to testing a hypothesis (Atkinson & 
Hammersley, 1998). It is not a case of having no aims, as this would result in voluminous 
and unfocused data that potentially does not address the original motivation for the 
research. Rather, ethnographic research has flexibility built within its aims (Agar, 1996; Fox, 
2004; Hammersley & Atkinson, 2003). Instead of planning precisely what will be done at 
each stage, an ethnographic methodology responds to the research findings as they unfold 
and narrows its focus though on-going analysis (Lofland, 2002).  While this flexibility allows 
for the research to develop in light of ongoing analysis it also holds the danger of 
methodological arbitrariness that is not always easily justifiable to those outside of the 
project (Flick, 2009b). In conjugation with this, like many qualitative research approaches, 
subjectivity is a potential methodological issue in ethnography, as the interpretation of the 
culture under study is variable, dependent upon the researcher’s positioning and 
perceptions (see Sections 2.4 & 2.4.1 ) (Goodson & Vassar, 2011). The level of emphasis 
placed on context within an ethnography makes it problematic to generalise findings to 
other populations, because the information that is generated is based on cultural and even 
site-specific responses (Goodson & Vassar, 2011; Savage, 2000) in a way that would not 
hold as true with a purely interview based approach that used purposive sampling across 
multiple contexts. It also needs to be noted that ethnographies have a greater potential to 
invite ethical issues associated with invasion of privacy and informed consent (Denscome, 
2007). I discuss how I have approached issues of generalizability and consent in Sections 
2.7.4 and 2.9 respectively.  
One of the main criticisms of traditional ethnography at a more theoretical level is that it 
depicts the people it studies as being in a void, uninfluenced by time and broader social 
constructs (Agar, 1996). In modern ethnography research sites or cultural settings, often 
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referred to as ‘fields’, are no longer considered to be discrete entities or stuck constructs; 
rather they are seen as overlapping and time dependent, with some fields only existing for 
a finite amount of time (Hammersley & Atkinson, 2003; Hannerz, 2003; Marcus, 1998). This 
is likely to apply within the epilepsy research community, as research groups form and 
disperse as research projects are identified, developed, funded and end. Moreover, 
members often belong to more than one group, with many members of the broader 
epilepsy community knowing or knowing of each other3. Therefore, it would be superficial 
to carve out one ‘site’ or ‘field’ within this area. Multi-sited ethnography (MSE) developed 
to accommodate this conceptual broadening of the field and was first seen in migration 
studies where both the points of departure and arrival were studied (Watson, 1977).  
MSE is translocal, as the object being studied cannot be confined to one place (Hannerz, 
2003). Marcus, (1998) one of the pioneers of MSE states that: "Strategies for quite literally 
following connections, associations and relationships are thus at the very heart of designing 
multi-sited ethnographic research” (p. 81). The ‘object’ being followed can consist of the 
people, an artefact, a metaphor, a story, a biography or a conflict (Marcus, 1998). It is this 
conceptual link that differentiates MSE from comparative studies (Hannerz, 2003).  This 
broadening of the ‘field’ has been reflected in a number of health related ethnographies. 
Traditionally such ethnographies focused on one location such as a hospital ward (Coser, 
1962) or clinic (Good, Herrera, Good, & Cooper, 1985; Cowie & Roebuck, 1975) rather than 
taking a more conceptual perspective. However, later studies adopted a broader 
conceptual perspective. For example, Martin’s (1994) MSE on the role of immunity in 
American culture viewed the immune system and the ‘field’ rather than looking within one 
‘site’. For Martin, the immune system could only be understood by looking at it though the 
perspective of actors who were differentially positioned in relation to the problem and 
from different settings. These included volunteering as a ‘buddy’ at a centre for HIV 
sufferers, observations in an immunology lab and analysing public representations of the 
immune system in advertisements. Cooper (2012) used MSE to explore organ donation in 
black and ethnic minority communities. Rather than focusing on a single site, data were 
collected across two acute hospital Trusts and in the wider ‘community’ such as religious 
temples. Narrative and observational methods were used to understand the experiences of 
intensive care staff, donation nurses, religious leaders and minority ethnic transplant 
recipients. The importance of exploring all facets of the organ donation process was seen as 
                                                          
3
 This was evident during data collection. 
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key, as it was concluded that low minority donation rates are not a result of a discrete 
temporally- bound decision making process but rather a result of a set of situated processes 
that draw on the experience, preconceptions and cultures of all involved (Cooper, 2012; 
Kierans & Cooper, 2013).  
When compared to traditional ethnography, MSE is seen as providing a wider breath of 
knowledge but less depth (Hammersley & Atkinson, 2003). MSE does not aim to give a 
complete account of the world as this would be unachievable, but rather to provide enough 
of an insight to be useful (Marcus, 1998). Due to logistics and time constraints it is not 
possible to dedicate the same amount of time to many sites as it would be to a single one. 
However, as Hannerz (2003) notes in many of the new fields of study people are often 
physically and socially confined (e.g. sitting at a computer or on their own in an office) and 
it would not be beneficial or practical to spend a substantial amount of time observing 
them in such contexts. This, combined with the multisitedness, means the MSE is based 
more on interviews and less on observation than traditional ethnography (Hannerz, 2003). 
The resultant decrease in field time can create a conflict with the requirement of 
ethnographers to develop an ‘intimate’ understanding of the phenomenon. Hammersley 
(2006) suggests that these changes in the nature of ethnography have led to an increased 
chance that the data collected is ‘ahistorical’, failing to take into account the wider local 
and historical  perspectives; and with the ethnographers sometimes treating people as if 
their behaviour is entirely a product of the situation being observed rather than who they 
are and what they do elsewhere, because the ethnographers do not have observational 
data relating to the rest of the lives of those they study.  
In order to still achieve depth, as well as breadth of knowledge the number and types of 
sites needs to be given careful consideration at the design stage. Accordingly, MSE consists 
of a selection of sites from all possible sites that could be included. In tune with the 
unfolding nature of the method, sites may not be predetermined but rather be chosen 
gradually as the story develops, insights are gained, and to some extent by chance 
(Hannerz, 2003). This method of site selection can be a problematic aspect of MSE, as there 
is a chance that optimal data might not be obtained (Lofland, 2002).  
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2.4.1 Assessing the quality of ethnographic research  
Unlike quantitative research, it is not possible or necessarily desirable in qualitative 
research to attempt to pursue or measure reliability, objectivity and validity as 
conventionally defined (Bailey, 1997). Nevertheless the need to establish what is 
‘trustworthy’ data and what constitutes a ‘plausible’ interpretation of the data remains 
(Lather, 1991; Wilcott, 1990). Whittemore, Chase and Mandle (2001) synthesised key 
validity criteria within the literature and concluded that there are four primary criteria by 
which qualitative research should be judged. These are credibility (how believable the 
findings are), authenticity (if the subtle differences in the voices of all participants are 
explored), criticality (evidence of critical appraisal of the data) and integrity (repetitive 
checks of validity and unpretentious presentation of findings). In line with these generic 
criteria for assessing qualitative research, Hammersley (1990) offers a composite list of 
evaluation criteria that are specific to ethnographic research, four of which are considered 
key validity measures for an ethnography (Savage, 2000, p.1401):  
1. The extent to which the influence of the research design and strategy on findings is 
considered (the reflexivity of the account), and the existence of an audit trail 
2. The extent to which findings have relevance to those in similar settings 
3. The credibility of the account to readers and those studied  
4. The consistency of claims compared with empirical observations and data 
Silverman (2006) stipulated that the most logical way of meeting these criteria is a 
combination of ‘triangulation’ and respondent validation. Triangulation involves collecting 
multiple and divergent data sources to corroborate findings, testing one source of 
information against another to prove or discount a theory (Fetterman, 2009). Creswell 
(2007) advocates the use of prolonged participant observation as one of the forms of data 
collection to provide opportunities for respondent validation/checking. Observation and 
triangulation of data in this research was integral as part of the MSE approach (Fetterman, 
2009) (see Section 2.6). Respondent validation or ‘member checking’ involves obtaining 
participants’ views on the accuracy of the findings, to corroborate how ‘truthful’ the 
findings are. Respondent validation in my research was iterative and extensive. The time 
frame and method of the research allowed me to clarify points that were raised in early 
interviews in latter ones and to directly ask questions about things that I had observed to 
test my interpretations. The number of informal interactions I had with participants 
allowed me to explain my current theories to them and get their feedback. Developing 
findings were periodically presented at a range of events that allowed me to get feedback 
from professionals who, while not directly involved in my sites, had extensive PPI 
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experience. In addition, as explained in more depth in 2.6.2 my primary supervisor was also 
a participant in one of my sites; consequently she was present at a number of my 
observations and could compare and contrast her interpretation of events with my own.  
A factor that is key in determining the quality of qualitative research but is often not 
explicitly stated is the competence of the researcher (Guba & Lincoln, 1998). Through my 
undergraduate and master’s studies I developed a basic understanding of qualitative 
research methods. I was able to put this knowledge into practice during my four year role 
as a research assistant, conducting semi-structured interviews, focus groups and data 
analysis. To further develop my practical skills, I undertook two courses in Neuro-Linguistic 
Programming, which enhanced my methods of communication, giving me a greater insight 
into verbal and non-verbal language, observation skills and rapport building. As mentioned 
in Section 2.3 as part of my PhD training, I undertook an advanced qualitative research 
methods course that focused on theoretical and methodological aspects of such research. 
This present research required all of my theoretical and practical knowledge. Working with 
a new population in an unfamiliar setting required me to apply and develop my skills. I also 
had to learn more about conducting observations and writing fieldnotes as this was not 
something I had previously done in a formal capacity. In order to ensure the research was 
of sufficient quality, my supervisors looked in depth at my early interviews and we had 
regular ongoing discussions regarding data collection and content.  
A common methodological problem within ethnographies is the tendency to defer to, or 
side with those in the subordinate group (Becker, 1966). In the present case this could 
result in me being more sympathetic to the representatives’ perspectives rather than giving 
a balanced analysis. Liebling (2001) maintains that it is possible to appreciate competing 
perspectives and give equal consideration to all sides. I aimed to achieve this neutrality in 
part though the respondent validation process and my own reflectivity, particularly with 
reference to drawing on my experience of both the patient and researcher roles.  
2.5 Why epilepsy and epilepsy research?  
When choosing the context for my research it quickly became apparent that I needed to 
establish clear parameters for investigation. My view is that it would be possible to 
conceptually link most occurrences of PPI in health research, this would create an 
unmanageable number of possible research sites. An efficacious way of establishing 
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selection criteria was to identify a single health condition to focus on and a story4 that had 
closely related, clearly defined sites. The aim would then be to address both the context 
specific nature of PPI and facilitate the comparison of different approaches (research 
Objective 4). I will now explain why I chose to focus on epilepsy research and how I 
developed my knowledge of this area.  
In 2006 The UK National Institute for Health Research (NIHR) established a Comprehensive 
Clinical Research Network (CCRN) to support and coordinate clinical research and to 
facilitate the conduct of clinical trials and other high quality studies (UKCRN, 2010). 
Consisting of six topic-specific Clinical Research Networks and a Primary Care Research 
Network, the CCRN’s aim was to establish national research priorities and support a 
national portfolio of clinical trials and other studies (Ng & Weindling, 2009). Within these 
networks PPI was prioritised from the beginning, with designated funding attached to a PPI 
‘lead’ role, with the remit of facilitating PPI in the network. The drive to integrate PPI within 
the networks was: “based on the premise that involvement is ethical, enhances research, 
demonstrates the openness of research, improves recruitment, and enriches the process” 
(Stewart, 2010, p.5).  
The focus of the six topic-specific networks reflected the Department of Health (DH) 
priorities at the time they were established (Cancer, Dementia and Neurodegenerative 
Diseases, Diabetes, Medicines for Children, Mental Health and Stroke). For this reason 
some clinical topics were not represented by their own topic-specific networks, falling 
instead within the remit of one of the six CCRNs. For example Parkinson’s disease, Motor 
neurone disease and Huntington’s disease are part of the Dementia and Neurodegenerative 
Diseases portfolio. However, epileptologists5 across the UK considered it important that an 
epilepsy-specific research network was created, in order to ensure the quality of epilepsy 
research and drive forward an evidence-based research agenda. As a result of this 
researcher-led initiative, funding was obtained from various UK epilepsy charities and the 
UK Epilepsy Research Network (UKERN) was launched in February 2010.  
                                                          
4
 The word ‘story’ is being used for its MSE connotations. The ‘story’ includes the tracking of 
processes, narratives and associations within a specific context (Marcus, 1998).  
5
 Neurologists who specialize in the treatment of epilepsy are ‘Epileptologists’, but when used less 
formally within the epilepsy community this term is also refers to researchers and other health 
practitioners with the same focus.  
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In 2008 the Medical Research Council, in partnership with the NIHR, established eight 
research ‘Hubs’ for Trial Methodology Research. In line with the CCRNs the hubs were 
created as a resource to improve the design, conduct, analysis, interpretation, and 
dissemination of clinical trials, particularly in methodologically challenging areas (MRC, 
2010). The North West Hub for Trials Methodology Research (NWHTMR), which funded my 
PhD, is a collaboration of three Universities: Liverpool, Lancaster and Bangor. It has a focus 
on three methodological research themes (early phase trial design and analysis, later phase 
trial design and analysis, and patient perspectives), with the aim of developing and 
translating methods for application across key clinical areas including Drug Safety, 
Medicines for Children, Cancer and Epilepsy. The inclusion of epilepsy as a key clinical area 
within the NWHTMR reflected the large numbers of epilepsy-focussed researchers and 
clinicians working within Liverpool, some of whom work as part of the Hub and in turn were 
involved in the development of the UKERN.  
Like the NIHR-funded networks, members of the UKERN placed great importance on PPI 
and were starting to develop their own PPI strategy about the same time that this research 
was being conceptualised. This offered a unique opportunity to follow the process of PPI 
implementation within a research network from its inception, exploring how decisions 
about PPI were made and the consequences of these decisions. Further exploration into the 
UKERN as a potential ‘story’ identified a range of other benefits. The UKERN research 
portfolio could provide a range of potential research sites, covering different aspects of the 
PPI process, which were not just conceptually linked but belonged to the same story. This 
could facilitate my aim to compare different types of methods or approaches to PPI within 
a similar context. Epilepsy research generally consists of clinical drug trials (see Section 
2.5.1) which links with the remit of the Hub and the original funding for my PhD. In 
addition, my focused literature review revealed little or no research exploring PPI in 
epilepsy or research networks. Therefore, the UKERN was chosen as the main site from 
which the other sites were identified.  
I followed the development of the UKERN from its launch for 25 months (see Figure 6 for 
detailed timeline). From the outset four sub-groups consisting of a management group, and 
three Clinical Study Groups (CSGs) were established. Each of the CSGs had a remit to focus 
on a different aspect of epilepsy research: Diagnosis and Aetiology, Interventions and 
Therapies, and Impact and Outcomes. Each group had between 10 and 20 members 
consisting of two representatives, clinical and non-clinical researchers. The CSGs initially 
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agreed to meet approximately every three months through a teleconferencing service and 
annually face-to-face at the annual conference of the UK branch of the International League 
Against Epilepsy (ILAE). Later, an additional yearly face-to-face meeting was included. 
Through consultations with one of the main epilepsy charities it was decided that 
representatives would be selected through a formal application and interview process. The 
six selected representatives then attended a research methods training day run by 
members of the network before becoming active members of the CSGs.  
2.5.1 Developing my understanding of epilepsy research  
In order to understand the UKERN I needed to develop my understanding of epilepsy and 
epilepsy research. Initially my knowledge was limited to ‘common’ knowledge, that of a 
general member of the public. For instance, I knew people with epilepsy have seizures that 
can be difficult to control, that this may affect their ability to drive and that seizures can be 
brought on by flashing lights and images. When first going into the field I was unsure what 
level of epilepsy knowledge I required. This uncertainty originated from the fact that 
epilepsy was not the focus of my research and that naivety about a setting, commonly 
known within the literature as taking the role of a ‘stranger’, can be considered 
advantageous in ethnographic research (Schuetz, 1944). It is argued that identifying 
discrepancies between the taken-for-granted knowledge in the field and your own 
preconceptions and cultural norms throws pertinent information into relief, thereby aiding 
analysis (Agar, 1996). Also, in line with my method and methodology, facts about epilepsy 
are not as important as what the people involved believe to be true (Crotty, 1998). 
During my observations I paid particular attention to epilepsy related information that both 
the professionals and representatives took for granted. I recorded and researched terms 
identified during data collection whose meaning I did not know. I based my initial broader 
reading on the recommendations of my informants. These included reading two books 
written as guides for people with epilepsy, ‘Epilepsy The Facts’ (Hopkins, 1984) and ‘Living 
With Epilepsy’ (Chadwick & Usiskin, 1987) and looking at the leaflets produced by the UK 
epilepsy charity, Epilepsy Action (EA). These leaflets cover the most pertinent issues and are 
often the first point of call for people wishing to learn more about their epilepsy (EA, 
2012b). In addition I found Joanne Taylor’s (2010) PhD thesis on ‘The natural history of 
cognitive functioning in people with newly diagnosed epilepsy’ particularly useful, as it 
outlines the aetiology, diagnosis, treatment and progression of epilepsy. In order to place 
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my findings within the epilepsy context, I will now summarise some of the key aspects of 
epilepsy and epilepsy research that I discovered over the course of my data collection. 
The International League Against Epilepsy (ILAE) an international forum for debate about 
key issues in epilepsy, currently uses the following definition of epilepsy: 
“An epileptic seizure is a transient occurrence of signs and/or symptoms due to 
abnormal excessive or synchronous neuronal activity in the brain. Epilepsy is a 
disorder of the brain characterised by an enduring predisposition to generate 
epileptic seizures and by the neurobiological, cognitive, psychological, and social 
consequences of the condition. The definition of epilepsy requires the occurrence of 
at least one epileptic seizure.” (Fisher et al., 2005, p.470)  
The importance of this definition of epilepsy is that it reflects that having epileptic seizures 
can have far reaching consequences in a person’s life that may be more debilitating than 
the seizures themselves (Taylor, 2010). For example: 
“The physical hazards of epilepsy resulting from the unpredictability of seizures; the 
social exclusion as a result of negative attitudes of others toward people with 
epilepsy; and the stigma, as children with epilepsy may be banned from school, 
adults may be barred from marriage, and employment is often denied, even when 
seizures would not render the work unsuitable or unsafe. Furthermore, epilepsy is a 
disorder associated with significant psychological consequences, with increased 
levels of anxiety, depression, and poor self-esteem compared with people without 
this condition.” (de Boer, Mula, & Sander, 2008, p.540) 
Epilepsy and epileptic seizures are not homogeneous, with these terms encompassing a 
range of approximately 50 neurological conditions with differing courses, neurological 
effects and prognosis as reflected in the complex classification system (Engel, 2001; Joint 
Epilepsy Council of the UK & Ireland, 2012). At the most basic level, seizures are classified 
as focal (partial) or general. Focal seizures originate in one part of the brain, general 
seizures involve epileptic activity in both hemispheres. Seizures are then further 
categorised by the specific areas of the brain affected and how the activity spreads over the 
course of the seizure (EA, 2012a). The development of chronic epilepsy in childhood is likely 
to be a result of congenital, genetic and developmental conditions. Head trauma, tumours 
and infections may result in epilepsy at any time (de Boer, Mula, & Sander, 2008). Risk 
factors for epileptic seizures include metabolic disturbances, stress, sleep deprivation, 
fatigue, alcohol, exercise, the menstrual cycle, toxins and drugs (Taylor, 2010). During my 
research both professionals and representatives repeatedly highlighted the complexity of 
epilepsy, stressing the point by providing examples such as a teenage boy with epilepsy 
having very different concerns and priorities from those of a pregnant women; also, that 
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those who have seizures regularly may have a very different experience to those who have 
them sporadically. 
In terms of the prevalence of epilepsy, it is generally agreed that five percent of a given 
population will experience at least one epileptic seizure in their lifetime and one third of 
these will then be diagnosed with epilepsy (Sander, 2003). Currently there are 
approximately 500,000 people with epilepsy in the UK (Joint Epilepsy Council of the UK & 
Ireland, 2012). Although epilepsy can be diagnosed at any age it occurs more frequently in 
those under 20 or over 60 (de Boer, Mula, & Sander, 2008). People with epilepsy have a 
standardised mortality rate two to three times higher than the general population (Sander, 
2003). It has been estimated that symptomatic epilepsy may reduce life expectancy by up 
to 18 years (Gaitatzis, Trimble, & Sander, 2004). However, the majority of people with 
epilepsy will achieve seizure freedom following treatment with antiepileptic medication. 
Cockerell et al (1995) found that after nine years, 68% of patients with epilepsy had 
achieved a remission of five years and 86% had achieved a remission of three years.  
Reynolds and Trimble’s (2009) article on the history of epilepsy reflects that throughout 
most of its recorded history, epilepsy has been viewed as a supernatural or a mental 
disorder, linked to possession and insanity. Even in the second half of the 19th century, 
when neurology developed as a discipline giving new understanding to conditions such as 
stroke and Parkinson’s disease, epilepsy was still considered a mental disorder. This was 
because epilepsy was not found to be linked with brain lesions and the psychiatrists 
treating those with epilepsy associated their symptoms with mental or behavioural 
disorders (Reynolds & Trimble, 2009). It was not until 1960 that the World Health 
Organisation categorised epilepsy as a neurological condition rather than a mental disorder 
(Reynolds & Trimble, 2009). This history, combined with the stigma associated with 
disability and mental illness, has become a deep rooted part of the epilepsy community’s 
psyche.  
As the understanding of epilepsy has developed, so have nonmedical support systems in 
the UK. In line with the evolution of PPI in health research and the development of public 
activism (see Section 1.5.2) the epilepsy community as a whole is increasingly more 
politically shrewd, using their national infrastructure of charities and groups to influence 
both policy and research (Lee, 2000). As such they are no longer a passive patient group, a 
trait reflected in their representatives.  
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Since the recognition of epilepsy as a neurological disorder there has been a proliferation in 
the development and use of AEDs (AED was the first acronym that I witnessed used as 
‘common knowledge’; after looking it up I found it stands for Anti-Epileptic Drug). AEDs are 
now the primary treatment strategy for epilepsy (Taylor, 2010). Reflecting this, a 
substantial amount of epilepsy research involves clinical trials, aimed at developing or 
comparing AEDs and is a key area of interest for representatives. There is also a significant 
amount of research looking into possible genetic causes of epilepsy. Consequently 
alongside the vocabulary and knowledge linked to research methods, representatives must 
also contend with the chemical and biological terms used. The extent to which 
representatives need to understand this knowledge is a point of contention raised in the 
results chapters.  
2.6 Data collection methods  
In line with the ethnographic methodology I used multiple methods of data collection, with 
the majority of my data coming from interviews and observations. The number of 
observations and interviews I conducted at each site were context specific but the 
approaches I used were largely consistent across the sites. In this section I explain the data 
collection methods I used in relation to the UKERN site. In Section 2.7 I outline how I 
implemented these same approaches within the other sites.  
2.6.1 Observations 
As previously discussed, observation is one of the cornerstones of ethnographic data 
collection. The main goal of observational data is to describe (Patton, 2002). Observation 
requires the systematic noticing and recording of events and behaviours, focusing on what 
is done, as well as what is said is done (Marshall & Rossman, 1995). One benefit of this type 
of data collection is that it provides opportunities for the researcher to catalogue routine 
occurrences that may be key to a culture but are so ingrained that they are not apparent to 
its members and as such may not be mentioned in an interview (Patton, 2002).  
While conducting observations the researcher places themself on a continuum between 
participant and complete observer (Marshall & Rossman, 1995). For this research I was 
overtly present to observe PPI in the network and all members were aware of the reason 
for my presence. However, I did not just observe, I also interacted with the network 
members and participated as required. Vinten (1994) categorised this type of observation 
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as explicit observation. The main advantage of this type of observation is that it offers 
flexibility within the role without engendering the ethical problems associated with some 
observational approaches. It also allowed me to have direct communication with 
participants, reducing the likelihood of imposing my own preconceptions on what I was 
observing, while maintaining some degree of separation (Flick, 2009a). Schatzman and 
Strauss (1973) also raised the point that ‘pure’ observation without interaction can leave 
participants unsettled and wondering what the researcher is ‘really up to’, thus impacting 
negatively on participants’ state of mind.  
The disadvantage of this type of explicit observation is that the more I interacted with the 
field the more I potentially affected it. I tried to keep my impact to a minimum by saying as 
little as possible in the meetings I observed, only talking when called upon. However, as 
Atkinson (1976) acknowledges reciprocity is key to any relationship, and if a researcher is 
always ‘taking’ from the participants and never ‘giving’ discontent can occur in field 
relations. He suggested that this can be avoided by the researcher occasionally ‘helping 
out’. With these two contradicting motivators in mind, I tried to periodically help out in 
ways that would have minimal impact. For example, on a few occasions the network 
coordinator could not be at a meeting and I would produce the minutes from my audio 
recording. Occasionally, I would transfer practical information across groups, for example, 
confirming whether another group had completed a task. This kind of knowledge transfer 
seemed benign, but I had to be very careful with my responses, if asked questions about 
others’ opinions, to avoid breaking confidentiality (see Section 2.9.2).  
Due to my presence from the start of the network and at all of the different CSG meetings, I 
am confident to say I was seen as part of the network. This had two main benefits, firstly it 
helped to limit the observer effect, as members of the group accepted me as one of them 
and as such were less likely to alter their behaviour. Indeed, they seemed remarkably happy 
to talk to me when they had time or something to say and ignore me when otherwise 
occupied. Secondly, when combined with the extended data collection time, it helped me 
to build rapport with the participants, allowing me access to more honest and holistic 
accounts and compensate for the odd faux pas I made. Although it must be acknowledged 
that my presence gave the implicit knowledge to both the representatives and the 
professionals that PPI was something to be aware of, which might not otherwise have been 
the case for all group members.  
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I originally focussed on ‘descriptive observation’, presuming that I knew nothing and trying 
to pay attention to everything (Angrosino & de Perez, 2000). After the first set of CSG 
meetings that included the representatives, I felt that I was starting to get a understanding 
of what was and was not pertinent to my study aims, so I shifted to a more ‘focused 
observation’. As the name suggests, I used a more selective approach as to what I focused 
my attention on and recorded. The advantage of this was that I could obtain more 
information about the things I was focusing on, such as interactions between 
representatives and the ‘professionals’. As with most focused observations the criticism of 
this method is that a third party might find it difficult to evaluate the choice of criteria used 
to determine what is and what is not attended to, as it is not always possible to articulate 
the reasoning for judgment calls made in a given situation (Vinten, 1994).  
The nature of the network meant that I could observe the majority of the CSG meetings, 
since they rarely took place at the same time. On the three occasions they did, I alternated 
which group I attended and obtained copies of the meeting minutes from the others. I also 
observed the recruitment process (including discussions pre-recruitment and the 
interviews) for the representatives and a number of network events. Caron-Flinterman, 
Broerse and Bunders (2005) note that due to the implicit privacy agreements in the rules of 
most committees, members often do not feel comfortable giving details to outsiders about 
the decision-making process. My observer position meant I had access to information that 
would not necessarily have been revealed through interviews alone.  
As noted earlier many of the CSG meetings were conducted via teleconference. I was able 
to audio-record these conversations, allowing for verifiable and accurate fieldnotes to be 
taken (with transcriptions of pertinent sections), but many of the criteria defined in the 
guidelines for writing ethnographic fieldnotes were not applicable as there were no visual 
cues. My fieldnotes that accompanied all observations and interviews were based on the 
recommendations made by Emerson, Fretz and Shaw, (1995) in their book, ‘Writing 
Ethnographic Fieldnotes’. They emphasise the importance of indigenous meanings, 
interactional detail, being aware of your audience and documenting emergent thoughts 
and processes. It took me a few attempts to develop my own style of fieldnotes and there 
are situations where, in hindsight, I had not judged the level of detail correctly. I also learnt 
when and where it was appropriate to write my notes. It was often entirely acceptable to 
write notes during the formal meetings as others were also writing. Outside of the 
meetings I jotted down some cues and prompts for later elaboration. Or, if I felt that 
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something was particularly important and needed more intensive notes, for example, the 
wording of a conversation, I would sequester myself in the ladies’ toilets to write so as not 
to draw attention to myself. This is a trick regularly reported by ethnographers, though it 
must be used sparingly to prevent missing activities or your participants thinking you have 
bladder problems! At the nearest opportunity, normally on the train home, all my notes 
were expanded in as much detail as possible and typed up. Gibbs (2008) noted that 
fieldnotes are often loose, unruly and messy. I found this to hold true with regards to my 
own notes. All my notes were revisited a day or two after the observation to ensure 
maximum information was recorded. I also made sure that my initial thoughts and more 
reflective thoughts were distinguishable within my notes.  
The initial time frame for observing the UKERN was set at two years to fit in with the 
timeline of a PhD. However as noted ethnographic methods are flexible and adapt to meet 
circumstances. Towards the end of my designated data collection period the decision was 
made to delay the final representative interviews and include an additional three months of 
observations. The reason for this extension was to allow for the inclusion of a period of 
increased activity within the network and the observation of a ‘catch-up and feedback’ 
telephone conference between the representatives and the Network Director.  
2.6.2 Interviews  
In the course of conducting my observations I undertook a number of informal 
ethnographic interviews. Some researchers consider informal interviewing and participant 
observation as separate entities. They are however, arguably part of the same thing, with a 
large quantity of ethnographic, observation data coming from informal interviews (Fontana 
& Frey, 2005; Lofland, 2002). Informal interviews are essentially conversations but with an 
information gathering focus. Patton (1994) argued that people may be inclined to tell you 
more in a natural setting than in a formal interview setting, especially with regard to 
sensitive or emotive topics. I found that the information obtained in uncensored moments 
during casual conversations to be particularly revealing and useful.  
In addition to the informal interviews, I conducted more formal, semi-structured interviews 
with selected participants. All individuals approached agreed to be formally interviewed in 
addition to being observed. This included the six representatives, the three CSG leads, the 
Network Director, the Network Coordinator and two advisers from an epilepsy charity. The 
formal interviews were done at key time points, with the representatives, Network Director 
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and CSG leads taking part in multiple interviews (see Table 3). The advisers from the 
epilepsy charity were interviewed first, after the launch of the network but before the 
representatives were recruited. The representatives and Network Director were 
approached to be interviewed just after the interview process but prior to representatives 
attending their first meeting (time point one), after one year (time point two) and at the 
end of data collection (time point three). The CSG leads were approached to be interviewed 
at time point one and three. Not all of the representatives or professionals were available 
at all time points. Table 3 gives a detailed accounting of the number of interviews by 
participant and time point. On average interviews lasted for around 50 minutes, ranging in 
duration from 20 minutes to 75 minutes (see Appendix 2 for example interview extracts). 
 A key professional informant for this site that is not adequately accounted for in the prier 
description is my primary PhD supervisor Professor Ann Jacoby. Ann was involved in the 
development of the network, recruiting and training the representatives and was an active 
member of a CSG group. As such she was an invaluable source of information about aspects 
of the network that I had no direct access to. Her reflections about events worked as a 
comparison point for my own observations, and her opinions obtained though informal 
interviews are common place among my fieldnotes. She is the one informant that was not 
given a pseudonym as our relationship needed to be explained for transparency (Ann gave 
consent for her lack of anonymity).  
Due to time and resources constraints I decided not to formally interview the professionals 
in the CSG groups other than the leads. Instead I obtained their opinions through the other 
data collection methods. The semi-structured approach I used in my more formal 
interviews allowed me to have some consistency across the interviews while providing 
flexibility about what was discussed. The original topic guides (see Appendix 3) were 
developed to address the research aims. They were adapted and refined over the duration 
of data collection, taking into account the findings of my data analysis, the context and the 
timing of the interviews. To make the interviews as convenient and comfortable as possible 
for the participants they were offered a choice of face-to-face or telephone interviews. If 
they were face-to-face they took place at a location chosen by the interviewee, e.g. their 
home, place of work or in a café. Telephone interviews required me to adapt my 
interviewing style to compensate for a lack of visual clues, with more verbal communication 
on my part to maintain rapport. 
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In addition to the observations and interviews, 55 documents including the completed 
application forms, feedback forms from the training day and minutes from CSG meetings 
were collected. 
 
Table 3: UKERN, participant information 
Site Pseudonym Role Basic biography
6
 
UKERN 
Alex Professional Network Director, clinical researcher  
(Interviews at all-time points) 
David Professional CSG lead, clinical researcher 
(Interviewed at time points 1 & 3) 
Francis Professional CSG lead, clinical researcher  
(Interviewed at time points 1 & 3) 
Lee Professional CSG lead, clinical researcher  
(Interviewed at time point 2) 
Lucy Professional Epilepsy charity representative 
(Interviewed prior to representative recruitment)  
Emma Professional Epilepsy charity representative 
(Interviewed prior to representative recruitment) 
Angela Professional Network coordinator 
(Interviewed at time point 2)  
Ann Professional CSG member, facilitated recruitment and training of 
representatives, Professor, non-clinical researcher  
Faye Representative Epilepsy since she was 29 following a stroke, health 
professional, a representative for an epilepsy charity, 40 
yrs. old (Interviewed at all 3 time points)  
Hazel Representative First fit aged 20, following birth of her daughter, largely 
controlled but when changing drugs had periods of 
uncontrolled epilepsy, worked for the government, 
masters in social work, a representative for an epilepsy 
charity, daughter has epilepsy, 66 yrs. old 
(Interviewed time point 1 & 2) 
Katie Representative Retired school teacher, epilepsy for 15 years, also had 
breast cancer, approx. 65 yrs, old 
(Interviewed at all 3 time points) 
Rick Representative Clinical practitioner working with people with epilepsy, 
teenage daughter has had uncontrolled epilepsy since 
the removal of a brain tumour when she was approx.12 
weeks old, epilepsy charity volunteer, 51 yrs. old 
(Interviewed at time point 2) 
Ron Representative Health professional, had epilepsy since he was 15, 
daughter also has epilepsy, both controlled, 56 yrs. old 
(Interviewed at all 3 time points) 
Rose Representative Health professional, brother has had severe epilepsy 
since he was 8 (36 years in total), 41 yrs. old  
(Interviewed at time points 1 & 3) 
 
                                                          
6
 The information provided about each participant in this and subsequent participant information 
tables varies as a result of the amount of information known about each participant and the need to 
maintain anonymity. Approximate ages are given when actual age is unknown but enough other 
information was provided to make an informed guess.  
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2.7 Further site selection  
Once the UKERN had been selected as the main site and context for this research, as 
justified in the preceding sections, decisions needed to be made regarding the selection of 
the other sites. Clinical trials are a key part of the activity of all the UK research networks 
and a central component of epilepsy research. It was hoped, therefore, that as the network 
developed, it would be possible to observe how PPI was implemented within a number of 
trials supported by it. Within the time frame of my research it would not be possible to 
follow a single clinical trial from the funding application stage through to dissemination of 
findings, as most trials take significantly longer than the period of time my studies allowed 
for. Additionally, given the multiple possible PPI approaches, I considered it advantageous 
to look at the different PPI approached adopted at both the network and the clinical trial 
level. The UKERN was in its infancy, so had a limited trial portfolio. The Network Director 
identified three clinical trials (the only ones formally attributed to the network at that time) 
that I could potentially follow, all three of which were at the design and funding stage. 
While this was not ideal, as I had hoped to look at PPI across all stages of the research 
process, it did provide an opportunity to look at different approaches to PPI at the design 
stage of multiple trials within the same disease context. Arguably this is the time point 
where PPI may have the most impact on the design and implementation of a project. With 
the Network Director and my primary supervisor acting as gate keepers, I was able to gain 
access to all three trials with ease (see Appendix 4 for a copy of approach letter). In fact, 
the lead investigators all seemed genuinely interested in my research. Two of the clinical 
trials had already been submitted for funding at the start of the data collection period. 
While they were both subsequently funded, one did not become active until after the data 
collection period for my own research had ended and so could not be included as a site. 
The third trial was at the design stage when I started my studies and, at the time of writing, 
funding has yet to be secured. However, PPI was central to the process the group designing 
the trial went through to develop the bid and related projects. Consequently this trial made 
for an interesting site. In order to demonstrate the relationships between the different 
research sites, they are described as they would appear in a hierarchical tree structure (see 
Figure 5). The trials are ‘child’ sites stemming from the ‘parent’ UKERN, whereas the sibling 
sites are not dependent on the UKERN, but come from the same ‘grandparent’, the 
research network concept. This section gives a brief description of each site and details of 
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participant selection. Chapter 3 describes each site in more depth, exploring the PPI process 
each site undertook.  
Figure 5: Research design 
 
2.7.1 Child site one: intervention study 
In order to maintain confidentiality it is not possible to give information that might identify 
any of the sites; so the following information has been anonymised as much as possible 
while still aiming to provide enough context to understand the data analysis7.  
The research team at child site one (CS1) were working toward submitting a grant 
application for a specific epileptic condition. They were active in ensuring that they had PPI 
in both the development of the funding bid and the proposed psychoeducational 
intervention to be studied within the research if funded. The approach they took was a 
consultative one; they obtained funding to run a research user group (their terminology) 
four times over a six month period prior to the main funding bid submission, with a view to 
keeping the group going if the project was funded. The group consisted of eight 
                                                          
7
 It is not possible to anonymise the UKERN and the lack of anonymity has been agreed by the 
Network Director.  
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representatives, four of whom attended most meetings, two who attended sporadically, 
and two who joined the group late (during my second observation). The group was 
organised and facilitated by the project research assistant (Rachel) with the lead researcher 
(Nick) in attendance part of the time.  
The group followed a prescribed agenda set by Rachel and Nick, for example commenting 
on the proposed intervention, the patient information sheets and the departmental 
website. At the start of data collection the group had already met twice, consequently I 
observed two meetings (in addition to taking fieldnotes I was given permission to audio 
recorded these meetings, which I later transcribed) obtaining copies of the minutes and 
documents from the previous two and a later meeting that I could not attend. In addition to 
these documents the research team generously allowed me access to the research bid and 
intervention documentation. 
Rachel and Nick were the professionals I interviewed at this site. Although there was a 
larger group of professionals involved in developing the bid itself, they were not actively 
part of the PPI process and as such were not approached. Following Rachel’s advice I 
contacted the six representatives who were present during my observations of the user 
research group via email. Five responded to say they were happy to be interviewed. I was 
then able to secure interviews with three of them. The three representatives I interviewed 
from this site were the only representatives who were present at all of the user group 
meetings (see Table 4); this was advantageous because they were the most knowledgeable 
representatives about the PPI in the site. However, had it been possible, I realise it would 
have been interesting to see if there were any differences between the core and sporadic 
representatives with regards to their motivations for involvement. All interviewees chose to 
be interviewed in person and on average interviews took 45-50 minutes.  
2.7.2 Child site two: clinical trial  
Child site two was a UK-wide randomised controlled which trial focused on the clinical 
management of pregnant women with epilepsy. The study was awarded funding and 
commenced in spring 2011. The approach the research team used for PPI is difficult to label 
as the researchers did not define it as such. This made for an interesting site as they did not 
deliberately set out to incorporate PPI into the research process (see Chapter 3). Rather, 
the researchers stated that they conducted a feasibility study where patients were asked to 
comment on the relevance of the proposed study, prior to compiling the funding bid. They 
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had also appointed a patient representative to the data monitoring committee and steering 
group. Data collection at this site consisted of observations of two trial meetings, scrutiny 
of the responses by patients to the feasibility study, the successful bid and interviews with 
three of the four key professionals involved in the development of the funding bid and PPI 
process. The fourth professional was approached and agreed to be interviewed; 
unfortunately, scheduling problems prevented this from happening (see Table 4). The trial 
was just starting to recruit when my data collection phase ended. While a patient 
representative had been appointed by that stage they had been unable to attend the first 
data monitoring committee meeting. It was decided that as the representative was yet to 
be actively involved in this site it would not be appropriate to interview them.  
Table 4: Child sites, participant information 
Site Pseudonym Role Basic biography 
Child site 
one 
Rachel Professional Research assistant, Psychology degree, 4/5 years’ 
experience of researching this type of epilepsy 
condition, approx. 28 yrs. old  
Nick Professional Lead researcher, Reader and Honorary Neurology 
Consultant, specialised in epilepsy for ten years, 
extensive involvement with epilepsy charities 
Moira Representative  ‘Sufferer’ for 5 ½ yrs, set up a support group 
which is now a registered charity which she runs 
with husband Jim, 31 yrs. old  
Jim Representative Moira's husband and carer, Chairmen of a charity 
he founded and runs with Moira, 31 yrs. old 
Claire Representative ‘Sufferer’, also had a number of physical and 
mental health conditions currently unemployed, 
37 yrs. old 
Child site 
two 
Sue Professional  Trial co-ordinator, first clinical trial, one previous 
research post which was related to epilepsy,28 
yrs. old 
Oliver Professional  Practicing Neurologist and epilepsy specialist 
who identified the research question and was a 
co-applicant on the funding bid, approx. 35 yrs. 
old  
Bill Professional Primary investigator, medically trained as a 
doctor specialising in obstetrics and gynaecology, 
became an academic, experienced trialist, 
approx. 55 yrs. old 
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2.7.3 Sibling site one: comparator epilepsy network  
In October 2004, prior to the establishment of the UKERN a government funded research 
network was established to create a multi-disciplinary and co-operative approach to 
epilepsy research in a designated region of the UK and to enhance best clinical and 
investigative practice in epilepsy. This network was selected as a study site for a variety of 
reasons; (i) it could provide a disease-specific comparator research network which used a 
different approach to PPI, (ii) it could provide insights into PPI activities in an already well-
established network, which would not be possible from the UKERN, (iii) the UKERN drew 
upon this epilepsy network’s structure and experiences during the early phases of its own 
development and (iv) it had overlapping aims and professional membership with the 
UKERN, making it part of the same ‘story’. 
The comparator epilepsy network (CEN) was made up of four research and development 
groups; Biomedical, Clinical, Health Professional and a Patient Forum. The Patient Forum 
was made up of 18 representatives, a coordinator (Jess) and a Neurologist (Tom), who met 
face-to-face approximately every three months, with email communication between 
meetings. The Patient Forum both consulted on projects for the rest of the network and 
identified its own research priorities. In contrast to the UKERN the representatives in the 
comparator network were not required to fit pre-specified criteria; rather anyone who 
wished to be involved could be, thus offering an insight into the potentially diverse 
experiences of different ‘types’ of representatives.  
Due to geographical distance and the frequency of meetings, with the support of my 
supervisors, I decided that a one-off approach to exploring PPI in the comparator network 
would be most appropriate. Jess acted as a key informant and gate keeper. She provided 
me with copies of the minutes of all past meetings and examples of feedback the group had 
provided to researchers. She identified representatives who she believed reflected the 
spread of people and opinions within the group and arranged for me to interview them 
over a two day period either side of a patient forum meeting (two of the interviews were 
done in husband and wife pairs at their request) (see Table 5). She also drove me to the 
various interviews, meaning that in addition to the formal interview I undertook with her, I 
also had the opportunity to have extensive informal conversations that I documented in my 
fieldnotes. In addition to the representatives and Jess I also interviewed Tom and the 
Network Director, giving me both ‘on the ground’ and policy level perspectives on PPI in the 
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comparator network. My observation of the Patient Forum meeting was audio recorded 
and transcribed providing a more in-depth account of the meeting alongside the fieldnotes. 
Table 5: Sibling site one, participant information 
Site Pseudonym Role Basic biography 
Sibling site 
one 
Tom Professional PhD student linked to the network, taking a break 
from his Neurologist training, clinical researcher, 32 
yrs. old 
Jess Professional Network coordinator, completed an epilepsy related 
qualitative PhD, clinical practitioner, researcher, 
approx. 30 yrs. old 
Les Professional Network Director, genetics professor.  
Max Representative Retired, worked in skilled and academic occupations, 
diagnosed with epilepsy 20 yrs. ago, how controlled 
his epilepsy has been has varied over time. 
8
 
Matt Representative Support worker, working for ten years with people 
with learning difficulties, the majority of whom have 
epilepsy.  
James* Representative Retired head teacher, diagnosed with epilepsy 10 
years ago, been on and off drugs in that time, 
relatively ‘mild’ and mostly controlled, 59 yrs. old 
Jill* Representative Retired teacher, James’s wife, approx. 60 yrs. old  
Paul Representative Had epilepsy since he was 12yrs old, frequency of 
seizures has varied over time and medication, 
averages 1 seizure every 7 weeks, part of the British 
Epilepsy Association, had not yet attended a CEN 
meeting, 42 yrs. old 
Sam Representative Had epilepsy since he was 12, it was uncontrolled until 
he was 21 then ‘controlled’ until he was 55 now 
uncontrolled again leading to clinical depression. 
Successful career while controlled, one of his children 
has epilepsy and other medical difficulties, approx. 69 
yrs. old 
Molly Representative Brother died from epilepsy aged 21, she has had 
epilepsy all her life, active fund raiser, cancer survivor 
and part of the cancer network. Two teenage children 
Chris Representative Husband and career to Molly, had a work related head 
injury 
*    interviewed together. 
 
 
                                                          
8
 Controlled seizures mean that the seizures have stopped having responded to treatment; 
Uncontrolled seizures are ones which continue, even though the person has tried one (or many) 
medications. 
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2.7.4 Sibling Site two: the UK topic specific research networks  
As previously mentioned, the National Institute for Health Research (NIHR) established a 
Comprehensive Clinical Research Network (CCRN) in 2006 resulting in six topic-specific 
Clinical Research Networks and the Primary Care Research Network. Within these networks 
PPI was prioritised from the beginning, with designated funding attached to a PPI ‘lead’ 
role, which was mandatory in all networks. The CCRNs were included as a site in order to 
understand the broader context within which PPI is currently operationalised in UK health 
research and to gauge to what extent the findings obtained from the epilepsy sites are 
disease specific. The aim was not to generate a detailed understanding of the PPI processes 
implemented across the Networks (to do this, each of the seven networks would have to be 
treated as an individual site, which was outside of the scope and aims of this research). 
Rather the aim was to get an overview of PPI processes and an understanding of key issues. 
It was decided that this would be achieved by interviewing the PPI leads. All seven PPI leads 
in the CCRN were contacted via email, five responded and were interviewed, three face-to-
face and two over the telephone (see Table 6). 
Table 6: Sibling site two, participant information 
Site Pseudonym Length of time in post 
9
 
Sibling site two  
Sarah 4 yrs. 
Owen 5 yrs. 
Lyn 6 months  
Fred 4 yrs.  
Charlie 2 yrs. 
Adele  6 yrs. 
Although observation of the CCRN PPI leads at work was not part of my original research 
plan, I took advantage of opportunities that presented themselves. For example, I was able 
to observe a CCRN PPI network leads meeting and regularly interacted with some of the 
more locally based leads at PPI related meetings such as the North West People in Research 
Forum. Around the time I started data collection, the CCRN conducted an internal 
evaluation of PPI in the networks. This resulted in two key documents: ‘The Way Forward 
Report’ and the ‘Making a Difference Report’. These were both included in my data 
analysis.  
                                                          
9
 It is not possible to provide more information and maintain anonymity due to the small number of 
people with this job role.  
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Figure 6 shows the timeline of data collection, highlighting which sites I was actively 
following at a given time. Table 7 provides a summary of the data collected across all sites. 
Table 7: Data summary 
Site Data Type 
UKERN 
26 Observations  
24 Interviews with 13 people  
55 Documents Inc. 26 applications  
Intervention study 
(CS1) 
2 Observations 
5 Interviews 
15 Documents 
Clinical trial 
(CS2) 
2 Observations 
3 Interviews 
5 Documents 
Comparator epilepsy 
network  
(SS1) 
1 Observation 
9 Interviews with 11 people 
13 Documents 
Network PPI leads 
(SS2) 
4 Observations 
6 Interviews 
2 Documents  
Total  
35 Observations 
47 Interviews 
90 Documents 
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Figure 6: Timeline of data collection 
 
 2010 2011 2012 
  Feb May June July Aug Sep Oct Jan Feb April June Aug Sep Nov  Feb March  
UKERN 
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Reps 
  Professionals 
Interviews  
Training 
Day 
First 
meeting 
with PPI 
Reps 
    Reps 
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face 
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Minutes  
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              Interviews               
 
Note: Blocked out sections represent when the site was being actively followed, Reps= representatives, only a sample of the UKERN observations 
are detailed in this figure.  
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2.8 Analysis: understanding my data  
Qualitative data analysis is not seen as a discrete stage in the research process to be 
conducted once all data has been collected. Rather it is a pervasive and integrated activity 
throughout the research (Coffey & Atkinson, 1996). This is particularly important in 
ethnographic studies where later stages are generally dependent upon earlier ones. Gibbs 
(2008) argues that data analysis is essentially the interpretation of what is going on. 
Analysis therefore starts to take shape informally in the ethnographer’s analytical notes, 
initial ideas and hunches (Hammersley & Atkinson, 2003). Consequently the construction of 
my fieldnotes was part of the first stage of my analysis process (Fetterman, 2009), as I 
made sense of what I was observing and highlighted areas of interest to be followed up and 
further explored (see Figure 7). 
Ethnographic analysis is an iterative process, building on ideas and perceived patterns 
throughout the study (Fetterman, 2009); with the continual development of theories, 
testing and funnelling of information, and becoming progressively more focused over time 
as ideas solidify and become more robust to testing (Hammersley & Atkinson, 2003). This 
must be done while paying attention to both the detail and the larger context (Fetterman, 
2009). The time frame of my data collection and ethnographic approach reinforced the 
recursive nature of the analysis process and I was often simultaneously in different phases 
of the analysis process at a given time. Thematic Analysis, Grounded Theory, Interpretative 
Phenomenological Analysis (IPA) and Narrative Analysis can all be used within an 
ethnographic methodology (Cooper, 2012; Fetterman, 2009; Flick, 2009a; Silverman, 2006). 
I chose to use a thematic analysis as it allowed me to look both across and within sites and 
roles.  
Figure 7: Data analysis process 
 Stage One  
During data collection  
Stage Two  
Focused analysis 
C
o
n
cu
rr
en
tl
y 
Discussions with supervisors, colleagues & 
member checking 
Discussions with 
supervisors & colleagues 
Fieldnotes: identifying possible patterns & 
areas of interest- testing these patterns  
Focused thematic 
analysis 
Initial thematic coding- emphasis placed on 
comparator epilepsy network and participants 
undergoing multiple interviews. 
Write up  
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2.8.1 Thematic Analysis  
My analysis was based heavily on the work of Braun and Clarke (2006) and their step-by- 
step guide to thematic analysis. I chose this approach as it is more prescriptive than others 
while remaining flexible, is in line with my theoretical stance and addresses the research 
aims. Thematic analysis is a method for identifying, analysing and reporting patterns (or 
themes) within data. At its most basic level it organises and describes the data, with more 
sophisticated analysis interpreting aspects of the phenomenon under scrutiny (Boyatzis, 
1998).  
A common discourse within thematic analysis and qualitative analysis in general, is that of 
‘themes emerging’ from the data during analysis. Taylor and Ussher (2001) argue that: 
“Discursive themes do not just lay about waiting to be discovered, they do not simply 
emerge, but must be actively sought out” (p.310). Braun and Clarke (2006) develop this idea 
further by highlighting that describing themes as ‘emerging’ presents analysis as a passive 
process and does not take into account the active role the researcher plays in identifying, 
selecting and reporting themes. This implies that the themes exist in the data independent 
of the researchers’ interpretations, a position that is not consistent with a 
phenomenological stance. Braun and Clarke stress the point that thematic analysis is about 
making decisions regarding the data and recognising them as decisions.  
Thematic analysis can be either deductive or inductive. Deductive analysis works from a 
pre-existing coding frame generated from theory or building on prior research. Inductive 
analysis generates themes from the data with no prior assumptions or framework (Boyatzis, 
1998; Patton, 2002). As the purpose of this research was to explore the PPI process from 
the perspective of those involved, with the belief that currently little is ‘known’ in the 
literature, my analysis was an inductive one. All codes and themes originated from my 
interpretations of the data during the analysis process, with the research objectives as a 
guide. Figure 8 describes Braun and Clarke’s (2006) six phases of thematic analysis which I 
used as the basis of my analysis. In addition, in keeping with the ethnographic approach, I 
viewed my fieldnotes as part of phase one (Hammersley & Atkinson, 2003) and viewed the 
process of writing as an ‘analytical tool’ to further data analysis and integration of related 
empirical literature (Hammersley & Atkinson, 2007). This placed greater importance on 
phase six than implied by Braun and Clarke.  
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Figure 8: Phases of thematic analysis, from Braun and Clarke (2006, p.87) 
 
As each interview was completed it was transcribed verbatim by a professional scribe. The 
decision not to transcribe the interviews myself – useful to facilitate the familiarisation 
process – was based on two factors. Firstly the number of interviews meant that 
transcription would be very time consuming and I might not be able to finish one set before 
the next round of interviews, affecting the iterative nature of the ethnography. Secondly 
the use of correct spelling, grammar and punctuation is extremely important during 
transcription as it can affect the meaning of and in turn the interpretation of a sentence. 
Achieving the required level of accuracy is outside of my abilities given my dyslexia. Once I 
received a completed transcript I checked it against the audio recording to ensure accuracy 
and anonymity. 
As detailed in Section 2.6.1 alongside the formal, semi-structured interviews I also collected 
data in the form of fieldnotes from my observations and relevant documents. As I collected 
data they were combined in one NVivo database, making up my data corpus. Each piece of 
data was cross-referenced by site, type of data, type of participant (professional or 
representative) and pseudonym. This was necessary to manage the quantity of data 
collected and reduce the likelihood of information getting lost or missed. NVivo’s ‘query’ 
function allows for cross-referencing and pulls out information based on code and category. 
For example, it can pull out all data coded as ‘challenges’ within the representatives’ data, 
or data coded as ‘process’ in a given site. This made it easier to analyse the data as a whole 
and by sub-group, which was required for reasons that will become apparent later in this 
section. 
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Each type of data was treated in the same exact same manner. As it was imported into 
NVivo I read it through carefully (at least twice), recording any thoughts or ideas for further 
exploration using the ‘memo’ function (phase 1). During this time I also started to generate 
initial codes (phase 2). These early codes were very broad sweeping and loosely based on 
the interview questions, for example: benefits, challenges, motivations and understanding 
of PPI. Rather than adopting a grounded-theory, line-by-line coding method (Glaser & 
Strauss, 1974), I used a broader point-by-point approach to help keep the parts of the data 
linked to the whole (Riessman, 2008). The time frame of the data collection (see Figure 6) 
meant that I was able to do preliminary coding of the data from the comparator epilepsy 
network prior to conducting interviews at other sites. After reviewing these initial codes 
and reading over the ‘memos’ I started to identify possible areas of interest (phase 3), to 
explore further during subsequent observations and interviews (phase 4). Throughout my 
data collection period I cycled through phases 1-4 as new data was collected. I went 
through preliminary coding and I identified potential areas of interest that were then 
explored. Alongside regular reflective discussions with my supervisors (one of whom, as 
noted, was also a primary informant), I had many opportunities to explore and test my 
developing theories with different participants across different sites, both formally as part 
of interviews and informally during unstructured conversations, providing a consistent form 
of member checking. I prioritised analysing data from participants who were interviewed at 
multiple time points and keeping track of potential themes or things to ‘follow-up on’ in my 
fieldnotes to ensure that later interviews were grounded in, and developed from, pre-
existing data. One of the main advantages of conducting multiple interviews was that it 
gave me an opportunity to clarify any ambiguity arising from preceding interviews in 
subsequent ones. This iterative method of analysis meant that both my fieldnotes and 
interview data became enmeshed as information from the fieldnotes helped to determine 
interview questions, and participants responses in interviews affected what I focused on 
during my observations.  
Consequently, by the end of my data collection period I was already very familiar with the 
data and had developed ideas about codes and themes for when I shifted to a period of 
more focused and intense analysis. Building on the preceding analysis the whole data 
corpus was re-read and coded. I felt that this was particularly important as some of the 
earlier data had not been looked at in light of later insights and codes. By this stage of the 
process the codes were less linked to the original topic guide and were more detailed. For 
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example, rather than just coding data as a ‘challenge’, it was also coded by ‘type’ of 
challenge, which by this stage of the analysis consisted of 43 sub-codes that I had identified 
over the course of the data collection and analysis process. By the end of the data analysis 
process as a whole there were 109 codes and 169 sub codes, although it needs to be noted 
that many of the codes heavily overlapped.  
Having established this overview of the data corpus I started to define and name themes 
within the data (Phase 5). It became apparent to me that there were four main areas of 
interest that I then pursued by conducting more focused analysis. 
The first area of interest and analysis concentrated on data related to the PPI processes 
within each of the sites (this was largely based on the professionals’ data and fieldnotes). 
Drawing on the questions, what did they actually do? and why did they do it?, this helped 
to address research objective 1: ‘To describe how PPI was implemented within the specific 
context of the UKERN, and in the research linked to this network’, and to provide a context 
for the rest of the findings (see Chapter 3). The second area of interest and analysis drew 
exclusively on data from the professionals to explore their experiences and views of PPI. 
The findings of this analysis are presented in Chapter 4. The same process was then 
repeated with the focus on the representatives for the third analysis (see Chapter 5) thus 
addressing research objective 3: ‘to describe the experiences of the representatives and 
professionals involved in the PPI process, including their perceptions of the benefits and 
challenges of PPI’.  
During the second and third focused analysis the professionals and representatives were 
initially treated as a cohesive group. The data was then further analysed to look at the 
experiences across and within sites, this was part of the fourth ‘synthesis’ analysis. As 
explained in section 2.3 the hermeneutic circle moves between interpretations of the parts 
of a phenomenon under study and the whole (Chadderton, 1994) so that by systematically 
exploring the whole, new insights and an increased depth of understanding of the 
phenomenon will be produced. This information is then used to examine the sub-
components of the phenomenon, in turn resulting in new understandings that need to be 
re-explored in terms of the whole (Leonard, 1994). I drew on the premise of the 
hermeneutic circle during the fourth analysis in order to address objective 4: ‘to compare 
different approaches of implementing PPI, by contrasting the experiences of the 
professionals and representatives across the different research sites’. As insights were 
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gained from the three sub- components or themes they were then used to examine my 
data as a whole. For example was there any consistency across all the groups about what 
were considered essential aspects of PPI? Was there any consistency in the decision making 
process about the approaches to PPI adopted by each of the sites? Where was there 
dissidence in opinion? Was there any anomalous information that provided insight into a 
majority view? As I developed my understanding of PPI in my sites as a whole this 
information was then evaluated and re-tested within the sub-components, which in turn 
fed into my understanding of the whole. This continued until I had reached the point that I 
considered ‘optimal understanding’ (see Chapter 6). 
My ideas were developed through discussions of my findings with my supervisors, informal 
discussions with my colleagues and presenting at the PhD data analysis sessions in my 
department. These meetings provided me with space to step back from the data and to 
obtain the opinions of others not immersed in it. This was invaluable as it helped me 
evaluate and justify the decisions I was making with regard to my analysis.  
As identified by Broun and Clarke (2006) the 6th phase of a thematic analysis is producing 
the report. In writing my results chapters I was continually refining themes, making 
decisions regarding which themes and codes were pertinent, linking them to each other, to 
the research question and relevant literature. It was also the point at which I had to choose 
which extracts in my substantial data set most supported my findings. During the 
concentrated data analysis process I found that the data from documents was not, on the 
whole, as pertinent as that from interviews and fieldnotes. While in some cases they gave 
insight into process, they gave little understanding of people’s experiences and 
perceptions. Consequently they are only sparsely represented in the following results 
chapters. As previously mentioned my fieldnotes were enmeshed with my interviews, many 
of the issues identified in my fieldnotes were discussed directly with participants in the 
formal interviews. In presenting my data in the following chapters, I have prioritised 
examples of findings from the interview data over that of fieldnotes as it allows for more of 
the results to be supported by participants’ own words.   
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2.8.2 Presentation of data 
For stylistic purposes and ease of reading, quotes presented in the results chapters have 
been ‘tidied up’ of some of the hesitations and repetitions, while still maintaining their 
integrity. For example, ‘umm ere er uummm I guess’ is presented as ‘ummm er I guess’ or ‘I 
don’t know, don’t know …. ur I suppose I don’t know the answer’ is reported as ‘don’t 
know…. ur I suppose I don’t know the answer’. The quotes are formatted based on 
recommendations in British Psychology Association style guide (2004), Table 8 describes 
the transcription symbols used. The number of quotes used to support the findings varies 
as a result of the number of participants linked to a given point and the level of divergence 
in the related quotes.  
Table 8: Transcription symbols 
Symbol Meaning 
…. Brief pause 
..[..].. Jumps to a latter point in the same 
transcript 
[No.] Timed pause in seconds 
[ ] Additional information to make the quote 
clearer  
‘ ‘ Indirect or approximate quote 
“ “ Direct quote  
(( )) Description of something that cannot be 
transcribed verbatim.  
‘Text in Grey’ Data from Documents and Fieldnotes  
2.9 Ethical Considerations  
This research complied fully with the ethical practice guidelines laid out by the British 
Psychology Association and the University of Liverpool. After a detailed discussion with the 
chair of the local NHS Ethics Panel and the University of Liverpool Ethics Board, it was 
agreed that the project did not require NHS ethics committee approval and should be 
vetted though the University Ethics Board (See Appendix 5). While some participants were 
working as clinicians within the NHS or were patients in the NHS system, they were not 
approached in these capacities; instead they were approached in their roles as academic 
researchers and individuals with epilepsy and/or an interest in epilepsy research. 
Consequently, the research was deemed to lie outside the remit of NHS ethics. The 
ethnographic nature of this research meant that additional attention was paid to issues 
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surrounding informed consent and anonymity, for reasons explained in the following two 
sections.  
2.9.1 Informed consent 
All participants who were interviewed gave signed, informed consent. Prior to consent they 
were provided with an information sheet about the study (see Appendix 6). They were also 
given time to discuss the study with myself or anyone else they wished to. They were told 
that they could withdraw their consent and leave the study at any time without giving a 
reason. Consent for audio-recording the interviews and fieldnotes was included within the 
consent form.  
Consent for observations was sought from the person facilitating the event. All participants 
gave informed verbal consent at the beginning of each observation, but written consent 
was only obtained from the facilitator. At no point were the observations covert or 
conducted without all participants’ knowledge.  
Informed consent within an ethnographic study has to be considered differently to the 
standard anticipatory regulatory regimes that take place in most research processes 
(Murphy & Dingwall, 2007). As the ethnographic research process evolves the questions 
being asked may change and the levels of access can expand and therefore cannot be 
completely agreed to in advance (Parker, 2007). Therefore in addition to the standard 
forms, consent in an ethnographic study is a sequential process and must be revisited 
throughout the duration of the research (Murphy, Dingwall, Greatbatch, Parker, & Watson, 
1998). Although the wording of the participant information sheet described the developing 
nature of the study, particular attention was paid to ensuring that participants were aware 
of any changes within the study and that they were still happy to give their consent. Where 
participants were interviewed more than once, I reconfirmed their consent at the start of 
each interview.  
2.9.2 Data Protection and Anonymity  
The research complied with the Data Protection Act of 1998, concerning the handling, 
processing and storage of the study data. All data (consent forms, audio-recording devices, 
fieldnotes, interview transcripts etc.) were kept secure in locked filing cabinets and the data 
used in the write-up was anonymised using pseudonyms and the removal of any identifying 
features such as names and places. This was also the case for any fieldnotes that others 
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might have access to. In situations where it might not be possible to completely anonymise 
data, for example where there was only one person in a specific role within one of the 
organisations in the study, this was addressed either at the data analysis stage or through 
consultation with the individual concerned. Particular care had to be taken when asking 
participants their views about issues that had arisen, as it might be possible for others 
within my sites to guess who I was referring to. That I was following more than one group 
helped with this as I could generalise to outside of individual sites.  
2.10 PPI in this PhD 
In accordance with the ethos of this research I considered it important that the 
perspectives of patient and public representatives were considered at multiple stages in my 
research process. It was hoped that such involvement would help to ensure the relevance 
of the PhD research, give a measure of validity and help to address any emerging 
methodological issues. As both professionals and representatives are potential users of this 
research it was important that both groups’ views were obtained.  
As previously stated ethnography is an iterative method with information from each step 
informing the next. Accordingly, research participants continually shaped the research 
questions and process. For example, if one participant highlighted something as important 
it could be integrated into the topic guides for subsequent interviews. Therefore it can be 
argued that all participants had a collaborative role within this research. It was also 
considered important to provide discrete opportunities for patients and the public external 
to the research to give feedback on the research as a whole.  
Due to time and resource constraints I considered it appropriate to gain initial feedback 
about my research ideas, aims and methods from a pre-existing PPI group, rather than 
establishing a new group of individuals. Epilepsy Action (EA) is a registered charity providing 
a range of support for people with or affected by epilepsy. EA hosts a member-based 
group, the Epilepsy Action Research Network (EARN), which is composed of representatives 
tasked with giving feedback on grant applications submitted to the charity and input into 
other related research projects.  
The consultation with EARN members took place approximately four months into data 
collection. This allowed the topic guides and research focus to be developed during initial 
interviews and observations before obtaining feedback on them, while still providing time 
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for the representatives’ views to be integrated into the project. In consultation with the 
EARN coordinator, a letter was drafted to the group outlining the research and its aims. 
Enclosed with the covering letter was a feedback sheet asking for their opinion on the plain 
English abstract, the groups of people that might be interviewed, the draft interview topic 
guides and the relevance of the study (see Appendix 7). Feedback was received from 20 
EARN members, with 14 agreeing to be contacted again if needed in the future. The 
comments I received from the EARN members helped me to clarify different aspects of the 
plain English abstract, validate the research questions and highlight a potential additional 
group of participants. 
2.11 Summary  
Epilepsy, and more specifically the UKERN, was chosen as the context in which to: Generate 
a detailed understanding of patient and public involvement in health research. This was 
achieved by using a multi-sited ethnographic approach which addressed both the research 
aims and my theoretical positioning. In line with the chosen methodology data were 
collected using a variety of methods including informal interviews, semi-structured 
interviews, observations and fieldnotes, which were thematically analysed. The data were 
divided into three broad analysis groupings: process, professionals’ experiences and 
representatives’ experiences. These are each addressed in turn in the following three 
chapters. 
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Chapter 3. How PPI was operationalised  
3.1 Introduction  
In Chapter 2 I emphasised that the ethos of a multi-sited ethnography is not to carve out 
one part of the story but rather to try to look at the whole, as each part is intricately linked 
to the others around it. This, I found, held true when I was conducting my data analysis. 
When trying to separate out the experiences of the professionals from those of the 
representatives, or from the process, I quickly learnt that the one does not make sense 
without consideration of the others. The perceptions of the professionals influenced their 
approach to PPI, different approaches resulted in different experiences, the experiences of 
professionals and representatives directly impacted on their counterparts, and their 
experiences in turn confirmed or changed the perceptions of those involved. However, to: 
‘describe the experiences of the people involved in the PPI process, including their 
perceptions of the benefits and challenges of PPI’ (Objective 1) or: ‘to compare different 
approaches to implementing PPI’ (Objective 4) it seemed important to first separately 
explore how PPI was implemented in the UKERN and in each of the sites. To give an insight 
into what it means to ‘do PPI’ and provide the context for later explorations of the data, in 
this chapter I describe and interpret the process that each of the epilepsy related sites 
undertook in setting up and implementing PPI, highlighting key aspects of the decision 
making process and the factors that were of importance to them. 
Once I have described the site specific PPI processes I then go on to explore some of the 
commonalities and differences across the different approaches. Throughout this chapter I 
largely focus on the information I obtained through interviews and observations with the 
key professionals at each site. The reason for this is that they were involved in each stage of 
the process and as such had access to aspects of the PPI process that the representatives 
were not involved in. They were also nearly entirely responsible for any choices made 
around PPI in their site and as such, in this context, their explanations in general, provide 
more insights into the development of the PPI approach and decision making processes 
than those of the representatives. However, I draw on information from the 
representatives whenever their perspectives enhance the description of the process.  
In Chapter 2 I explained that sibling site two, the UK topic specific research networks, was 
approached differently to the other sites. The aim of including it was to provide an 
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overview of PPI experiences and an understanding of the perceptions of the key issues 
among the Network PPI Leads, who had considerable experience of implementing PPI, 
rather than to generate a detailed understanding of the particular PPI processes they had 
implemented. Given this and that my research objectives focus specifically on describing 
PPI in epilepsy research, data from sibling site two is not described in this chapter, but is 
considered in Chapter 4.  
The comparator epilepsy network (CEN) was established prior to the UKERN; as such the 
UKERN drew on the CEN when developing its own process. Therefore to fully explain the 
PPI process within the UKERN, it is necessary to first describe the approach to PPI in the 
CEN. This ordering also feels particularly appropriate to me as the CEN is the first site that I 
completed.  
3.2 Sibling site one: comparator epilepsy network 
As I explained, in this chapter I am mainly drawing upon the interviews and observations I 
conducted with the lead professionals; within this site they consisted of Les, Jess and Tom. 
Les, a Professor of Genetics, was the founder of the network and as such was able to offer a 
unique insight into its inception and initial stages. He acknowledged that he knew little 
about the day to day functioning of the patient group but in line with his role he had clear 
ideas about its purpose and how it was perceived within the Network as a whole. Jess, the 
Network Coordinator, had been in post since funding for the network had been obtained 
five years previously. Part of her role was to set up and facilitate PPI within the network. 
Alongside this she co-ordinated the rest of the network and completed an epilepsy related, 
qualitative PhD. At the initiation of her role she had no previous PPI experience. Tom was a 
PhD student linked to the network. He had taken a break from his Neurologist training to 
focus on researching epilepsy and viewed himself as Jess’s helper, taking the role of the: 
“non-threatening clinician” (Tom) within the group. He had sat on groups with patient 
representatives before but this was the first time he had taken an active role in enabling 
PPI.  
During the first year of the network three research development groups (RDGs) were 
formed. The close knit nature of the professional epilepsy community meant that they: 
“already knew who might want to get involved” (Jess). Once the RDGs had been established 
attention was given to PPI. Les explained that the purpose of the network was to involve as 
many different people as possible in epilepsy research: “because of the nature of the 
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funding call as well, where involving people was at the centre of one of its core principles” 
and as such PPI was integrated into the aims of the network: “well, on the mission 
statement, our network is a collection of scientists, clinicians and patients in partnership” 
(Tom). Drawing on this core principle of partnership the lack of patient and public 
representative presence within the network was seen as something that needed to be 
addressed: “a discussion in 2004, myself and there was about 10 other people including 
epilepsy nurses, and we just decided this would be a good idea“ (Les). 
What makes this site different from the others I studied is that other than knowing they 
wanted representatives to become part of the network the researchers: “didn’t have strong 
ideas about what we might get from it, and so without that kind of, the constraint of about 
how to set it up” (Tom). In addition, Jess’s lack of knowledge and experience of PPI meant 
that she did not have any preconceptions about the best method of implementing PPI. 
Consequently, she took a very different approach to establishing PPI than the other sites 
(see Figure 9).  
Figure 9: PPI process in comparator epilepsy network  
 
Synonymous with how she coordinated the professionals RDGs, Jess started by contacting 
representatives who she identified might be interested in being involved. These firstly 
consisted of people who either Jess or her colleagues had met during the course of other 
projects and who had also expressed an interest in further involvement in the research 
process: “we had met lots of really lovely, really interested people who were always saying 
‘oh if there is anything else I can help with if you are doing any other research let me know” 
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(Jess). She also contacted epilepsy nurses and clinicians asking: “do you know of anybody 
who would like to attend this sort of thing?” (Tom). She asked the identified people if they 
would like to: “come along and sit perhaps on the other RDGs and kind of be a 
representative” (Jess). The representatives, however, did not wish to sit on the other RDGs. 
They told Jess they wanted their own group, in order to have an opportunity to consider 
their own research questions, something that they did not feel would happen if they were 
integrated into the other groups:  
“The feedback we got said that is not really what they wanted to do, they would 
much rather have their own research development group, that they had lots of ideas, 
and instead of being a representative on somebody else’s group they would really 
like to have their own group so, I guess that is where it all started from.” (Jess) 
This request for their own patient RDG was supported by Jess, Les and Tom’s belief that 
representatives would be more confident, and therefore more likely to have honest input 
to group discussions, if they were surrounded by other representatives as opposed to being 
outnumbered by professionals.  
It was decided not to have any selection criteria for membership to the patient RDG, rather 
anyone who wished to be involved could be: “we sat down at the beginning and decided 
whether or not we should place restrictions on who should come to the RDG or try and 
select and in the end we decided not to” (Jess). Jess believed that if they were to have 
selection criteria they would only include individuals with academic ability and extensive 
research knowledge. While this would have been advantageous in terms of applying for 
funding and conducting research, Jess felt that such representatives would not be genuinely 
‘representative’ of the epilepsy community as a whole. As such it would go against the 
ethos of the network which was to include anyone interested in epilepsy research: 
“If I was looking back to when we were thinking whether we should set limits, I guess 
we were thinking about people who understood research, who were academically 
able enough to perhaps write papers with us, or review things properly. So I guess 
that was the kind of the people we, we might have constrained it to. But again, even 
then it was obvious that they weren’t the kind of people, ok, so there are people like 
that who have epilepsy, of course there are, but there are lots of people who aren’t 
like that, that have epilepsy so, I guess that’s why we chose not to do it because they 
would be representative of their own kind of people, not of people with epilepsy. 
Yeh, does that make sense?“ (Jess) 
Les and Tom also placed considerable importance on the ‘representativeness’ of the 
representatives. In line with this it was not just patients that became part of the group but 
family members and friends as well. The group was extremely varied in terms of experience 
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and ability and while Tom acknowledged that the group could never be truly 
representative, he felt that they were as close to achieving that as possible: 
“You know we couldn’t hope to get a genuine variety of experiences with only 16 
people or 20 people or a wider group. You know we don’t permanently have 
somebody who is pregnant on the group; we haven’t gone out looking for a complete 
balance. Um, we don’t have children on the group you know, but I think within the 
naturalistic style of the way that it was created, urm, that the scope is very fitting 
actually, I think it’s very suitable.” 
The lack of a clearly defined purpose for the group initially meant that the first few 
meetings revolved around establishing how the group was going to work and what they 
wanted to address. Jess and Tom admitted that this was difficult to begin with as they did 
not want to dictate how the group functioned, as the representatives had ownership of the 
group. At the same time the representatives needed Jess’s and Tom’s knowledge to make 
the group work:  
“Some people [representatives] were a little bemused, I think some people just gave 
up their time, because it was a good thing and didn’t really know what they were 
giving up their time for, didn’t know, even after a couple of meetings what this was, 
you know whether they were, you know had power, whether they had money to 
spend, uerm whether they had a bigger role.” (Tom) 
Jess reflected that the way she dealt with this uncertainty was to be honest with the 
representatives that she was not clear about how the group was going to work and that 
they would have establish together what they wanted out of the group and how they were 
going to achieve it: 
“It’s been a real learning curve both for us and for the patients, and the people who 
come to the group as well. But I hope from the very beginning we have been really 
honest about that and kind of, very clear that this is a journey that we are on 
together, and it’s, it’s not going to be perfect straight away and there is work to do.” 
(Jess) 
Originally there was meant to be a different representative acting as Chair of each meeting, 
but this proved to be problematic because under this system the group did not manage to 
cover everything on the agenda, so Jess took over managing the meetings:  
“Ahh although we have a patient chair, Jess has to chair it because, it has come to 
pass that Jess has to be ipso facto chair, because of time and structure and she is 
much more familiar with the mechanics of how the meeting runs, and leaving it to 
the elected patient chair, er it didn’t keep the kind of structure that would make sure 
you, could do everything within the time allotted.” (Tom) 
The meeting that I observed was the group’s sixth. By this time the members had worked 
out how they wanted the meetings to run. The group decided to meet approximately once 
every three months and to considered itself as having two main functions. The first was to 
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provide feedback to the other RDGs about their projects and the second was to develop 
their own research ideas. It quickly became evident to those involved that the two hour 
time slot given to each meeting was not sufficient to cover everything and to accommodate 
the diverse range of personalities and abilities of the group. It was decided that the 
majority of work would be done outside of the official face-to face meetings, either by 
email or in smaller working groups:  
“We decided that most of the actual work would go on outside those meetings. So 
what we will sometimes do is we will say right, we are thinking about putting a grant 
application in on this subject, if you would like to be involved let us know and we will 
arrange a meeting outside this time. Or if we get asked, um, to review patient 
information sheets or consent forms and stuff, we will send round the group and say 
if you can within the next few weeks can you let us have your feedback, and the 
meetings have become just a really nice opportunity for all the members to get 
together, throw research ideas around, perhaps getting someone to come and talk 
about their work, catch up with each other and I guess just be in that kind of 
stimulating environment.” (Jess) 
Another thing that quickly became apparent was the need to establish guidelines for 
researchers who wanted feedback from the group. In the beginning the group were 
frustrated with how little time they had to return their feedback, as often the researchers 
approaching them were working to an imminent deadline. They needed to explain to the 
rest of the network that the group could not function efficiently like that and if they were 
only given 48 hours’ notice it was likely that only one or two members would be able to 
give cursory feedback. Alternatively, if they were given, say, three weeks most people 
would have time to give detailed responses. The representatives suggested to Jess that 
they would have an easier time providing feedback if researchers came to the group in 
advance and talked about their research in general so that they could place the information 
that they were looking at it context. Consequently the first half of the meetings normally 
consisted of a guest speaker:  
“They have then elected to have people come and just talk about their research in 
general, so we talked about brain imaging in general, um so people can ask questions 
about it, understand his, you know why look at the brain, why at the concept level so 
that when he comes in a year’s time, 3 years’ time, with projects you sort of 
understand him and the reason why.” (Tom) 
Over dinner after the meeting that I attended, Tom remarked that: ‘one of the speakers had 
acknowledged that this was particularly beneficial for him as he did not think he would be 
able to leave enough time when writing grant applications to get feedback outside of the 
meeting, but he could incorporate what he had learnt during the group discussion’ 
(paraphrased in fieldnotes) thus making the group work for him. 
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The second half of the meetings were dedicated to discussions around the representatives’ 
own research ideas. They found the most productive way to achieve this was for one 
representative per meeting to put forward their idea and get feedback from the group. The 
less confident representatives found it reassuring that they could pass their ideas though 
Jess outside of the group first. Although they had not yet been successful in taking any of 
these research ideas past the grant application stage the group was optimistic that they had 
ideas worth pursuing.  
The choice not to screen the representatives prior to recruiting them to the group 
combined with some of the problems associated with having epilepsy meant that there 
were some difficulties within the group:  
“Maybe up to a third of people with epilepsy will have mood problems in their 
lifetime. Some people with epilepsy have learning difficulties; some people may have 
problems with concentration and memory. That probably describes the normal 
population as well, but it doesn’t always fit in well with, um, getting on with other 
people, sticking to structure, that sort of thing. We have got one member of the 
group who erm had a [name of condition], who the rest of the group have learnt to 
deal with well, but in the first couple of groups he would cut across everything 
because he would stick to a certain idea and keep on saying it and be out of kilter 
with everything going on around him, and he would stick to his routines. All great 
behaviours but not at the right time, or the right place in the meeting.” (Tom) 
However, the consistency of the group membership meant that the less socially 
comfortable representatives were able to get to know the others around them, making 
them feel more confident in the group setting and increasing the likelihood they would 
contribute (see Section 5.4). Also by learning about each other’s quirks and foibles the 
group was able to self-manage their dynamics to reduce disruptions: 
“By not changing the number, the faces around the table all that much, people have 
learnt how to get on with each other well, so it’s not as disruptive, as it was, or as it 
could be.” (Tom) 
I feel it is important to say here that both Jess and Tom were adamant that they had made 
the correct decision to be inclusive in terms of group membership. They felt that the 
information that came from the group more than made up for issues in social dynamics and 
that often the most disruptive individuals made the most insightful comments.  
Jess felt that one of the most difficult things about their approach to PPI was the fact only 
herself and Tom had the skills and responsibility to act upon the information the group was 
producing, for example writing grant applications or following up lines of enquiry. As 
facilitating the group was only part of her role and in Tom’s case his input was largely 
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voluntary, they could not dedicate the amount of time to the group that they felt it 
deserved:  
“We don’t have the capacity to do this properly. If we were going to do this properly I 
would want somebody devoted to the patient RDG, at least 2 days a week so that 
they could be in touch, every week just to say how is everybody, em so that there 
was always somebody who was at the other end of the phone if they had any 
questions but also there are so many good ideas that come out of the patient RDG 
that me and Tom just don’t have the capacity to sit there and write grant applications 
just solely for what comes out… ideally I would like somebody sat writing applications 
every day based on what the patient RDG does…… I think that’s my biggest flip side. 
That I feel constantly we are just not doing enough, that they give us so much, and 
we are working at capacity but we just can’t deliver on everything that they want us 
to deliver on.” (Jess) 
“We really like a project that someone is offering, bubbling under, because it’s 
working out, if I am giving up my time voluntary, how do I then slot her research 
project into my work time? Is it, should it be me? How do we facilitate, you know 
getting her project off the ground and writing it properly without stealing her ideas, 
or without twisting them into a form she had never identified in the first place.” 
(Tom) 
To address this problem the network was applying for additional funding to allow more 
research support to be dedicated to the patient group.  
One problem that Jess and Tom felt had permeated the group from the first meeting was 
how uncomfortable they felt about the difference they perceived between how the group 
was meant to run in theory and how it operated in practice. This was demonstrated earlier 
in relation to how the group made decisions about how they would function and who acted 
as the facilitator. The ethos of the group was that it belonged to the representatives and as 
such both the representatives and the professionals were presented as being equal 
stakeholders. In many respects this was not truly the case, with Jess and Tom having 
responsibility over the agenda and the outputs: 
“You are saying it’s all equal, it’s all level playing fields but Jess is producing the 
agenda so she knows what is happening and she is not including extraneous things.” 
(Tom) 
 Also, due to their professional codes of conduct with members of the public, they did not 
feel they treated the representatives in the same way as they would other colleagues and 
this: “small bit of dishonesty” (Tom) did not sit well with either Jess or Tom. Dealing with 
the blurring of their professional boundaries and roles was stressed by both Jess and Tom 
as one of the most challenging aspects of this form of PPI. Challenges around roles were 
also raised by some professionals in the other sites and I discuss them in more depth in 
Chapter 4 (see Section 4.5.4). However, the particular purpose and the social dynamics of 
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the CEN seemed to exacerbate these issues in a way the other PPI approaches did not 
appear to.  
3.3 Main study site: the UKERN  
PPI in the comparator epilepsy network and other sites (as discussed in Sections 3.4 & 3.5) 
was largely dependent upon the work of two or three professionals. The UKERN took a 
more collaborative approach and as such there were eight professionals who played a key 
role in the development and execution of PPI within this network (see Table 9). The 
influence of each person changed throughout the stages of the approach (see Figure 10) 
and this is reflected in my description of the process. 
Table 9: UKERN key PPI professionals  
Pseudonym  Role 
Emma & Lucy  Epilepsy charity research leads 
Alex Network Director  
Ann Network member, PPI specialist & primary supervisor 
of my PhD 
Angela Network coordinator  
Francis, Lee & David CSG leads  
 
Figure 10: PPI Process in UKERN 
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The other key difference about this site compared to the others described in this chapter is 
that I was able to observe the majority of the events discussed and, as I explained in my 
methods section, I never formally interviewed Ann one of my key informants. 
Consequently, I draw more on my fieldnotes in this section than I have when discussing the 
other sites in this chapter. 
According to Alex and Emma PPI in the network was initiated during the first exploratory 
meeting at which the idea of establishing such a network was discussed. This meeting, 
which consisted of researchers, epilepsy charities and other potential stakeholders, 
discussed the viability of setting up a UK-wide epilepsy research network (both Alex and 
Emma were in attendance). Once attendees expressed genuine commitment to developing 
a network, they looked to the established comparator network for a template. The UKERN 
adapted the three RDG structure to form three clinical study groups (CSGs), with each 
group focusing on a different part of the epilepsy journey. Understandably, when discussing 
the comparator networks’ structure, the idea of a patient group was raised and PPI as a 
broad issue was discussed. What I understood from Alex and Emma was that while some 
members of the group were not PPI enthusiasts, as a whole, they were easily in agreement 
that there should be PPI in the network.  
Emma felt that it was Alex’s support for PPI that led to it being integral within the network. 
As such I feel his motivation and perceptions of PPI are particularly salient in understanding 
how and why PPI was implemented in the UKERN. When asked, Alex said that the purpose 
of PPI in the network was to: “make sure that the research is relevant to patients and the 
public”. One of the aims of the network was to identify and prioritise gaps in epilepsy 
research for further investigation. As such, anything that might contribute to the relevance, 
importance and usability of the identified research priorities would be seen as beneficial. 
Lucy also raised the point that the network was largely publicly funded though charities, 
placing emphasis on the moral and ethical motivations for PPI as discussed in Chapter 1 i.e. 
if the public are paying for the network they should have a say in it.  
Unlike the comparator epilepsy network, Alex made the decision to have representatives 
on each of the CSGs as opposed to having a standalone representative group. This decision 
was largely championed by Emma: 
“There was a proposal about having a separate user group because that’s the 
Comparator Network’s [my wording] model and I said no, don’t do that, that’s you 
know, to me I felt that was completely wrong, so I was very vocal about it and I said I 
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think there should be user involvement on the panels and should be, have sort of 
equal part in there.” (Emma) 
Emma felt that having patients in a separate group would be tokenistic, reduce their 
involvement and their potential impact in the network. This position was supported by Lucy 
and Ann, who as PPI experts were also influential in Alex’s decision. Lucy felt that if the 
representatives were in a separate group they would not be integrated and in turn not truly 
involved. Ann stressed her belief that without a ‘substantial professional presence’ within 
the same group as the representatives, nothing a representative said would be acted upon. 
Emma summarised many of these points:  
“I felt that looking in the longer term that wouldn’t achieve anything, because that 
group would meet to discuss research but erm, [04] how would a, would the 
discussions from that group have sufficient influence on network sort of strategy, 
that was one of my concerns and it seemed very tokenistic you know to siphon 
service, you know users away into one little group for them to talk amongst 
themselves. It just seemed very, very old fashioned and, and, and just, completely 
wrong to me. Er because I felt that they should be er treated as equals.  
As I elaborate below, the UKERN members were working from a very different stance to the 
comparator epilepsy network in terms of their perception of what is and is not 
involvement. Alex had no clear preference and as the PPI experts felt so strongly he said it: 
“just seemed like the way to go”. 
Convictions about what constitutes ‘real’ or ‘meaningful’ involvement appeared to be at 
the core of this group’s PPI decision making. Throughout the observations and interviews 
there was a sense that all the UKERN professionals were in agreement and viewed their 
method as self-evident and logical, with a perception that no other method would have 
made sense in this context. The choice of six representatives resulted from suggestions in 
best practice guidelines and past experience which indicated that: “we would recommend 
that you have more than one person [per group]” (Lucy). Given this, and taking into account 
the size of the CSGs (core group of around 10 people with individual specialisms), it seemed 
to follow that there should be two representatives per group. The UKERN professionals did 
not think it was possible for six people to be representative of the epilepsy community, so 
this was not an aim in the representative selection process: “it’s just the nature of the beast 
…[..]... you can never be representative I don’t think” (Lucy). Instead, emphasis was placed 
on having individuals who would be able to make a ‘meaningful’ contribution. By 
‘meaningful’ they meant that the representatives would be able to actively interact with 
other network members and not be intimidated into silence when surrounded by 
academics and medical professionals: “If you are going to have any form of, erm, lay 
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representation that is meaningful you probably need to go for people who are articulate” 
(Emma). Conversely having representatives who were not able to function in this 
environment was viewed as futile: “You know there is no point in setting, putting somebody 
up in a situation where they are not going to be able to contribute” (Lucy). 
The decision to have two representatives on each CSG group was put forward to the CSG 
leads during the first Management Group (MG) meeting which took place at the UKERN 
launch: “Alex informed the MG that he envisioned having two patient / public members per 
CSG, and potentially a patient / public member on the Management Group sometime in the 
future” (Extract from MG minutes). The structure of the day meant that after introductory 
talks the CSG groups met for the first time. During the inaugural meetings they agreed to 
meet every three months via teleconference and at least once a year face-to-face. They 
also discussed the purpose of the groups and elected group leaders, who then proceeded 
to participate in the management group meeting. Patient and public involvement was the 
third item on the agenda in the first MG and issues such as payment, selection and role of 
representatives were discussed:  
“It was suggested that one role for patient/ public members could be to look over 
publications resulting from UKERN-supported studies and comment on their 
readability. Alex reminded the group that the time these members spent on this 
would need to be budgeted for. ..[..].. Lee added that it is very important to get the 
right people applying for PPI, who are genuinely interested in epilepsy research 
(not there for their own agenda). Alex agreed that this warranted further 
discussion.” (Extract from MG minutes) 
It was also during this meeting the issue of the training and mentorship for representatives 
was raised for the first time, with the group as a whole agreeing that both were important:  
“Lucy highlighted the importance of training patient/ public members in 
preparation for CSG participation. All agreed that knowledge of epilepsy research 
and how to contribute to the CSG (and CSG meetings) were emphasised as key 
training points. The idea of having one or two people within each CSG act as 
mentors for patient/ public members was also discussed.” (Extract from MG 
minutes)  
After this meeting Lucy developed a role descriptor and application form for representative 
candidates to complete. The reasoning behind this formal application process was that, 
combined with interviews, this was the most effective way to determine if someone would 
be able to function within the group. It was also seen as the fairest way to select 
representatives. By advertising for representatives on different websites and using word of 
mouth, more people had the opportunity to apply, not just representatives already known 
to the professionals. Constructing the role description also was seen as having the added 
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bonus of forcing the CSG leads and network professionals to be clear on what they viewed 
the representative roles to be within the group:  
“I couldn’t think of another way of doing it. If you are asking people to fulfil a role 
then they have to know what that role is..[..]...so that you know that people are able 
to fulfil that role, and that is from say our side, but from the side of the person then 
they know what is expected of them. So I think we went about it the right way, I 
think it was good practice.” (Lucy) 
The role descriptor and application form were approved by Alex and the CSG leads after a 
few adjustments by Ann. The application form mainly consisted of two open ended 
questions: 
1. Having read the role description please tell us, giving examples, how you believe 
that your skills and experiences would enable you to fulfil this role. Please also 
explain your interest in epilepsy research and your reasons for wanting to work 
with the Clinical Study Group(s) you have indicated. (750 words max) 
2. Please describe any training you feel you would need to support you in this role. 
Twenty six people applied for the posts and nine were shortlisted for interview. Alex, Ann, 
Francis (one of the CSG leads) and Lucy conducted the interviews. With the applicants’ 
permission I was also in the room. While the representatives were all happy to be 
interviewed (it follows that if they had not they would not have applied) and felt that it was 
important, some of them did remark that it was somewhat intimidating and much more 
formal than they were expecting for a volunteer position (see Figure 11). Each of the 
interviewers had a scoring sheet and after all the interviews were conducted the scores 
were totalled and the top six applicants were selected. They were assigned to CSG groups 
based on their own expressed preferences and experiences. As I detailed in Table 3, the 
representatives selected by this process were highly qualified people and most had 
experience of working in a health or education setting. They were a mix of people with 
epilepsy and close family members (father/sister) of people with severe epilepsy.  
Figure 11: Drawing of Interviews (reproduced from Fieldnotes) 
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Following on from Lucy’s comments at the Management Group meeting, before the 
representatives took part in their first CSG meetings they attended a training day. Because 
of the timing of the interviews and training, the representatives were not able to 
participate in the second round of CSG meetings. The CSG chairs took this opportunity to 
explain to the other CSG members that two representatives had been appointed to the 
group and to give a little background on each. While discussing the terms of office for group 
members it was agreed that: “that PPI representatives would serve either three-or-four year 
terms in the first instance, followed by three-year terms; and that recruitment would follow 
the same process as before” (Extract from CSG minutes). This was congruent with the 
professionals’ terms of office. It was also agreed that as long as the rest of the CSG had no 
objections any member of the group could hold consecutive terms on one CSG.  
The training day was run by Ann, Lee and Lucy at Lucy’s charity’s headquarters. The training 
ran over two days with everyone arriving early evening on the first day. The evening 
consisted of ice breaking activities and dinner. This allowed the training day to start 
comparatively early; it also helped the representatives relax around each other and the 
professionals, thereby helping to create a relaxed atmosphere. Dinner also served as a 
‘thank you’ to the representatives for their time. The second day included presentations on 
PPI, the UKERN, the epilepsy charity and an introduction to research. There were group 
discussions around what skills the representatives felt were needed to be an effective 
representative and what challenges they thought they might have. They also read a 
selection of lay summaries of research projects and prioritised them for funding. From the 
representative feedback forms and my interviews with the representatives and 
professionals, the overall feedback from the training day was very positive.  
After the training day the representatives started attending the CSG meetings. By chance 
the next meeting was a face-to-face meeting. It had been decided that as most of the 
epilepsy community usually attends the International League Against Epilepsy (ILEA) UK 
branch annual conference, it made sense to have the meeting at the same time. 
Unfortunately this first meeting did not go as well as the CSG leads had hoped. The 
meetings were placed at the end of the conference by which point many of the 
professionals had left. Also, two of the representatives belonging to the same CSG group 
were unable to attend. The representatives who were in attendance met with the CSG 
leads in advance of the meeting to discuss their role and any requirements they had. They 
valued the opportunity to meet the rest of the group and introduce themselves face-to-face 
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before taking part in the teleconferences. However, they did feel it was a long way to travel 
for what turned out to be a short meeting (the longest was 30 minutes) (see Section 5.5.5). 
Nevertheless, after this meeting the representatives became a fixture of the CSG groups. 
As suggested by Lucy in the original Management Group meeting, each of the 
representatives was supposed to be allocated a mentor from within their CSG. It was 
decided by the Management Group that the mentors should not be the CSG leads but 
rather volunteers from within the groups. This was to ensure that mentors would have time 
to respond to any questions their representatives had. In practice some of the 
representatives were not assigned mentors and those who were rarely in communicated 
with them. This was in part, due to how the CSG groups functioned. Representatives were 
in contact with different members of their CSG group beside their mentors and linked in 
with the other representatives. After the network had been running for two years Alex 
decided to hold a ‘check in’ meeting with the representatives to see if there were any 
problems or suggestions that need addressing (incidentally, this was my last observation of 
the network).  
From my observations and the reflections of the representatives and professionals, the 
selection process appeared to be successful. By this I mean the representatives were active 
members in both the face-to-face and teleconference meetings. The experiences of the 
representatives and the CSG leads varied by group and are explored in the following 
chapters.  
3.4 Child site one: intervention study  
In this section I am draw upon my interviews and observations with Rachel and Nick. At the 
time of data collection, Nick was a Reader and Honorary Neurology Consultant. He had over 
ten years of PPI experience both in research and service development and was the lead 
researcher on the project. Rachel’s formal job title was ‘research assistant’ but she 
explained that her role was closer to that of a research coordinator. She worked on 
multiple research projects at a time and was responsible for their organisation and 
execution. She had been involved in the project (developing a non-drug intervention for a 
specific epileptic condition) since the beginning. This was the first time that she had taken 
responsibility for PPI and as such she was able to give a detailed account of the entire 
process (see Figure 12).  
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Figure 12: PPI process in child site one 
 
 
When I started my observation of this group, funding had been secured for a ‘user group’ to 
help in the development of a research funding bid for an intervention study. The group had 
met on two previous occasions, involving seven core representatives, four patients and 
three carers. Having funding to support the group was seen as essential; Rachel felt it 
would not be possible to do PPI without it. Although the original research funding bid for 
the intervention study was not successful, by the end of the period of my data collection 
other potential sources of financial support for the research were being explored. The 
following description touches on earlier stages of the research process but focuses in depth 
from the point at which PPI funding had been obtained. It covers the reasoning for having a 
user group, how this group was recruited and how it functioned.  
As illustrated in Figure 13 there appeared to be three main motivations behind the 
implementation of PPI in this research. Each of these motivators came with associated 
beliefs about how they were best addressed and the three in combination resulted in the 
chosen approach to PPI. I will now describe the professionals’ accounts of each of these 
motivations in turn. 
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Figure 13: Motivations for PPI 
 
Rachel and Nick both unabashedly stated that their initial motivation to have PPI in the 
development of the bid was that they knew that the funding body they were targeting 
viewed PPI as good practice and, as such, would be more likely to think favourably of their 
application for research funding if it included PPI: 
“I think in order to get at funding we had to set up this group so I mean really that 
was you know ((Laughs)) was the reason you do it because you have to sort of thing.” 
(Rachel) 
These two individuals are among the minority of researchers who explicitly told me that 
this was one of their primary motivators. From the interviews and my observations it was 
apparent to me that they believed that PPI had to be of a certain standard in order to 
secure funding. In particular, they believed that it had to be in-depth and sustained. Even 
without this external financial motivator Nick said they would have still sought feedback 
from representatives. However, it would probably have been through a focus group or 
other less time intensive methods. For these researchers, it appears that this incentive 
offset the time investment needed for this form of PPI in a way that other motivators did 
not:  
“Probably without the insistence I don't think we would have done it because it is of 
course an investment in terms of time ... well actually would we have done it, I think 
what we would have done is we would have had a focus group to go over our 
materials because that is kind of essential.” (Nick) 
In contrast to the initial funding motivator, the other two motivators were more implicit in 
participants’ accounts, drawing upon the understanding Rachel and Nick had of the 
purpose of PPI. They both believed that PPI improves research design and process, and 
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both motivators are linked to this. The aim of their research was to establish an education 
and support package for people newly diagnosed with a specific epileptic condition. Rachel 
believed that understanding what such people felt and experienced post-diagnosis was 
fundamental to developing a useful intervention, and as such, accessing representative 
knowledge was integral to achieving the research aim: 
“Part of the study is kind of understanding what erm… patients feel like when they 
receive the diagnosis, when we do certain things to do them, so it just seemed really 
relevant and important really to include people that had been through that 
experience, or going through that experience as to how… how they had felt about it.” 
(Rachel) 
As the NHS service offered to newly diagnosed patients with this condition differed widely 
across the UK, to truly draw upon representative experiences it was seen as important to 
get opinions from across the different regions: “So definitely where you come from and 
what services are available, are going to affect how they think” (Rachel). In addition to 
informing and potentially improving the intervention itself, Nick and Rachel believed that 
by making the changes suggested by representatives to the participant information sheets 
(that from their view were appropriate to incorporate), the research would become more 
‘acceptable’ to patients, potentially increasing recruitment and reducing attrition:  
“But like I said we were dependent on the comments from... our research user group, 
to make a study acceptable and more likely to succeed. … we felt we could benefit 
from their input..[…]… I mean, yes I mean I said that, apart from fulfilling the, ticking 
the right boxes the main purpose was to develop this research..[..]..Despite the fact 
that we worked with the patients for many years and you think you know what they 
are like but erm... there is always, new insights.” (Nick) 
Rachel also found it personally reassuring to get early feedback and validation for the 
project, as she believed that without representatives’ insights a project might get funding 
that was not worthwhile to the target group:  
“You know asking for money or trying things out that just aren’t going to be 
worthwhile at all and I guess if you don’t ask people about that, you are never going 
to know are you so just from asking them straight off, ..[…]..was positive for us really 
((laughs))… early feedback.” (Rachel) 
Nick was strongly aware of the more political and moral imperatives for PPI. He felt that 
these make PPI a good idea in theory. However, this alone did not seem sufficient to 
motivate him: 
“I think, it serves a number of different purposes, erm... it erm... ensures the 
patient's perspective is heard erm... there is a degree of quality control, erm... it 
helps with accountability erm... of researchers, erm... it helps also to erm... ensure 
that projects are ethical, erm... [pause 10] don't know whether I have left anything 
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out, but there is quite a lot of reasons why erm... PPI is a good idea in principle.” 
(Nick) 
Given these multiple reasons for PPI in the research Nick reflected that having PPI just 
seemed to: “make a lot of sense of course.” 
Once the decision had been made to implement PPI, establishing a user group was 
considered the most viable approach. As the purpose of PPI was to gain input from a variety 
of individuals, having a single representative on a working group would not achieve this: 
“An obvious advantage of having a larger group is that it's slightly more 
representative so we wanted not only people with seizures, also wanted carers and 
erm... people who have responded quite well to treatment, people who have not 
responded and they are all in that user group.” (Nick) 
The choice of a separate user group was reinforced by colleagues’ PPI experiences and 
Nick’s belief that having a single representative on the steering group would be ‘tokenistic’. 
He felt they would not be able to follow the language used during steering group meetings 
and as such would not be able to participate (potentially having an inhibiting effect on the 
rest of the group), defeating the point of having PPI. Again this illustrates how multiple 
motivators impacted on the chosen method of PPI. If Nick and Rachel were implementing 
PPI to satisfy the demands of the funding body alone, it would not matter to them if they 
had used what they perceived to be a tokenistic approach: 
“Of course we could invite somebody into the steering group if we erm... didn't want 
to take it particularly seriously, ideally somebody who never says anything you know, 
I am sure we could select somebody like that who would come but not say anything 
and erm... you know we could then say we have a lay member on our steering 
group... but like I said we were dependent on the comments from... from our 
steering group, from our research user group, to make a study acceptable and more 
likely to succeed.” (Nick) 
Their next step was to secure funding for the user group, as best practice documents 
outlined the need for payment and travel expenses for representatives. Around the time 
PPI funding was secured Rachel took responsibility for facilitating PPI in the development of 
the funding bid. The first thing she did was to talk to two fellow researchers: “that have 
done quite a lot of work in PPI” and attended a training day. Throughout her interview she 
came back to how useful the training and support had been in terms of the organisation, 
pitching of information and determining the content addressed by the group. Receiving 
training was also one of her ‘top tips’ for researchers starting to initiate PPI: 
“I literally didn’t have a clue …[..]..so going to their little course they did was brilliant, 
because that just gave you so much information and just how to talk to people..[…].., 
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it was really worthwhile going to something like that and talking to other people as 
well.” (Rachel) 
Once she had completed the training, Frank (one of the experienced researchers) 
volunteered to help her establish the user group and even attended the first meeting to 
support Rachel and ensure the group had an optimal start: 
“It was definitely it was Frank that helped me, erm… so sort of he talked me through 
you know how to recruit people and all this, so we sent all that out. Then we had to 
think about erm… we introduced like group rules, and things like that, so how we 
would all… what we would talk about, and that you know what we spoke about 
wouldn’t go anywhere else, those sorts of things.” (Rachel) 
When Rachel started recruitment of the representatives she prioritised the need for 
representatives to be representative by region and treatment experience. Moreover, they 
not only wanted patients as part of the group, but also carers. During my observations both 
Rachel and the representatives explained that they believed carers have a breadth of 
knowledge about the patient’s condition that neither the patient nor the professionals had 
access to (for example, what they observed happening to the patient during and after a 
seizure, this was viewed as particularly pertinent for seizures associated with memory loss). 
Also, carers were often seen as instrumental in supporting patients through treatment. 
Through discussions with two local sources, a psychotherapist and charity that focused on 
the targeted group, Rachel identified potential representatives. She had no official criteria 
for those contacted; rather she made judgment calls about potential representatives 
known to the researchers, based on whether or not they might be able to function in a 
group setting:  
“Maybe a screening yes. Yes. I guess erm… from some of the ones that yes, we 
already knew, erm… some you know we knew I mean some have quite severe social 
phobia, and those sorts of things so they are clearly not going to be appropriate and 
for you to ring them and as them, is only going to make them uncomfortable sort of 
thing so, but a lot of people really know, we did erm… ones we didn’t know much 
about erm… it was quite an open invitation in the beginning really to just find willing 
people.” (Rachel) 
The other factor Rachel was aware of during recruitment was the potentially upsetting 
content of the material to be discussed in the group. She never made explicit how this 
affected her choice of representatives, only that it did: 
“For a lot who have gone through a lot of trauma or things like that, if we are then 
talking to them from a research basis rather than a clinical basis you have to.. you 
have to be wary about you know what you are asking them….so we had to be careful 
who we were going to invite in, but everyone seems to have erm… been fine anyway 
((laughs)).” (Rachel) 
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Neither Rachel nor Nick felt that the representatives needed to have research knowledge 
themselves in order to contribute to the group. They felt that their own role was to provide 
the research skills and the representatives were there to give insights from their 
experience:  
“It’s more interesting to hear from them what the barriers might be, erm… those 
sorts of things, than to say well I think you would get a more valid question if you 
asked it this way, or that sort of thing because I think that is kind of what we have got 
the experience in, what they have got the experience in is how we are going to be 
more inclusive and prevent people getting distressed or those sorts of things so.” 
(Rachel) 
While they invited people from across the country to attend the meetings many were 
unable to do so because: “obviously it’s just such a long way to travel for some of them” 
(Rachel). Therefore, most of the core group members lived locally or in neighbouring cities. 
Two of the representatives were the carer and patient who had set up the charity that had 
recommended possible representatives. Having these individuals involved in the user group 
was seen by Nick and Rachel as a great advantage, they were seen to not only bring their 
own experiences but also able to draw on their interactions with members of the charity, 
providing an additional level of representativeness to the group: 
“So they had set up a support group so they were sort of ideal candidates, straight 
away because they were going to have erm... a lot of experience about talking to 
other patients as well, erm… so they kind of brought you know a whole group of 
people by just inviting them really.” (Rachel) 
When starting the user group Rachel followed Frank’s advice and the INVOLVE guidelines 
for best practice. For example, at the start of the first meeting they discussed the purpose 
of the group, set out group rules and covered what would happen if anyone had a seizure 
during a meeting. Representatives were given the option of a cash payment or vouchers 
(they chose cash) to reimburse their time and expenditure. Fitting with the purpose of the 
group, each meeting was used to look at specific components of the research design such 
as the intervention pack, questionnaires and participant information. The agenda and 
relevant documents to be discussed were determined by Rachel and Nick, with electronic 
and hard copies circulated in advance of the meeting. This choice of a focused and pre-set 
agenda was reinforced by Nick’s previous PPI experiences. Although occasionally he had 
received ‘useful’ information from unstructured discussions, and could provide examples of 
this, from his own observations he felt that: “there are significant problems with having a 
free discussion with your user group about erm... research that you might want to do or that 
they think you ought to do”. This is because he felt that research priorities determined by 
these groups were not normally scientifically grounded, that the conversation often strayed 
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from the topic and there were not enough tangible outputs. Both Nick and the 
representatives I interviewed valued having outputs at the end of each meeting. They had 
taken the time away from other work and family commitments and having evidence of the 
group’s productivity helped ensure that it did not feel like it was: “a waste of time” (Jim, 
representative).  
Rachel explained that initially she had set up an online discussion forum to run alongside 
the group: “where they could communicate with each other and us”. However, the 
representatives never used it or mentioned it in my interviews with them: 
“They haven’t really taken that up very much. Erm… I have tried to add things on 
there and you know ask people to comment and things, but they haven’t [38.54] no. 
They come to the meetings and they do what is necessary for that, but then they kind 
of tend to drift away.” (Rachel) 
Despite the fact the discussion forum was not currently being used, Rachel hoped that in 
the future it might be a way of getting people from different parts of the county involved, in 
order to increase the number of representatives providing input and thus make the group 
more representative: “I think in the future we would quite like to invite a lot more people 
that could also discuss things on there and wouldn’t always have to come for meetings” 
(Rachel). 
All the people I formally interviewed for this site brought up two factors that they felt had a 
direct impact on how the group functioned. These were the facilitator and the size of the 
group. During my observations I had the opportunity to see how the group functioned both 
with and without Nick being present; and I recorded in my fieldnotes that the mood of the 
room was much more stilted when he was present, with the representatives less likely to 
make comments. Rachel articulated this by saying: “it all goes very quiet and formal when 
Nick comes in, whereas before I think we kind of just chat about everything”. This 
observation was also made independently by both Nick and the representatives during 
their interviews. This shift in atmosphere seemed to stem from Nick being seen as an 
expert in the field and because of his position as a Consultant Neurologist (and clinician to 
some of the representatives); whereas the group knew less of Rachel’s background and 
viewed her as non-threatening. While Rachel found the lack of recognition of her own 
knowledge difficult she clearly saw the advantage of this in terms of getting information 
from the group:  
“I would say that is probably quite an important thing really for them to not feel that 
they can’t really voice their opinions because somebody who they are talking to, has 
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more experience than them in it, ….[…] … So I think it’s maybe better to have people 
who they view as non-threatening erm… and not as experienced as them because 
you will probably get better information from them. I mean I don’t think Moira 
probably knows, I am sure well she doesn’t know my background really or you 
know… how much work I might have done in this field so I just kind of bite my tongue 
you know but it doesn’t bother me in the slightest, I would much prefer to have a 
good meeting and to get good information from her than to try and fight her 
((laughs)).” (Rachel) 
The effect of the facilitator is as issue which I discuss in more depth in the following 
chapters (see Sections 4.5.4 & 5.6). It is important however to note here how the facilitator 
role was addressed within the meetings. The meetings were split into two parts. Nick 
attended the first half so that he could get a direct sense of the perceptions of the 
representatives and as Claire (representative) reflected, help to reinforce the feeling that 
the opinion of the representative was valued. During the second part of the meeting Nick 
deliberately left the room, leaving Rachel to facilitate the meeting, removing his ‘inhibiting’ 
presence. When I asked Nick his opinion of using a completely independent facilitator Nick 
refuted the idea, as he believed it would limit the functionality of the group: “you do need 
somebody who knows about the research and answers their questions and somebody that 
doesn't inhibit the answers.”  
The size of the group was the other issue consistently raised. Although other 
representatives attended some meetings there was a core group of four people that 
attended all of them. This raised questions for Rachel and Nick about the 
representativeness of the group. The representatives also felt that the limited group size 
meant that often the same points were repeated and that it would be better to get more 
varied views and input. While it was evident that everyone involved wished for more group 
members, they were less clear on what would be the optimum group size. Indeed, despite 
their wish for more diversity they felt that smaller groups had the advantage that each 
member had space to provide their input which might not happen in a larger group, 
particularly from the less socially gregarious members: 
“I think having a smaller group can be quite useful in that they you know obviously 
you are not getting as many varied views, but you are I think probably getting more 
out of them than some of them might say if there was a lot of… a lot of people there 
and especially as you say that didn’t know each other.” (Rachel)  
The representatives explained that it was not necessarily the group size in itself that 
influenced their level of contribution, but rather the consistency of the group membership. 
Having the same people present allowed them to get to know the others, increasing their 
confidence to contribute and to an extent, self-manage the group (see Section 5.4). Jim also 
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recognised that if the group continually had new members they would have to go over past 
information in much more depth, suggesting that given the choice, representatives would 
opt for a smaller, consistent, group over a larger varied one: 
“Whereas if you keep the group erm, or the same people should I say coming in 
attendance then you will be able to progress fairly well because they will have a, a 
clear or should have a clear idea of right this is section 1, we are now on section 2, 
this is it, we will soon be on section 3, you know whereas if you get different people 
coming they will come in half way through, you will have to spend an hour telling 
them what has just been done, they will then want to give feedback into that you will 
then have to take that on board, to try and change the section that they are now at 
and it will just go to pot. ((laughs)). It will be a nightmare.” (Jim)  
“I think by now people know me and know that you know I have got a few issues, and 
if they need to just prod me in the right direction as it were, so that I can erm, carry 
on saying what I was saying, rather than not remembering.” (Claire) 
Along with the value placed on consistency of group membership and the motivations 
behind PPI, Nick felt that it was important that the group meet regularly. However, neither 
the researchers nor the representatives wanted to meet just ‘for the sake of it’. This and 
the slow moving nature of this sort of work meant that this group had reached a stagnant 
phase in the project towards the end of my data collection period. Nick and Rachel 
addressed this problem by broadening the purpose of the group, establishing them as a 
consultation group for the department rather than just for the project and obtaining 
additional funding from within the department to do so:  
“Research is a fairly slow process and you know if you want their help on the ethics 
application then fine, then writing you know the erm… information sheets and 
questionnaires, or interview schedules all those sorts of things but then after that, 
there is not a huge lot to talk about them, so that we have kept up regular meetings, 
tried to keep them every sort of 6 months…. we have then asked them about other 
projects, erm… just because they are there anyway sort of thing and they are 
interested in knowing what sort of, what projects are going on at the time.” (Nick)  
Indeed, while Rachel had no prior PPI experience before this group, she found the 
representative feedback so useful that she: “now put everything past them”. In terms of the 
future of the group’s involvement in the original research project, Nick was sceptical about 
how usefully they could be involved at the data analysis or writing up stages but could see 
their potential for facilitating wider dissemination. 
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3.5 Child site two: clinical trial 
My main informants for this child site were Oliver, Bill and Sue. Oliver was a practicing 
Neurologist and epilepsy specialist who identified the particular research question around 
which the group had been established (focused on the clinical drug management of 
pregnant women with epilepsy) and was a co-applicant on the funding bid. Bill was a 
women’s health specialist. He had no past experience of epilepsy research but was an 
experienced trialist and consequently the primary investigator. Sue, the trial co-ordinator, 
was brought in once funding was released. This was her first formal research post although 
one of her past roles had been related to epilepsy research.  
From my initial conversations with Oliver about access to the trial, I had the impression that 
he had given little or no thought to PPI: ‘I guess we are going to have to think about that 
[PPI]’ (Oliver, paraphrased in fieldnotes). As such, I was expecting to observe an example of 
a trial with minimal PPI which would make an interesting and potentially ‘deviant’ case of 
PPI relative to my other sites. I based this on my belief that the majority of researchers are 
not as enthusiastic or committed to PPI as the individuals responsible for shaping it in the 
other sites and as such they may not reflect ‘typical’ PPI processes. This did not turn out to 
be the case. There was some form of PPI at each stage of the research process; it was 
simply not recognised or badged as such by those involved. Figure 14 outlines the PPI 
process in their site up to the cessation of my data collection. I will now describe this 
process in more depth.  
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Figure 14: PPI process in child site two 
 
The idea for this clinical trial came from Oliver and his colleagues disagreeing over an 
aspect of treatment for women with epilepsy. Bill then convinced them that the only way to 
resolve this issue was to conduct a clinical trial: 
“The background to this is that erm… that service that delivered care for epileptic 
pregnant women in our hospital had clinicians with opposing views, so they 
presented those opposing views to me as part of a discussion over coffee and erm… 
in fact they suggested one solution could be through designing a research study and 
then I explained that to do such a study is not something one could do in their own 
clinic over a few weeks or months, and it’s going to require a big effort.” (Bill)  
Once the potential need for a clinical trial had been identified clinical epilepsy specialists 
and women with epilepsy were approached to see if this was a question that would interest 
them and if they would, theoretically, be amenable to taking part: 
“Right from the beginning even before the protocol was developed erm.. we 
requested some patients who we knew to see whether they thought this was a 
question worth asking. We also asked people whether they would be prepared to be 
randomised, erm… so yes sure we asked people whether if we embarked on such a 
study it would be feasible.” (Bill) 
 93 
 
At this stage patient involvement was very informal, consisting of eliciting patient opinion 
though conversations at the epilepsy clinic where Oliver worked. When the response was 
positive, a more structured questionnaire survey was conducted, 51 patients from the same 
clinic completed an eight-item questionnaire. The feedback was heavily in favour of the 
proposed research: “96% (n=49/51) considered the question posed in the study important 
needing further research and 78% (n=40/51) expressed willingness to participate in a 
randomised trial” (Extract from the questionnaire summary report). This form of 
‘consultative’ PPI could be seen as superficial, as representatives had no direct power in the 
decision making process. However, I do not believe this to be the case here as the patients’ 
views were a deciding influence in whether or not to pursue the research:  
Beth  “So if up front you were being told actually no I wouldn’t even think about 
doing it… 
Oliver  We wouldn’t have bothered with the trial yes. And that’s still a big issue if 
we get all this, and the patients to say they don’t want to go into it, we 
have got well what did we do all that for it was pointless. Erm… so that’s 
why it was such an important part of this, you know feasibility particularly 
in pregnant women.”  
Both Oliver and Bill reflected on the fact that getting patient input at this stage was just an 
automatic thing to do, requiring no prompting for outside sources:  
“For me it is natural whenever I plan a study I.. tend to ask people who will be 
engaged in the study in the future, whether they think it’s a question worth asking.” 
(Bill) 
This is consistent with Bill’s perception of the purpose of PPI. Throughout his interview he 
alluded to different motivations for involvement but when explicitly asked he said that the 
point of PPI was to establish whether or not people would take part in a trial and how to 
facilitate this. As recruitment is a main reason cited for trial failure, it makes sense that as a 
trialist this was one of his primary concerns and that he valued anything that might help 
prevent this failure:  
“Ok, to me the key purpose of patient and public participation is… to determine 
whether erm… [pause 04] recruitment will be feasible, and whether through their 
engagement it can be accelerated.” (Bill) 
Alongside confirming the importance of the research question and feasibility of the trial to 
the investigators, patient support for the project was seen to have helped justify the 
research to others and was perceived to have helped facilitate the research process:  
“We put it in the protocol just to back, justify the research and why it needed to be 
done so it was written in the start of the protocol. It has been put in the ethics 
application to justify the reason why the research needed to be done.” (Sue) 
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At the bidding and application stage there was involvement from epilepsy charities. As 
these charities support and represent patients and the public, drawing on group knowledge 
rather than individuals, it was considered by Bill to be a form of PPI. Epilepsy charities were 
also co-applicants on the grant. This was seen as vital by the professionals. They believed 
that to achieve the level of recruitment required, the epilepsy community as a whole 
needed to ‘buy in’ to the research and they intuitively thought that endorsement from the 
epilepsy charities would strongly influence their members’ views: 
Beth  “So quite a lot of involvement at the kind of charity / committee level? 
Bill That’s correct yes. That’s very important in this study because it’s a study 
that will run over 40 centres, and erm… there will be no more than a couple 
of patients per month recruited, so erm… the need to encourage if you like 
patients to ask the question to their clinicians whether or not they should 
be in the study is very strong in this case.”  
At patient level the team next asked for feedback on participant information sheets, 
consent forms and recruitment posters. Alongside asking an epilepsy charity for their 
comments, five patients selected at the epilepsy clinic were approached for feedback: 
Beth “So it was just kind of a case of you handing it them, and then going what 
do you think? 
Sue Yes, I just said that this is for some research that we are planning on doing, 
would you mind just… this is what we are planning to give to patients so we 
can tell them more about the research would you mind giving me feedback 
and I just left them to have a look and they came and found me and just 
said this is what we think. Yes.”  
What was very evident to me here was the ease with which the investigators could access 
patient opinion, both though the clinic and though the research systems of the pre-existing 
patient networks. This was paralleled in how they recruited a representative for the 
steering group and data monitoring committee. Between them they gave three separate 
motivators for having a patient representative on these groups; firstly that it was common 
sense to have representatives of all stakeholders; secondly, the benefit of getting a 
different perspective, and thirdly that it was a requirement of the funder. 
To recruit the representative the local epilepsy nurse and an epilepsy charity were asked if 
they knew anyone who they thought would be ‘appropriate’ and willing to sit on the 
groups. The charity put them in contact with a possible representative, who then agreed to 
be involved:  
“Yes she e-mailed to say that she would be happy to do that, she wanted clarification 
first of what her role would be, erm… and what she would have to do and I gave her 
that information, by e-mail erm… and yes she was happy to erm… attend.” (Sue) 
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There were no formal selection criteria for the patient representative (indeed little was 
known about the chosen woman). The trial team were clear however, on what they wanted 
from the representative and her role within the groups. In line with the earlier patient 
consultations, the nature of the study meant that the researchers wanted feedback from 
women with epilepsy and preferably from women who are, or who have been, pregnant, as 
opposed to partners, carers or the wider public because: “You can only really get patient 
perspective, from a patient” (Oliver). 
Sue was indifferent about whether the representative had research knowledge or not, as 
she could: “argue the situation both ways.” Whereas, both Bill and Oliver felt that there 
was no need for the representative to have research knowledge as that component would 
be covered by other members of the group:  
“To build a trial requires a number of different expertises, to do it and it’s the same in 
patients isn’t it, they have an expertise in their illness but they don’t have an 
expertise in trial design..[..]…, I don’t worry about the obstetric part, and wonder 
whether erm… whether you know, the scan at 28 weeks, what kind of scan it is, I 
leave that to the obstetricians you know and they are competent, erm… and I leave it 
to them. I am not worried about it, and I am worried about the epilepsy side of things 
and that part of the trial.[ …]. you know I don’t understand it all but I can still be 
involved with it…[..]... It’s the same with the patient I don’t think they need to know 
everything about the trial, but they need to know what affects the participants.” 
(Oliver)  
Building on this, Oliver felt that representatives having a research or medical background 
could be detrimental to getting a ‘true’ patient perspective. He not only valued the 
opportunity to get the perspective of someone with epilepsy but someone who did not 
have a ‘medicalised’ view of the world: 
“So the benefit would be then they may think of problems you haven’t thought of as 
a clinician which …[…].., you know they are thinking from a patient perspective 
because we are thinking about what data we collect, blood levels they would be 
thinking God all these forms that’s ridiculous…[..]. so thinking of novel problems that 
we haven’t thought of.[…].. because we have all be trained to think the same way.” 
(Oliver) 
During my data collection at other sites it was repeatedly raised that having one 
representative on a committee is likely to be tokenistic (see Nick’s comments in child site 
one). When I put this to Bill he was of the opinion that it is only tokenistic if you do not 
listen to them: 
“If you invite people to contribute then you have to first of all give them a chance to 
say what they are saying, then you have to have an appropriate response, it’s not 
necessary that what every individual contributes has to be implemented but it has to 
be heard ((laughs)).” (Bill) 
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At the end of my data collection, Ethics Committee approval had just been received for the 
trial. While my informants had no concrete plans for additional PPI, they commented that if 
the trial failed to recruit they would consult with patients to find out why women were not 
joining the trial and identify how to address this. However, as there was a qualitative 
research study attached to the trial it was likely this information would be obtained through 
participants, rather than via independent representatives. There was also the presumption 
from the professionals that epilepsy charities would help with the recruitment and 
dissemination stages of the research processes.  
Consistent throughout the interviews with Oliver and Bill was the view that they did not see 
PPI as something separate from the research process. They took the line that talking to 
patients was what they did as doctors and that it was ‘good research’ to seek out, respond 
to and incorporate patients’ perceptions, just like that of any other stakeholder (e.g. 
statistician, trialist and obstetrician). In addition, it became evident that Oliver was 
uncertain about the specifics of PPI terminology: 
Beth  What is your current understanding of what patient, public involvement is? 
Oliver I don’t… the answer is I don’t know. Ok. Because it sounds like it means a 
specific thing and I am aware of them you know that we have got 
somebody a member of the public on the trial steering committee, and I 
remember that we involved patients in terms of the trial design, in terms of 
the feasibility would they be involved, you know real women that were 
pregnant would they consider a trial and they said yes, the majority have 
said yes. I understand that kind of involvement but I don’t know what that 
quite means in these terms. 
This may be why, initially, it was difficult for them to identify PPI in their project, as they did 
not set out to have PPI in their trial or classify it as such, they sort to gather information 
from all stakeholders as appropriate. 
3.6 Discussion 
In this chapter I have explored the different processes and approaches that the each site 
used in implementing PPI. Consistent across all four sites were three factors that influenced 
the PPI approach used: the initial motivation(s) for PPI, the perceived purpose of PPI and 
the preconceptions of what ‘involvement’ means (see figure 15). 
 97 
 
Figure 15: Influencing factors 
 
Preconceptions about what constitutes ‘meaningful’ involvement and what constitutes 
‘tokenistic’ involvement were clearly evident throughout the sites. The professionals in the 
intervention study did not consider having representatives on their steering group as they 
thought this would be ‘tokenistic’, believing the representatives would struggle to 
contribute. In contrast, the professionals in the clinical trial felt that as long as the 
representatives were listened to, then having them present at their steering group and data 
monitoring committees meant that they had meaningful PPI. The comparator epilepsy 
network felt that representatives would not contribute if they were part of the main 
research development group and as such this type of involvement would be tokenistic. In 
contrast the UKERN believed that keeping the representatives separate from the 
professionals would result in them having no direct impact on the priorities and functioning 
of the network and as such they would not truly be involved. All of these views seem to be 
underlined by the same belief that for representatives to be involved in research they need 
to be given the opportunity to voice their opinions and have them taken into consideration. 
This fits with, and builds on, the perception in the literature that regardless of the method 
of involvement a key component is that there is an active, genuine partnership between 
the researchers and the representatives (Boote, Barber, & Cooper, 2006; Caron-Flinterman, 
Broerse, & Bunders, 2005; Rhodes et al., 2002; Williamson, 2001). What varied is what was 
and was not determined to be a ‘valid opportunity’. Another influential preconception was 
the professionals’ beliefs about representatives’ capabilities. These views helped to 
determine how representatives were selected, which in turn seemed to influence other 
aspects of PPI such as whether or not representative were included in meetings of the 
research teams, decisions around inclusivity and perceptions of what is tokenistic 
involvement. 
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The motivation(s) for and perceived purpose of PPI overlapped heavily within and between 
the sites but, as demonstrated in the intervention study, they were not necessarily the 
same. While a range of motivators for PPI were given by the professionals, such as 
increasing the chance of obtaining funding or because it is ethically right to do so, the 
sustaining motivator seemed to be the professionals’ underlying belief that the purpose of 
PPI is to improve the research process and in turn having PPI is ‘just good research’. The 
ways in which they expected PPI could improve the research process directly impacted on 
their approach to PPI. For example, if professionals thought representatives could only be 
helpful in initial stages they would not include them in data analysis and dissemination. 
Whether or not the professionals believed PPI needed to be broadly representative of 
everyone within the epilepsy community, or that representatives were there solely to 
reflect their own experiences impacted upon the number of representatives included in 
each model. During my observations the effect of funding on motivation was repeatedly 
alluded to. This was not in terms of obtaining it but rather that when research is a publicly 
funded enterprise, as with the UKERN, the moral and ethical arguments for PPI have a 
greater importance than in privately funded situations. Having detailed the process of PPI 
the following chapter explores the professionals’ experience and perceptions of 
undertaking PPI in more depth.  
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Chapter 4. Professionals’ experiences and 
perceptions of PPI  
4.1 Introduction  
In Chapter 3, when discussing the site-specific motivations and decision-making processes 
around PPI, the professionals’ perspectives were paramount as they had access to aspects 
of the PPI process that the representatives were not involved in. As such, I have already 
started to address the first half of the third research objective: ‘to describe the experiences 
of the people involved in the PPI process, including their perceptions of the benefits and 
challenges of PPI’. In this chapter, I will build on this and also address the remainder of the 
objective by exploring the professionals’ perceptions and experiences of PPI more broadly. 
Where appropriate I will then start to: ‘compare and contrast the theoretical underpinnings 
of PPI with its practical application’ (Objective 2). In Chapter 3 I compartmentalised 
information from four of the study sites in order to convey the individual PPI stories as case 
studies. In this chapter I will draw upon all of my ‘professional’ data across the main, sibling 
and child sites. As described in Chapter 2, this consists of 25 interviews with 21 
professionals, fieldnotes from observations and two key documents10. I will first describe 
how the professionals experienced and understood PPI, then their perceptions of its main 
benefits and challenges.  
4.2 PPI as an emotive topic  
Whatever else the professionals’ experience of PPI might have been, it was rarely a passive 
one. Whether as part of my formal data collection or when discussing my PhD in passing at 
my own departmental coffee morning, it was clear that everyone had an opinion on its 
value. I was presented with many examples of polarised views both for and against PPI. 
There were those that felt it should happen at every stage of the research process and 
conversely, those who felt it should not happen at all. It should be noted that those in 
favour tended to be more vocal. This may reflect the moral discourse that permeates PPI 
(see Section 1.5.1) and the current Department of Health stance (see Section 1.5.3) on PPI 
                                                          
10
 ‘The Way Forward Report’ and the ‘Making a Difference Report’- both of which were generated by 
the NIHR Clinical Research Network internal evaluation of PPI. 
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which may make it seem ill-advised to express the view that PPI is a waste of time. The 
strong feelings around PPI were something that Fred (NL11) described: 
“I am sure you will find that, there are people who have very strong opinions one 
way or another. You will get professors, although you probably won't get to talk to 
them, but you will get professors who secretly think it's all a complete waste of time, 
and completely illogical, erm... and then you will people who erm... are kind of like 
very strong militant campaigners for PPI as if erm... you could never have too much 
erm... and (laughs) yes strong feelings.” 
Between these extreme positions lay the majority of professionals, who seemed to be of 
the opinion that PPI is essentially a good thing and should happen. They were however 
‘sceptical’ about how much impact PPI actually has on research: “just the sheer scepticism 
on both sides actually, on the part of researchers that, can patients can make a difference, a 
positive difference to their research” (Charlie, NL). Professionals who had multiple 
experiences of PPI seemed to easily recall both good and bad experiences, but believed that 
overall PPI: “tends to be positive and beneficial” (Nick, CP12). In line with this, the majority 
of my key informants can be described as having a mostly positive, but somewhat sceptical, 
attitude to PPI. There also seemed to be a large group of academics who valued PPI but 
were glad that it is someone else’s job to facilitate it:  
“I think, generally people think of it as a good thing [the patient group], you know, 
you know, you couldn’t knock it urm, And I think lots of people are pleased that other 
people are running it, you know, that it happens, they don’t have to invest so much 
time into it, and if they wanted to access it, it would be there.” (Tom, CP) 
4.3 Professionals’ understanding of PPI  
In my initial interviews I asked the question ‘what is PPI’? This tended to elicit fairly similar 
answers and while the question was an ‘open’ one, the answers seemed ‘closed’ or 
superficial, leaving little or no room for exploration. Around the third interview I realised 
asking the question ‘what is the purpose of PPI?’ resulted in a more personalised, open and 
revealing responses. 
4.3.1 What is PPI? 
The answers professionals gave to the question ‘what is PPI?’ were largely variations on the 
idea that PPI is ‘about involving people in research.’ This was most neatly articulated by 
Francis (CP): “It’s what it says it is. It is about involving non-professionals, so involving public 
and patients, so patients and carers and people who have got a personal experience of 
                                                          
11
 NL= Network PPI Lead  
12
 CP= Clinical Practitioner  
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epilepsy rather than necessarily a professional one”. Only one professional drew upon the 
different theoretical categorisations of PPI discussed in Chapter 1 ((e.g. Consultation, 
Collaboration and Consumer controlled, (Boote, Telford, & Cooper, 2002)). When 
describing what PPI is, the majority gave a range of examples of types of PPI that they were 
aware of, such as representatives on steering groups and PPI in the development of patient 
information and study design:  
“It's patient and public involvement in research process. And of course it can happen 
at all stages of research, in the generation of research ideas, in the formulation of 
research projects ... in the erm... [pause 05] preparation of materials like information 
sheets, consent forms, in the recruitment of patients. In the analysis of data 
sometimes, in the communication of findings ... also patients, public are now 
involved in the regulation of and supervision of research so if you apply to funding 
bodies then they will have patient, public representation on the grant award 
committees, there will be, patient, public involvement in the ethics application 
process.” (Nick, CP)  
As demonstrated in Chapter 3, professionals placed importance on ‘meaningful’ or ‘real’ 
Involvement, emphasising that representatives needed valid opportunities to express their 
views. This was intrinsically linked with their understanding of ‘tokenistic’ PPI which is 
addressed in section 4.5.2. 
4.3.2 What is the Purpose of PPI? 
In Chapter 3 I also highlighted how the professionals across the sites had different 
motivations and goals for incorporating PPI in their own research. However, professionals 
were consistent about the generic purpose of PPI. Nearly all either explicitly stated or 
alluded to the idea that the purpose of PPI is too ensure that research is ‘relevant’. For 
example: “It’s to try and make sure that the research is relevant to patients and the public,” 
(Alex, ND13) and: “it’s a means to root what we do in a way that is relevant to people that 
have the condition that we are studying” (David, CP). ‘Relevant’ research equated to 
‘beneficial’ research that would be useful to the public, which for these professionals was a 
key aim of conducting research:  
“The main goal, of patient and public involvement in research and all our activity is to 
produce and deliver research that is to the benefit of patients....[..]..So that is the 
outcome that I would want to see. It is effective research, quality and effective 
research that is shared to the benefit of patients. That the research is implemented 
into care, and treatment.” (Lyn, NL) 
“The research focus shifted erm, if it’s required shifted a little towards the patient 
benefit, what actually patients are going get out of it, at the end of day, what sort of 
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care might be influenced, erm by having a, perhaps the research question changed 
slightly or maybe even the approach to, to possible participants changed slightly.” 
(Owen, NL) 
“I guess at the end of the day what we are trying to do is improve the quality of life of 
patients through research and surely they should have a say in how that is done and 
organised.” (Alex, CP & ND) 
This suggests that although increased ‘relevance’ is one of the most commonly listed 
perceived benefits of PPI in the literature (see Section 1.6.1), for these professionals it is 
not just one of many benefits, it is the primary function of PPI. This was seen as particularly 
important because some of the professionals thought researchers have a predisposition 
towards pursuing a topic because they find it inherently interesting or because funding is 
currently available, rather than because it is potentially beneficial. This type of research was 
referred to as ‘navel- gazing’ or ‘having a hobby horse’. Professionals also suggested that a 
researcher could be pursuing a topic that they thought was useful, but in practice, the topic 
is unlikely to be ‘important’ to patients. They believed that PPI could help reduce the 
likelihood of such a situation arising, in turn increasing the relevance of research:  
“There are certain kinds of research projects I have seen where I think it is a little 
self-serving, it is because it will produce papers, it’s because erm… it will bring in 
grant money, prestige, other factors there are these things to consider.” (Charlie, NL)  
“I don’t know if you were in the research session here this morning, but it was about 
experimental epilepsy and it was about studying epilepsy models that conceivably 
have no relevance at all to the experience of people with epilepsy. Erm, and I think 
it’s very easy as a researcher, to get interested in what you do, and interested in 
what your peers are doing but to have no focus whatsoever on how this translates 
into patient benefit. And, I think it’s also very easy to assume that we know what 
patient benefit is, when actually most of us in epilepsy research don’t have epilepsy. 
So I think that grounding what we do, rooting what we do, in terms of a clear and 
knowledgeable focus on what will be to the benefit of the people with epilepsy is 
essential, and certainly for me that’s where PPI involvement becomes crucial.” 
(David, CP) 
“The hope being that that would, you know, increase the chances of you answering 
questions that mattered to patients. That you come to some sort of agreement 
between what the doctor thinks is important and what the researcher thinks is 
important with what the patients think is important because they are often not the 
same.” (Francis, CP) 
This supposition is supported by Boote et al’s (2012) reflective case study on how PPI led to 
researchers abandoning a proposal based on representatives’ feedback, even though it had 
received positive interest from other professionals. Some of the professionals also 
highlighted that PPI is likely to be most effective in ensuring relevance if it occurs during the 
prioritisation and design stages of the research process:  
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“By having involvement at the very beginning of this trial design, not just when it 
comes to designing the patient information leaflets, then you know there is more 
chance of it being relevant to the public and you know, so that’s I think that’s the 
ultimate goal.” (Adele, NL) 
In addition to increasing relevance of research, some of the professionals thought that the 
purpose of PPI was to improve the research process by drawing on different points of view 
and experiences. These issues were covered in more depth when I asked professionals 
about the broader perceived benefits of PPI. Therefore, in line with how the professionals 
framed these issues, I explore them in more detail in 4.4. 
4.4 What are the benefits of PPI?  
In my review of the literature I concluded that there is very limited evidence about the 
positive or negative effects of PPI on professionals. This gap in evidence might be partially 
explained because the benefits to the researcher (the main subset of professionals) and 
benefits to the research process were viewed fundamentally as one and the same by 
professional informants. Since much of their professional identity was linked to the 
research process, anything that benefited the research was also perceived as directly or 
indirectly benefiting them.  
4.4.1 Increasing relevance  
Given that most of the professionals perceived increasing the ‘relevance’ of the research to 
patients as the primary purpose of PPI, it is not surprising that this emerged strongly as an 
apparent benefit. What is interesting here is how the professionals saw PPI impacting on 
them personally and, in turn, the relevance of the research. They felt that PPI helps: 
“reminds us why we are here” (Sara, NL) and: “I suppose it brings them [researchers] back to 
reality” (Adele, NL). Alongside increasing motivation for their work, PPI was seen as bringing 
the need to be ‘outcome’ or ‘patient’ focused to the forefront, the logic being that if patient 
benefit is an aim of the researcher it will be translated into the research process, increasing 
the likelihood that research and its outputs are relevant. This would especially be the case 
where representatives were helping to confirm what is and what is not relevant:  
“Going back to my initial point of patient-centric research, you know it reminds you 
about why, why you know people do their 12/14 hour days, you know why people do 
go the extra mile when they have to write grants and, erm, papers, and it is, you 
know it is really about urm, you know a difficult, chronic, community based-
condition, which needs far more multi-disciplinary approaches.” (Lee, CP) 
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“I think the group erm reminds us of what we are doing and who we are doing it for, 
not everybody in the group has the opportunity to go to epilepsy clinics, meet people 
with epilepsy face to face.” (Tom, CP) 
In addition, having representatives’ confirmation that they considered the research to be 
‘relevant’ was reassuring to some professionals. This reassurance could help increase their 
own confidence in the research question and could also be used when justifying the 
research to others: 
“We were able to feel confident that we were asking questions and trying to answer 
them in a way that was relevant to patients.” (Alex, CP & ND) 
“Just to hear that people are happy with what we are planning really, you know 
when we ask them about... [..]..to hear from them straight away what they would 
think about receiving this sort of thing erm… and to hear from them that they 
thought that it was a positive, … [..].., I went down to give a presentation the other 
night and someone asked me a question. And I said well funny you should say that 
because our, you know research user group, said….“ (Rachel, RC14) 
4.4.2 Gaining funding and ethics approval  
Although, superficially, funding and ethics are two different elements of the research 
process, the professionals believed that PPI has four potential ways of influencing both of 
these elements. Firstly, when submitting an application to either an ethics or funding panel 
it is likely that applicants will be asked whether they have involved or intend to involve 
representatives. A positive response was seen as potentially increasing the likelihood of 
gaining ethical approval or funding: “From a rather slightly flippant administrative point of 
view it means you, you have ticked that box on the application forms” (Alex, ND).  
Secondly, many ethics and funding panels have patient or public representatives as 
members. Having PPI in place prior to a panel’s review of the funding application was seen 
by some as pre-emptive, in the sense that it helped to address any potential issues about 
the research that the representatives on the panel might have. This may reduce the chance 
that an application would have to be resubmitted based on the representatives’ comments:  
“The funders are using erm, their patient groups to, to comment on what might be a, 
an interesting study, something they might be interesting in taking part in. So I think 
it sort of closes the loop a little bit really, that the patients are commenting on that, 
as lay members do on ethics committees too. Actually having the patient early just 
solves problems that may come along later.” (Owen, NL) 
Thirdly, PPI was seen as providing evidence to the panels that the research was ethical or 
relevant: 
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“It’s that word of mouth that perhaps actually getting patient input early seems to 
work. Erm, I think it does, I think sometimes the erm, the applications that go in will 
say we have talked to, to some patient groups within the network or outside of the 
network and discussed this with, with them before, or during, the er sort of 
preparation for the proposal and that, that seemed to carry some weight especially 
with, erm, with lay reviewers.” (Owen, NL) 
Fourthly, and arguably most importantly, some of the professionals expressed the belief 
that PPI does actually make research designs more ethical and more relevant and, as such, 
more likely to be successful at the funding and ethical approval stages: 
“There has been a few cases where the parents especially have said, actually you 
know this, is unethical to do this research as it stands, as it’s designed like this and 
you know, and suggested ways to make it ethical.” (Adele, NL) 
Alongside the professionals’ wishes to undertake relevant and ethical research was the 
more pragmatic acknowledgment that research is a slow process and anything that can 
expedite it was considered advantageous, or as noted by Charlie (NL): “things getting 
through Ethics Committees quicker will please researchers.” Professionals’ perceptions 
about how PPI can impact on the ethical aspects of research overlap with those identified 
by INVOLVE. INVOLVE’s (2012d) review of ethical aspects of PPI in three literature reviews 
identified five ways in which PPI can potentially make research more ethical: i) making 
research more relevant, ii) helping to define what is ethically acceptable, iii) improving the 
process of informed consent, iv) improving the experience of participating in research, v) 
enhancing the dissemination of research both to the participants and the wider public.  
4.4.3 Increasing recruitment and retention  
When discussing the potential positive impacts of PPI, the professionals identified a variety 
of different benefits to the research process, including access to ‘a different perspective’, 
better communication and increased networking and dissemination. These were linked by 
the belief that improving these areas of the research process would improve recruitment 
and retention of participants to research studies.  
The professionals strongly valued PPI as an opportunity to ‘get a different perspective’. 
They believed that representatives’ perspectives were grounded in their personal 
experiences of being ill and receiving treatment (or caring for those that have been ill). 
These experiences were seen to give representatives important and unique knowledge only 
available to those ‘within’ the condition. Consequently having PPI was seen as a way for 
professionals to draw on information that they could not access though any other means: 
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“That although I am cynical about PPI, what they [representatives] will provide is a 
unique and interesting perspective because that perspective will come from 
something that none of us possess and that is the experience of being ill with that 
particular condition, with epilepsy.. and that is a unique perspective.” (Lee, CP) 
“The benefits of having that patient perspective is so valuable because they bring a 
different perspective to the table, and very often things that your agenda is not even 
addressing, you are not even thinking about it.” (Fred, NL) 
Within the literature this type of embodied knowledge is sometimes referred to as 
‘experiential knowledge’ (Caron-Flinterman, Broerse, & Bunders, 2005). It is this 
experiential knowledge that representatives use to make judgment calls about the 
relevance and practicalities of a research aim and design. The validity of making research 
decisions based on experiential knowledge, which by its nature is subjective, has been 
debated in the literature (Caron-Flinterman, Broerse, & Bunders, 2005; Popay & Williams, 
1996). It is clear however, that professionals in the present study thought such experiential 
knowledge could help improve the research process and, in turn, believed that improving 
the relevance and design of research would result in higher participation and retention 
rates:  
“Things that can seem small, like taking a certain question out of a questionnaire, all 
those sorts of things, just erm… You know research is difficult enough and 
particularly in these sorts of patient groups, and so, anything you can get really that 
is going to be a potential barrier and is going to mean that you lose people along the 
way, if they pick up on those straight away and we can take them out you know 
before we even start the research, then potentially really beneficial.” (Rachel, RC) 
“If trials are well designed then they are more likely to retain, you know, the patients 
in the trials as well.” (Adele, NL) 
One of the most common forms of PPI is obtaining feedback on recruitment materials such 
as participant information sheets, the intention being that if participants can better 
understand the research being presented to them and see why it is relevant, they will be 
more likely to participate:  
“So that if somebody is approached about it, that they can actually see the benefits 
that that research may give to the wider public. Erm which sometimes is not always 
obvious for the general public and for those being approached, I think sometimes 
they will look at certain studies and just think, “well what the hell has this got to do 
with me?”, where I think some good patient / public involvement early on could 
actually make it far more obvious to participants so I think that helps on the 
recruitment side.” (Owen, NL) 
Some of the professionals felt that PPI could help improve verbal as well as written 
communication. They openly acknowledged that communication between academics and 
the general public in the research process can be far from ideal: ”I think up to now the 
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research community has been relatively poor in erm, in really communicating with the 
general public” (Owen, NL). By interacting with representatives who have a remit to say 
when something is unclear professionals saw PPI as giving them an opportunity to have 
their assumptions about what is common knowledge challenged and could adapt how they 
communicate accordingly:  
“I have to sort of kind of think, oh hang on I had better not use that jargon, and I 
think that’s, that is a good thing, I think that can only be a good thing if we start 
discussing research in ways that are understandable to non-academics. I hope they 
[representatives] will just sort of, facilitate that. ..[..]..There are times that I think 
they have struggled a bit with the language. I think that actually is good for us 
because it makes us as I say, re-explain things, or clarify or you know things that 
seem obvious to you as a professional who has been working in epilepsy for 20 years, 
then sometimes it does need someone else to kind of go “sorry I have absolutely no 
idea what you are talking about” ((laughs)) for you know to realise you are making 
assumptions about people's knowledge.” (Francis, CP). 
If somebody says OK we need to be looking at voltage-gated potassium channels in 
Rasmussen’s syndrome, you know I think I need to translate erm, and hopefully other 
members of the committee will start to [02] maybe communicate a little bit more 
clearly, and in a way that a lay person would be able to erm, helpfully understand 
and engage and contribute.” (David, CP) 
Lastly, the professionals acknowledged how useful PPI could be in the dissemination of 
information about the research. While a couple of researchers speculated that 
representatives might be useful in disseminating the findings of individual projects, most 
focused on the representatives’ abilities to raise awareness of specific research projects or 
the research network as a whole though their social networks. There was always the 
chance that a representative interacting with their peers might mention a research project 
to an eligible friend who was not aware of the research. On a larger scale, a representative 
might also take part in other research projects or belong to charity groups, hence allowing 
access to a larger group of potential participants (e.g. through a website) or interested 
colleagues:  
“Another benefit is those lay people can sometimes act, they will sometimes mention 
the network when they are wearing other hats, so if they are patient, public 
involvement person in the network they might also happen to sit on their local erm... 
PCT or whatever they are calling them in the future erm.. Patient board or that, and 
they might raise research issues there.” (Fred, NL) 
“Here are some very concrete benefits, such as improved recruitment into studies, 
erm, so for example where we have collaborated with erm epilepsy voluntary sector 
organisations, they have then publicised the research to their membership er and 
that has given us access to a whole new pool of research participants, that we 
wouldn’t necessarily have seen through our clinics.” (David, CP) 
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As previously noted, failure to recruit is reported as a primary reason for non-completion of 
clinical trials (McDonald et al., 2006; Watson & Torgerson, 2006). Non-completion of 
research can be detrimental to researchers’ careers and PPI was sometimes valued for 
these potential and varied ways it might prevent this from happening.  
4.5 What are the challenges of PPI? 
My analysis of the data identified six main aspects of PPI that that the professionals 
reported finding challenging or difficult. I have categorised these challenges as: those 
representatives, the problem of tokenism, time issues, blurring of roles, disruption of 
academic norms and worrying about getting it right. It is worth noting here, that in my 
literature review I found few references on the challenges PPI posed to professionals, with 
the only concerns mentioned being the blurring of roles (Faulkner & Thomas, 2002) and 
issues of representativeness (Entwistle, Renfrew, Yearley, Forrester, & Lamont, 1998; 
Entwistle, Sowden, & Watt, 1998; Rhodes et al., 2002; Lindenmeyer, Hearnshaw, Sturt, 
Ormerod, & Aitchison, 2007). 
4.5.1 ‘Those’ representatives  
Without exception, every professional I encountered had at least one story about the 
difficulties of ‘one of those representatives’. The professionals held a shared understanding 
of what one of ‘those’ representatives’ meant, referring to them in conversation the same 
way as one might use a cultural idiom. Common traits of ‘those’ representatives as 
identified by the professionals included: “having an axe to grind”, “have an agenda”, 
“troublesome”, “aggressive”, “argumentative”, “self-centred”, “hobby horsing”, 
“destructive”, “angry”, “looking for a soap box” and “harping on a single issue”.  
The fundamental problem that the professionals expressed themselves as having with ‘one 
of those representatives’ was that they believed the person concerned was not involved in 
the research to contribute to it, but rather, solely for their own purposes, for example, 
trying to get better care or to having an opportunity to express their anger about their 
condition and its impacts:  
“When you have people who are basically angry about the services that they are 
getting. And use it as a kind of, use their involvement as kind of soap box to voice 
their dissatisfaction with services rather than what they are there to do which is to 
help with the research at hand or they just, they are just angry people. They are just 
destructive.” (Charlie, NL) 
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“There have, on occasions, been individuals who have become involved who clearly 
have an axe to grind and that it’s not actually about contributing to the development 
of research or to research strategy but it’s about you know, a specific issue that 
affected this specific person for which they want some kind of specific outcome.” 
(David, CP) 
“I want to know whether they are there because of, because they are really 
interested in research, or they are there because there is a political agenda that they 
want to meet or address.” (Lee, CP) 
To compound the issue, ‘those’ representatives ‘grinding their axe’ were often perceived to 
do so in a way that was not socially acceptable to the professionals, being seen as verbally 
(or in some cases physically) aggressive or rude. The point was raised that were a fellow 
professional to act in such a way, there would be ways to address their behaviour. 
However, due to the uncertainty of roles (see Section 4.5.4) and the wish not to upset the 
representative (see Section 4.5.6) the professionals often felt that they had no acceptable 
recourse in such a situation: 
“Because it’s a research team it’s not a, they are not under our control. …I think that 
is a problem. That almost anything is accepted, you know, aside from someone 
actually physically attacking someone erm.. there is too much acceptance of bad 
behaviour. ….I think there is a fear of upsetting people.. people tend to sort of say 
but I am ill, you know that’s why I was swearing or that’s why I was behaving this 
way. They cover themselves in the patient cloak dishonestly so in the majority of… 
sometimes it’s true though sometimes they are ill. Most of the time I think it’s used 
as an excuse.” (Charlie, NL) 
“They were almost, you know, fighting who could speak loudest and first, and it was 
very difficult to erm… sort of take the lead role and to say ok, that’s really important, 
but now can we ask somebody else to speak.” (Rachel, RC) 
“That is quite difficult and needs some very sensitive handling. You know there may 
be people who feel that they are very generously giving their time, but actually from 
the perspective even of other PPI individuals, they are bringing a problem rather than 
some kind of benefit.” (David, CP) 
It appeared that where a professional’s first or only experience of PPI was with one of 
‘those’ representatives, the experience instantly made them dubious about the value of PPI 
and considerably less likely to see themselves engaging with PPI in the future: 
“Health care professionals think, well patient public involvement doesn’t work, this is 
what you get from it, you get one patient, who goes on about the same thing every 
time we meet. …[..]..So that sort of thing can alienate people from, from actually 
getting involved in patient public involvement and I have seen it on a couple of 
occasions with a couple of researchers who are quite senior, erm, but have just seen 
one bad experience and, and are now erm almost sort of set against us in engaging 
and involving people.” (Owen, NL) 
The professionals were quick to point out that the majority of representatives were not like 
‘those’ representatives: “In my experience vastly, vastly more people are willing to listen, 
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willing to argue their case in a very sort of open and fair way, than there are people that 
have axes to grind. It’s 100:1 but it’s just the odd one that can actually set people on edge” 
(Owen, NL). They also freely acknowledged that some professionals were also axe grinders. 
However: “it fosters a kind of cynicism on everyone’s part which I think is unhelpful” 
(Charlie, NL) and while: “I wouldn’t want to overplay this as a problem, it is something that 
is a very real phenomenon” (David, CP). 
4.5.2 ‘Tokenism’ as a dirty word 
One topic that was repeatedly raised was that of tokenism, with professionals highlighting 
that: ‘you must not be tokenistic’, ‘I would not do that, it would be tokenistic’, ‘I did not like 
the way they did that it was very tokenistic’. Tokenistic PPI from the professionals’ point of 
view was seen as doing the ‘bare minimum’. This often consisted of having a person present 
so that it could be said that PPI had happened, even though professionals had not wanted, 
been able to, or allowed representatives to contribute in a ‘meaningful’ way. Examples 
cited of tokenistic PPI included not providing the information representatives needed in 
order to contribute meaningfully, using jargon so they don’t understand what is being 
discussed and using a representative known to the professionals rather than someone that 
is ‘appropriate’ for the research in question. This type of PPI was also referred to as ‘lip 
service’ or ‘tick box’, and in one case as ‘window dressing’: 
“To fulfil the requirement with the minimum effort erm... necessary and without 
making any effort to actually integrate this person. Of course we could invite 
somebody into the steering group if we erm... didn't want to take it particularly 
seriously, ideally somebody who never says anything you know, I am sure we could 
select somebody like that who would come but not say anything and erm... you know 
we could then say we have a lay member on our steering group.” (Nick, CP) 
“Well I guess it’s [not being tokenistic] making sure that people aren’t just sat round 
a table for the sake of it, erm, that if they are round a table they know why they are 
there, along with the other members, erm, and that they have a clear remit, purpose, 
for being there, and that any feedback or input they give, erm, is they are given 
support to, to bring that to the table. ..[..]... making sure that, you know, people do 
contribute, meaningfully, that it does have in some way an impact or influences the 
debate or discussion or the quality of the discussion …[..]… people were being set up 
to fail, because there weren’t the structures and processes to actually enable them 
to get on and do a piece of work properly and that some of the activities were 
perhaps a bit more tokenistic ..[..].. I think also putting, involving people in things 
where decisions have already been made about particular pieces of work you know, 
erm if there realistically is no opportunity for people to influence or change.” (Sarah, 
NL) 
There seemed to be a general consensus among professionals that PPI is often tokenistic 
and that engaging in tokenistic PPI either unintentionally or intentionally was 
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reprehensible. It appeared that many of the professionals felt that it would be better to 
have no PPI at all than to have tokenistic involvement. The issue of tokenism was also 
raised as an area of concern in ‘The Way Forward Report’ a PPI evaluation report generated 
by the NIHR Clinical Research Networks: “concerns were expressed around certain pockets 
of tokenism and some of the inappropriateness of such involvement e.g. putting someone 
on a committee for the sake of ticking a box” (p. 2), offering further evidence that it is area 
of importance to professionals. Like PPI itself, professionals had strong opinions about 
tokenistic PPI indeed, they often seemed to consider it as an abhorrent thing to do: ‘being 
tokenistic is wrong, when I watched it happen at a meeting it disgusted me’ (fieldnotes: a 
researcher who was not directly linked to one of the sites but who was present at an 
observation during a conference). They placed great importance on not being, or not being 
seen as, being tokenistic, as they saw being tokenistic as culturally or morally (and in most 
cases personally) unacceptable.  
As the issue of tokenism was repeatedly raised by the professionals, in later interviews I 
asked them to explain their understanding of what tokenism is (as described above). 
Though they were happy to explain what they thought was tokenistic PPI none of them 
explained why they saw tokenistic PPI as being unacceptable. As is the case for many 
culturally accepted norms, articulating exactly why something is acceptable or 
unacceptable can be difficult or seen as unnecessary. Coinciding with this, the 
professionals’ beliefs and concerns about the prevalence and significance of tokenistic 
involvement are not reflected in the current literature. During data collection, I anticipated 
that because tokenism was such an important issue to professionals that it must be heavily 
addressed in the literature. On investigation I realised that it had not come out in my 
review of the literature and on further investigation I was only able to find passing 
reference to tokenism in a few papers, normally in relation to types of PPI and with no 
explanation about its meaning (Arnstein, 1969; Dewar, 2005; Thompson et al., 2009). 
Rather than being based on the literature, it appeared that the professionals’ perception of 
the prevalence of tokenistic PPI came from their own experiences, for example, having sat 
on management, steering or ethics committees that involved representatives who were 
treated in what they perceived to be a tokenistic manner. The representatives also had 
strong opinions about what is and is not tokenistic PPI, providing examples of what they 
viewed as tokenistic and what they viewed as ‘meaningful’ (see Section 5.2.2).  
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One approach that some of the professionals identified to avoid tokenistic PPI and to 
ensure ‘meaningful’ involvement was to be strategic or pragmatic. They describe this as 
involving representatives when they could have the most ‘perceived’ impact on the 
research process, rather than having potentially tokenistic involvement at all stages ‘for the 
sake of it’: 
“We have to think in each case is this going to add value to the whole of the meeting. 
What is on the agenda, how can PPI influence the agenda, can it influence the 
agenda, is there appropriate erm, is there agenda items that actually could be dealt 
with outside of the meeting and fed back into the meeting. So those, those, erm, 
really questions because of resources we have got to be erm, show added value that 
now we have to be a little bit more innovative about the way we embed PPI in our 
work…[..]…it’s how with limited resources do we embed PPI and again I think, it is a 
challenge but it’s an opportunity because erm, it makes, especially with the Way 
Forward [report] one of the recommendations is to be more targeted, to come 
together and actually do things together, instead of it things going on in different 
networks because what we have recognised is there is lots of good practice out 
there, but there might be a bit of duplication.. more about now moving towards 
coordinating activity, doing erm, developing activity together so that, that eliminates 
it, so that is a better use of resource.” (Lyn, NL) 
This was also seen as a way to manage limited time and resources: “because the resource 
limits we have, there are things we would like to do but you just have to be, what is 
achievable really within the resources and be honest with people (Sarah, NL).” This position 
does not fit easily with the government recommendations to have PPI in all stages of the 
research process and the hierarchical models of PPI offered in the literature (see Sections 
1.4.1 & 1.5.3).  
Focusing on PPI quality rather than quantity makes sense in light of the benefits and 
challenges professionals reported experiencing as part of the process. This type of PPI 
could, of course, be dependent on the professionals own (self-proclaimed) ‘sceptical’ view 
of PPI. As such, if they were unsure whether or not PPI could have an impact on their 
research, they might chose not to include it to avoid ‘tokenism’. In addition at this level, 
preventing tokenism could be used as an acceptable moral argument against facilitating 
PPI. This is particularly pertinent in the value-led culture of PPI. 
4.5.3 Is it worth the time? 
A recurring challenge or barrier raised by the professionals was the amount of time 
meaningful, non-tokenistic PPI took out of their working day. Professionals pointed to the 
additional practical difficulties they encountered in organising a meeting with 
representatives in comparison to a meeting with colleagues, including having to send paper 
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copies of documents prior to the meeting to all representatives, additional emails 
reminding representatives to attend and liaising with different university departments to 
ensure representatives received payment. While often finding these tasks frustrating, the 
professionals did not find them difficult; rather, it was the time required to complete the 
tasks that made them onerous:  
“It is a lot of organisation. It’s not as simple as just kind of saying oh lets hold a group, 
you have to think of you know, setting the agenda, and sending all the information 
out in plenty of time, erm… then people say they haven’t got it because the hospital 
post systems are so rubbish and then you have to send it all out again, and erm… just 
you know coordinating things like that and finding the time when everyone is free, 
erm… can be quite time consuming really. Erm.. and then of course all the problems 
that come after of not getting their money and you are having to chase people all the 
time and things you know, for one meeting it takes up a good few hours of my time 
really.” (Rachel, RC)  
In conjunction with the additional time it took to organise the meetings, professionals also 
identified ways in which having meaningful PPI in meetings could result in them lasting 
longer. They suggested that representatives might need more clarification and explanation 
than professionals, be more likely to raise issues that had not been thought of and be less 
concise in their explanations, all of which could lead to lengthier discussions and in turn 
longer meetings. These issues, combined with the potential need for representatives to 
have more frequent rest breaks and to arrange the meetings at a time and place 
convenient to them rather than for the professionals, increased the amount of a 
professional’s time given to any one meeting:  
“It is a fact that if there are lay people in a meeting the meetings take longer.. 
because whether they ask for explanations or not and sometimes they will do, 
repeatedly, you do have to erm... take longer explaining things... and so meetings 
take longer which obviously means that... it puts people off attending or people have 
to leave half way through and ... so that is a very practical negative consequence it 
makes things more difficult to organise...[…]… it means the meetings sometimes have 
to be in the middle of the day …. if you are involving patients, or carers you, you can't 
easily start a meeting at 8.30, you know meetings with patients and carers 
traditionally are most successful, or certainly in my field, is they are in the middle of 
the day like you know 11.30 till 2.45 or something like that. It is a lot more time 
consuming. But these are all obvious in a sense practicalities and costs you know.” 
(Fred, NL) 
Fred (NL) also suggested that some of the more tokenistic types of PPI were the result of 
professionals trying to minimise the time commitment to any given meeting: 
“So a Professor on a committee may well do everything they possibly can to avoid 
getting anyone that is going to be argumentative, or make meetings take longer or 
erm.. put awkward points or view or put things on the agenda that you know are not 
what the Professor who is chairing the meeting is interested in. Not for, not because 
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they are evil, but because they are busy and they want to get business done and they 
have only got 2 hours for a meeting.”  
As well as emphasising the additional time and complexity that PPI introduced to meetings, 
professionals also identified other practical components of ‘meaningful’ PPI that required 
their time. These included seeking training for themselves and the representatives, the 
process of recruiting representatives, support for representatives and allowing time for 
representatives to provide feedback:  
“The problem is that it’s, you can’t expect people in the research development group 
to be able to get you feedback in 24 hours, 48 hours. Realistically they want a good 
couple of weeks, or a week to think about things properly, whereas a lot of the 
academics that we work with and researchers are much more used to, to working to 
deadlines, and so they probably don’t even start putting bits together until the week 
of a deadline and, and getting signatures and things all take time, so that has been 
quite difficult.” (Jess, NC15) 
As alluded to by Fred (NL) above, it was a ‘fact’ accepted both by the professionals and 
representatives that professionals are very busy, with competing demands on their time: 
“researchers are very busy people..[…]… my heart goes out to most researchers in a sense 
about, because, they are so busy and so to have another thing to do, to be able to just get 
this research out” (Adel, NL). As such, they must prioritise how they spend their time. In 
addition, ‘doing’ PPI is not something that is traditionally allocated as part of a researcher’s 
academic role. It was evident that the professionals in my research sites believed that the 
benefits of PPI were worth the cost in time and as such were prepared to be engaged in the 
PPI process. This seems to mirror heavily Salmon et al’s (2007) research findings in relation 
to GPs (an accepted ‘busy’ group of professionals) and their decision making about the 
economy of their time. Salmon et al found that GPs attribute lack of time as their main 
reason for not engaging in research and that this was seen as morally acceptable. However, 
when the GPs could identify intrinsic clinical, personal or professional value in a research 
project, they would release some of their ‘own time’ or ‘work time’ in order to participate. 
In other words, professionals find time for activities that they personally value but do not 
find time for things that they do not value:  
“I think they [professionals] have come round to that and thought actually, it’s not as 
bad as I thought you know, and so, it is erm, it seems to work…[..].. we have had to 
sort of like train them in a sense well look this is going to be beneficial for you, it isn’t 
just a tick box exercise, if you get the input and you are willing to take it on board, 
then surely your research is likely to succeed.” (Adel, NL)  
                                                          
15
 NC= Network (and PPI) coordinator  
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The professionals in my sites clearly valued PPI enough to invest their time in the process. 
To determine the extent to which time acts as a barrier to PPI would require further 
investigation with professionals who choose not to partake in PPI, which was outside of the 
scope of this thesis.  
As discussed in the Literature Review (see Section 1.6.1) added time commitment is often 
highlighted as a consequence of PPI, however there is very little detail about why PPI is 
time consuming (Boote, Baird, & Beecroft, 2010; Boote, Telford, & Cooper, 2002; 
Staniszewska, Jones, Newburn, & Marshall, 2007; Trivedi & Wykes, 2002). The professionals 
in my sites did not express concerns about PPI increasing the overall length of the research 
project (which to some extent might be compensated for by quicker recruitment) as 
suggested by Boote, Telford and Cooper (2002), but rather about the amount of their own 
time needed. Being aware of exactly how PPI incurs additional time allows for it to be 
budgeted and planned for.  
4.5.4 Blurring of roles  
In Chapter 3 when describing the PPI process in the comparator network, I raised the point 
that Jess and Tom did not feel they treated the representatives in the same way they would 
other colleagues (see Section 3.2). They linked this to the issue of professional boundaries 
and the blurring of their roles as researchers and clinicians. While issues of role uncertainty 
and clarity were touched on by many different professionals, as reflected in the latter parts 
of this section, they were particularly important for Jess (SS1), Tom (SS1) and Nick (CS1) 
who were my only informants with a clinical relationship with the representatives outside 
of the research. The approach to PPI adopted by the comparator networks involved 
frequent sustained interactions with the same representatives. Tom and Jess felt this 
compounded difficulties related to professional boundaries, raising the dilemma of how to 
maintain a working and potentially a more personal relationship, with representatives while 
still maintaining enough professional distance to work with them in a clinician-patient 
capacity. Jess and Tom both gave long detailed descriptions of their concerns:  
“The other thing that I found really hard is that, as a clinician or as a doctor, you’re 
trained to maintain professional boundaries. That these are your patients that you 
care for them, you provide a service to them, and so I found it increasingly different, 
difficult that these people I was beginning to care about, I cared about them a lot, 
um, and I worried that we saw them in a research capacity, but then Tom would see 
them in clinic or I would see them in my other role, un, and I find that, I found that 
really difficult but actually I am beginning to become more comfortable with that. 
..[..].. I actually have begun to like the fact that they are my friends and not just 
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people of the RDG but I to start with I found that very, very difficult...[..].. I do think 
that that is a really important point about involving people in research that, that you 
will, they will become your friends, you will begin to care, and you can’t then provide 
them a service. So, yeh I guess I found that really hard. Lots of people have since told 
me that I guess its expected to kind of run into these kind of troubles, if you are going 
to get close to a group of patients, and you can’t expect to please everybody all of 
the time. So I guess they for me are the two flip sides, that I don’t feel like we are 
giving them enough, and I think sometimes there are issues about professional 
boundaries, and that you have to acknowledge whether you are just going to forget 
them, or whether you are going to try and maintain them for the benefit of what you 
are doing. But I think people need to have that discussion with themselves.” (Jess, 
NC) 
“Then people ask about er professional barriers, so people ask about epilepsy advice, 
you may have met them once in clinic, you may not know them at all, you may know 
a bit about their epilepsy from what we have talked at the table you may not know 
and you have got to be very careful about what is general sensible advice about 
epilepsy and what is specific advice. And particularly you don’t want to be getting 
sucked into giving advice about changing drugs, urm drug doses particularly if you are 
not the regular er physician, it’s much safer to say this is sensible advice, contact 
somebody or you know, or I will arrange to see you, I will arrange a clinic 
appointment, probably I won’t arrange to see you because I think once I see them 
outside uerm I would probably prefer a um colleague to see them in clinic. Um I 
wouldn’t have a big problem with it but I think it might just be a little bit easier. Um I 
mean in terms of professional boundaries, yep, we are not dating anybody on the 
group you know, its, its, we’re not that intimate but you could end up giving 
somebody a lift to the train station and you get a little bit of your professional 
identity chipped away when they are sitting next to you in the car and they are 
seeing you, you know are sitting down having a cup of coffee and maybe that’s a 
good thing, but I have to be aware that it is happening. Erm, so we don’t give out our 
mobile phone numbers to people, in the group. Urm, and yet I would accept a 
number from someone else, or their e-mail address and so there is always a bit of 
power imbalance there, you wouldn’t say it was a partnership and they are all co-
equals, but there is a bit of a power imbalance because I don’t want to lose the ability 
to be their physician, ur their clinician at any stage.” (Tom, CP) 
That the RDG group was meant to be led by the representatives and only facilitated by Tom 
and Jess also exacerbated role issues. They were not meant to be present in an 
authoritative or leading role. However, they felt they needed to take control of and guide 
the group to ensure it achieved its aims and acted on their suggestions, and these were two 
contradictory positions to hold. This difficulty did not seem to arise in the other sites. 
Rather the professionals at the other sites seemed to pre-empt potential role uncertainty 
and boundary complexities by having clear views on what was their role and what was the 
representatives. Therefore, many of the professionals did not think that the representatives 
needed extensive research knowledge as they considered it the professional’s role to direct 
the research process and the representative’s role to provide experientially based advice. 
 117 
 
The other professionals also avoided issues of power discrepancy as they did not aim to be 
equal in the decision making process. 
The influence of the particular PPI approach adopted on boundary complexities is 
demonstrated by Nick’s account (the other professional with a clinician-patient relationship 
with his representatives). Nick did not express the same concerns about boundary issues as 
Tom and Jess. However, he believed that his role as the representatives’ doctor had an 
inhibiting effect on the PPI process, that because they were used to being his patients they 
were less likely to be forthcoming in their discussions (this is something I noted in my 
fieldnotes and was also raised by the representatives, see Section 5.6). Nick found this 
frustrating because of the time it took in meetings to get representatives to relax enough to 
contribute, and also that he was present at the meetings in the first place because he 
wanted to hear their opinions: 
“I often don't go for the whole meeting, in part because I think I might inhibit what 
they would say and they might be more open when just Rachel is there. Because I 
think there is still this doctor patient thing going on, I don't know will it ever go but 
erm... I think at the moment the reality is lagging behind our aspirations. Erm... it 
maybe my fault you know that I am somehow not, fault is a bit [30.26] sounds a bit 
depressing anyway maybe that I am not involving them sub optimally or... or, 
somehow I am not communicating clearly enough what does it matter but it still 
feels, like every time we meet I have to reannounce the framework you know, 
explicitly state, this research... we are meeting here because we are really interested 
in what you have got to say and so you know I have to kind of you know officially, 
erm... empower them to speak you know and if, if the situation was what it is 
intended to be, then that shouldn't be necessary but it feels like it is. Maybe if I just 
sat there and said nothing they would start piping up but I still feel the need to 
announce the sort of you know to define the setting, in this setting it is ok for you to 
speak, I am a doctor but you know I really am dependent on you and you know you 
really must have your views and very much cherish your input all this sort of stuff… 
what Rachel tells me and you know it always seems that the more interesting stuff 
happens after I have left so you know that's fine. Initially I think I was there for the 
full first meeting probably but after that I started to only come in for the beginning or 
part of it. ... sociology seems to get in the way, of what we want to achieve you 
know, we want to achieve this level playing field partnership situation, but it just isn't 
there, ((laughs)) it ain't possible, sociologically, so you have to kind of bridge this gap 
and it involves a lot of heavy lifting on both sides and so the patients have to give 
themselves a push I am going to say this although it's the doctor here you know 
although he knows so much more than me but I am just going to risk it.” (Nick) 
This frustration about representatives not voicing their opinion was echoed by some of the 
other professionals. In Chapter 5 I address this issue from the representatives’ perspective 
and discuss some of the reasons representatives believed that professionals would prefer 
to hear from their colleagues rather than from them, and as such might refrain from 
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speaking. When I discussed this with the professionals, they adamantly disagreed, saying 
that in this context they would prefer to hear from the representatives as they have more 
opportunities to access the views of their fellow professionals than they do to access the 
views of representatives:  
 “Yes but we get professionals’ views all the time, we need the patients view 
((laughs)) there needs to be time set aside, or there needs to be equity of access to 
comment really.” (Alex, ND) 
4.5.5 Disruption to academic norms. 
Another difficulty that professionals spoke of was that while, logically, they understood that 
representatives might not know the cultural codes of behaviour within the research 
context, they were still uncomfortable or offended when these ‘unwritten’ rules were 
violated by representatives. Most of the rules that professionals were sensitive about 
surrounded conduct in meetings. They placed importance on being punctual when 
attending a meeting, sending apologies in advance of non-attendance or anticipated 
lateness, being prepared by reading relevant documents, talking for a short length of time, 
completing tasks post-meeting that you agreed to by a certain date (and rearranging the 
date if you cannot make it): 
“Sometimes you kind of get a group and it’s just the same people saying things really 
and a lot of them just sit back and as much as you encourage them, they are not 
necessarily very forthcoming and then some people don’t turn up on the day and 
things like that and you think well, if you are being paid then that is a sort of 
professional role and maybe, they could, I mean I, then I have sent them off with 
things and say you know, and can you send me your feedback and these things and 
they haven’t done, so they kind of attend the meetings and they come along, but I 
am not necessarily sure that they all put in the amount of effort that I would do if 
somebody was giving me £50 to do something.” (Rachel, RC) 
Not adhering to these rules of conduct was considered rude by the professionals and cast 
representatives (and, equally other professionals) in a ‘poor light’. Charlie (NL) noted that 
conforming to these rules might be difficult for the representatives as a result of their 
condition or responsibilities as a patient or carer:  
“It just comes down to culture, people having mental health problems, people 
forgetting what time you know, what time the meeting is, where it was, what is it 
about.” (Charlie, NL) 
Another key academic norm was the importance of evidence-based practice. The moral 
justification for undertaking PPI suggests that PPI should happen whether or not it has an 
impact on the research process, with the more vocal PPI proponents arguing that it goes 
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against the ethos of PPI to try and measure impact at all16. This perspective does not fit 
easily within a biomedical culture based on evidence and accountability: 
“You have got to be accountable, if you said you are doing something then, you have 
got to do it…[…]… I mean rightly so the Department of Health are saying what 
actually is PPI doing? I am giving you a million pounds a year, for the networks what 
is it that it is achieving, you know and we have to move away from this, you know 
erm, oh well we helped, we helped design a leaflet to promote the network, well that 
is not worth that amount.” (Adele, NL)  
4.5.6 Worrying about getting it right 
In addition to having concerns about “those” representatives, professional identity and 
demands on their time, professionals were uncertain about different areas of the PPI 
process and their role within it. Many of the professionals admitted that this uncertainty 
made them worry and question their decisions and behaviours with regard to PPI, 
emphasising the potential for negative emotional effects of PPI on the researchers. Some of 
these worries were specific to the individual or context and only expressed by one or two of 
the professionals. For example, Rachel (RC), who was a researcher and also a clinician, 
spoke of worrying when one of her representatives did not know they were still having 
seizures and was unsure whether to broach the subject, as the representative was not 
interacting with her as a patient and it was not her role to advise them in this context. As 
discussed below other worries such as the ‘representativeness’ of the representatives and 
upsetting representatives were much more prevalent.  
As evidenced in Chapter 3, some of the professionals had clear ideas about who should and 
should not be a representative, while others were less certain. The source of this anxiety 
seemed to be a concern about how representative a representative can be expected to be. 
Representativeness holds a specific meaning in the context of quantitative research, with 
studies being designed to obtain a sample that truly reflects the wider population. In the 
context of the epilepsy research community, people with epilepsy were seen by 
professionals as having extremely varied experiences and views based on age, gender, type 
of epilepsy, education, profession, treatment and social class. Professionals therefore 
worried that the people they were selecting to involve were not really representative of the 
epilepsy community as a whole: 
“I think the epilepsy experience, is varied. We have got um carers of people with 
epilepsy there, erm both partners and people who work in the care system, um 
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 This was evident from my fieldnotes at the INVOLVE conference 2010, not within my sites.  
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somebody who has lost a brother to an epilepsy death, parents who have lost their 
son to an epilepsy death, a person with mild learning difficulties and his mother, 
umm a chap who with learning difficulties who comes on his own, we have eerm, 
people with really mild epilepsy, a couple of seizures and nothing more. People who 
have had epilepsy improved with surgery and no more seizures, and people with 
really difficult epilepsy that keeps coming and coming. And I don’t think any one of 
them could give you the patient experience.” (Tom, CP) 
This, in turn, led to professionals worrying that they were being tokenistic or not engaging 
in meaningful PPI. The way most of the professionals dealt with this worry was either to 
have as many representatives as possible (SS1 and CS117) or to accept that achieving ‘real’ 
representativeness was impossible and to select representatives that they felt could have 
the most effective input in a given situation (UKERN and CS2):  
“PPI suffers from language being used in a very bad way. Like a user representative 
for example, no user can be a representative you know, erm… people who use 
services any service, are always diverse as anyone else. And no one is really a 
representative, they’re a patient.” (Charlie, NL)  
“It is inevitable that there are going to be a range of views and a range of 
constituency across epilepsy, er, I think we have to, we have to accept that and we 
have to do the best that we can to ensure urm a wide selection of view are taken, but 
at the end of the day we can only accommodate a certain number of people in the 
study groups be that be patient public or clinicians and researchers, it means to take 
a similar view that you know there are a number of clinical domains er which aren’t 
necessarily represented in the network as it stands. So it is not really specific to PPI 
its er it is, it is a the brood scope and heterogeneity of epilepsy, within research and 
society.” (Alex ND & CP) 
The professionals concerns about how ‘representative’ a representatives can and should be 
are reflected within the PPI literature (Entwistle, Sowden, & Watt, 1998; Entwistle et al., 
1998; Rhodes et al., 2002).  
In comparison to professionals’ worries about representativeness, their worry about not 
wanting to ‘upset’ the representatives is harder to describe. It was clear that professionals 
worried about their interactions with representatives far more than they did with their 
colleagues. In some cases this worry seemed to directly impact on the professionals’ 
behaviour and it seemed to be consistently present for some of the professionals, but it 
was not always clear why. Alex (ND & CP) suggested that it is because he felt a level of 
responsibility for the representatives, and in his clinical role as a neurologist he was used to 
taking care of patients:  
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 CS1= child site one, CS2= Child site two, SS1= sibling site one. 
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Alex “You do feel like you have got a strange responsibility actually.. erm... it's 
quite different erm..., erm... and I can't necessarily articulate why but it's 
quite different having a responsibility for one's fellow academics as 
opposed to erm... the patient and public representatives there is a kind of 
different feeling of responsibility I think.  
Beth I know you just said it's hard to say why but... 
Alex Don't know, don't know perhaps I want to, perhaps I am being too 
paternalistic. Erm... and I guess in part they are patients in a sense they 
might be, in my subconscious they might be half way between patient and 
professional colleague. That's probably my problem that I need to deal with 
((laughs)) but erm... there you are I have articulated that.” 
This responsibility Alex felt seemed to hold true across the different groups of 
professionals. It seems that the very act of choosing the representatives and bringing them 
into the project made the professionals feel responsible for their welfare in a way that did 
not hold true for fellow professionals. This may have been due to professionals’ awareness 
of the power discrepancies within the group; however I did not identify and address this 
during data collection.  
Les (ND) suggested another reason for worrying about representatives was the 
acknowledgment that they might have a personal and emotional investment in the 
research that the professionals did not have. They were therefore seen as more vulnerable 
to being upset on a personal level, by the rejection of their ideas or by the language the 
professionals used: 
“I think that their position is quite vulnerable, vulnerable because of that. Urm, and, 
because people are only there to represent themselves, they have got sometimes a 
personal reason to be there, so I have mentioned the mother and father who are 
there because their son died of an, of a epilepsy related death, a SUDEP18 death and 
they would be particularly vulnerable to any project involving SUDEP and then there 
is also somebody who has lost their brother there, and so you know if we put in 
money for one of those kind of projects, and it, it, was deemed to be not scientifically 
strong enough, or erm if they thought they were supporting something that was 
going to give a more positive answer or more definite answer and it never got there I 
think people can be quite vulnerable.” (Tom, CP) 
“Sometimes they can get things wrong and go home insulted, or go home, er, just 
thinking they have, you know they feel as though you haven’t understood something 
and their backs go up and the barriers go up and so, there are..[..].. Well I think it just 
comes down to sometimes as professionals you use language which is scientific 
eeerm and so, for example if we say mutations in the gene, we know what that 
means but to the lay public that can mean several different things. Urrr and, um, and, 
I think you know sometimes patients can get it wrong from that perspective. Urm I 
think there has been one situation ahh, where you know Jess has rightly said to 
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 SUDEP stands for Sudden Unexplained Death in Epilepsy  
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patients look we can’t form, buddy, buddy relationships here, we do have to make 
sure that we guide you rather than form you know, long life friendships and I think 
one or two got were insulted by that. So I think you know, so sometimes we get it 
wrong, in terms of language, urm in terms of over scientific presentation, 
misinterpretations.” (Les, ND) 
As touched upon when discussing the professionals’ concerns about ‘those 
representatives’, professionals were aware that some of the representatives were ill, and as 
such they did not want to draw attention to or exacerbate the symptoms of their illness and 
in doing so risk causing offence or distress. Other ways in which the professionals worried 
that the process of PPI could cause distress to the representatives included having them 
involved in a bid that then did not get funding, not being able to act upon their suggestions, 
representatives becoming frustrated over the slow pace of the research (or network), being 
insulted, failing to communicate in a way they understand and introducing new information 
on their condition which could led to increased anxiety on the part of the representatives.  
4.5.7 Feeling demonised  
It is not only representatives who might feel ‘insulted’ during their interactions with the 
professionals. A small number of the professionals reported experiencing interactions with 
representatives that left them feeling ‘demonised’ and ‘upset’: 
‘This woman came up to me and said I was only interested in my career, that I was 
not doing research to help people with epilepsy, that I was only interested in getting 
paid, that I did not care about them.’ (Ann, supervisor, paraphrased in fieldnotes) 
“I had an e-mail from the woman which was aggressive um, and nasty and horrible 
and told me that um, said I had the wrong attitude, that she didn’t respect me 
anymore, that I should be ashamed of myself that I wanted to work in the health 
profession if I had um, issues with boundaries, and that upset me so much.” (Jess, 
NC) 
‘She [a representative] came up to me and was like ‘What do you know, you have not 
been though it’ and I thought well actually I have been though years of training and 
worked in this field for a long time. It felt like she was telling me that was worth 
nothing’ (researcher, paraphrased in fieldnotes from INVOLVE conference) 
While this was the least prevalent challenge in my data it seems to have been particularly 
upsetting for those involved. It appears that the professionals felt the representatives in 
question were directly and fundamentally challenging or disrespecting their professional 
and in some cases their personal identity.  
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4.6 Discussion 
In this chapter I have described the professionals’ experiences and perceptions of PPI, 
demonstrating that they viewed increasing the relevance of research as the primary 
purpose and overarching motivation for PPI, rather than any moral or political justifications. 
Overall the professionals had a largely positive attitude towards PPI. However, they were 
‘sceptical’ about its impacts and unsure about the best methods of implementation. Ways 
in which the professionals believed that PPI could benefit the research process included: 
helping to gain funding and ethical approval, increased relevance, and increased participant 
recruitment and retention, all of which are congruent with those given in the PPI literature 
(see Section 1.6.1). The professionals rarely identified any benefits to themselves outside of 
the research process. They did however identify a range of personal as well as academic 
challenges linked to PPI, including: working with ‘those’ representatives, issues of tokenism, 
time commitments, blurring of academic roles, disruption to academic norms, worry about 
getting it right and feeling demonised, 
The professionals differentiated between ‘tokenistic’ and ‘meaningful’ involvement, 
advocating the use of strategic meaningful PPI in some stages of the research process over 
potently tokenistic PPI in all stages ‘for the sake of it’. This approach to PPI conflicts with 
the Department of Health’s’ policy (2006) to have PPI in all stages of the research process. 
It also does not fit easily within the models of involvement that conceptualise power over 
outcome as equivalent to level of involvement (see Section 1.4.1) because how 
‘meaningful’ the involvement is perceived to be by professionals appears to have little to do 
with the degree of power over outcome.  
Issues raised in this chapter are explored in more depth in the discussion chapter. The 
discussion chapter also takes into account the representatives experiences as described in 
the following chapter.  
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Chapter 5. Representatives’ experiences and 
perceptions of PPI  
5.1 Introduction  
In Chapter 3 I focused on the professionals’ site-specific motivations and decision making 
processes around PPI. This was then built upon in Chapter 4 where I explored more broadly 
the professionals’ experiences of PPI. The current chapter shifts the focus from the 
professionals to the patient and public representatives, describing and interpreting their 
experiences of, and reflections on, PPI. 
Mirroring the presentation of the professionals’ data in Chapter 4, in this chapter I draw 
upon all of the data from the representatives. As my interactions with the CCRN PPI 
network leads (SS2) and the clinical trial (CS2) did not result in any direct interactions with 
PPI representatives, this chapter addresses the representatives in the remaining three sites: 
UKERN, the comparator epilepsy network (SS1) and the intervention study (CS1). As 
described in Chapter 2, this consists of 23 interviews with 17 representatives and fieldnotes 
from site observations. I will first explore how representatives described their 
understanding and conceptualisation of PPI. I go on to discuss their motivations for 
involvement and the personal benefits they identified. Issues surrounding ‘confidence’ are 
then discussed in depth, as this seemed to be a key influence in how the representatives 
experienced PPI. Lastly, I discuss the challenges that the representatives experienced.  
Throughout this chapter any differences in reported experiences across sites are 
highlighted to further address research objective 4: ‘To compare different approaches of 
implementing PPI’ from the representatives’ point of view, building on the information in 
Chapter 4. This chapter also draws attention to how the representatives’ experiences: 
‘compare and contrast to the theoretical underpinnings of PPI’ (research Objective 2). 
5.2 Understanding of PPI 
In contrast to the professionals, the representatives did not appear to differentiate clearly 
between ‘What is PPI?’, ‘What is the purpose of PPI?’ and ‘What are the benefits of PPI to 
the researchers and the research process?’ Their responses to these questions were 
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enmeshed. Therefore I present the findings in this chapter in a way that reflects how the 
representatives expressed their understanding of PPI.  
5.2.1 What is the purpose of PPI? 
Many of the representatives admitted to being unsure about the purpose of PPI prior to 
their own involvement in research. Those who described having some awareness said that 
they developed their understanding by observing PPI in panels and groups on which they 
had fulfilled a professional role (these were mainly the UKERN representatives). Others 
described developing their understanding of PPI though experiencing it themselves as a 
representative. Consequently, some representatives were less confident in articulating 
their understanding of PPI than the professionals were:  
Beth: “What is your understanding of what public patient involvement in research 
is? 
Faye Really limited, really limited I suppose. Erm, well maybe it’s not I don’t 
know, maybe I am waffling, erm I suppose because of the service user 
involvement in mental health and learning disabilities that I know a little bit 
about it I suppose my, my understanding is probably not as limited as I am 
portraying it.” (UKERN) 
When discussing the purpose of PPI the representatives tended to situate it outside of the 
research context and spoke of PPI within the NHS, service improvement and other 
government schemes: 
“Public patient involvement. Involvement in various ways in, I suppose, the National 
Health Service. I guess it might be in other areas of government I don’t know, I know 
that they have been advertising for the local hospital at one stage, erm, and in this 
instance, they are wanting us included in the planning of the research programmes.” 
(Hazel, UKERN) 
“I was sort of vaguely aware that in the wider world that you know there is much 
more listening to erm, the public, I sort of have been to a couple of meetings for a 
local mental health trust, they are trying to set up themselves as a foundation trust, 
and you know again beginning to realise that they want carers and patients 
involvement in that..[..].. The NHS was across the board if you like wanting patient 
input, patient and public input.” (Katie, UKERN)  
Like the professionals, the majority of representatives agreed on what they perceived to be 
the purpose of PPI. Instead of focusing on increasing the relevance of the research as the 
professionals did, they tended to take the position that the primary function of PPI was for 
professionals to get a ‘different point of view’ or more specifically a ‘patient’s perspective’. 
Accessing a different point of view was seen by the representatives as resulting from their 
own experiential knowledge of epilepsy but also, in some cases, from the perspective of a 
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non-professionally trained person. Both of these factors were seen to allow representatives 
to identify issues that would not be in the professionals’ purview: 
Beth: “So from the doctor’s point of view or from the researcher’s point of view 
what do you think the point of them asking patients’ perspectives is? 
Claire They are only seeing it from the doctor’s point of view, they see the 
patients all the time, but they don’t know how patients may feel about the 
information they are being given, the treatment they are being asked to 
undertake, you know, certain, a lot of aspects of what they might have to 
go through and it’s not always possible for a doctor to see the research in 
that way because they have obviously been through training for however 
many years it is, so they can see it from their point of view but not 
necessarily, take that step back and see it from the patient’s perspective.” 
(CS1) 
Beth  “So an advantage of having patient involvement is that they might point 
things out that a clinical person might not realise? 
Ron Or thought about, or have thought about. I mean it’s like any committee of 
people, if you get a body of opinion, generally speaking there might be 3 or 
4 people who think the same thing but there will be always 1 or 2 or 1, who 
will think of something different, and I think to have a range of opinions, be 
it scientific, psychological, erm, just general public involvement will give a 
different view of that, whatever it might be. I think the whole, the 
conclusions that you would draw as a group from all that information is 
going to be more, erm, what’s the word, more precise, and more likely to 
be realistic.” (UKERN) 
One of the advantages that the representatives believed that their perspective could bring 
to the research process was a ‘de-jargoning’ of the language used. The general consensus 
was that professionals have a tendency to talk in a way that ‘normal’ people do not 
understand and it was their role as a representative to help professionals communicate in a 
way that would make sense to a wider audience: 
“The people the field of neurology that I have come across are extremely clever, and 
are extremely.. I want to use the word gifted at what they do, however, they don’t 
have very good people skills so when they are explaining something to a patient, it is 
matter of fact, it’s all kind of cut and dry and they will use a lot of Latin in there, and 
people will go ok, ok, and then they will leave and they will be like, oh what? 
((laughs)) so, erm, we want to make sure, my personal feeling is part of this group is 
to try and cut that out as much as possible, yet still get as much reliable information 
in there as possible.” (Jim, CS1) 
“If you have got somebody in that room who is going to be brave enough because 
you are going to need somebody with a bit of balls ((laughs)) really to say I am really 
sorry but I haven't got a bloody clue what you are talking about ..[..].. Not to be 
irksome but because that is our role, that's what we are, that is part of our role.” 
(Faye, UKERN) 
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Between them the representatives identified two distinct ways that simplified, de-jargoned 
language could positively impact on the research process. Firstly they felt that it could 
improve study recruitment, because if potential participants understood what was being 
presented to them they would be more inclined to agree to take part. Also, they would be 
less likely to be offended or discouraged from participation by the language used in the 
research documentation. Representatives also spoke of how they might be able to provide 
suggestions on how to improve recruitment outside the issue of the language used, for 
example by giving suggestions on the way potential participants were approached:  
“They kept using the word erm, psychogenic and you know ‘psycho’ the word 
‘psycho’ a lot in things, erm, and I personally feel that if you tell someone they are a 
psycho in the opening line of a statement, they are going to not be interested in what 
you have got to say. Because this is a mental condition, people already have you 
know, preconceived ideas of what a mental condition is, and I think if you go at 
somebody who has just been freshly diagnosed with a mental condition and use the 
word psycho you are going to freak them out and they are not going to be interested 
in ((laughs)) anything that you have got to say from there on in because all they will 
hear is that word. So I suggested they change that and they have changed that, and I 
think that will now have a more positive impact on the people that they are trying to 
target because they won’t be so frightened just by reading the first opening 
sentence.” (Moira, CS1) 
“Well there definitely things that you can comment on... you know the approach 
given to erm... to inviting people with epilepsy to take part in the research for 
instance, definitely have thoughts on how that might be best approached.” (Katie, 
UKERN) 
Secondly, it was suggested that by altering the language, the findings of the research could 
be disseminated to a wider audience, thus increasing its chance of having an impact and 
helping to ensure that researchers were accountable to the wider public:  
Beth: “So, if you are then going to be recruiting someone into a study, you need to 
be able to explain to them in clear ways what they are getting involved in, 
so using this excuse of well it's difficult to explain… 
Faye  …Absolutely but not only that, if you want the world to know, how are you 
going to tell the world. You can't just publish it in one of your obscure 
scientific journals and hope that some journalist will pick it up and interpret 
it for you, there is a whole world who needs to know what you are doing 
really. They just say, oh it's very complicated that is just not good enough 
and it also leaves you open to not being accountable to people and I think 
this is the same here.” (UKERN) 
The majority of tasks that representatives had undertaken within their PPI roles required 
them to give feedback on the readability of protocols and participant information. It 
therefore made sense that they presented this as one of the main benefits of PPI. Similarly, 
representatives who had made suggestions on the research design process, for example 
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those in CS1, or on relevance or priority setting like those in the UKERN, were much more 
likely to have mentioned these as benefits of PPI. 
In conjunction with the representatives’ belief that their experiential knowledge of epilepsy 
would help the research process, there was a general perception that PPI would also more 
broadly benefit the professionals. This was because it provided them with an opportunity to 
interact with representatives outside of the normal clinical context, increasing their 
knowledge of their patients’ experiences and, in turn, improving the service they provided. 
This issue was amplified by the observation that most doctor-patient interactions are time-
constrained, and all of the representatives had experienced interactions with busy or 
dismissive health professionals:  
“I think it [PPI] really does help because you learn things at university and you learn 
things at medical school and you see people in a 10 minute consultation, and you 
can’t gain information, you don’t get what it feels like to have it, and I do think it’s 
really important that people who are offering a service, or interacting with people 
who have a condition, have a certain amount of empathy to what it feels like to live 
with it ..[..].. If you have got knowledge, more of knowledge from this side it helps 
you deliver a better service. And I think that, people participating in research who 
have the condition that is being researched, it does help people to get more of an 
understanding of what it is like on a day to day basis, then they can deliver a better 
service.” (Moira, CS1) 
“I think for Tom [CP,SS1], he, he listens and he hears people, coming from the heart if 
you know, what I am saying like and urm the more people he hears, and the different 
things he hears about, that is bound to have an effect on him, and hopefully that will 
be fed back to his other peers, or whatever it is like you know other doctors, and so 
that can only improve the service that is being given.” (Matt, SS1)  
5.2.2 What is meaningful PPI? 
When conceptualising and reflecting on PPI the representatives, like the professionals, 
drew a distinction between what is meaningful PPI and what is tokenistic PPI. The 
representatives in my sites remarked that meaningful involvement only occurred when 
they could potentially have an impact on what they were involved in; to an extent whether 
or not they actually did have an impact was secondary. This was particularly pertinent as 
resulting from the moral and ethical justifications for PPI, there were a number of 
professionals who strongly believed PPI should occur regardless of whether not it made an 
impact on the research process or those involved (see Section 1.4.2)19. In contrast the 
representatives viewed this form of involvement as tokenistic and a waste of time: 
                                                          
19
 This was particularly apparent in my fieldnotes from the 2010 INVOLVE conference rather than 
within my site specific data.  
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“We have made suggestions and they haven’t changed them and it’s disappointing, 
but they say, they say things like oh this is the set structure and we can’t alter it, you 
just think, well ok, you have to kind of accept it, but sometimes I think why did you 
ask us if you can’t change it. Why would you ask somebody their opinion of 
something if it can’t be altered, because it can’t be altered so it doesn’t really matter 
what somebody else’s opinion of it is. So, because if you are going to give somebody 
a criticism about something you need to know that it is going to be changed, and 
some things that we have suggested of like wording or, you know this question 
should be added, when they have done questionnaires we have said this question 
should be added, and they said well we can’t because it’s a set number of questions 
and those kind of things. It seems like a pointless thing to do really ((laughs)) what’s 
the point?” (Moira, CS1) 
As explained in Chapter 4, the professionals believed that meaningful involvement occurred 
when representatives had valid opportunities to express their views. The representatives 
built on this idea, giving examples of situations that were and were not ‘valid’ from their 
perspective. Understanding what they were being asked to comment on was seen as 
particularly important. This did not necessarily mean understanding all of the detail of the 
research or medical components. Rather it meant having enough information to place the 
research in context and enough direction to know where to direct their focus or attention: 
“If you just give somebody a piece of paper and say read this and then tell me what 
you think, they don't know what they are telling you, what they think about in 
context because they could just say well it's a very nice paper actually, I quite like 
that, or it makes no sense to me, it has nothing that I can tie onto..[..].. But if I gave 
that paperwork to my parents, and said what do you think... you would at least need 
to narrow their field of judgement, so that they were making a decision on 
something that was pertinent and relevant to what you wanted and whether you do 
that through giving them a bit of a research background or whether you do that 
through just giving them a bit of a, clinical background I don't know or whether you 
just say to them, do you think it's important for you to know this.. I don't know.” 
(Faye, UKERN) 
“I still might not know or understand is the direction and I think it’s just a lack of 
knowledge, I am sure that if somebody had, if I sat down and explained to me right 
this is what we are trying to do, I would have got that.” (Paul, SS1) 
The UKERN representatives felt that they had some sense of the context of the research as 
a result of their professional backgrounds but that their understanding was further 
developed by the training day and their attendance at the International League Against 
Epilepsy (ILAE) conference. The representatives from the Comparator Epilepsy Network 
found that listening to the researchers discuss their area in general before being asking to 
make comments on a particular project provided a frame of reference that they would not 
otherwise have had.  
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Having the opportunity to give their opinion and it being listened to was also seen as 
imperative to meaningful involvement. This might seem self-evident, but just because a 
representative was present at a meeting or part of a group did not mean that they had the 
opportunity or the ability to contribute:  
“Some groups erm I have been involved with are actually larger and you can feel that 
you are not actually getting your own, you know getting your point across because 
there is like if there is 20 people in the group, then you have got a lot of people 
talking and you have only got a short amount of time to actually erm, talk about what 
you erm, you know want to talk about. It can be quite difficult because, if like, in one 
group I go to one person is erm, quite chatty.” (Claire, CS1) 
Hazel for example was told that she was going to be asked to comment on some 
documents; however due to time constraints the group leader did the work themself rather 
than sending it out to the group. While she understood the logic she felt it defeated the 
point of having her and her fellow representative as part of the group: 
“I know that when you have got somebody in who really doesn’t have the same 
knowledge and understanding as you, it’s much quicker to do it yourself, or just for 
one person or two people to do it isn’t it? Erm.. but I guess that’s not what it’s 
supposed to be about is it? It is disappointing because I think we both wanted to be 
involved but erm… it’s not really happened…[..]..It makes it [PPI], it actually has made 
me feel that it’s just a paper exercise frankly and I don’t say that the people or 
certainly not all the people who are involved erm… are just going through the 
motions but it feels that perhaps, it is something that has come down from 
government that you are supposed to do and it ticks boxes and we are being ticked 
off, but we are not actually being involved.” (Hazel, UKERN)  
In turn, once the representatives had the opportunity to give their opinion they wanted to 
be listened to and have their opinions taken into consideration by the professionals. The 
majority of the representatives felt that the professionals involved in the different sites 
actively listened to what they had to say. This perception was reinforced when the 
professionals took time to explain why they were not intending to incorporate some of 
their suggestions: 
“My recollection is that there was no difficulty, in you know, having a discussion that 
involved everybody and that everybody contributed and everybody listened I didn't 
think that was a problem at all.” (David, UKERN) 
“Actually feeling like people listen to you, because you know when Rachel (RC) is 
there she is taking notes so erm, you know that she is actually listening to what you 
are saying and, taking on board the comments that you are actually making. So that’s 
good, so it feels like you know you are, your involvement and the time that you are 
spending actually erm, getting involved with this is not being wasted..[..]... you know 
if Nick doesn’t really agree with you, he will give you an indication of why he doesn’t 
agree with that or why he doesn’t think that is a good way of doing things, which 
from my point of view, I prefer because even if you know he is not going to take on 
board what you are saying, he is telling you why he is not you know, why all the 
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reasons behind it, which is better than just being told no we don’t want to do it like 
that, end of conversation.” (Claire, CS1) 
Representatives also focused on the meaningfulness of the small changes that they could 
make. They did not perceive the purpose of PPI as being to make wholesale changes, rather 
that by ‘tweaking’ words and making adjustments to process they could have substantial 
impact: 
“Hopefully when the research is completed, you can have a hand in actually erm, 
shaping the way things are done. You know probably not in a major way, but in a, a 
small way that may help out the patients in ways that may not have been thought 
about.” (Claire, CS1) 
5.3 Motivations and benefits  
I found it surprising that representatives’ motivations for taking up a PPI role did not appear 
to be touched upon in the existing literature. In my own study, the representatives’ 
motivations for involvement influenced their experience and in light of the concerns some 
of the professionals expressed about the motivations for involvement of ‘those 
representatives’, insight into the representatives’ motivations seems particularly pertinent.  
Representatives seemed to have a sense that they should say they were motivated by the 
wish to ‘give back’ to the research and medical community which had treated them: 
“perhaps giving a bit back is what you should say isn't it?” (Ron, UKERN) or, that they 
should only be altruistically motivated to ‘help’ others: “The hope that it benefits other 
people, and benefits me in the future. So it’s perhaps not as altruistic as it originally sounds” 
(Katie, UKERN). While giving back and helping others were partial motivators for some, they 
were not the only reasons for their involvement. The representatives identified four main 
motivations for their involvement: personal interest, making a difference, restitution and 
value. Representatives also identified the opportunity to learn and opportunities for social 
interaction as additional benefits of PPI. I will now discuss each of these in more detail.  
5.3.1 Personal interest  
The most commonly stated reason for involvement by representatives was that they were 
‘interested’ in the area. When I asked them ‘how/why did you get involved in [site name]?’, 
nearly all of the representatives responded with a variation of: “she asked me if that was 
something I was interested in, you know getting involved with, and I said, yes I was” (Claire, 
CS1). They attributed their interest in both the topic of epilepsy and the research aspects to 
their own experiences and academic curiosity:  
 132 
 
“I had been reading research articles because I just wanted to find out more about 
epilepsy generally. I suppose I am sort of interested in sort of [laughs] academic stuff 
a bit anyway, so it was sort of a joint thing of erm you know, wanting to find out 
more about epilepsy and, erm, you know interested in the fact that people you know 
people’s research and also you know slightly personal academic reasons as well I 
guess.” (Katie, UKERN) 
“The whole thing of epilepsy per se is an interest because of my family connections 
and also my community work …[..].. it’s an interest in addition to the interest I have 
already got in that it will get my head back into academia to a degree, I like reading 
scientific …[…].. I am doing it for self-interest. I have to be honest; I am interested, 
genuinely interested in it, it's my favourite subject.” (Ron, UKERN) 
“It’s also, you get to be interested in it [in the condition], don’t you? So we thought 
this is a way of, we had the time, and we were interested so. We could maybe 
contribute something.” (Jill, SS1) 
In turn, the representatives identified ‘finding it interesting’ as one of the main benefits of 
their involvement: 
“Benefits? I find it fascinating hearing what the research proposals that are going on. 
I like being able to express my views, erm, I like looking at research proposals, I have 
always been interested, sort of interested not involved, but I guess my academic 
background I think by nature too, I am, I like to analyse things.” (Hazel, UKERN) 
“It’s been quite interesting, um, you know, Jess (NC) and Tom (CP) um, have had 
important doctors and specialists there doing saying their, their pet subject then if 
you like and what the ideas that they want to see, put on, or put in or however you 
want to word it, um, so it’s been quite interesting for us.” (Chris, SS1) 
5.3.2 Making a difference  
Another of the representatives’ recurring motivations for involvement was to ‘make a 
difference’. However, each representative’s motivation for wishing to do so varied. Faye’s 
(UKERN) wish to make a difference came from a wider belief that if you are unhappy with 
something you should at least try to change it: 
“It’s a part of a personal political stance for me, I am a great believer in if you don’t 
like something, or if you are not happy with something then you should try and 
change it. I don’t believe you can complain about something if you sit on your arse 
and don’t do anything about it. So, it just gives me a sense that I have a right to moan 
[laughs]. No but it’s more, I think it’s more about I have a sense that I am trying to 
make a difference somewhere along the line, and that feels better for me it just feels 
like I am trying somehow.”  
For Sam (SS1), who had recently lost his job, after his epilepsy changed from being well 
controlled to uncontrolled and having also been diagnosed with depression, he felt that his 
self-worth rested on his ability to affect the world around him: 
“I can still have an effect, I can have an effect on how people can possibly 
benefit..[..]..speaking as a person who would love to get involved, in research, 
because it will make a difference, that’s really why I wanted to get involved with 
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research is that I could make a difference for, well I say my fellow man, but people 
who are, people like myself who are suffering with epilepsy, ..[..]…. being involved in 
something it makes a tremendous difference to your personality, to your sense of 
belonging…[..].. I felt a lot more positive, when I was involved. That’s on a personal 
basis, really, I felt a lot more erm, (s4) enthusiastic, I had the opportunity to help 
others.”  
For Rose (UKERN) the chance to make a difference helped her feel less powerless in a 
situation where she could not directly help someone she loved: 
“Having the kind of knowledge of my brother’s… the issues for my brother, and what 
it’s like for someone whose epilepsy isn’t controlled and erm… has you know sort of 
complex epilepsy erm… I felt that I could perhaps represent him to some degree and 
it might be helpful erm… it’s something I can do. Because sometimes you know it 
feels very difficult to know what you can do to help and it’s quite hard, you know you 
feel a bit powerless really when you are watching somebody have a difficult 
time…[..].. It’s just being able to do something practical.. Yes it doesn’t probably 
make a difference to his life (laughs) but, it makes me feel like I am doing something I 
suppose.”  
The other reason articulated for wanting to make a difference was to help others, and 
potentially themselves, by improved research and, in turn, services and treatments:  
“To see if my 10 penneth I could put in, would anyone could relate to it and either 
help me or help them you know.” (Matt, SS1) 
“It is just exciting to think that you, you can really, or you should be able to, really, 
really help people.” (Sam, SS1) 
As Moira (CS1) explained, one of the main reasons for wanting to help others was because 
she knew what it felt like when things did not go as you would like and she wanted to help 
prevent others having the same experience she did. This seemed to be true for several of 
the representatives:  
“You can potentially help a lot of other people..[..].. So if you can work with 
professionals and other sufferers to develop something that can make people not 
have to go through that and feel like I felt, then you have just got to do it, you have 
just got to do it. I just find the whole group positive because it’s actually making a 
change to what, to the service that is there at the minute, so from the charity’s point 
of view because I speak to thousands of people with this condition who are 
absolutely desperate you can then turn round and say well you know in the future 
things will be there to help you, they are not there now, but they are working on 
them and they will be distributed as soon as they can, so it just gives people a bit 
more positivity about the future really.”  
5.3.3 Restitution  
As mentioned in Section 5.1, the representatives viewed PPI as an opportunity to express 
their views and experiences to professionals outside of their normal clinical interactions. As 
well as seeing the potential benefits to the professionals and the research process, they 
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also personally valued this opportunity. The majority, if not all, of the representatives had 
experienced clinical interactions with medical professionals that had left them feeling 
‘deflated’, ‘devalued’, ‘disrespected’ or ‘dismissed’ (most often with General Practitioners or 
Consultants) with no direct opportunity for restitution. This was highlighted by James (SS1): 
“Everyone in the group can come back with a story saying you know, well the doctor said 
this and really, it was rubbish.” From my interactions with the representatives I recognised 
that they saw having the opportunity to express their views directly to a professional as 
validating their knowledge and experience, compensating for a previous negative 
experience, regardless of it not having been with the same professional. I have labelled this 
benefit of PPI as ‘restitution’, as it appeared to allow for a rebalancing of the 
representatives’ sense of self-worth.  
5.3.4 The value of the research activity  
While the motivations so far discussed could be viewed as not specific to a particular site 
and could have resulted in the representatives taking up any research-related PPI role, the 
representatives also discussed being motivated to take part in a given network or trial 
because they could see its individual value. As such they felt it was worth giving their time, 
effort and commitment to: 
“If there is all this research around, and it's all ad hoc, it's not going anywhere, there 
is no, there is no focus for it is there at all, and.. nobody is saying well hang on a 
minute we have got this big gap here that, you know really we feel you could 
probably do a lot with this we just need somebody to have a look at it, unless the 
gaps are identified, they can't do it you know [identifying gaps in the research was 
the main task of the UKERN].” (Ron, UKERN)  
“Everything that has been discussed at those meetings is, is important because there 
isn’t anything at all so putting anything, however small or meagre in to the mix is 
going to help people because at the minute they have got nothing. ..[..].Because 
there is absolutely nothing at all for this condition, your expectations are get 
something out there and get it out there now. And that is exactly what, what the 
group is trying to do, and that is what we discussed at the meetings.” (Moira, CS1) 
5.3.5 Learning about epilepsy and epilepsy research 
As outlined in Chapter 2 (see Section 2.6.2) past research suggests that representatives 
value gaining knowledge of their condition and of the research process, alongside gaining 
new skills (Minogue et al., 2005; Newell & South, 2009; O'Donnell & Entwistle, 2004; 
Rhodes et al., 2002). Indeed, the opportunity to learn more about epilepsy and epilepsy 
research was the personal benefit of PPI that representatives in my study most commonly 
identified. In addition to learning new information during the meetings, the representatives 
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also highlighted other components of the PPI process such as information from training 
events, attending academic conferences and having access to other sources of information 
such as newsletters and journals:  
“The training was brilliant ..[..]..I enjoyed it, it was a really good day, ((laughs)) and 
that's one of the most positive things about the whole thing I think was the training 
was ..the training was very good.” (Rose, UKERN) 
“No it’s changed I think, because I didn’t really know what research properly was. I 
mean I suppose before I joined this, I just thought research was testing tablets an, 
and you know, didn’t really know anything about it, so yes, it has changed a bit 
because I have seen a different side of it.” (Molly, SS1) 
“I found that excellent actually, the conference I learnt so much, from that one day at 
the conference, I thought it was really good ..[..].. because you have got these very 
short term [20.10] prize winner you know, post-graduate research things which are 
actually quite accessible, I think, for patients you know for us, so again it is just nice 
to have to actually get involved in, in the field you know, just hearing things generally 
even if you can't take it in you get much more of a sense of what research is out 
there, what is current you know, what they think is really important that sort of thing 
just to switch you in a bit more I think.” (Katie, UKERN) 
The UKERN representatives also viewed PPI as an opportunity to apply the research skills 
they already had but were unable to use in their current job roles: 
“So for me it’s quite important sort of professionally and personally that I still have a 
hand in research somewhere.” (Faye, UKERN) 
“It will get my head back into academia to a degree, which that is where I started 
years ago, I was a potential PhD student, so I have always been sort of a bit that way 
inclined anyway. And I spent the last 30 odd years having nothing to do with it, so 
from a personal perspective, I like reading scientific stuff ..[..].. it's been good to read 
stuff again, because you don't read scientific papers in your day to day job, you don't 
and that, I have always, I have always found scientific papers interesting so it's good 
to be able to do that again.” (Ron, UKERN) 
“My training involved having a sort of somewhat of a research background so just 
being able to kind of feel like oh yes I do remember a bit about that ((laughs)). You 
know I can, understand a little bit about research, is quite a nice thing as well.” (Rose, 
UKERN) 
5.3.6 Social interaction 
Another benefit of PPI for the representatives in my study which has previously been 
identified in the literature is the opportunity to meet others with a similar condition, 
providing new opportunities for peer support and exchange of information (Minogue et al., 
2005; Rhodes et al., 2002). This appeared to be particularly true for Claire (CS1), as her 
condition was rare and she had limited opportunities to meet others with the same 
diagnosis: 
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“It is also nice to meet other patients that have actually erm, been diagnosed with 
erm, you know the same condition so you can also feel that you are not alone or 
going stark raving bonkers, which is also a good thing. So it forms friendships in that 
way.”  
Katie (UKERN) also found the opportunity to compare her experiences with others with the 
same condition useful in identifying what was, and what was not, a result of her epilepsy, 
helping her develop her own understanding of the condition:  
“Actually meeting people like Ron and Hazel and actually being able to discuss how it 
has affected us so from that point of view because I probably wouldn't have, if I 
hadn't done this I probably wouldn't have had that experience, well and meeting the 
people at various epilepsy events and doing the same sort of thing and just sort of 
saying oh yes well I feel like that you know I didn't realise that was part of you know, 
or potentially part of the epilepsy that sort of thing.”  
Ron (UKERN) noted that his current PPI role not only allowed him to develop relationships 
with the other representatives, but also work with epilepsy professionals who he 
respected:  
“It's like friendly people getting together and having a chat and both Katie and myself 
scenario at [event] last year and also Hazel and myself and Katie at [place], the meal 
the night before the meeting was really enjoyable and it was good. It's nice to see 
people, it's just nice to see people whose names you know..[..].... from a personal 
point of view that's really, really gratifying because I have had an interest in epilepsy 
for 30 years, 40 years, god knows 40 years, erm... so to actually get some of these 
guys, to get to meet some of these people who are, who are doing the stuff that they 
are doing is fantastic.”  
While the networking and social support aspects of their PPI role did appear to be seen as a 
benefit by representatives, it did not seem to be one of the primary benefits of involvement 
as alluded to in the literature (Rhodes et al., 2002; Minogue, Boness, Brown, & Girdlestone, 
2005). Rather it appeared to be a pleasant side effect. Lastly as stated by Ron above, 
representatives could find PP enjoyable and: “quite exciting” (Molly, SS1) activity to take 
part in. 
5.4 Importance of confidence 
As specified in Chapter 1, increased self-confidence has been identified as a potential 
benefit of PPI for the representatives. More specifically, representatives have reported 
increased confidence in their own capabilities and influence (Newell & South, 2009) and in 
giving presentations (Minogue, Boness, Brown, & Girdlestone, 2005). However, there is 
nothing in the literature that describes specifically what aspects of PPI give the 
representatives confidence in their knowledge or what affects their confidence in 
expressing their views in a given situation. The importance of confidence cannot be 
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overstated, since if representatives do not have the confidence to make their views known 
then, according to both their own and the professionals’ definitions, they are not 
meaningfully involved.  
This theme of confidence was woven throughout the representatives’ discussions with me, 
at times being both a benefit and a challenge. Different components of the PPI experience 
appeared to positively or negatively influence their confidence. It was within this that the 
influences of the ‘different approaches to implementing PPI’ became particularly apparent. 
When discussing confidence, the representatives placed emphasis on their confidence in 
their own knowledge, the confidence to express their views and their confidence to 
disagree with professionals. In this section I am will address each of these in turn, although 
it will be apparent that they were heavily interlaced with each other.  
5.4.1 Confidence in the value of their own knowledge 
As described in Section 5.1, the representatives were working from the assumption that 
they had knowledge that was valued by the professionals. It follows that if they had not had 
this underlying belief, then they would not have become representatives. The perception 
that their experiential knowledge was unique to them increased their confidence in their 
knowledge, as they argued no one knew more about their experience than they 
themselves. This was particularly important for Claire (CS1), who initially felt that her 
knowledge was not as valuable as Moira’s (CS1):  
“Because erm, Moira was there, she is you know, erm, in this trust [charity] so she 
knows a lot more about it so, it did feel at first that you know, what’s the point in me 
actually being there, because this person knows, more about it than I do, so you 
know why should I erm, take part. Then you realise that you know, your opinion is, 
well as valid as what theirs is, you may have less experience but you have may have 
a, well, I would say I have a unique, erm perspective on certain things that they may 
not have. So, my involvement is, I feel you know quite as relevant as actually them 
because they do not have my point of view on my situation, so I can say, you know 
well you should include this, or, you know it’s maybe not a good idea to phrase it in 
that way because, if they have got this issue or, a similar thing, may be offended by 
it.” 
In contrast, because a representative’s knowledge was limited to their own experiences, 
this could also reduce their confidence, as they worried about representing people with 
epilepsy who might have had very different experiences (see Section 5.5.1). However, 
interacting with others with the same condition through their job roles, support groups, 
attendance at conferences or volunteer work, increased their confidence to represent 
others: 
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“I am fairly fortunate because I can bring it from two different aspects I can bring it 
from a personal level with my own daughter and dealing with her seizures, on a daily 
or a weekly basis and also seeing it from the other side where it's dealing with the 
general public, as a whole you know [in his role as a paramedic].” (Rick, UKERN) 
“My experience of it and living with this condition and with the enormous amount of 
people that I meet and interact with that have got this condition, it is, you know gives 
me a lot of information, plus there is a huge resource and wealth out there, from the 
papers and yes you have to sit down with a medical paper and Wikipedia open and a 
dictionary open to try and figure out what it’s all saying but I do and I get there. But if 
somebody asked me a question like at the medical conference we had last year, erm 
people were asking me questions and I would say well as a charity we do this, then 
you know, personally I think it’s shocking that it’s this bad.” (Jim, CS1) 
Hazel noted that the more meetings she attended where she was unable to contribute, the 
less confident she felt and the more tokenistic she believed her involvement to be. Given 
that she was previously generally confident in her knowledge and in putting across her 
views; her experience highlights the potentially damaging effect of perceived tokenistic PPI 
on representatives’ confidence:  
“Well clearly we don’t have the same knowledge do we ((laughs)) and some of the 
doctors are very… well they are excellent they are really good you know. Erm.. and 
yes experts in their field, I am quite impressed with them which is very reassuring. 
Er… but how we could… how we can contribute, is difficult to know really. I think it 
leaves me with that really, it leaves me with less confidence in how we can 
contribute but I am willing to continue trying.” (Hazel, UKERN)  
As Hazel indicates, the value that the representatives perceived in their own knowledge 
was sometimes relative to their perceptions of the value of the professionals’ knowledge. 
This concept was particularly well demonstrated by Katie (UKERN) who felt that while her 
knowledge was valuable, if given the choice, professionals would find comments from their 
colleagues more useful than comments from her:  
“I did say a couple of things and it wasn't so much that I didn't have anything to say 
or... erm... was too scared to say it really, it was just that, there was such a short time 
after each speaker, that I felt that the professionals obviously should have a go first 
..[..].. well I think the professionals are going to add more because they just know a 
lot more really erm... and I don't think... unless it has impinged on you personally it's 
very difficult to give a really erm... definitive first sort of you know, sort of first 
comment really. I erm... you know there were aspects that you could comment on 
but, as I say a lot of the times the professionals said it anyway, you know.”  
Within my fieldnotes from the above day (a UKERN meeting were members presented 
research ideas to the network for constructive feedback), Katie explained to me that the 
difference between the situations when she chose to talk and when she did not, came from 
how passionate she felt about the topic and how important she felt it was in that context 
for the professionals to hear her point of view. Ron, who was at the same meeting, 
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expressed feeling in ‘awe’ of the professionals’ knowledge and that he was less likely to be 
confident in his opinion in front of them. However, if the facilitator gave him the 
opportunity to voice his opinion then he would: 
“These guys are like up there, aren't they, I mean in terms of the research and stuff 
they are doing, and while I will have a grasp of it from my professional qualification, 
erm... and so I know about the drugs and stuff like that,... they are dealing with brain 
chemistry on a day to day basis, and it's mind-blowing, brain chemistry is fantastic, I 
love it, but it's like it is really mind-blowing, no pun intended. So yes you tend to be a 
bit in awe of people like that. So if I am going to be invited to comment I have got to 
be pretty sure that what I am saying is reasonably ok, erm... so that's why I tend not 
to unless invited, if I am asked then yes I will give an opinion yes, every time. And I 
don't have a problem with giving an opinion, not at all, but when you are dealing 
with, when you are with a group of people who are obviously very knowledgeable 
and you are not, it takes quite a lot of guts to actually chip in... unless you have got a 
very valid point that you know is going to be a valid point and sometimes that 
happens it has not happened yet but, I am sure it will because the other thing is also 
true, and this is why PPI exists I guess, the science becomes so obviously important 
that you miss the point about the ethics and the morals and stuff.” (Ron, UKERN)  
Representatives also felt they gained external validation of their knowledge by being 
selected to take part as a representative. The formal application process provided 
validation for the UKERN representatives, as they felt they had to have the requisite 
knowledge and skills to successfully complete the application form and interviews. The 
more informal selection process, as used in the intervention study (CS1), also provided 
validation because if the recruiting professional did not believe them capable of 
contributing, representatives believed they would not have asked them to be involved in 
the first place: 
“I know with this group, I think Isobelle [researcher and clinician] chose the people 
that were getting involved, well yes it was Isobelle that actually sent the letters out, 
so, I assume there is people that actually she had seen that actually were getting 
involved with this, so she knew they would be erm, good at this and wanting to get 
involved in the first place.” (Claire, CS1) 
5.4.2 Confidence to speak  
When discussing their confidence to express their opinions, none of the representatives 
referred to written communication. Rather, the focus was on expressing their views 
verbally in the groups. Representatives whose professional roles involved presenting ideas 
and taking part in discussions reported higher initial confidence in expressing their views: 
“I can be quite commanding when I need to be. So, if I am, I used to give lots of talks 
and such in my other jobs, so I just stand there it’s like be quiet, listen this is what I 
have to tell you, you are here for information this is the information, and it’s carer 
hat, but its crap I am sorry, you know so, I don’t really have that much of an issue 
 140 
 
with it. I can usually get my point across how it’s needed to be put across so people 
understand, well hopefully help people understand it the best ((laughs)).” (Jim, CS1) 
Also, representatives with jobs that either had a health or research focus were more likely 
to feel confident in talking, as they felt they had a good understanding of the issues 
involved: “I can read a protocol …[..]..I have always read protocols” (Ron, UKERN). This was 
also true of representatives with other PPI experience. For example Molly (SS1), who 
reported feeling lacking in confidence prior to her involvement in the Comparator Epilepsy 
Network, spoke of how she was much more confident when she later became a breast 
cancer representative. One of the things that Molly felt had increased her confidence was 
the group dynamics of the patient research development group: 
Chris “You are not made small, you know you are not made to look small as if you 
have said the wrong really. 
Molly No,  
Chris You know it’s great. 
Molly Because everybody is kind of in the same situation we have all got an illness 
in some kind of way, so they all kind of understand really if you say the 
wrong word it don’t really matter.”  
Good group dynamics were particularly important for the representatives from the 
intervention study (CS1) and the comparator epilepsy network (SS1), as it made them feel 
confident enough to speak (see Section 5.5.3) and also, like the professionals, they noted 
that the more knowledge they had of other group members the more they could manage 
their own and other people’s idiosyncrasies. The role of the facilitator was seen as key in 
establishing conducive group dynamics and ensuring representatives had the opportunity 
to speak. This is covered in more depth in 5.6. 
5.4.3 Confidence to disagree with professionals  
Having the confidence to disagree with or to challenge professionals was seen by 
representatives as more difficult than having the confidence to give positive or general 
opinions in group settings. A variety of reasons were given for this, including not knowing 
how the professionals would respond, feeling embarrassed, believing the professionals 
knew more about the topic area than they did and being worried about whether 
disagreeing with their doctors might affect the care they received. Again, the factors 
determining how confident representatives felt about challenging a professional included: 
the facilitator, the sense of rapport, feeling like they were being listened to, having 
confidence in what they were saying and past experience: 
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“I am thinking back relating to some of the, I suppose the different work I do with 
Age Concern. Erm, some of my professional work has taught me that I can speak out 
supposedly erm, top people you know, you don’t have to be bowing and erm, you 
know cap in hand and erm, they are people, they are just people the same as you or 
I. Erm, I try not to erm, talk about something I know nothing about, but yes I think 
you challenge people as I did in my professional life, you know, I would be standing 
up talking to judges and giving my view or, you know, the defence, prosecution, 
solicitors etc., and to parole boards and I guess with my fencing too, erm, I am not 
the best fencer in the world but I stood up at World Championships and gave 
decisions.” (Hazel UKERN) 
“You have to be kind of forthright and you have to be erm... able to speak what you 
think and not be [pause 04] not be, not feel pressurised or feel embarrassed by 
speaking to Consultants erm... I often find that, with working in a hospital 
environment, erm... a lot of people are a bit in awe of consultants we have had 16 
years of dealing with consultants ((laughs)) and erm... they have all got their ideas, 
but they have got to get past, they have got to put them past and sell themselves to 
us, erm... what they are proposing to do with my daughter erm... so I don't hold 
consultants particularly in awe, that's as I say quite often I, when I speak to patients 
in the erm... in the clinics oh you can't say that to a consultant, I can't ask that, I say 
well why not? They are just human beings just like you and I, I said yes they have got 
more knowledge but I said if you have got questions, they need to be asked you have 
got to ask them, you cannot just erm... not ask because it's, because it's a consultant. 
You know and I often find that. Not only in the epilepsy clinics but also in the casualty 
kind of environment as well. I say if you have got questions ask, and but they won't, 
they are reluctant to ((laughs)).” (Rick, UKERN)  
The ability to challenge the professionals was seen as particularly important: “not to be 
irksome but because that is our role, that's what we are there for” (Faye, UKERN). This role 
perception seems to contrast to that reported by a group of cancer representatives who 
viewed themselves as ‘friendly observers’, and did not see it as their place to challenge or 
question the ‘experts’, but rather to support them (Thompson et al, 2012).  
5.5 Challenges  
As evidenced in my literature review, while previously reported research has touched only 
lightly upon benefits of PPI to the representatives, even less is known about the challenges 
of their experiences. During my data collection for this study, I observed that the 
representatives seemed less comfortable discussing the challenges they experienced as 
part of their involvement, when compared to discussing the benefits. The ethnographic 
methodology I employed was useful when trying to understand these challenges, 
particularly those related to emotive and practical issues. From my observations it was 
apparent that the professionals were not always aware of the challenges the 
representatives were experiencing and this lack of awareness in turn negatively impacted 
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on their perceptions of the representatives. In this section, I give examples of such 
situations in relation to the challenges the representatives experienced while fulfilling their 
PPI roles.  
5.5.1 Representatives as patients  
One consistent challenge that the patient representatives had to contend with was that of 
the side effects of their epilepsy and their epilepsy medication. Unlike representatives with 
acute health conditions the representatives in this context still had epilepsy, a long-term 
and often poorly controlled condition. In addition, some of the representatives had 
comorbidities such as stroke, head injury, chronic pain, learning difficulties, depression and 
anxiety disorders. All of these had their own additional associated challenges.  
Many of the patient representatives highlighted problems they had with their memory. This 
could result in multiple challenges in relation to the PPI role, including forgetting that they 
needed to do something or attend a meeting, forgetting what had happened in past 
meetings and problems when communicating. The representatives developed ways of 
working around these problems. These often involved drawing on support from the people 
around them:  
“I have had a stroke and my memory is completely buggered, so actually 
remembering what people are saying can be erm, quite a challenge and also can get 
a bit annoyed because sometimes I just stop mid-sentence and forget what I am 
saying. But that’s just another aspect of it, so that’s why, when I am at the group, I 
try and if I can write down what people are saying or what people are asking me so 
then I have got a, a written record and I can look down and remember what I am 
talking about. But it’s good to actually involved because I think by now people know 
me and know that you know I have got a few issues, and if they need to just prod me 
in the right direction as it were, so that I can erm, carry on saying what I was saying, 
rather than not remembering.” (Claire, CS1) 
“I have got a really bad memory because of my epilepsy, but I should have read over 
things before you came today.” (Molly, SS1) 
“Let’s face it, I have had a head injury I forget. Molly is epileptic, she forgets, but if it’s 
really important Jess (NC) will text Molly or ring her you know, and we go ‘oh right 
we will go and check our e-mails’ so you know there is um, we are ill you know.” 
(Chris, SS1) 
Another way that the representatives tried to minimise the impact of their memory and 
also concentration problems was to ensure that they did not get too tired, as tiredness 
could exacerbate these problems, potentially affecting their involvement in meetings and 
also having: “a high personal cost” (Faye, UKERN). So, for example, when traveling to 
meetings, the UKERN representatives made the decision to make the journey the evening 
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before the meeting to help ensure they were able to participate. However, regulations 
stipulated that they should not claim hotel costs, as theoretically they could all leave for the 
meeting after eight am and be home before nine pm the day the meeting was scheduled:  
“Angela saying afterwards that we shouldn't have claimed for a night before because 
we should have been able to get up and back again for the meeting... for myself you 
know being a little bit older and Hazel is quite considerably older, that is quite an 
effort really ((laughs)) you know so, for that sort of distance but you know what the 
trains are like I mean I didn't get home until about 9 because it was a complete 
disaster going back.. I think we had all thought that it does help us.” (Katie, UKERN) 
This issue of tiredness was important enough that two of the representatives were willing 
to pay for future accommodation themselves in order to travel in advance of meetings. 
However, it did leave a couple of the representatives feeling slightly resentful and 
undervalued:  
“I personally didn't claim the money you were supposed to have erm... you know for 
going for the day, so another time I would just know to sort of pay for the hotel room 
myself and the meal instead of claiming that you know but it was a little bit sort of 
erm... ((laughs)) you know you didn't need to do this type of thing which is slightly off 
putting.” (Katie, UKERN) 
It should also be noted that individuals with epilepsy commonly experience clinical 
depression and other mental health difficulties. As Sam (SS1) noted this could directly 
influence both their motivation and ability to get involved:  
“It is a waste of time, I have been trying to get out of it, because I, I have become, 
unable to take part in a lot of things through, things like er (s2) speech there we are, 
my speech is affected, memory, depression, anxiety, and I go to a meeting these 
days, I used to be the chairman, I used to take part, I used to organise everything, 
now I kind of sit in the background and I don’t, think my ideas have any value.”  
Other medical issues that caused problems for the representatives were more person-
specific, for example Faye (UKERN) also suffered from chronic pain and was unable to sit for 
long periods of time: 
“I am not brilliant at sitting for long periods because it sparks off my chronic pain, so I 
can’t do things like that of an evening [comment on participant information sheets], 
if I have spent hours in the chair, or if I have spent hours sat down during the day, so 
I just have to be a bit sensible about where I fit them.”  
5.5.2 Practical issues 
Throughout the data pertaining to the experiences of the representatives there were 
examples of practical challenges they encountered. For example, meetings of the 
comparator epilepsy network always happened in the evening, to allow those with work 
commitments to attend. However, this raised child-care difficulties for some: 
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“It’s in my diary to have gone tonight but my ex-wife has dropped my daughter on 
me this evening, but which I obviously don’t mind, but erm so can’t actually make it 
to the meetings.” (Paul, SS1) 
The UKERN meetings took place during the working day which caused attendance problems 
for three of the representatives who had full-time jobs. Rose, for example, was unable to 
take the time off work to attend one of the face-to-face meetings. Both Faye and Rick made 
arrangements in their working day to take part in teleconferences, but on one occasion 
were unable participate due to pressing unexpected work demands: 
“I missed one of them,.. I stupidly went to work and asked if I could do it as CPD time 
and erm… then a crisis call from one of my clients came in so I ended up having to go 
out and just missed it, literally missed it.” (Faye, UKERN) 
“One of the meetings I was actually on duty on the day and had every intention of 
erm... staying on station and doing some paperwork until the time of the conference 
and then joining in the conference but erm... but my control room had other ideas. 
That's why I came in really quite late, because I had a job to do.” (Rick, UKERN) 
Unfortunately both of these events related to the same teleconference and neither 
individual was able to send their apologies due to the last minute nature of their work 
commitments. They also did not explain their absence to the professional lead after the 
meeting. This behaviour was seen as conflicting with academic norms and led some of the 
professional members of the group to question the representatives’ commitment and 
possible contribution: 
“The second meeting was a telephone conference, one never turned up and the 
other turned up about 5 minutes towards the end of the meeting. Not sure that was 
particularly helpful, so I have yet to see evidence of what contribution they are going 
to make at this stage.” (Lee, CP) 
In addition to causing discord between the professionals and the representatives, missing 
out on meetings also meant the representatives felt ‘out of the loop’ and had trouble 
completing some of the tasks they were allocated as they had not been present for 
explanations of what was involved.  
Rick was meant to have designated research time within his job role and as such should not 
have needed to take annual leave to attend meetings. However, his line manager said that 
his participation in the UKERN had to occur in his own time. This disagreement led to him 
missing the first three meetings: 
“I had problems at work with the, with my line manager erm... asking for, time to 
attend things like this erm... if those meetings were actually taking place on a... erm... 
on one of my shift days, I asked if I could take erm... like I didn't want to take annual 
leave, and I felt as if it was, because it was research orientated that my service would 
accept that fact and give me research time, which they have to give me. My line 
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manager took a really negative approach to this and said no, if you want to do things 
like that, it has to be, in your own time, so I was kind of a bit aggrieved because I 
thought well this is, this is not only benefitting me personally but I could pass this 
information on to my patients, erm... any information that I deemed relevant...[..]… I 
took the huff at because I thought well, they are wanting people to get involved in 
community type projects, I have to do it for to keep my registration, I am doing this 
off my own bat, but yet I am getting no support and no help from the service you 
see.” (Rick, UKERN)  
He did not however, explain this to the CSG lead or respond to any emails from the network 
for approximately six months.  
Other practical difficulties representatives experienced included problems concerning 
payment, information technology problems (such as websites being down) and difficulties 
using academic search engines. Resolving these issues was time consuming and frustrating 
for the representatives:  
“If you say that you are willing to offer them money for coming, make sure you are 
able to give them money for coming, erm because at the moment we are still 
waiting, from the last lot to be paid and it seems to be a bit of a farce that we are 
having to chase up to be paid for it, erm and I don’t think it’s right that we should be 
put in that position. So either give people money for coming or don’t erm, don’t 
make it difficult in that way because that could, it doesn’t put me and Moira off but it 
could put other people off especially if people are taking time out from work and 
such to do that.” (Jim, CS1) 
“I was unlucky or I am just thick ((laughs)) I really struggled with this in that I couldn’t 
access the erm.. the original documents. .. we were advised to look in one particular 
website, PubMed, erm… which I went on and I spent hours and hours trying to get 
on, as you probably know there are different, there are different PubMeds, there is 
an American PubMed as well which it took me a while to realise that.. er… I did 
eventually get access to er… the correct PubMed and as I say I spent a long time 
doing it, you know I would say several hours, over 6, or 7 or 8 hours even I would say 
in total. When I eventually did get on the right PubMed it is obvious that the reason I 
wasn’t getting any response because there wasn’t any publication ((laughs)) I found it 
really frustrating.” (Ron, UKERN) 
5.5.4 The problem of ‘jargon’ 
In Section 5.1.1, I explained that the general consensus among representatives was that 
professionals have a tendency to talk in a way that ‘normal’ people do not understand. It is 
therefore not surprising that representatives reported experiencing difficulties 
understanding some of the language used in meetings and research documents. This was a 
problem that all representatives experienced, even those with a health or research training: 
“I went over to one meeting and realised I hadn’t a clue what anybody was talking 
about because they all use these strangest anagrams and acronyms or whatever, it is, 
and I asked a few questions, just made me feel dumb you know.” (Sam, SS1) 
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“People were firing stuff in, ideas and it was all going over my head, it really was 
going over my head and some of it was due to language they were using and the 
acronyms that people use and I am as guilty of that with my own field as anybody 
else but it's assumed that you know what a PCL whatever a PCL is, ((laughs)) and a 
PPR for that matter you know and erm... so these things flying about don't help.” 
(Ron, UKERN)  
As Rose (UKERN) highlighted, this might not necessarily have been a representative specific 
challenge, as she observed that some of the professional members in her group might have 
had difficulty understanding some of the projects as well: 
Rose “I found that easier to answer for the non-basic science stuff I don't think I 
would have been able to answer it ((laughs)) for the basic science at all. 
Beth I think there is only about 1% of the population that could. 
Rose Well yes, basic scientists probably. ((laughs)) So erm... but I mean you know 
that is not to say we shouldn't be looking at it but it makes it harder to look 
at that kind of stuff.”  
I also observed that Katie took a glossary of research and epilepsy words with her to a few 
of the UKERN meetings. When I asked her about the glossary she said: “it was certainly 
helpful because you could sort of glance down it erm... from time to time” (Katie, UKERN). 
Katie suggested that an updatable glossary might be useful for when new terms needed to 
be included. Representatives felt that they did not need to understand all of the jargon 
(their term) used to make a meaningful input into discussions; rather the challenge was 
knowing when they did and when they did not need to understand the detail.  
5.5.5 Is PPI worth the time?  
As discussed in Section 4.4.3 and in the literature review (see Section 2.6.1) the amount of 
time PPI takes was seen as one of the main challenges for the professionals. This also 
appeared to be true for the representatives. In line with the professionals’ experiences, PPI 
was reported to take up a substantial amount of the representatives’ time. Not only did 
they need to take time out of their work or private lives to attend meetings (see Section 
5.5.2) but it also took time to look at the relevant documents, prepare for meetings (for 
example reading the INVOLVE guidelines for representatives), attend training events, 
complete the application process (UKERN), travel to meetings and do background reading 
about the topic. Some of the representatives also found managing their time between their 
PPI role and other commitments challenging:  
“You go through that process where you spend a lot of time thinking about filling in 
applications, going up for an interview, and then actually wanting to get started.” 
(Hazel, UKERN) 
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“Organising your time so that you can, you can do it you know because you have 
other commitments and at the moment you don’t really know when erm, it’s going 
to be you know sort of, it will land on your doorstep or whatever, you know so and 
how much time that it’s then going to take to do that, so it is time management as 
well. Erm, [05] yes I would say that’s my, for me that’s the main challenge.” (Katie, 
UKERN) 
In addition to taking time, the representatives noted that they needed time to look at and 
understand research documents to formulate opinions. As such they might need a longer 
turnaround time than professionals were used to offering: 
“When do we get the stuff to read, and how much time do we get to read it, erm 
before the conference or whatever it might be, that sort, that sort of detail it 
needed…[..].. It was important we had time to do more research and organise our 
thoughts and formulate any queries we might have..[..].. I only got this document 
yesterday so I am feeling a bit unprepared for the meeting this afternoon.” (Ron, 
UKERN)  
They might also need time within meetings to formulate their answers: 
“Getting your thoughts together coherently enough in the time I think I would feel a 
bit, being part of the general audience was ok but I, I did feel being part of erm... 
being part of the panel I would have found it a bit pressured to get my thoughts 
together I think if you know what I mean. I think this why I suggested you know 
perhaps jotting down comments to submit later.” (Katie, UKERN)  
The representatives also drew attention to how they needed time to establish rapport with 
the professionals and other representatives in the group, in order to not just understand 
the research but also to adjust to group dynamics and feel confident in expressing their 
opinions: 
“There is a catch 22 because if you are only meeting once some people may want to 
get involved more than if you are meeting a couple of times …But of course, you 
don’t get time to actually get to know everybody.” (Claire, CS1) 
This need for more time could potentially conflict with the professionals’ wish to keep the 
research process as short as possible and the academic convention of quick turnaround 
times, e.g. sending out documents for meetings the day before they take place.  
The length of time research took was also challenging for the representatives. While they 
accepted that the research process can be a lengthy one and were willing to make on-going 
commitments over months or years, at the same time they found it frustrating and 
disappointing when the amount of expected involvement did not match the actual amount 
of involvement:  
“Because it’s a new concept, erm…. It’s going to take time so, it is frustrating in the 
sense that… it’s slow really, because I ran a business you see and you don’t get time 
((laughs)) you know you don’t usually get time you have just got to do things and 
then set them in motion and that’s that. But erm… I do appreciate that people are 
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doing other things you know so it is obvious that while it’s important it’s not a 
priority number 1 for most people. So it will take time. So I am not, I don’t have any 
particular problem with the speed of it it’s just that, it is new to me.” (Ron, UKERN) 
“If you have got people who are sort of wanting to be enthusiastic and erm... 
involved and I guess it could be then a bit off putting if it's taking a long time to set it 
up really. ….I suppose people just might feel a bit disappointed that it's kind of not 
what they thought it was going to be.” (Rose, UKERN) 
“We make progress but maybe we take 3 steps forward and maybe one back then, 
and so it’s slow progress but it’s, it’s bound to be isn’t it, especially the first couple of 
years, as we get to know each other and get to know what is happening in the whole 
area of research in epilepsy.” (Jill, SS1) 
This time cost to the representatives seemed to be the underlying reason for their 
emphasis on meaningful involvement. If they believed they could have an input, could see 
some concrete sign of being listened to or outputs from their efforts or could see some 
personal benefits, then PPI was worth their time. If they could not see any meaningful 
benefits of their involvement they ‘lost interest’ in the research activity which, as noted in 
section 5.3.1, was the primary motivation for involvement. As described in Chapter 2, 
UKERN held their meetings during an academic conference that professional members 
were already attending. This limited the time commitment for the professionals, but meant 
the representatives had to travel specifically for the network meeting. It was therefore 
more disappointing for them and significantly more a ‘waste of time’ if a meeting turned 
out to be short or non-productive: 
“I was a little bit disappointed, we were literally in the meeting for 15 minutes and 
they were just going through the list of erm... research and it was only doctors that 
could you know, professional people that could actually contribute, we could 
contribute nothing at all to that and erm... it just seemed a big waste of time really 
((laughs)) and that they probably should have realised that and sort of said you know 
just leave it really. I mean we tried to make it more, erm... beneficial for ourselves 
[travelled 2 hours both ways to get there] by going to the morning in the conference 
that was sort of an added thing but if it was not for that… we should have realised 
that it was going to be a complete waste of time for us really.” (Katie, UKERN) 
5.5.6 Issues of ‘representativeness’  
As described in Chapter 4 (see Section 4.4.3), some of the professionals worried about 
selecting representatives who were really representative of the epilepsy community. This 
was a worry also shared by some of the representatives: 
“I don’t think there is a big enough cross section of erm, sufferers going and carers 
going. Carers tend to be partners or parents, erm, sufferers tend to be because of 
the, the way the condition is mainly female but I think it would benefit from maybe a 
male sufferer a young sufferer, an old sufferer erm, and people from different 
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backgrounds so, erm, you know somebody from a, I don’t know how really, how to 
put it other than different backgrounds really.” (Jim, CS1) 
“I understand from my point of view, from my daughter’s point of view or the people 
I have been in contact with, but there is all sorts, you know epilepsy is so wide, it’s 
erm, I have limited, I have had limited contact with people with disabilities etc., and I 
know that my knowledge of that is quite small really. At least I perceive it to be. 
[laughs] it might not be so small compared to some other people.” (Hazel, UKERN)  
Some of the representatives saw the role as carrying a responsibility for the epilepsy 
community as a whole and worried about how they could represent others when they only 
had their own experience on which to make judgements: 
“Because you are not getting everybody’s view, you are getting that person’s view. 
And that person has to be careful about how they speak for the masses, and to have 
an understanding about how they have a very important role but it might not have, it 
might not be their view point they have to think about how it’s other people’s views 
as well they are representing. I think it’s a, I do think that it’s quite an honourable 
position to be, erm, a representative in form or another but it carries a huge weight 
and I think that is a sometimes undervalued aspect to it. And the weight is that you 
have to try and remember that you are not just speaking for yourself.” (Faye, UKERN) 
One way the representatives appeared to reconcile this worry was to comment from ‘their 
experience’ or from ‘their point of view’. As such they were able to feel that they were not 
potentially misrepresenting the views of others. Another way to address this worry was to 
interact with the wider community outside of the research context and informally collate 
others’ views so they could feel more confident in stating ‘we think’.  
Alongside worrying about whether they were representative in terms of epilepsy 
experience, four of the UKERN representatives were worried that they were not 
representative of the wider epilepsy community due to their medical or research 
background. They believed that they might be less able to give a non-professional 
perspective as they saw themselves as ‘more professional’ than non-professional. Overall, 
however, they seemed to view their professional knowledge as a benefit and not a 
hindrance, since it allowed them a greater understanding of the context of the research 
and, as their training was different to the professionals, it provided them with another set 
of knowledge to contribute. While they felt they could separate out what was their 
representative perspective and what was their professional perspective it was something 
that they felt they had to be consciously aware of. Ron described his experience of this 
issue in the most depth: 
“I try and look at it from a purely lay perspective, erm... but I can't entirely do that 
you know..[..].. it’s difficult at times. Erm... because inevitably, instinctively, as soon 
as I see something on paper I analyse it, it's part of my job erm... I should be doing 
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that but not in a professional sense. ..if you are not careful you get sucked into the 
actual mechanics of the trial itself rather than the objectives of the trial and that's, 
that will get easier and to take an holistic view of the trial at the moment is quite 
difficult because I am not too sure whether we are actually at that point or not yet, I 
think we are still trying to identify gaps and also where treatment is good, where 
research is good and to that end you do need to have some technical knowledge. So I 
find that really useful. So it's not all a bad thing, and erm... so some of the scientific 
stuff as I say I can't understand it, some of it I can so that's helpful. Erm... whether it's 
a particular problem, which is the question you asked it probably is yes? But only 
because I am aware of it and perhaps in that sense it's not, but I do tend to read it on 
two levels, I do tend to read stuff on two levels and erm... I mean it's not always 
possible to read it in a lay level because it's scientific, at which point as a lay person I 
should be thinking I don't understand that, and that is perfectly ok I would imagine 
but I don't I try and understand it ((laughs)) and that's where it becomes a bit of a 
problem. So erm... the word problem I am not sure is the right word I don't think it is 
a problem because it's not been so far but it is certainly something I am aware of.... I 
have worked it out and I can now work with it, recognising as I do that I will always 
inevitably look at stuff from a scientific view point because that's what I am trained 
to do, now I need to look at it again you know ((laughs)) which I am quite happy to 
do.” (Ron, UKERN) 
Thompson et al (2012), found that representatives drew on their relevant expertise (career, 
education or training) to legitimise their position as a credible participants within a cancer 
setting. In contrast the representatives within the UKERN appeared worried that it reduced 
their legitimacy as a ‘real’ representative. 
5.5.7 Emotionally challenging aspects of PPI 
Throughout this chapter the emotional effects of PPI on the representatives have been 
raised, for example issues of confidence, enjoyment and frustration. Building on this, the 
potentially adverse emotional impacts of PPI can be seen as challenging to the 
representatives in their own right.  
Representatives repeatedly stated that initially their role in the PPI process made them feel 
‘nervous’ and they worried about ‘looking stupid or silly’. Their nervousness seemed to 
arise from finding themselves in a social situation where they were uncertain how the 
professionals and other representatives would respond to them, rather than as a 
consequence of being involved in the research process per se:  
“The first meeting, yes I was very nervous about the people. Erm, that was actually in 
the group because I was very nervous about meeting anybody I didn’t know at that 
time…[..].. , you know you never know what, how people may react to different 
situations so, if you have got many conditions like I have, then it can be a challenge 
meeting new people.” (Claire, CS1) 
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“No when I first went in, actually I was quite scared. I remember going there thinking 
oh my God, what are we going in here to, were not good enough for this you know 
because we are no doctors or anything, but then when you actually go into the 
meeting and you sit down and you start to talk you realise everybody is just a person, 
and um, we were all treated the same so it was really lovely. We were made to feel 
at home and explained what it was about and it is really nice.” (Molly, SS1) 
Unsurprisingly, this nervousness was most challenging for less confident representatives; 
however, it was something that all the representatives expressed feeling. Linked to this, 
representatives worried about being judged by the rest of the group and the majority of 
representatives (regardless of background or level of confidence) expressed feeling 
apprehensive about being considered silly, or stupid:  
“That's just natural I mean that's because you don't want to look stupid it's as simple 
as that. I mean I think I know what I am talking about, but these guys are like up here 
aren't they, I mean in terms of the research and stuff they are doing, these guys... 
they are dealing with brain chemistry on a day to day basis, and it's mind-blowing, 
brain chemistry is fantastic I love it, but it's like it is really mind-blowing, no pun 
intended. So yes you tend to be a bit in awe of people like that. So if I am going to be 
invited to comment I have got to be pretty sure that what I am saying is reasonably 
ok, erm... so that's why I tend not to unless invited, if I am asked then yes I will give 
an opinion yes, every time. And I don't have a problem with give an opinion not at all 
but when you are dealing with, when you are with a group of people who are 
obviously very knowledgeable and you are not, it takes quite a lot of guts to actually 
chip in... unless you have got a very valid point that you know is going to be a valid 
point.” (Ron, UKERN) 
Beth “You said that with your idea you told Jess and Tom before you told the 
group, 
Molly Yes 
Beth Why do you think that is, why do you think you…  
Molly I suppose I felt that it wasn’t good enough, I felt shall uum, I tell them, 
shan’t I tell them and I didn’t really want to go to the whole of the group 
and tell them in case they would say oh no it’s been done before, or, or 
they would say oh no it’s silly, or they would laugh or you know I felt a bit 
insecure about reading something out um, and them turning it down, so I 
was a bit nervous about it so I thought I would prefer to mention it to them 
first and then when they said it was a good idea they said write it all down 
and then put it to the group and er yes, so I was really nervous about 
coming forward, with it I suppose in case it would be I suppose rejected but 
a lot of people, aren’t nervous like me, um, er about getting I suppose 
knocked back you know, but I think it’s partly maybe that could be because 
of my epilepsy with my schooling and that, because I have had a lot of 
knock backs over the years, so it’s a bit of a lack of confidence I think with 
me. So I think I was just happier approaching them first before putting it 
forward yes.” (SS1) 
As Ron noted, the worry about looking stupid is particularly relevant as it might prevent 
representatives from voicing their opinions. As such the value of a form of PPI that involved 
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multiple meetings with a consistent membership was once again acknowledged, as the first 
meeting with new people was the most nerve-wracking and familiarity with the group 
helped increase confidence to speak (see Section 5.4.2).  
Furthermore, and potentially more importantly, the representatives within this study were 
involved as a result of their personal experiences related to epilepsy. Because of this they 
could find discussions around epilepsy highly emotive. In comparison to the issue of 
nervousness about voicing opinions, none of the representatives identified the personal 
emotional effects of the content of the research in their interviews. However, that this was 
an issue was apparent within my fieldnotes, the clearest example occurring at the ILAE 
conference a few hours before the UKERN representatives attended their first meeting. 
Kate and Hazel had spent the morning listening to conference presentations:  
“The first session was the prize winners which meant the presentation of three 
essays/ bits of research, then a ‘case that changed your practice’. These were 
presented clearly. After the session both Katie and Hazel said that they had found 
listening to the talks very emotional especially the ones that applied to themselves, 
or as in Hazel’s case, her daughter. They seemed to have run it though their own 
experience saying thing such as ‘my daughter also has diabetes’, and talking about 
their own memory problems. (Something covered in one of the talks). They even said 
to me, that this is something to include in your side effects of PPI- the emotional 
effect of listening to research. Katie during the questions at the end of the memory 
presentation put her hand up and made a comment that as a person suffering from 
the disorder just mentioned, information on memory loss would be really useful in 
the early stages (not certain she said early stages) even if they could not do anything 
about it. I remember thinking at the time that if she as willing to talk in a large 
majestic ballroom full of people with a microphone- something I personally would 
have been very reluctant to do, then she will probably not have a problem talking in 
the CSG meetings.” (Extract from fieldnotes at the ILAE conference)  
What seemed particularly pertinent to me was this idea that they would have to ‘have run 
it through their own experience’ in order to make a judgment. Essentially this required 
them to relive potentially upsetting aspects of their past. Neither Katie nor Hazel raised this 
challenge spontaneously in subsequent interviews. When I asked them directly about this 
incident, Hazel reflected:  
“Being involved in anything to do with epilepsy erm, can be emotionally draining for 
me because, there is a lot of emotional content there for me. I am retired now, but I 
don’t think I would emotionally be able to deal with working full time in it, so I think 
that’s why, in the early years, that I didn’t get involved at all. Erm, too close to me 
emotionally because of my own circumstances and my daughter’s I think.”  
This issue, perhaps more than any other presented in this chapter, helps to demonstrate 
the benefit of the ethnographic methodology I adopted, as it appears this emotionally 
disrupting component of PPI was not something easily articulated in interviews, but it was 
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clear within my observations that it had an marked impact on representatives’ experiences. 
It also needs to be acknowledged that some of the representatives had family members 
who had died as a result of epilepsy. As well as being personally upsetting, hearing about 
their experiences affected other members of the group also.  
5.6 The importance of the facilitator 
Besides consistency in group membership one factor the representatives identified as 
helping them overcome their general nervousness and the worry of looking ‘stupid’ was the 
influence of the group facilitator, who set the tone of the group interactions: 
Chris “And even if you say the wrong thing 
Molly It doesn’t really matter does it 
Chris You are not made small, you know you are not made to look small as if you 
have said the wrong really. 
Molly No,  
Chris You know it’s great.” (SS1) 
The importance of the facilitator resonated throughout the interviews with the 
representatives, for example how they managed group dynamics and created space for 
individuals to contribute could increase their confidence to speak in the group setting:  
“If I am going to be invited to comment I have got to be pretty sure that what I am 
saying is reasonably ok, erm... so that's why I tend not to unless invited, if I am asked 
then yes I will give an opinion yes, every time.” (Ron, UKERN) 
“If you have got a smaller group like you have got, I don’t know 6 / 8 / 10 people then 
it’s a bit of a better dynamic because you have, you have, you have got a chance to 
actually erm, give your point of view and I think one thing Rachel does she actually 
erm, she actually asks you, if she notices that you haven’t said anything she actually 
says well have you got anything to actually comment on this, You might not have, but 
you might also feel too embarrassed to actually make that comment, and you know 
sometimes when people does that, it, it can make you want to speak out, or can 
actually make you feel, why is everybody looking at me.” (Claire, CS1) 
Hewlett et al (2006) support this observation, by stressing that good chairing of a meeting is 
a key factor in enabling representatives to contribute: “particularly initially when partners 
may require additional support, such as being specifically asked for their experiences to 
enable them to enter the discussion”(P. 677). 
The facilitator also needed to be able to control the group, working around strong 
personalities while being sensitive to emotive issues, staying on topic while not shutting 
down conversation: 
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James “There is always a danger that that group will be a moaning group and er, I 
think Jess and Tom are aware of that. I mean there are tendencies I think, 
um you know you saw last night that you know, certain members of the 
group can be carried away with their personal problems, so I mean that’s 
fair enough. 
Jill And it sort of repeats itself every meeting doesn’t it. Sometimes I feel that, 
we and Jess must feel that we could be making more progress, than we are, 
James But on the other hand these people are suffering you know, 
Jill Yeh they are suffering and I think the way Jess and Tom deal with them and 
allow them to, to speak every you know, all the time is good for the patients 
isn’t it.” (SS1) 
“Some people who are ill are not, ur, don’t know when to stop talking or talking 
about the wrong things urm, could possibly upset somebody just by saying the wrong 
thing. Erm, and you know whoever is in charge of the meeting has got to handle it 
with kid gloves sometimes and be quite clever the way they er run the meeting you 
know.” (Chris, CS1) 
The UKERN representatives emphasised that a good facilitator was vital during telephone 
conferences where the visual clues they would normally draw on were missing: 
“Francis is good, she chairs those well in our group erm.... and it's quite easy to kind 
of you know I think, I have never done anything like that before you think oh it will be 
a bit weird doing it all over the phone but it's actually quite sort of relatively easy to 
follow what is going on.” (Rose, UKERN) 
In Section 4.5.4, I reported on Nick’s reflection that he felt his clinical relationship with the 
representatives might have an inhibiting effect on the discussions. This was also 
commented on by the representatives themselves (and documented in my fieldnotes). 
They suggested that this might be due to fear of the comments made within the meeting 
affecting their clinical relationship outside of the meeting: 
“You can sometimes think well I don’t want to say too much because I don’t want to 
upset the patient relationship with your GP, or your consultant or whatever so I think 
some people can be a little bit cagey, sometimes, I have looked round that meeting, 
that the NEST meeting and I have thought are you holding back, you know when you 
can tell in someone’s body language they want to say something but can’t, I have 
often thought is that because you are a bit anxious about there is a consultant there 
who is listening to everything you are saying and might say you know, might be a bit 
upset if you say the wrong thing, but you know I think it is more important that they 
hear the truth.” (Moira, CS1) 
Also, they were used being in a clinical relationship with Nick and as such to interacting 
with him in a particular way. It is possible that this pre-established relationship was a factor 
in their inhibitions, independent of potential future consequences.  
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The representatives generally felt that responsibility lay with the professionals to make PPI 
work and enable useful interactions: 
Faye “He should hear what you have to say, that is the point. 
Beth I also interviewed the researcher and he was going, no, I want to know 
what they have to say that is why I am asking them. 
Faye Isn't that interesting that he hadn't communicated that enough for her to 
get that. 
Beth Yes 
Faye Because somewhere along the line he hasn't given her the signals that that 
is ok. 
Beth He was like, no, I want to know what they want to say I can talk to 
professionals by walking down the corridor, I want to know what these 
people think. 
Faye So how has he not, how have they not managed to explain that I wonder, 
fascinating that isn't it?” (UKERN) 
“Perhaps it’s, that professionals need to erm... you know... kind of manage their own 
feelings about it [being criticised] better really because you are not going to avoid it 
and if you truly do want patients involved and people involved then that is one of the 
things you are going to have to deal with isn't it and otherwise you will just, you 
know if you just want all the ones that say nice things ((laughs)) and don't annoy you, 
and do as you say then that's not really how it works I don't think...[..].. they 
[professionals’] get defensive rather than sort of think about how they can help that 
person understand this is how we do a meeting, erm... yes I think it's difficult. I think 
yes, I think probably you know there needs to be a lot of preparation, work and 
support and, and you know just maybe sort of talking to the person about those 
issues rather than just moaning about them. ((laughs)).” (Rose, UKERN) 
Lastly, it should be noted that representatives might not see the impacts of their 
involvement, should these impacts occur outside of the meetings. It was often the 
communication with professionals (and more specifically, with the facilitator) and the 
feedback representatives received that indicated to them whether they were being actively 
listened to and if their contributions were having an impact. It was this knowledge that 
helped representatives to judge if their involvement was meaningful.  
5.7 Discussion  
In this chapter I have described my analysis of the experiences of the patient and public 
representatives within my research sites and how they conceptualised PPI. Representatives 
viewed the primary function of PPI as being for professionals to get a ‘different point of 
view’ or more specifically a ‘patient’s perspective’. This different point of view was seen by 
the representatives as resulting from their experiential knowledge about epilepsy but also, 
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in some cases, from the perspective of a non-‘professionally’ trained person. Building on 
this, they viewed ‘meaningful’ involvement as having the opportunity to give their opinion 
and have it listened to in situations where their contributions could potentially have an 
impact. To an extent, whether or not they actually did have an impact was secondary.  
Representatives felt that PPI could help improve the research process, resulting in 
improved recruitment and dissemination. They also identified personal benefits that they 
had experienced as part of their involvement that overlapped heavily with their original 
motivations for involvement in research. These included: personal interest, making a 
difference, restitution, the value of the research, learning about epilepsy and epilepsy 
research and social interactions. Consistent with their understanding of ‘meaningful’ PPI 
the representatives appeared to be primarily motivated by pragmatic or consequentialist 
reasons rather than moral or political ones. 
Representatives also articulated experiencing six main challenges as part of their PPI role. 
This included, dealing with side effects from their illness, practical issues, the problem of 
jargon, time commitments, worries about representativeness and the emotional effect of 
being involved in research linked to a condition of which they had personal experience. My 
review of the literature suggests that majority of these challenges are not currently 
articulated within it. 
This chapter draws attention to two important aspects of the PPI process; the role of the 
facilitator and the level of confidence the representatives have in their own knowledge, to 
speak in groups and to disagree with the professionals. To an extent, these factors seem to 
link back to the representatives’ perception of underlining power differences between 
themselves and the professionals. This effect of perceived ‘power’ distribution is discussed 
in more depth in the discussion chapter.  
 
 
 157 
 
Chapter 6. Further consideration of key findings 
about process and perceptions  
6.1 Introduction  
In the preceding results chapters I have offered a detailed account of the PPI 
implementation process undertaken within each of my sites (Chapter 3) and the 
experiences and perceptions of the professionals (Chapter 4) and representatives (Chapter 
5) involved. In this chapter I will consider these findings from the previous chapters at a 
more conceptual level and to address objective 4: ‘to compare different approaches of 
implementing PPI, by contrasting the experiences of the professionals and representatives 
across the different research sites’. As detailed in section 2.8.1 this meta-analysis was 
achieved as part of my thematic analysis process, drawing on the premise of the 
hermeneutic circle. As I gained insights from consideration of the three sub-component 
data sources I then used them to examine my data as a whole. As I developed my 
understanding of PPI as a whole this information was then evaluated and re-examined 
within the sub-component data sets, which in turn fed into my understanding of the whole. 
This process led me to focus on how both representatives and professionals classified the 
different types of PPI, identifying the strengths and limitations of the different PPI 
approaches adopted by each of the sites. I then looked at these strengths and limitations 
on a more generic level, proposing seven factors of ‘quality’ PPI against which to evaluate 
my sites. Lastly I drew on the data to set out what I understand to be the fundamental 
characteristics of ‘meaningful’ PPI. 
6.2 Typology of PPI  
Throughout my data analysis it became apparent that neither the professionals (see Section 
4.3) nor the representatives (see Section 5.2) described or conceptualised PPI in terms of 
the currently available models of involvement (see Section 1.4.1); and having explored the 
PPI processes implemented in each site (see Chapter 3), I reached the conclusion that it was 
not appropriate or desirable to try to classify the type of PPI being implemented within my 
sites using these traditional PPI models (see Section 1.4.1). My participants placed little or 
no emphasis on classifying PPI by power over outcome and in addition the traditional 
models seemed to offer an over-simplification of the different ‘types’ of PPI implemented 
within my sites. Drawing specifically on the ‘influencing factors’ (see Section 3.6) and key 
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process points identified during Chapter 3, in conjunction with the rest of my data analysis, 
I have therefore developed my own typology to describe PPI. Within this typology I identify 
four key dimensions along which, I would argue, PPI can be considered: 
1. Personal-Proximal-Distal positionality  
2. Partnership-Advisory role within PPI process 
3. Integrated- Separated organisation of PPI activity  
4. Targeted - Generic nature of PPI 
Each of these dimensions is detailed in Table 10. Similar to the dimensions described in 
Gibson et al’s (2012) model of involvement, these four dimensions are intended to be 
conceptualised as a non-static continuum rather than a dichotomy; over the course of the 
PPI development process the position on any dimension may change.   
Based on this typology, my epilepsy specific sites would be labelled as follows: 
 
Main site, UKERN: integrated, personal/proximal, generic, partnership 
- Integrated: the representatives were part of the same group as the professionals 
- Personal/proximal: representatives were chosen because they had experience of the 
condition either personally or through a close friend/ family member 
- Generic: once representatives were part of the network, they could, at least in theory, 
take part in all network activities  
- Partnership: representatives were presented as equal stakeholders in the network.  
SS1, the Comparator Epilepsy Network: Separate, personal/proximal, generic, partnership 
- Separate: representatives have their own group separate from the professionals  
- Personal/proximal: had experience of the condition either personally or through a close 
friend/ family member 
- Generic: representatives were not included to achieve a specific goal; rather they 
decided their own purpose.   
- Partnership: while part of the representatives group’s function was to provide advice to 
the rest of the network they also shaped the network and had developed their own 
research suggestions.  
CS1, Intervention Study: Separate, personal/proximal, targeted, advisory 
- Separate: representatives met separately from the main group of professionals.   
- Personal/proximal: representatives were selected because they had experience of the 
condition either personally or through a close family member. 
- Targeted: representatives were present to comment on specific aspects of the research 
process. 
- Advisory: representatives were included to provide feedback only.  
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Table 10: Typology of key dimensions of PPI 
Dimension 1: Personal, proximal, distal involvement 
Personal The representative(s) have a ‘lived experience’ of the condition themselves. For 
example in CS2 (clinical trial), the professionals were concerned with accessing the 
opinions of women with epilepsy who were, or who had been, pregnant.    
Proximal The representatives(s) have experience of the condition through an affected close 
family member or friend. For example in SS1 (comparator epilepsy network), 
representatives were not only those with personal experience of having epilepsy, but 
also family members of people with epilepsy and professionals working with people 
with epilepsy.  
Distal 
 
The representative(s) have no experience of the condition either personally or 
through a family member or friend, but are present to give a generic ‘non-
professional’ or ‘public’ opinion.  
Dimension 2: Partnership- advisory involvement  
Partnership Representatives are equal stakeholders in the research process. For example in SS1 
(comparator epilepsy network) the representatives worked with the professionals to 
determine the purpose of the group; and in UKERN representatives had the same 
collaborative role as professionals.    
Advisory  Representatives are asked to provide feedback on discrete areas identified by the 
professionals. For example in CS1 (intervention study) the representatives were 
asked their opinion on the study design and associated documents.  
Dimension 3: Integrated- separate involvement  
Integrated  Representatives are physically situated with the professionals. For example in UKERN 
and in CS2 (clinical trial), the representatives were members of the research groups.   
Separate Representatives are detached from the professionals. For example in SS1 
(comparator epilepsy network) and CS2 (clinical trial) the representatives met 
independently of the professionals.  
Dimension 4: Targeted - generic involvement  
Targeted The representative(s) are present to achieve set tasks or goals. For example in CS2 
(clinical trial) they were present to give feedback on specific issues such participant 
information sheets and the website.  
Generic  Representatives are involved in the whole process. For example in SS1 (comparator 
epilepsy network), where they determined their own purpose and how they wished 
to function.    
 
CS2, Clinical Trial: Separate/integrated, personal, targeted, advisory 
- Separate/ integrated: During the feasibility study representatives were independent of 
the research team, however through the Steering Group and Data Management groups 
they were integrated with other stakeholders.  
- Personal: representatives had to have had personal experience of the condition 
(pregnant female with epilepsy). 
- Targeted: representatives in each stage of the PPI process were present for a specific 
aim. 
- Advisory: representatives provided feedback and advice to the research team.  
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Before I discuss the application of the typology (see section 6.6), I am first going to describe 
the findings of the analysis of the strengths and limitations of each of the approaches to PPI 
implemented within my sites.  
6.3 Strengths and limitations of four PPI approaches  
Barber, Boote and Cooper (2007) noted a lack of comparative studies focusing on different 
approaches to PPI and how this has limited the ability of PPI research to evaluate the 
different methods in relation to each other. This prevents both professionals and 
representatives from making informed decisions about their involvement in the PPI 
process. I attribute this lack of comparative studies to three key factors. Firstly, ‘models of 
involvement’ that classify level of involvement by power over outcome intrinsically imply 
that the higher levels are ‘better’ than the lower levels (see Section 1.4.1). Secondly, the 
existence of strong moral and ethical arguments in support of PPI could be a direct 
deterrent to scientific challenge and scrutiny (Salmon & Young, 2005). Because PPI was 
originally morally and politically motivated, researchers may be reluctant to examine it 
critically, particularly at the present time, as it is seen currently as something that must 
occur, regardless of the outcome. Thirdly, some components of the PPI process are clinical 
condition-specific and it may be problematic to compare approaches of PPI across different 
conditions. For example, issues surrounding involving someone in a wheelchair may differ 
substantially to those of involving someone who has had a stroke. The research reported in 
this thesis provided an opportunity to compare different approaches to PPI within a single 
condition, epilepsy, thus removing the third factor from consideration.  
Tables 11 and 12 give a brief summary of the key components of the approach to PPI 
adopted by each site and detail the strengths and limitations of that approach as identified 
by both my research participants and myself through the analysis process. The strengths 
and limitations that were raised directly by the participants and explored specifically in 
other chapters are designated by the Section number in which they were discussed. Those 
derived indirectly and attributable to my own interpretation of the data are donated by my 
initials (ED). As explained in Chapters 2 and 3, the UK topic-specific research networks (SS2) 
were approached differently to the other sites. The aim of including them as a research site 
was to provide an overview of the experiences and perceptions of the key issues around PPI 
among Network leads, who already had considerable experience of implementing PPI, 
rather than to generate a detailed understanding of the particular PPI processes they had 
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implemented. Given this and that each of the topic-specific research networks had 
implemented a range of PPI approaches, I chose not to include them in this comparison and 
confine my analysis to the epilepsy research sites only.  
 
It was apparent that the individuals involved in developing and implementing PPI at each 
site felt that their particular approach to PPI was the most appropriate one for them. This 
took into account the original motivation(s) for PPI, the aims of the research and 
preconceptions about representatives, ‘representativeness’ and what counts as a ‘valid’ 
opportunity for representatives to express their views (see Sections 6.5 & 3.6). For 
example, the professionals implementing PPI in the intervention study (CS1) did not 
consider having representatives on their steering group, which they thought would be 
‘tokenistic’, as they believed representatives would struggle to contribute. In comparison, 
the professionals in the clinical trial (CS2) felt that as long as the representatives were 
‘listened to’, having them present at the steering group and data monitoring committees 
meant that they had meaningful PPI.  
As detailed in Tables 11 and 12, different strengths and limitations can be attributed to 
each approach. For example, the separate representative group adopted by the comparator 
epilepsy network (SS1), allowed for the inclusion of a greater range of representatives and 
so could be argued to be more ‘representative’ of the epilepsy patient community as a 
whole. However, a major limitation of this approach was that there was not sufficient 
professional capacity to act on all of the information generated. In contrast, in the 
intervention study (CS1), where there was also a separate representatives group, there was 
the professional capacity to act on the group’s suggestions, but the presence of the ‘known’ 
clinical researcher appeared to inhibit discussion and debate. Representatives in the UKERN 
valued being part of the ‘professional’ groups as it made them feel properly integrated. 
Furthermore, the recruitment process they undertook helped ensure they had the self-
confidence to actively participate. This also meant that they might not be seen to be really 
‘representative’ of the epilepsy patient community and occasionally they were  involved in 
meetings that were, from their viewpoint, a ‘waste of time’.  
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Table 11: Strengths and limitations by site (i) 
Summary of site processes  Strengths (S) and Limitations (L) 
UKERN (main site): Integrated, personal/proximal, generic, partnership 
Formal application and 
selection process for 
representatives 
Training day for 
representatives 
Representatives integrated 
within the network groups 
Six representatives in total 
Two representatives per 
network topic group 
No previous connection 
between representatives and 
professionals 
S The application process ensured a clear understanding of the 
representatives’ roles (ED) 
S Representatives meeting the recruitment criteria had the confidence 
and skills to contribute to the meetings (see Sections 3.3 & 5.4) 
S The formal approach to training was seen as a benefit by the 
representatives (see Section 5.3.5) 
S Professionals within the integrated group had the ability and 
capacity to act on suggestions made by representatives (ED) 
S 
 
S 
 
Representatives felt like part of the network, as they were 
integrated into the topic groups with other stakeholders (ED) 
Having two representatives per clinical study group provided peer 
support for the representatives and a dual PPI perspective for the 
professionals (ED) 
L The nature of the formal selection process meant that 
representatives could be seen as not be truly ‘representative’ of the 
epilepsy community ( see Sections 4.5.6 & 5.5.1)  
L In some situations, where representatives were only passively 
present, they felt their presence had been a waste of time (see 
Sections 5.2.2 & 5.5.5) 
Comparator epilepsy network (sibling site one): Separate, proximal, generic, partnership  
No selection criteria for 
representatives 
A ‘Representatives’ group 
involving two professionals 
and eighteen representatives 
Half of the meeting time 
given to representatives’ own 
research ideas 
Half of the meeting time 
given to feedback to 
professionals in the wider 
network 
Ownership of the group lay 
with the representatives not 
the professionals  
Potential for future clinical- 
patient relationships between 
individual professionals and 
the representatives 
S No selection criteria potentially allows for greater 
‘representativeness’ of the epilepsy community (see Section 3.2) 
S Both professionals and representatives felt the clear outputs from 
the group provided evidence, that the PPI was ‘meaningful’ (see 
Section 3.2) 
S Consistency in group membership allowed for self-management of 
group dynamics and increased representatives’ confidence to 
contribute their opinions (see Sections 3.2 & 5.4) 
S 
 
 
Good group facilitation made representatives feel meaningfully 
involved and increased their confidence to contribute their opinions 
(see Sections 5.4 & 5.6) 
L The lack of clear roles specified from the outset of the group raised 
concerns among professionals around blurring of roles and ‘power’ 
imbalances (see Sections 3.2 & 4.5.4) 
L The separate nature of the group, and having only two professionals 
present meant that there was limited capacity for professionals to 
act on representatives’ suggestions (see Section 3.2) 
L Not having a formal selection process for representatives, combined 
with some of the problems sometimes associated with having 
epilepsy, meant that some of the representatives did not always act 
‘appropriately’ for a meeting situation. This could make it difficult to 
complete the agenda and increase the likelihood of members being 
offended or upset (see Section 3.2) or feeling like they were wasting 
time.  
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Table 12: Strengths and limitations by site (ii) 
Site summary  Strengths (S) and Limitations (L) 
Intervention study (child site one): Separate, personal/proximal, targeted, advisory 
Consultation group 
Eight representatives  
Two professionals, one of 
whom worked with the 
representatives in a clinical 
capacity  
Informal selection criteria 
for representatives   
Agenda set by professionals 
prior to the meeting  
S 
 
Having set aims for each meeting that were then met provided clear 
outputs from each meeting, offering evidence to both the 
representatives and professionals that PPI was ‘meaningful’ (ED) 
S Having the professionals integral to the project present meant that 
they could explain why or why not representatives’ comments were 
being incorporated, providing evidence that they were ‘being 
listened to’ (see Sections 3.4 & 5.6)  
S The consistency of membership of representatives group allowed for 
self-management of group dynamics and increased individual 
members confidence to give opinions (see Section 5.4) 
S Representatives group established at the design/ funding bid stage 
so could potentially influence the whole research process (ED) 
L Only four representatives consistently attended meetings, this was 
not enough for those involved to feel they were being truly 
representative (see Sections 3.4 & 5.5.6) 
L The presence of the research lead, who was also acting in the 
capacity of clinician to some group members, inhibited discussions 
(see Sections 3.4, 4.5.4 & 5.6) 
Clinical trial (child site two): Separate/integrated, personal, targeted, advisory 
Feasibility survey involving 
representatives  
One representative on 
steering and data 
management group  
Feedback on participant 
information 
S 
 
The decision over whether or not to submit the research bid rested 
on representatives’ feedback, which was collected through the 
feasibility study. Offering clear evidence that the representatives’ 
input was being taken into consideration and, in turn, of  
meaningfulness of PPI (see Section 3.5) 
S PPI was seen as intrinsic to the research not an add on; it was valued 
by the professionals as part of the research process (see Section 3.5) 
L 
 
 
 
L 
As PPI was seen as intrinsic to the research process, there was no 
formal plan on how it would be achieved and it appeared to happen 
on add-hoc basis. As such opportunities may have been missed 
when PPI could have improved the research process, e.g. during the 
design stage (ED) 
Only one representative was a member of the steering group and 
the data monitoring committee. When she could not attend, there 
was no PPI representation. (see Section 3.5) Also it is extrapolated 
that this may lead to a lack of peer support.  
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6.4 Seven factors to ensure ‘quality’ PPI  
Comparing my four research sites inevitably raised the question: is there one PPI approach 
that is better than others? Having considered the data in this comparative fashion, taking 
into account the four dimensions of my typology and drawing on the rest of my data 
analysis, I propose that it is not the ‘approach’ to PPI, in of itself, that determines ‘quality’ 
PPI but rather the alignment of aims, approach and purpose that facilitates ‘better’ PPI.  
As discussed in my literature review, since PPI requires working with a diversity of 
perspectives in varying contexts for differing purposes, I support Ross et al’s (2005) 
assertion that there cannot be a ‘one size fits all approach’. For PPI to be effective, the 
approach used needs to align with its aims and purpose; and depending on the scale of the 
research project, multiple methods could be implemented, for example having a separate 
representative group and a representative on the steering group. However, building on the 
findings already considered in this chapter, I have identified seven factors that appear to 
cut across all of the approaches to PPI, within my research sites and that help to ensure 
‘quality’ PPI:  
1. There should be a clear channel of communication between representatives and 
professionals, allowing representatives to see the effects of their contribution and 
ensuring the information reaches those with a capacity to act on it. Participants within 
the UKERN (integrated) and the intervention study (CS1, separated) both emphasised 
the importance of the representatives’ input being directly communicated to the 
professionals who have the ability to act on it, both to ensure that it is ‘taken into 
consideration’ and so that there is evidence that they are ‘being actively listened to’.  
2. Professionals need to have good interpersonal and facilitation skills to help ensure 
representatives have both the confidence and opportunity to contribute. This is 
particularly true of the ‘facilitator(s)’ (see Section 5.6) but holds true to all of the 
professionals involved.  
3. There needs to be clear roles and responsibilities for both professionals and 
representatives. Having clear roles increases representatives’ confidence (see Section 
5.4), facilitates the provision of ‘valid opportunities’ (see Section 3.6) and reduces 
professional-representative boundary issues (see Section 4.5.4) (For more detail on the 
importance of clear roles see Section 6.5)   
4. Where possible, professionals should not have a direct clinical relationship with 
representatives, in order to limit role confusion and power discrepancies. The 
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professionals in my sites who had clinical relationships with the representatives (Jess, 
SS1; Tom, SS1 and Nick CS1) noted the most difficulty with professional boundaries and 
in Nick’s case his duel relationship with the representatives inhibited discussion.  
5. Training and support for both professionals and representatives is an important 
requirement. Representatives viewed formal training as a benefit of taking part in the 
research process (see Section 5.3) and as helping to reassure them in relation to 
queries about how they could fulfil their roles. Additionally training and support in 
implementing PPI can help reassure professionals that they are ‘getting it right’ and 
help them to make informed decisions about which approach to PPI will most likely 
address their motivations and aims.   
6. It is important to allow for the development of rapport and self-confidence and the 
management of individual personalities. One way to achieve this is for group to meet on 
multiple occasions, with some consistency in group membership. The importance of 
group ‘self-management’ of personalities was mainly been raised in the context of the 
comparator epilepsy network (SS1) and the intervention study (SS1) in relation to a 
variety of ‘types’ of representatives and learning to work with different ‘difficult’ 
personality types. The broader importance of ‘getting to know each other’ also held 
true in the UKERN, as both professionals and representatives found that ‘getting to 
know’ each other made them feel more confident about working together.  
7. Professionals need to be aware of, and make adjustments for, representatives’ illness-
related difficulties, e.g. in the case of epilepsy, having awareness that tiredness can 
induce seizures and exacerbate memory problems and planning the timing of meetings 
according. 
Using these seven ‘quality’ indicators as a framework by which compare and contrast the 
four PPI approaches used in my epilepsy specific sites at a more conceptual level allowed 
me to examine whether or not any one of my sites had a ‘better’ approach to PPI than the 
others, irrespective of their varying aims, approach and purpose.  
In Table 13 I summarise how each of the sites was positioned in relation to each of the 
seven ‘quality’ factors. 
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Table 13: Positionality of epilepsy sites in relation to ‘quality’ indicators of PPI 
Main site, UKERN 
Integrated, personal/proximal, generic, 
partnership 
SS1, Comparator Epilepsy Network 
Separate,  personal/proximal, generic, 
partnership 
CS1, Intervention Study  
Separate, personal/proximal, targeted, 
advisory. 
CS2, Clinical Trial Separate/integrated, 
personal, targeted, advisory. 
 
1. channel of communication between representatives and professionals 
Representative sat on the same group(s) 
as the professionals and therefore 
directly communicated with them.  
A lack of direct communication between 
the representatives’ group and the rest of 
the network reduced the amount of PPI 
information the network as a whole had 
access to and the number of 
professionals with the capacity to 
implement the information. 
Although the group met separately from 
the wider research team, unlike the 
comparator network there was direct 
communication with those whose 
responsibility it was to act on the 
information as the lead researcher 
attended the meetings. 
The representative sat on the same group 
as the professionals  
The feasibility study (questionnaire) 
findings were turned into a report and 
distributed to the research team.  
2. Professionals need to have good interpersonal and facilitation skills 
The three group leads all had good 
facilitation and interpersonal skills. 
The representatives felt that the good 
facilitation of the group gave them each 
space to talk (which could be challenging 
given some of the ‘difficult’ personalities 
present) and the confidence to do so. 
Both professionals had good 
interpersonal and facilitation skills.   
 
While the data monitoring committee 
seemed to function well, managing the 
different professional stakeholders, I did 
not see them interact with the 
representative so I have no data for this 
indicator.   
3. There needs to be clear roles and responsibilities for both professionals and representatives 
The formal application process meant 
that there was a written role description 
for the representatives so overall their 
role was clear. 
During some of the meetings 
representatives felt that there was no 
clear purpose in them being present. 
The group was supposed to be 
representative-led making the 
professionals uncertain of their roles.   
Initially there was no clear role for the 
group but by the time of data collection 
they had established their own purpose. 
Very clear roles, responsibilities and 
purpose overall and in each meeting.  
 
Professionals had clear perceptions of 
what role the PPI representatives would 
fulfil in specific situations but had no 
overarching understanding of their role 
within the research 
I did not have the opportunity to interact 
with the representative so I have no 
indication if they were clear on their role.  
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Main site, UKERN 
Integrated, personal/proximal, generic, 
partnership 
SS1, Comparator Epilepsy Network 
Separate,  personal/proximal, generic, 
partnership 
CS1, Intervention Study  
Separate, personal/proximal, targeted, 
advisory. 
CS2, Clinical Trial Separate/integrated, 
personal, targeted, advisory. 
 
4. Professionals should not have a direct clinical relationship with representatives 
None of the professionals had clinical 
relationships with the representatives 
and were unlikely to develop them in the 
future.  
Professionals had the potential to be in a 
future clinical relationship with their 
representatives and had difficulties 
determining the extent to which they 
needed to maintain standard 
professional boundaries (see Section 
4.5.4). 
The lead researcher had a clinical or 
potential clinical relationship with the 
representatives and when he was present 
discussion was more stilted. He 
deliberately only took part in half of the 
meetings. 
The second researcher was not in a 
clinical relationship with the 
representatives.    
 
No clinical relationship between the 
professionals and the representative on 
the data monitoring and steering group  
 
5. Training and support for both professionals and representatives is an important requirement 
A training day was run for the 
representatives.  
The facilitators were given packs on how 
to facilitate PPI. 
Representatives were assigned mentors 
for support but did not hear from them 
The professionals provided a lot of 
support for the representatives both 
within and outside of the meetings.  
While representatives did not have a 
formal training day like the UKERN they 
had to opportunity to attended generic 
PPI training events and members of the 
wider network gave more focused 
‘training’ about their area of research. 
Professionals did not undertake specific 
training on how to facilitate PPI, rather 
they drew on their clinical training and 
interpersonal skills.      
The facilitator undertook PPI training and 
found a mentor for support. 
Unclear what if any training was provided 
for representatives   
 
I do not know what/ if training the 
representative was given 
Only one representative will be present 
at each meeting, so there will be 
potentially a lack of peer support 
The professionals interviewed in relation 
to the site had not undertaken any PPI 
training  
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Main site, UKERN 
Integrated, personal/proximal, generic, 
partnership 
SS1, Comparator Epilepsy Network 
Separate,  personal/proximal, generic, 
partnership 
CS1, Intervention Study  
Separate, personal/proximal, targeted, 
advisory. 
CS2, Clinical Trial Separate/integrated, 
personal, targeted, advisory. 
 
6. Development of rapport and self-confidence confidence and the management of individual personalities 
As part of the training day there was a 
‘thank you dinner’. This allowed for the 
development of rapport both between 
the representatives and the professionals 
running the day. 
The group met on multiple occasions 
allowing for members to get to know 
each other.  
Many of the meetings were by tele-
conference which may have inhibited 
relationship development as there was 
no social interaction either side of the 
meeting, and they tended to have very 
focused content.   
The consistency in group membership, 
multiple meetings and good facilitation of 
the group increased representatives’ 
confidence to contribute and allowed for 
the self-management of different 
personalities and medical conditions. 
 
Multiple meetings, and evidence of their 
involvement impacting on the research, 
allowed for the development of rapport, 
self-confidence and self-management 
No data  
 
7. Professionals need to be aware of, and make adjustments for, representatives’ illness-related difficulties 
As the patient representatives in the 
group largely appeared well, I think it was 
easier for the professionals to forget that 
adjustments needed to be made in 
comparison to the intervention study 
(CS1) and the comparator epilepsy 
network (SS1).  
When representatives were expected to 
travel to attend meetings they often 
compensated for potential difficulties 
themselves (see Section 5.5.1) rather 
than the network adjusting the travel and 
accommodation policies 
The venue of the meeting was chosen to 
be easily assessable by public transport 
as many of the representatives could not 
drive. 
Professionals prompted representatives 
prior to the meeting or when work was 
pending to help compensate for memory 
problems.  
The group set guidelines for expected 
responses times for the network in order 
to give representatives enough time to 
process and respond to requests.  
Allowances given for the illness-related 
difficulties that some representatives 
experienced in group/ social situations. 
Awareness that representatives might 
find some of the issues being discussed 
emotionally distressing impacted on the 
representatives selected.      
 
No data 
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As noted in the summary of the Clinical Trial (CS2) in Table 13 the fact that a representative 
had not yet been present during the meetings at the cessation of data collection meant 
that it was not possible to determine how the site was positioned with regard to all seven 
quality indicators. Focusing on the other three sites reinforces the findings in Section 6.3 
that different strengths and limitations can be attributed to each approach. Based on this 
comparison, it could be argued that the UKERN had a slightly higher ‘quality’ approach to 
PPI in comparison to the other sites as it addressed more of the issues around establishing 
clear roles, training (of both professionals and representatives), facilitation and 
communication from the outset.  
While my typology of PPI allows for a reconceptualization of different ‘approaches to PPI’ 
and the seven ‘quality’ factors cut across all of these approaches enabling their effective 
implementation, they do not in of themselves answer the central question ‘what is 
meaningful PPI’. 
6.5 What is meaningful PPI? 
Throughout my data analysis it became apparent that rather than defining PPI by the 
different types, methods or approaches both the professionals and the representatives 
focused on the distinction between meaningful and tokenistic PPI, using these terms in 
antithesis to each other. Being responsible for tokenistic PPI was seen as morally 
reprehensible by the professionals. Tokenistic PPI from the professionals’ point of view was 
seen as doing the ‘bare minimum’, for example having a representative present so that it 
could be said that PPI ‘had happened’, even though the professionals concerned had either 
not wanted, been able to or allowed representatives the capacity to contribute in a 
‘meaningful’ way. Factors that professionals associated with tokenistic PPI included: not 
providing representatives with sufficient information about the research, using too much 
jargon, not giving representatives the opportunity to voice their opinions and not taking 
representatives’ contributions into account during the decision making process (see Section 
4.5.2).  
The representatives also felt that having the opportunity to give their opinion and it being 
listened to were both imperative for meaningful involvement. Evidence of being ‘listened 
to’ included seeing, or being told about, changes to the research linked to their 
contributions. The representatives built on this, expressing the view that meaningful 
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involvement occurred when they could potentially have an impact on what they were 
involved in; to an extent whether or not they actually did have an impact was secondary. 
For example, if they had given a suggestion and the professionals explained why they were 
not incorporating it, they still felt listened to (and therefore involved in a meaningful way) 
even though they had not actually had a direct impact. Understanding what they were 
being asked to comment on was seen as particularly important by the representatives. This 
did not necessarily mean understanding all details of the research or its medical 
components. Rather it meant having enough information to place the research in context 
and enough direction to know where to put their attention and focus (see Section 5.2.2). 
 
Figure 16: Definitions of meaningful and tokenistic involvement 
 
 
Both the professionals and the representatives appeared to have developed their 
understanding of meaningful PPI by having observed or experienced what they considered 
to be tokenistic PPI, giving the impression of a perceived high prevalence rate of tokenistic 
PPI. Both groups viewed tokenistic PPI as a ‘waste of time’ and expressed the preference 
for a lesser amount of meaningful involvement, rather than involvement at all stages of the 
research process ‘for the sake of it’. This position does not fit with the Department of 
Health’s policy stance to have PPI in all stages of the research process (2006). Also the focus 
on meaningful versus tokenistic PPI may not fit easily within current models of 
involvement. For example, Boote, Telford and Cooper’s (2002) ‘levels of consumer 
involvement’ identifies three categories of involvement: Consultation (researchers obtain 
feedback from representatives, representatives have no power to ensure their suggestions 
are acted upon), Collaboration (on-going partnership between professionals and 
representatives, representatives have some power in the decision making process) and 
Definitions of involvement 
Meaningful involvement: Representatives are involved in an active manner and are in 
a position to potentially impact on the research process.  
Tokenistic involvement: Representative(s) are only passively present in the research 
process, and not able to contribute to it in a way that has potential for impact. 
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Consumer control (representatives hold all the power). This model, like several others (see 
Section 1.4.1), implies that power over outcome is equivalent to level of involvement. As 
such the more power the representatives have the more involved they are seen to be. The 
PPI literature is starting to acknowledge that this hierarchical criterion of power to denote 
the quality of involvement is an over-simplification (O'Donnell & Entwistle, 2004; Tritter & 
McCallum, 2006) Gibbson et al 2012). Certainly, neither the representatives nor the 
professionals within my sites defined meaningful PPI in terms of power over outcome, but 
rather in terms of input and impact, (impact on research process in first instance but also 
on representatives and professionals). I maintain that PPI can be ‘meaningful’ for both the 
professionals and representatives even when the representatives have no ‘direct power 
over the outcome’.  
Based on this emphasis on ‘meaningfulness’ and the findings of my analysis I revisited the 
question: what is involvement? (see Section 1.4) and further interrogated the question, 
what is meaningful involvement (see Figure 16)? I submit that within the data presented in 
the previous chapters there are five components of meaningful PPI (see Figure 17). I am not 
proposing that all five must be present for PPI to be meaningful, but rather that the 
likelihood of PPI being meaningful is increased proportionally the more of these 
components are present. I will now give a brief summary of each of these components.  
 
Figure 17: Components of ‘meaningful’ PPI 
 
 
 
 
 
Components of meaningful PPI 
o Professionals value representatives’ experiential knowledge 
o Clear motivations for PPI 
o Clear roles 
o Valid opportunities  
o Representatives’ input taken into consideration  
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Professionals value representatives’ experiential knowledge: 
The professionals involved believe that representatives have, or potentially have, useful 
information to contribute. Without this underlying assumption professionals will be unlikely 
to meaningfully engage with representatives. As detailed in section 4.5.3 professionals find 
the time for activities that they value, as the perceived benefits (see Section 4.4) outweigh 
the perceived challenges (see Section 4.5). The professionals in all my sites, to a greater or 
lesser extent, clearly believed that representatives added valuable information to the 
research process. This belief seemed to an extent to be self-fulfilling. Because they valued 
the representatives’ knowledge, they supported the representatives’ active involvement 
and utilised the representatives’ input, providing evidence to reinforce the belief that PPI is 
useful.   
Clear motivations for PPI:  
Both representatives and professionals (but particularly the professionals) need to have 
clear motivations for PPI in a given context, in order to help identify and facilitate 
opportunities for the representatives to fulfil their purpose. Having clear motivations for 
involvement such as the wish to ensure recruitment (CS2, clinical trial) or refine research 
design (CS1, Intervention Study) provides tangible ways by which to judge if PPI is having an 
impact on the research process. It also provides a framework for the type of PPI approach 
that needs to be implemented in order to achieve meaningful involvement.  
Clear roles:  
Establishing clearly defined roles and responsibilities helps to prevent conflict and boundary 
issues. It also allows people to know what is expected of them and increases confidence 
that they are focusing on the correct area. The importance of this is raised in the literature 
around functioning of multidisciplinary teams. The importance of clear roles was first 
brought to my attention by Emma and Lucy, the epilepsy charity advisers to the UKERN, 
who advocated the use of a role descriptor in the formal recruitment process, to ensure 
that all members of the network were clear on the representatives’ role. This was 
reinforced by the boundary issues identified within the comparator epilepsy network (SS1). 
The professionals were unclear of the nature of their relationship to the representatives, 
resulting in tensions around codes of conduct (see Sections 3.2 & 4.5.4). 
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Valid opportunities: 
Representatives are not just passively present but have an opportunity to actively 
contribute and are provided with appropriate information and support to do so. As detailed 
in Section 3.6 and discussed earlier in this chapter, each of the sites had different 
perceptions of what constituted a ‘valid opportunity’ and in turn endeavoured to provide 
them within their PPI process. What is salient here is that if representatives do not have the 
chance or support to ‘voice’ their opinions, the professionals will not have the ability to 
‘hear’ them. 
Representatives’ input taken into consideration: 
During the decision making process the contributions of the representatives need to be 
actively taken into account by the professionals. If they are not, then even with the other 
four components the involvement of representatives is likely to be tokenistic. This was an 
underling assumption present across all of my sites ‘what’s the point of having them there 
[representatives] if we don’t listen to them?’ This was supported by the responsibility that 
professionals felt towards the representatives, that having asked them to take part it would 
be disrespectful not to actively take into account their contribution (see Section 4.5.6).   
6.6 Summary  
Having considered the information from the preceding chapters I found that it was not 
appropriate or desirable to try to classify the type of PPI being implemented within my sites 
using the traditional PPI models (see Section 1.4.1). I therefore developed my own typology 
to describe PPI and then compared and contrasted these approaches to see if one of the 
approaches to PPI within my sites appeared to be higher ‘quality’ than the others. I 
concluded that it is not the approach to PPI, per se, that matters, but rather the alignment 
of aims, approach and purpose. I identified seven key factors that help to ensure ‘quality’ 
involvement regardless of the approach used. I then drew on my data to answer the 
question ‘what is meaningful PPI?’; defining meaningfulness and identifying five 
components that, when present, help to ensure that PPI is meaningful and not tokenistic.  
Although my typology of PPI, seven key ‘quality’ factors and the components of 
meaningfulness have been presented separately, they are all heavily interlinked with each 
other. Similar to Gibson et al’s (2012) model of involvement (see Section 4.1.1) the 
combination of the ‘typology of PPI’, ‘seven key factors’ and ‘the components of meaningful 
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PPI’, provide a framework for conceptualising and reflecting on the PPI process. I also see 
them as useful for planning and implementing quality, meaningful, PPI. By systematically 
working through the four dimensions of the typology in relation to the purpose of their PPI, 
researchers would able to identify the approach that would best achieve these aims. Once 
the overall approach had been determined the researchers could review if the seven key 
factors are automatically part of their approach to PPI or if they have to be actively 
incorporated, enabling effective or ‘quality’ implementation. For example if utilising 
‘separate’ involvement, is there a clear channel of communication? If adopting a one of 
‘advisory’ approach to PPI, how will rapport be built? In addition, considering the 
‘components of meaningful PPI’ in relation to the chosen approach will help to avoid 
tokenism. In the discussion chapter I provide more detailed suggestions on the 
implementation of PPI in practice and draw out other main findings.  
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Chapter 7. Discussion  
7.1 Introduction  
In the preceding chapter I considered the information from Chapters four to six in order to 
compare and contrast different approaches to PPI in an epilepsy context and conceptualise 
‘meaningful’ PPI. Building on this, in this chapter I draw together the main findings and 
place them in the context of the current literature, identify what they contribute to the 
current understanding of PPI and consider the potential implications of these findings for 
how PPI is implemented in policy and practice. Following this, I reflect on the research 
process as a whole, discussing the strengths and limitations of the chosen methodology and 
identifying ways in which my findings could be enhanced with further research. 
7.2 Main findings in the context of the current PPI literature.  
In the first part of my literature review (see Section 1.2) I explored the historical and 
political context of PPI, describing its evolution in health research in light of a combination 
of political and moral drivers. In the second part (see Section 1.6) I concluded that there is a 
lack of empirical evidence about the impacts of PPI. Linked to the historical context of PPI, 
the majority of the literature is theoretical or based on anecdotal evidence. This is a 
conclusion shared by a range of PPI review articles (Boote, Telford, & Cooper, 2002; 
Minogue et al., 2005; O'Donnell & Entwistle, 2004; Oliver et al., 2008; Staley, 2009a). I also 
determined that there is a prevailing focus on the potential benefits of PPI on both the 
research process and those involved, with little consideration of the possible challenges and 
drawbacks of PPI.  
My study generated an extensive amount of information about the implementation process 
of PPI in the context of health research. The key findings can be presented in seven 
categories: motivations for involvement; ‘meaningful’ PPI; Typology of PPI; benefits and 
challenges of PPI; the importance of confidence and the facilitator; differences across sites 
and approaches; and, issues of power and perception. I will address each of these 
categories in turn and consider how they inform the literature. 
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7.2.1 Motivations for involvement  
The professionals differentiated between the purpose, motivation(s), and benefits of PPI. 
They regarded the purpose of PPI as its primary function, the reason why it is done. The 
motivation(s) for PPI included specific reasons for conducting PPI in a given situation; and 
the benefits of PPI were the ‘additional’ positives that PPI brought outside of the original 
motivations.  
In comparison, the representatives appeared to view purpose, motivation(s), and benefits 
of PPI as largely one and the same. I attribute this difference in conceptualisation to the 
different ways the two groups developed their understandings of PPI, which reflected their 
roles within the research. The representatives developed their understanding of PPI 
primarily though experiencing it, whereas the professionals tended to have preconceived 
ideas based on the literature, interactions with other professionals and training, which 
were then tested though their own participation in the PPI process.  
The professionals believed that the overarching (non–site specific) purpose of PPI was to 
ensure that research was ‘relevant’. Relevant research equated to ‘beneficial’ research that 
would be useful to the public. This emphasis on relevance may explain why it is one of the 
most commonly reported perceived benefits of PPI in the literature (Caron-Flinterman, 
Broerse, & Bunders, 2007; Elberse, Caron-Flinterman, & Broerse, 2011; Fisher, 2002; 
O'Donnell & Entwistle, 2004; Popay & Williams, 1996; Rhodes et al., 2002; Wright, Corner, 
Hopkinson, & Foster, 2007). For professionals in my study however, relevance appeared to 
be not just one of many potential benefits; rather it was the primary function of PPI. In 
addition to helping directly to ensure the research question was relevant, the professionals 
believed PPI helped improve research design and implementation, so indirectly increasing 
its relevance. The professionals also gave site specific motivations for PPI including: 
increasing the chance of obtaining funding (CS1), because it is ethically right to be inclusive 
(SS1) and to ensure adequate recruitment (CS2). Even taking the site specific motivators 
into account, the primary sustaining motivator seemed to be the professionals’ underlying 
belief that the purpose of PPI was to improve the research process, thus making it more 
‘relevant’ (see Sections 5.2.1 & 5.3). It seems important to note that the professionals did 
not appear to have any personal motivations for PPI outside of the research process. 
Overall the majority of professionals seemed to be of the opinion that PPI is essentially a 
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good thing and should happen, although they were ‘sceptical’ about how much impact PPI 
actually had. 
Instead of focusing on increasing the relevance of the research, representatives articulated 
that the primary function of PPI was for professionals to get a ‘different point of view’ or 
more specifically ‘a patient’s perspective’. This different point of view was seen by the 
representatives as resulting from their experiential knowledge about epilepsy but also, in 
some cases, from the perspective of a non-professionally trained person. Representatives 
also believed that both of these factors allowed them to identify issues that would not be in 
the professionals’ purview, for example, how patients may feel about the information being 
given to them or identifying difficulties in understanding the technical language used. While 
this overlaps heavy with the professionals’ stance, the representatives focused more on 
how their knowledge could help improve individual components of the research process 
and improve the professionals’ understanding of the condition, rather than its overall 
applicability or relevance.  
The representatives also had more personal motivations for involvement. These included: 
having an innate interest in epilepsy and epilepsy research; the wish to feel like they were 
making a difference; helping others with epilepsy, valuing the research being undertaken 
and validating their knowledge and experience (see Section 5.3). These findings coincide 
with Canvin and Jacoby’s (2006) research into the decisions of people with epilepsy about 
recruitment to clinical trials. They found that although patients expressed some altruistic 
motivations for involvement in research, they were largely driven by reasons related to 
‘self-interest’. Representatives’ motivations for taking up a PPI role does not appear to be 
touched upon in the existing PPI literature. 
Overall, both the professionals and the representatives appeared to be aware of the moral 
and political motivations of PPI, but were primarily motivated by pragmatic or 
consequentialist reasons. This suggests, as noted by O’Donnell and Entwhistle (2004), that 
there is a need for more empirical evidence about potential impacts of PPI on the research 
process to motivate researchers who are more resistant to implementing PPI.  
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7.2.2 Typology of PPI 
Having explored the PPI processes implemented in each site I concluded that it was not 
appropriate or desirable to try to classify the type of PPI being implemented within my sites 
using the traditional PPI models. I therefore developed my own typology to describe PPI. 
Within this typology I identify four key dimensions: i) Personal-Proximal-Distal, ii) 
Partnership-Advisory, iii) Integrated-Separated, iv) Purposive–Generic. Each of these 
dimensions is detailed in Table 10 and are presented as a non-static continuum rather than 
a dichotomy; and over the course of the PPI process the position on any part of the 
continuum may change. It is hoped that when used in conjunction with the ‘seven key 
factors key factors’ (see Section 6.4) this typology would provide a tool for conceptualising, 
planning and implementing PPI, ensuring the alignment of aims, approach and purpose and 
facilitating ‘quality’, ‘meaningful’ PPI.  
7.2.3 Benefits and challenges of PPI  
As previously discussed, both the professionals and the representatives believed that the 
main benefit of PPI was that it improved the research process (and in turn the relevance of 
the research). More specifically, the representatives thought that by ‘tweaking’ the 
research process, PPI could improve recruitment and dissemination. The professionals 
developed this point further by stating that PPI could help in the process of acquiring 
funding and ethical approval, and increase retention as well as recruitment of research 
participants. Based on my review of the literature, the potential for PPI to increase the 
likelihood of obtaining funding and improve retention appears to be absent from the 
literature. The other perceived benefits that were identified around removing jargon, 
increasing recruitment, expediting ethical approval and broadening of dissemination are 
congruent with the findings of other research (Boote, Baird, & Beecroft, 2010; Hanley et al., 
2001; Iliffe, McGrath, & Mitchell, 2011; INVOLVE, 2012d; McDonald et al., 2006; Minogue et 
al., 2005; Staley, 2009a; Watson & Torgerson, 2006; Wyatt et al., 2008; Wight, Corner, J, 
Hopkinson, & Foster, 2006). The literature also suggests that PPI can facilitate more 
representative sampling, expedite data collection and improve selection of outcome 
measures (Elliott, Watson, & Harries, 2002; Boote, Baird, & Beecroft, 2010; Faulkner & 
Thomas, 2002; Fisher, 2002; Rhodes et al., 2002; Coupland & Maher, 2005). The 
representatives in this study also believed that interacting with representatives as part of 
the PPI process might help improve the professionals’ knowledge of what it is like to have 
epilepsy and improve their communication skills and, in turn, their clinical practice. This is 
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not something that the professionals identified as a benefit themselves. Other than the 
occasional comment (for example, Rachel stating she found PPI reassuring in terms of the 
value of the research) the professionals focused very little of their attention on the 
personal benefits of PPI beyond the improvements that it might offer to their research.  
In contrast, the representatives identified a range of personal benefits that overlapped 
heavily with their motivations for involvement. In addition to their original motivations 
(innate interest in epilepsy and epilepsy research; the wish to feel like they were making a 
difference; helping others with epilepsy; valuing the research being undertaken and 
validating their knowledge and experience) they also valued the opportunity to learn about 
epilepsy and epilepsy research in greater depth and the opportunities PPI gave them for 
interacting with other representatives and the professionals. A subset of the 
representatives also found increased self-confidence was a benefit of their PPI role. While 
these benefits to representatives are discussed briefly in the literature (Minogue et al., 
2005; Newell & South, 2009; O'Donnell & Entwistle, 2004; Rhodes et al., 2002), the 
representatives in my study placed more emphasis on personal interest and the learning 
opportunities they associated with PPI (see Section 5.3), whereas the existing literature 
focuses on the positive changes in representatives’ self-perception (Minogue et al., 2005; 
Newell & South, 2009) and interactions with peers (Minogue et al., 2005; Rhodes et al., 
2002). 
The representatives in my study also recognised a range of challenges that arose as part of 
their PPI role. These included practical issues such as information technology problems and 
managing conflicting obligations, problems of understanding scientific language and jargon 
and time commitments. Also worries about how representative they were of the epilepsy 
community as a whole, the potential emotional effects of being involved in research linked 
to a condition of which they had personal experience, and the need to work around their 
individual health issues. As I indicated in Section 1.6.2, other than the suggestion within the 
literature that some representatives found increased information on their condition 
elevated their anxiety levels (Rummery, 2009) and the concerns some representatives had 
about the perceived level of responsibility PPI brings (Newell & South, 2009), the PPI 
literature does not address these more challenging aspects of PPI for the representatives. 
Yet without an understanding of the potential challenges that representatives experience, 
professionals cannot take them into account when planning support and training needs.  
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The professionals also reported experiencing challenges around time commitments, 
organisational practicalities (such as additional complexities when organising meetings and 
liaising with different university departments to ensure representatives received payment) 
and worries about how representative of the epilepsy community their representatives 
were. They also expressed concerns about the best way of conducting PPI, worrying about 
upsetting or offending the representatives, the possible blurring of their academic roles and 
the erosion of patient-clinician boundaries. Coupland and Maher (2005) suggested that the 
‘blurring of roles’ provides professionals with new opportunities for learning and 
developing systems, as well as being disconcerting for the individuals involved. This more 
positive slant on the ‘blurring of roles’ does not appear to have been experienced by the 
professionals in my research sites.  
The professionals’ and representatives’ concerns about how to ensure that representatives 
are truly ‘representative’ of the group have also been raised by other authors (Entwistle, 
Sowden, & Watt, 1998; Entwistle et al., 1998; Rhodes et al., 2002). However, I would 
submit that it is not possible for one person or a small group of people to be truly 
‘representative’ of a given population and suggest that trying to achieve true 
‘representativeness’ is a fallacy that, in part, stems from the terminology used. Perhaps 
using terms such as ‘stakeholder(s)’, ‘partner(s)’ and ‘diverse purposive sample of the 
public’ would help overcome some of the complexities associated with the term 
‘representative(s)’. Nevertheless I will continue to use the term ‘representative’ in this 
thesis for constancy and clarity. 
7.2.4 Meaningful PPI 
Both representatives and professionals differentiated between ‘meaningful’ and ‘tokenistic’ 
PPI. As this has already been discussed in depth, in relation to the literature in other 
chapters (see Section 4.5.2, 5.5.2 & 6.5) only a brief summary is given here.  
Tokenistic PPI was seen as doing the ‘bare minimum’, having representatives present but 
not ‘allowing’ them to contribute in an active way to the research and was regarded as the 
opposite of ‘meaningful’ PPI. The representatives stressed that meaningful involvement 
occurred when they could potentially have an impact on what they were involved in; to a 
certain extent whether or not they actually did have an impact appeared to be secondary.  
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Being responsible for tokenistic PPI was seen as morally unacceptable by the professionals 
and both groups viewed tokenistic PPI as a ‘waste of time’. They expressed the preference 
for a small amount of meaningful involvement rather than involvement at all stages of the 
research process ‘for the sake of it’.  
Based on the findings of my analysis I believe that there are five components of meaningful 
PPI: (i) that professionals value representatives’ experiential knowledge; (ii) that there are 
clear motivations for PPI; (iii) that professionals and representatives have clearly designated 
roles; (iv) that there are valid opportunities for representatives to contribute; (v) and that 
representatives’ input is taken into consideration. With the exception of (v) I am not 
suggesting that all five must be present for PPI to be meaningful, but rather that the 
likelihood of PPI being meaningful is increased proportionally when more of these 
components are present.  
7.2.5 The importance of confidence and the facilitator  
In Section 7.2.3, when examining the perceived benefits of PPI, I discussed how some of the 
representatives found increased self-confidence was a benefit of their role. This is 
congruent with Newell and South’s (2009) findings that representatives report increased 
confidence in their own capabilities and influence. However, there is nothing in the 
literature which addresses what gives the representatives confidence in their knowledge or 
what affects their confidence to express views in a given situation. As noted in Section 5.4 
the importance of having confidence cannot be overstated. If representatives do not have 
the confidence to make their views known, then according to their own and the 
professionals’ definitions are they are not and cannot be meaningfully involved. Building on 
this, three key areas of ‘confidence’ were identified; representatives’ confidence in the 
value of their own knowledge; their confidence to speak in groups; and their confidence to 
disagree with the professionals. Factors that emerged as positively influencing 
representatives’ confidence included: their own professional occupation, group dynamics, 
consistency in group membership, past PPI experience, level of rapport with professionals 
and other representatives, feeling that they were being listened to and the skill of the 
facilitator. Conversely, issues around understanding the language used (jargon) and 
perceiving their involvement as tokenistic appeared to negatively impact on confidence.  
In relation to these factors, the influence of the group facilitator appeared to be 
paramount, as the facilitator set the tone for the group interactions, managed group 
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dynamics, created space for individuals to contribute and gave representatives evidence of 
their impact. Hewlett et al (2006) support this observation, by stressing that the chairing of 
a meeting is a key factor in enabling representatives to contribute. Therefore the choice of 
facilitator is important when making decisions about implementing PPI. Both the 
representatives and professionals noted that having a clinical-patient relationship with the 
group facilitator complicated their interactions. Because of this I would recommend that, 
where possible, the primary facilitator is not also the representative’s clinician.  
7.2.6 Differences across sites and approaches  
Research Objective 4: ‘To compare different approaches of implementing PPI, by 
contrasting the experiences of the professionals and representatives across the different 
research sites’, was addressed throughout the result chapters. Specific focus was given to 
this objective in Chapter 6 (see Section 6.3), when the benefits and limitations of each 
approach were detailed and explored (see Tables 11 & 12). I suggested that it is not 
possible to advocate one of these approaches over the others but identified seven factors 
that appear to cut across all the approaches to PPI within my sites and that helped to 
ensure ‘quality’ PPI (see Section 6.4 & Table 13). In particular I propose that it is the 
alignment of approach, purpose and ‘meaningfulness’ that results in high quality PPI.  
7.2.7 Power of perceptions. 
During the discussion section of Chapter 3 (see Section 3.6) I described how the 
professionals’ preconceptions about involvement impacted on their decision making 
process. On further reflection it was clear that the professionals held a number of 
preconceptions or beliefs about PPI, all of which could influence the PPI experience. These 
included: when representatives could have an impact; the representatives’ capabilities; the 
problem of those representatives; how important it was for representatives to be 
‘representative’ of the sample population and whether PPI was worth the time and effort 
involved. In turn the representatives also had beliefs about the professionals, the most 
pertinent of which was that they thought professionals would prefer to hear the opinions of 
fellow colleagues over those of the representatives. This appeared to strongly influence 
when and how the representatives contributed to the research process. Corroborating the 
work of Thompson et al (2012), it appears that representatives valued professional or 
‘certified’ forms of expertise over their own, and believed that the professionals did as well. 
This seemed to be in direct conflict with the professionals’ expressed view that they would 
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prefer to hear from the representatives in project team meetings, because they had other 
opportunities to access the views of their fellow professionals. 
This deferral to the ‘expert position’ by the representatives resonates with Pilnick and 
Digwall’s (2011) critical review of the asymmetry that is present in the context of doctor-
patient interactions in clinical care. They argue that asymmetry in the power dynamics of 
patient-clinician relationships is inescapable, due to patients’ reliance on the clinicians’ 
knowledge and the perception that they (the clinicians) have the responsibility for 
determining what action is to be taken. This results in a ‘functional asymmetry’ which both 
parties reinforce. In the context of PPI, this functional asymmetry seems to be reinforced 
where, in addition to the professionals feeling responsible for the representatives 
wellbeing, the decision making power and research knowledge lies with them. Like Pilnick 
and Digwall I would argue that these cultural and functional power discrepancies are 
difficult to remove. However, their effect can be minimised by those involved in the process 
being aware of them and providing good facilitation.  
7.3 Recommendations 
This section explores the potential implications of the thesis findings for the 
implementation of PPI in practice and policy.  
7.3.1 Practical recommendations for implementing PPI  
When discussing ‘meaningful’ PPI and the question: does the approach matter? (see 
Sections 6.2 & 6.3.1 respectively), I identified some suggestions for the implementation of 
PPI. Incorporating these with the rest of my data I have identified 13 practical 
recommendations for optimising the implementation of PPI: 
1. Having clear motivations for PPI before initiating PPI. This will help to identify and 
facilitate opportunities for representatives to fulfil their purpose.  
2. Providing clearly defined roles and responsibilities: thus helping to prevent conflict 
and boundary issues. This will also allow people to know what is expected of them 
and increase confidence that they are focusing on the correct area.  
3. Undertaking PPI early in the research process, preferably before the funding 
application is submitted, to ensure maximum ‘relevance’ as arguably this is the 
time when representatives can have the most impact on the research process. 
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4. Implementing PPI at time points and stages when representatives can have a real 
impact on the research process, rather than at every stage ‘for the sake of it’ to 
prevent it being ‘a waste of time’. 
5. Creating valid opportunities for involvement: representatives should have an 
opportunity to actively contribute and be provided with appropriate information 
and support to do so.  
6. Ensuring consistency in group membership, of both professionals and 
representatives, to aid establishment of rapport and to allow people to learn how 
to work with conflicting personalities and increase the representatives’ confidence 
to contribute.  
7. In line with the above point, the group should meet on multiple occasions to allow 
for the development of rapport, confidence and self-management of personalities.  
8. If there is an extended period of time between meetings, representatives would 
benefit from contact with the professionals, updates help them feel involved and 
valued.  
9. Identifying a facilitator who:  
i. Ideally is not the representatives’ clinician, as this exacerbates issues of 
power and blurs professional boundaries. 
ii. Should be linked to the research project to allow for direct feedback. 
iii. Should have good interpersonal and facilitation skills to help ensure 
representatives have the confidence and opportunity to contribute.  
10. Provide training to professionals regarding: the background, methods, possible 
impacts and how to ensure high quality PPI. 
11. Provide training for representatives as appropriate so that they understand the 
context of the research they are being asked to comment on.  
12. Ensuring clear channels of communication between representatives and 
professionals, ensuring there is feedback allowing representatives to see their 
impacts. This also makes sure information is with those with a capacity to act on it.  
13. Ensuring professionals are aware of, and make adjustments for, representatives’ 
illness-related issues; e.g. in the case of epilepsy, having awareness that tiredness 
can induce seizures and exacerbate memory problems, therefore meeting should 
take place at appropriate scheduled times.  
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7.3.2 Policy recommendations 
In Section 1.5.3 I explained that current policy documents advocate that: “… patients and 
the public must be involved in all stages of the research process” (DH, 2006, p.34). Based on 
the discussions around what constitutes tokenistic PPI and the identified practical 
challenges of PPI, I would suggest that emphasis should be placed on implementing 
strategic, meaningful PPI rather than advocating PPI be implemented routinely in all stages. 
I would also suggest that funders need to ask applicants to be explicit, not only about how 
they are going to implement PPI but also about why they are going to implement PPI, in 
order to ensure that there is a clear rationale for involvement outside of the need to do so 
to obtain funding. Funders should not be prescriptive as to how PPI is implemented but 
rather should seek to ensure that the approach proposed matches the purpose. In addition, 
if funders value PPI they need to provide adequate funding to support it at the earliest 
stage of development and throughout the research process.   
My work suggests that Universities need to support researchers with training and 
resources; providing money in order to allow PPI in the grant development stage; having 
clear procedures for the payment of representatives; and allowing researchers the time and 
providing them with resource to implement PPI.  Finally, policy makers should request 
feedback on the positive and negative impacts of PPI in order to extend the current PPI 
evidence base, about the potential benefits and costs of PPI.  
7.4 Strengths and limitations 
Within any research project it is inevitable that there are constraining factors. As a single 
researcher, approaching the complex area of PPI during a restricted time period, my work is 
no exception. In this section I offer some reflections on the research process as I 
experienced it and my ideas for further research. In Section 2.4.2, I described how to assess 
the quality of ethnographic research, indicating that Hammersley (1990) offers a composite 
list of evaluation criteria that are specific to ethnographic research, four of which are 
considered key validity measures for an ethnography (Savage, 2000, p.1401):  
1. The extent to which the influence of the research design and strategy on findings is 
considered (the reflexivity of the account). 
2. The extent to which findings have relevance to those in similar settings. 
3. The credibility of the account to readers and those studied.  
4. The consistency of claims compared with empirical observations and data. 
I will be using these four validity measures as the framework for this section  
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7.4.1 The influence of the research design and strategy on findings  
As noted in Chapter 2, instead of planning precisely what will be done at each stage, an 
ethnographic methodology responds to the research findings as they unfold and narrows its 
focus though on-going analysis (Lofland, 2002). In tune with the developing nature of the 
method, sites may not be predetermined but rather chosen as the research develops, as 
insights are gained, and to some extent by chance (Hannerz, 2003). This method of site 
selection can be a problematic aspect of multi-sited ethnography, as there is a chance that 
optimal data might not be obtained (Lofland, 2002). One of the aims of this research was to 
explore PPI across the entirety of the research process. It quickly became apparent that the 
research sites associated with the UKERN were all in the early stages of the research 
process and therefore it was not possible to explore the role of PPI in later stages, for 
example during data analysis and the dissemination of findings. Due to the slow nature of 
the process of obtaining research funding, one of the potential sites, a clinical drug trial 
linked to the UKERN, saw little activity during the data collection period and therefore was 
not included in my study. The limited time frame for data collection also prevented me 
from observing PPI in the management and data monitoring committees of CS2 (Clinical 
trial). Arguably however, it is at the early stages of the research process where PPI may 
have the most impact on the design and implementation of a project and my sites provided 
an excellent opportunity to look at different approaches to PPI at the design stage of 
multiple trials within the same disease context. As some of the professionals’ motivations 
and perceptions of the benefits of PPI, such as increased recruitment and relevance, may 
be less salient in later stages of the research process, further research is need to see if 
there are different associated motivations, benefits and challenges of PPI across the 
different stages of the research lifespan. I am also aware that the emphasis I have placed 
on the importance of PPI in the design stage might be overstated as result of the sites.  
When reflecting on the ethnographic nature of this research the advantage of multiple 
methods of data collection was clear. A defining characteristic of ethnography is participant 
observation, with the researcher participating in the daily lives and events being studied 
over an extended period of time (Hammersley & Atkinson, 2003), in order to access 
information that would not be revealed through interviews alone. I found this held true 
particularly when exploring the challenges associated with PPI. During my observations 
both the professionals and representatives would allude to or explicitly state things they 
found difficult, about the PPI process. They did not then articulate these problems within 
 187 
 
the interviews, unless I directly questioned them. Therefore, I propose that I was able to 
establish a more balanced and holistic understanding of PPI than would have been achieved 
by interviews alone. In Section 2.6.1 I asserted that the observational and longitudinal 
nature of the ethnography helped me to establish rapport with the participants, allowing 
me access to more honest and inclusive accounts. I feel this was particularly evident in the 
UKERN when comparing the transcriptions of my interviews at time point one, with 
interviews with the same participants at time point three. The latter interviews were far 
more informal than earlier ones, with participants talking more as they might with a friend 
than an interviewer, making regular reference to the fact: ‘you were there’. Building on the 
information from the multiple data sources, this rapport added to the breadth and depth of 
information collected and in turn providing more nuanced findings. 
7.4.2 Relevance of findings in similar settings 
To explore the experience of PPI required that the professionals sampled all had PPI 
experience. As I only had a limited capacity regarding the number of professionals who 
could be interviewed, I focused on professionals responsible for facilitating PPI. The 
advantage of this was that these professionals were involved in every stage of the PPI 
process and as such had experiences and knowledge that other professionals did not (for 
example the other UKERN clinical study group members). Consequently the findings are 
based on a subset of professionals’ perceptions and experiences and do not take into 
account the views of professionals who are more peripherally involved in PPI, or those who 
choose not to engage with PPI at all. Further research is needed to develop an 
understanding of the perceptions of PPI from the position of those professionals who adopt 
a more passive, ambivalent or negative stance towards PPI.  
The findings of this study are largely situated within epilepsy research. Some of the key 
findings from the epilepsy specific sites resonated heavily within my interviews with the PPI 
leads for the UK topic specific research networks (including: importance of a clear purpose, 
issues with those representatives, general scepticism from professionals and practical 
issues) suggesting a level of transferability to the findings. However, differences between 
my findings and the work of Thompson et al (2012) suggest that not all of the findings are 
applicable in other health research settings. Thompson et al (2012), found that cancer 
representatives draw on their relevant expertise (career, education or training) in addition 
to their experiential knowledge to ‘legitimise’ their position as a credible representatives. 
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This differs from the epilepsy representatives’ perception that the more professional they 
are, the less ‘legitimate’ or ‘representative’ they are of the epilepsy community as a whole. 
In addition, Thompson et al found that cancer representatives did not feel it was their place 
to challenge the professionals but rather to support them; whereas, my representatives 
considered this a key component of their PPI role. In order to more clearly understand the 
transferability of my findings, further research is needed into the experiences of those 
involved in PPI in different research contexts.  
7.4.3 The credibility of the account  
In line with the ethos of this research, I considered it important that representatives’ 
perspectives were considered at multiple stages in my own research process (see Section 
2.10). In addition to my first consultation with the members of the Epilepsy Action Research 
Network (EARN), I had originally planned to go back to the EARN members who had given 
me permission to contact them a second time during my data analysis phase. Unfortunately 
due to time constraints, this has not yet happened. However, I feel the values of PPI have 
been maintained though the iterative ethnographic nature of the research, with 
information from each step informing the next, ensuring that all my participants influenced 
the research process. In addition, I perceive the credibility of the account to ‘those studied’ 
was ensured though the extensive respondent validation or ‘member checking’ described in 
section 2.4.1 that was an integral part of this research process.  
While I maintain that I have systematically and extensively supported my findings with 
examples from my data, Hammersley’s’ (1990) fourth assessment criteria: ‘The consistency 
of claims compared with empirical observations and data’ and the first part of the third 
criteria: credibility of the account to readers; must be determined by you, the reader. 
In my methods section that I started this thesis with no: “particular understanding of the 
best method(s) for implementing PPI, or the specific benefits and challenges. I started from 
a value position that people with epilepsy and their families should be involved in epilepsy 
research; and that, if done well, PPI can increase the quality of research and also have an 
impact on those involved” (see Section 2.3).  
While it is still true that I believe that PPI is important and largely beneficial, I have gained a 
more in-depth and nuanced understanding of the issues regarding its implementation and 
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the potential benefits and challenges. This is something I will take with me as I move 
forward in my research career.  
7.5 Conclusions  
In this thesis I endeavoured to generate a detailed understanding of patient and public 
involvement in health research, focusing on the experiences and perceptions of those 
involved. The multi-sited ethnographic approach allowed for an in-depth, direct comparison 
across a variety of approaches to PPI within the same condition, something that is currently 
lacking within the literature. It allowed for PPI to be explored at both a conceptual and 
practical level, looking at the benefits and challenges that representatives and professionals 
experience as part of their involvement in PPI. It also provided clear suggestions for the 
implementation of PPI in policy and practice.  
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Appendix 1. Summary of selected references 
After the original 229 references were collated I conducted a citation search for each using: PsycInfo, Web of Knowledge and Google Scholar. I 
included Google Scholar as it accounted for a lot of the grey literature that the other databases do not and is now accepted as a valid tool in 
literature reviews (Kuss & Griffiths, 2012). The numbers of citations reported across all three search engines were comparable with reference to 
journal articles. In order to be consistent, the citation number given below is the number of citations a reference had according to Google Scholar 
in January 2012. A citation number of N/A donates a reference added after the original literature search. For ease of presentation, in this table any 
paper with more than two authors is identified by the first author then et al.  
Table 14: Summary of selected references. 
Author & Year 
 
Citations Focus of the paper Methods Main findings Strengths and limitations 
Abma (2005) 21 A responsive- 
constructivist 
approach to 
evaluating PPI  
Case Example That this approach to evaluation 
fits with the aims of PPI.  
Barriers to ‘dialogue’  
S: Highlights potential barriers, Uses a clear worked 
example 
L: The reflection process used is not clear, so it is 
not transparent how they reached their findings 
Abelson et al 
(2003)  
130 Deliberative 
framework applied 
to PPI in the health 
sector  
Literature 
review 
No direct comparisons of models 
of engagement, 4 key principles 
for design and evaluation of PPI 
S: Deliberation as a framework for PPI 
L: Methodology of literature review is limited, 
missing information in inclusion/ exclusion criteria, 
does not list total number of articles selected 
Allsop et al 
(2010) 
5 Methods of involving 
children with 
disabilities 
Literature 
review 
Tailoring information, giving 
feedback and not using proxy 
information are key to involving 
children  
S: Takes into consideration involvement methods 
from other disciplines 
L: Says it is a review of the literature but is actually 
a discussion paper. Doesn’t recommend methods 
Andejeski et al 
(2002) 
14 Impact of PPI on 
prioritising research 
proposals  
Content 
analysis & 
questionnaire  
Voting patterns were similar for 
representatives & Professionals 
S: Evidence based, comparative, evaluates impact  
L: Superficial as reasons for prioritisation not 
looked at 
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Author & Year 
 
Citations Focus of the paper Methods Main findings Strengths and limitations 
Avard et al 
(2010) 
42 PPI models 
promoted in policy 
documents 
Literature 
review 
Mostly consultation and 
collaboration recommended in 
policy documents  
S: 5 countries utilised. Extensive systematic review.  
L: Did not include all relevant documents.  
Barber et al 
(2007) 
19 Methods of PPI in 
NHS research 
Survey 17% of research actively doing 
PPI. Steering group membership, 
designing interments and 
research design most common 
methods.  
S: Sampling frame and generalizability 
L: Professional response bias  
Bastian  
(1994) 
34 PPI in the Cochrane 
Collaboration 
Discussion 
paper 
The need to account for culture 
clashes & expectations 
S: Accessibility.  
L: Referencing inconsistent, the reader cannot tell 
what is opinion or fact. 
Beresford 
(2002) 
85 Looking at past PPI in 
research and 
suggesting ways 
forwarded.  
Discussion 
paper  
That 'future' research into PPI 
needs to be systematic and 
critical taking the different 
methods and philosophical 
stances into account. PPI needs 
greater priority on the social 
policy agenda 
S: Looks at a range of models. 
L: No parameters defined in terms of what is being 
covered in the paper  
Blair & Minkler 
(2009)  
56 Participatory Action 
Research (PAR) with 
Older Adults  
Literature 
review 
The importance of valuing the 
experience of the 'elders' the 
need for bidirectional trust and 
effective training 
S: Did not include study's where 'elders' were only 
subjects or part of focus groups ('real' involvement 
only)  
L: Limited focus on the challenging aspects of PAR 
Boote et al 
(2010) 
41 Peer reviewed case 
studies of PPI in 
design of health 
research 
Literature 
review 
 4 key contributions to design, 5 
main barriers, 4 facilitating 
strategies  
S: Clear suggestions to facilitate PPI. Strict inclusion 
criteria 
L: Did not include 'prioritisation' stage, only 
included peer reviewed papers 
Boote et al 
(2011) 
0 PPI in research 
design 
Literature 
review 
7 papers Discuss PPI in research 
design, Barriers & facilitating 
strategies given  
S: Inclusion criteria, applicability of finding 
L: No model comparison, number of reviewers 
missing 
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Author & Year 
 
Citations Focus of the paper Methods Main findings Strengths and limitations 
Boote et al 
(2012) 
N/A How PPI can lead to 
researchers ideas 
being abandoned 
Reflective 
case Study  
PPI can prevent irrelevant 
research projects from being 
pursued. The earlier PPI occurs 
the less researchers time is 
wasted 
S: Focus on an example were PPI resulted in 
research being discontinued 
L: No information on the reflective process 
Boote et al 
(2002) 
81 Description of PPI in 
research 
Critical review 4 key areas for further research S: Explores all key aspects of PPI and associated 
arguments 
L: Little focus on the effect of PPI on the research 
process. Don't explain selection process for 
literature  
Brett at al 
(2010) 
N/A Conceptualisation, 
measurement, 
impact and 
outcomes of PPI  
Systematic 
Review 
Nature of the PPI evidence base, 
importance of context and 
process, impact on people 
involved 
S: Scope of the review, has clear recommendations 
L: Breadth means explanations of finding lack 
depth 
Brisolara 
(1998) 
48 PPI in evaluating 
social programmes 
Discussion 
paper  
"Critical questioning and 
reflexivity are integral to the PPI 
process". PPI makes a "powerful 
contribution to the development 
of practice and theory"  
S: Highlights some of the contradicting information 
around the origins of PPI and incorporates a 
variety of theoretical stances 
L: Does not give any suggestions how current 
debates can be addressed in practice. Does not say 
exactly how they contribute to the evaluation 
process 
Caron-
Flinterman 
(2005) 
28 To gain insights into 
how representatives 
prioritise research  
Focus groups 
& 
questionnaire 
The top priorities for research for 
Asthma suffers in the 
Netherlands  
S: Used participant validation to check findings 
L: Do not ask why they rank that way which is key 
to the research question  
Caron-
Flinterman et 
al (2005) 
31 Added value of PPI in 
Biomedical research 
Interviews 3 types of involvement 
(demands, ideas & judgments) 
PPI has a positive influence on all 
stages of research 
S: Interviewed the professionals and patients 
L: Detail of analysis missing, very focused analysis, 
no differentiation in perspectives 
Caron-
Flinterman et 
al (2007) 
24 PPI in decision-
making in biomedical 
research 
Workshop & 
interviews  
Current strategies not effectively 
involve patients 
S: Findings based on mixed methods data 
collection 
L: Superficial data analysis  
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Author & Year 
 
Citations Focus of the paper Methods Main findings Strengths and limitations 
Chalmers 
(1995) 
79 Clinician's/ 
researchers 
perspective on being 
a Patient involved in 
research  
Discussion 
paper  
Some benefits of PPI in research S: It provides an interesting perspective on PPI 
L: It is based on one person’s perceptions/ 
experiences does not add to the evidence base 
Charles & 
DeMaio (1993) 
95 A conceptual 
framework to 
categorise PPI 
Discussion 
paper  
A framework that incorporates 
Decision-making Domains, Role 
perspectives and level of 
participation 
S: Clear argument for the need of a framework for 
evaluating PPI 
 L: Limited justification for the three components 
of the framework. No evidence of its usability  
Coupland & 
Maher (2005) 
18 Evaluating 
representatives as 
researchers 
Interviews & 
focus groups 
Motivations for involvement, 
benefits, challenges, conflict 
resolution, blurring of roles  
S: Looks at both perspectives, empirical evidence 
L: Interviews conducted by member of the team, 
more details of analysis needed 
Crawford et al 
(2002) 
289 Papers that describe 
changes to health 
services based on PPI  
Systematic 
review  
PPI has an impact on health 
services and the people involved 
in the process but limited 
evidence of impact 
S: Reviewed over 300 papers including grey 
literature 
L: Lacks depth when describing impacts  
Dickens & 
Picchioni 
(2011) 
2 The terms used to 
refer to people who 
use mental health 
services 
Literature 
review 
Patient' is the most preferred 
term in the UK for mental health 
service users 
S: Breadth of search terms used 
L: Did not include qualitative studies or 
professionals opinions  
Dowling et al 
(2004) 
160 Conceptualising 
successful 
partnerships 
Literature 
review 
5 key types of process related 
success and 5 key types of 
outcome success. Little hard 
evidence of improved outcomes 
S: Links to wider partnership research  
L: Does not address impact on professionals  
Edwards et al  
(2011) 
N/A Consulting parents in 
the design of a RCT 
Description of 
PPI in a RCT 
PPI improved research design 
and participation rates 
S: Clear description of PPI method and specific 
examples of impacts 
L: More detail on why they responded to some 
suggestions over others would be useful 
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Author & Year 
 
Citations Focus of the paper Methods Main findings Strengths and limitations 
Elberse et al 
(2011) 
4 To what extent 
representatives were 
included in decision 
making  
Qualitative 
case study, 
interviews & 
observation 
representatives felt lessoned to, 
Researchers felt it when well but 
analysis suggests they were not 
fully included 
S: Triangulation of data 
L: Information in data analysis is missing  
Elliott et al 
(2002) 
12 Using peer 
researchers to access 
hard to reach 
populations 
Reflections 
from Authors  
lots of support needed, 
researchers learnt about culture 
or participants, increased data 
collection 
S: Clear integrated involvement 
L: Not clear how these conclusions were drawn/ 
anecdotal. No representatives feedback 
Entwistle et al 
(1998) 
92 A conceptual 
Framework to 
facilitate PPI 
Discussion 
paper  
The need for planning of PPI with 
a focus on outcomes and process  
S: Provides a logical process for researchers to 
work though when making decisions regarding PPI. 
L: Does not justify the framework. Limited 
evidence for its suppositions 
Faulkner & 
Thomas  
(2002)  
11 The value of PPI in 
psychiatry research  
Editorial User research creates more 
ecological valid & clinical 
applicable outputs  
S: Well written, range of issues covered.  
L: Opinion pieces but limited information of what 
these opinions are based on 
Fisher (2002) 31 How PPI benefits 
technical aspects of 
social research 
Discussion 
paper 
PPI can bring technical 
enhancements to the research 
design process 
S: Raises issues important to practitioners 
L: Unclear what evidence the conclusions are 
supported by 
Florin & Dixon 
(2004) 
39 Policy documents 
related to PPI in 
Health care  
Short 
discussion 
paper  
Current policies to increase PPI 
are piecemeal and disparate 
S: Clear information, raising many salient points 
L: Due to the length of the article lacks depth 
Fudge et al 
(2008) 
36 How policy on User 
involvement is 
interpreted and 
implemented.  
Qualitative 
Ethnography  
Values, commitment and 
organisational structures are key 
in implantation of PPI. Benefits 
are hard to quantify 
S: Followed over an extensive time frame, 
interviewed people that declined to be involved as 
well as those that were involved 
L: does not discuss the participants 
experiences/perspectives of the process or 
distinguish between groups. Not clear at what time 
point the interview took place or the link between 
the field and the ethnographer 
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Author & Year 
 
Citations Focus of the paper Methods Main findings Strengths and limitations 
Gillard et al 
(2010) 
 Is there a difference 
in the interviews and 
data analysis 
conducted by 
representatives and 
researchers? How is 
this measured? 
Secondary 
data analysis  
PPI does make a difference.  
Secondary thematic analysis of 
interview transcripts is a robust 
approach for evaluating impact 
of PPI on the research process 
S: clear, replicable method of measure impact in 
this context 
L: Joint interviews initially may be a confounding 
variable. Small sample 
Goodare & 
Lockwood 
(1999) 
56 The role of PPI in 
research and related 
publications  
Discussion 
paper  
Medical journal should insist on 
PPI at all stages of clinical 
research and have PPI in the 
review process 
S: Draws attention to the need to have PPI in 
dissemination.  
L: Lacks depth- due to length of editorial  
Gustafsson & 
Driver (2005) 
40 PPI policy and its 
implementation is 
Sure Start.  
Discussion 
paper 
Unclear  S: Looks in depth at the role of general government 
ethos' 
L: Confusing methodology unclear on sample and 
methods of data collection 
Hanley et al 
(2001) 
75 Audit Frequencies 
and types of PPI in 
RCT 
Questionnaire 
survey  
1/3 of centres reported PPI, 46 
reported positives (inc. Improved 
patient information) of PPI only 9 
noted negatives PPI  
S: Large sample size 
L: Does not look at representatives perspective 
Holmes et al 
(2002) 
50 Description of 
setting up a cohort 
study in a hard to 
reach population 
using community 
researchers  
Discussion 
paper 
The establishment of a cohort for 
longitudinal study, increased use 
of health service 
S: Demonstrates the value of community control in 
research, representative PPI representatives 
L: limited evaluation of the PPI 
Iliffe et al 
(2011) 
 Benefits of PPI 
facilitated by a 
research networks  
3 explanatory 
case Study’s 
Remedial action in helping 
studies that are not recruiting to 
target, problem solving in 
sensitive research topic areas, 
linking researchers to PPI sources  
S: Evidence based, Shows Impact 
L: Only focused on benefits. No comparison of 
methods  
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Author & Year 
 
Citations Focus of the paper Methods Main findings Strengths and limitations 
Kellett et al 
(2004) 
69 To demonstrate that 
with training and 
support children 
aged 8 - 12 can be 
effective researchers 
and empowered 
Case studies Evidence that 10 year olds can be 
effective researchers  
S: The children/ PPI were included as Authors. 
Highlights the need for training and working round 
the representatives ability 
L: Evidence about empowerment is anecdotal 
Krieger et al 
(2002) 
62 Examples & lessons 
learnt from Seattle 
partners for healthy 
communities (SPHC) 
Descriptive 
paper 
Participatory research methods 
enhance research projects 
S: Looks at a combination of take holders 
interactions not just researcher-public 
L: Anecdotal evidence, only the researchers 
perspective is reported 
Lindenmeyer 
et al (2007) 
12 Benefits of PPI to 
research and 
researchers 
Interviews & 
discussion 
group 
Balance of power, increased 
funding, improved research 
design, increased relevance & 
credibility  
S: Evidence based, level of detail on the model 
L: Benefits only, focus of paper is constantly 
shifting 
Minogue et al 
(2005) 
13 Impact of PPI in 
research 
Survey & 
audit 
Benefits for representatives 
mainly personal, benefits for 
trust was having users 
perspectives and focus  
S: look at both PPI & professional perspectives, 
focus on impact 
L: No detail on data collection & analysis  
Mitton et al 
(2005) 
29 Scoping lit review 
around PPI in priority 
setting 
Literature 
review 
On-going consultation most 
common. Cost biggest barrier 
S: data source from a range of disciplines were 
included 
L: Level of detail 
Morrow et al 
(2010) 
44 A 'process' model 
and measure for 
'quality' involvement 
Discussion 
paper 
The need to look at process not 
just outcome, The importance of 
quality, 'personal factors' & 
research contexts 
S: The Quality Involvement questionnaire could 
facilitate reflection on the PPI process 
L: The model & its development is unclear 
Mosavel et al 
(2005) 
50 Community 
participatory 
research in south 
Africa 
focus groups 
& informal 
interviews 
Working with multiple 
stakeholders offered learning 
points fundamental to useful 
health promotion 
S: Large and diverse sample from the community 
L: Confusing where PPI ends and participation in 
the research starts 
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Author & Year 
 
Citations Focus of the paper Methods Main findings Strengths and limitations 
Newell & 
South (2009) 
46 The experiences of 
Lay researchers 
Qualitative 
interviews 
Overall involvement had a 
positive impact on the self-
esteem, skills level and social 
awareness of researchers 
S: Findings are supported by evidence from the lay 
researchers as opposed to perceptions of the 
researchers (common in other papers). Some 
negative impacts were also identified 
L: Interviewer was linked to the project so 
reporting of negative impacts might have been 
affected. Interviews only conducted at one time 
point so recall bias might be an issue 
O'Donnell & 
Entwistle 
(2004)  
20 Why and how 
research funders do 
PPI. 
Postal survey 
& Focus 
groups 
42 of 69 research funders have 
PPI, motivations and barriers  
S: Mixed methods.  
L: No information on data analysis 
Oliver et al 
(2008) 
33 Developing and 
describing a 
conceptual 
framework for PPI  
Literature 
review & 
reflections 
PPI should be categorised by the 
types of people involved, the 
degree of public involvement and 
the initiators of the enjoyment  
S: Combines components of other frameworks 
L: Usability of framework and details on its 
development 
Popay & 
Williams 
(1996)  
199 Lay knowledge in 
public health 
research  
Discussion Importance of lay knowledge to 
improve public health research 
S:Takes a philosophical stance 
L: Sweeping statements 
Renedo & 
Marston 
(2011) 
N/A Representatives’ 
identities and social 
representations of 
PPI. 
Cross 
sectional 
ethnography  
Contradictory discourse in 
professionals understanding of 
the role of representatives.  
S: Evidence based, highlights the contradictory 
discourse 
L: Unclear when drawing on professional or 
Involvee data 
Rhodes et al 
(2002) 
8 Researchers & 
representatives 
perceptions on a PPI 
consultancy group 
Reflections Motivations for involvement, 
value to researchers and 
representatives, Need for 
training, 6 key factors for 
effective PPI 
S: Jointly written, shows both perspectives 
L: Evidence bases and analysis methods is vague/ 
anecdotal 
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Author & Year 
 
Citations Focus of the paper Methods Main findings Strengths and limitations 
Rummery 
(2009) 
8 PPI in health service 
development & 
provision  
Literature 
review 
Some limited evidence of 
improved outcomes, little sig 
involvement, mostly 
collaborative 
S: looks at challenges as well as benefits 
L: Very specific focus, detail of analysis, usability  
Schulz et al 
(2001) 
42 longitudinal 
research-community 
partnership 
Interviews  PPI impacted research from 
prioritisation to dissemination 
and benefited community 
relations  
S: Evidence of impact, relatively large sample size 
L: Exact sample size unclear, focused analysis, 
limited account of challenges  
Simpson & 
House (2002) 
123 PPI in delivery and 
evaluation of mental 
health services  
Literature 
review 
Mostly used as service providers. 
Benefits not reported negatives, 
differences between 
professionals and 
representatives in same role 
S: Only high quality research included 
L: Detail of both search and findings very limited  
Staley (2009b) 44 Evidence of impact 
of PPI in the 
literature  
Literature 
review 
Limited evidence of impact. Most 
evidence is informal, consistency 
of benefits and costs. 9 areas of 
impact 
S: Included grey literature as well as peer 
reviewed, used an inclusive definition of impact.  
L: Due to the breath of the report in places it lacks 
depth in terms of information and interpretation  
Staley (2012) N/A Evaluation of PPI in 
the Mental Health 
Research Network  
Interview  Great variation in the impact of 
PPI. Challenges to researchers, 
support needed and 
recommendations  
S: Evidence based , recommendations, focus on 
professionals experience 
L: Lacking detail on the criteria for the sub set 
explored 
Stevens et al 
(2003) 
N/A Overcoming the 
challenges of PPI in 
cancer research 
(linked to networks) 
Discussion 
paper  
Centralised coordination of PPI 
overcomes many of the 
challenges of PPI 
S: Raised some explanations for tokenism.  
L: Hard to tell what is from their experience and 
what is based on the literature 
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Author & Year 
 
Citations Focus of the paper Methods Main findings Strengths and limitations 
Stewart et al 
(2010) 
2 A framework for 
methods to address 
representatives and 
clinicians research 
priorities 
Literature 
review 
258 studies which draw on 
representatives or clinicians 
experience for priority setting. 
Only 9 obtained both  
S: Highlights the need for professional perspective 
in conjunction with representatives’ views 
L: Framework does not match purpose. Does not 
discuss the priorities/ perspectives as the title 
suggests 
Stickley (2006) 48 Power relationships 
in Mental health 
related PPI  
Discussion 
paper  
That patients now have power 
but need to establish it within 
the system 
S: It explores the relationship between policy and 
practice 
L: While stating that it takes a 'realist' perspective 
and thus generating new information no new 
salient issues are raised 
Telford & 
Faulkner 
(2004) 
43 Motivations and 
barriers of PPI in 
mental health 
research 
Discussion 
paper 
Ideological differences are the 
main barrier to PPI 
S: Raises importance of gray literature  
L: Sets itself up as a literature review but isn't. 
Does not justify 'motives'  
Telford et al 
(2002) 
37 Quantifying level of 
PPI in research (in a 
NHS region) 
Survey 13% doing PPI. Confusion 
between collaboration and 
consultation  
S: Evidence of level & type of PPI 
L: NHS trusts only 
Telford et al 
(2004) 
43 Achieving consensus 
on indicators of 
'successful' PPI 
Delphi 
process 
8 principles of 'successful' 
involvement  
S: Consumers and researchers involved in the DS, 
does not differentiate between successful and 
impact 
L: some principles may be difficult to put into 
practice/ access 
Terry et al 
(2007) 
37 Description of a 
advocacy groups role 
in genetic research  
Discussion 
paper 
Advocacy groups accelerate the 
speed of research 
S: Shows how PPI can be used in Basic science 
L: Anecdotal evidence 
Thompson et 
al (2012) 
N/A How representatives 
legitimise their 
knowledge  
Ethnography  In addition to their experiential 
expertise representatives 
legitimise their credibility though 
a range of strategies 
S: Evidence based, representative focused  
L: Context specific  
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Citations Focus of the paper Methods Main findings Strengths and limitations 
Thompson et 
al (2009) 
49 Health researchers 
attitudes to public 
involvement  
Qualitative 
interviews  
"differing constructions of public 
involvement in health research, 
the motivating factors an feelings 
of apprehension" 
S: The range of interviews. Exploration of the 
Researchers Apprehension 
L: telephone interview combined with known 'pro 
PPI' positioning of researcher may have affected 
findings  
Trivedi & 
Wykes (2002) 
43 Reflection on 
experience of PPI in 
research  
Discussion 
paper 
PPI leads to longer research 
process, but a better research 
design and content 
S: Gives practical information for others involved in 
PPI 
L: The ‘qualitative’ methodology is not explained 
neither is their approach to PPI 
Viswanathan 
et al (2004) 
313 Review of 
'community-based 
participatory 
research- (CBPR) 
evidence 
Literature 
review 
Essential elements of CBPR, 
benefits and challenges, 
variability in type of involvement. 
Disadvantages not often 
reported 
S: Looks at all aspects of process including funding 
(very few others look at this), process and 
evaluation 
L: N/A 
 
Van Staa et al 
(2010) 
N/A Chronically ill 
adolescents as co 
researchers  
Evidence 
based/ 
discussion 
Paper 
Involvement feasible and 
appreciated by researchers and 
adolescents. Peer interviews 
lacked depth, difficult to main 
involvement of the chronically ill 
S: Provides both benefits and challenges 
L: Does describe how they evaluated the different 
groups expresses 
Walmsley 
(2004) 
66 To reflect on past 
research that 
involved PPI in 
Disability research 
and draw out lessons 
learnt  
Discussion 
paper  
Issues of process, accountability, 
representation, and added value 
need to be considered when 
doing PPI 
S: Makes a balanced argument by highlighting 
some of the difficulties of PPI as well as the 
benefits. Shows the importance of 'context' in PPI  
L: Based heavy on the authors’ reflections limited 
evidence for findings. No justification for the 
choice of examples drawn on. Concludes the 
findings can be used in practice but does not say 
how 
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Citations Focus of the paper Methods Main findings Strengths and limitations 
Walter et al 
(2003) 
36 Effect of 'research 
impact' though 
partnerships a cross- 
disciplinary review  
Literature 
review 
Taking the challenges into 
consideration partnerships have 
the potential to increase 
research impact 
S: While not a traditional systematic review the 
data were collected in a structured and thorough 
manner 
L: Does not identify of differentiate between the 
'conceptual frameworks' 
Ward et al 
(2009)  
61 Researchers 
perspectives on PPI 
in health research  
Qualitative 
interviews 
The 'Know-do gap' researchers 
agree they should do PPI but 
don’t 
S: Strong evidence to support findings from a 
relatively representative sample.  
L: Only looks at the issue from one perspective.  
Weinstein 
(2006) 
46 Comparison of a PPI 
lead and a top-down 
lead service 
evaluation  
Document 
analysis  
PPI evaluation resulted in a 
higher response rate, more 
insightful data  
S: Comparison across two models within one 
context 
L: did not allow for participants to reflect on 
experience 
Wyatt et al 
(2008) 
N/A Evaluation with a 
focus on impact of 
PPI in LPCSP 
Multi-method 
Case study 
Description of involvement in the 
programme. Consumers 
impacted multiple aspects of the 
research process  
S: Mixed methods, extensive data, multiple 
perspectives 
L: Retrospective  
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Appendix 2. Interview extracts  
Extract one: Matt. Representative at comparator epilepsy network (Full interview 49.34 
minutes, conducted face to face) 
Matt Yeh, you know and so I think you know, hopefully it will make a difference for you 
as well you know what I mean, which will be good and that should be good for 
everybody. So, more of it.  
Beth Brilliant. Actually its really good because one of the questions I have got down 
here is, the benefits and positive impacts of people being involved in research, so 
you have already mentioned things like the names and the drugs and are there 
anything else? 
Matt I think, I probably, ur, when I first joined, urm, that sort of thing didn’t particularly 
enter my head to be perfectly honest. 
Beth So why did you join? 
Matt Erm, I,I felt I wanted to 1) find out what it was about to be honest and ur see if my 
10 penneth I could put in would anyone could relate to it an either help me or help 
them you know. I didn’t really know. Urm, but you know the more when you sat 
down and listened to Jess and the way she went on about things and then bringing 
in um, doctors as well you know with it all which has been superb, you know and 
you do feel that you can put yourself over to how about things and they are 
actually listening to you and er, I do think that’s good and I think that’s excellent. 
And I you know, now we are sort of, the group is sort of definitely on a lift off, and 
now we have got even more funding for another 5 years, in this climate of, of, of 
cut backs and that’s terrific. So we must be making a bit of a difference somewhere 
the way I see it, you know for that to happen, urm, and if its for the good and its for 
the benefit of everybody, then that is brilliant you know what I mean I was pleased 
to hear that we had um, funding for another 5 years which is fantastic, I was sad to 
hear that Jess is going but, you know, urm, you know she has got to get on with 
doing what she has got to do really I suppose and I am sure we will find someone 
else that is as, as enthusiastic as she is, and was, like, you know and yes that was 
good, that was the only sad point of the night I thought. Because she has been the 
mainstay about it I think really. Urm, It would be nice to get a few more people but 
as I say I don’t know as like I said it’s the first time I have been able to make it, I 
think people get there depending on what they have got on really, you know and so 
um, but as I said something very, very positive came out of it last night un, er, and I 
think that the mouthguard business I think try and take that forward because I 
think that is also a fantastic idea and that ul, will save a lot of people. Seeing it in, in 
the case of obviously nothing to do with rugby, nothing to do with epilepsy, but 
seeing it in the, how it helps rugby players when they take bangs and clink their 
teeth, you know that, thats is the, thats, you don’t wear a mouthguard really to 
 220 
 
save your teeth being knocked out 12. 55 it’s the umm the concussion that you 
have got to stop, that is what they are mainly for. Um And when they are fitted 
properly you know you can have some serious bangs and you don’t choke on these 
things un, and you know again that is something that we seem to be, we have 
picked up on, urm, and it will be great, to see if we can get that, going further 
because I think, that, would be a great help. I know Karl did say last night that you 
shouldn’t put things in people’s mouths but I do think that’s more the, the case 
when people are actually maybe having an episode, having a fit. I do think with the 
mouth shield, if its fitted to the individual, its you are not likely to swallow it, you 
know. I, I don’t know there is thousands and thousands of people use mouth 
shields playing sport and I am yet to hear of anybody, swallowing a mouth shield. 
You know an, you know and all you have got to do is you look at you know some of 
the players that play you know professional rugby players and things like that, that 
wear mouth shields, and the batterings they get like you know, and I, I think that’s a 
pretty good test on how safe they are. You know you can never say never as I think 
I said last night, but I think that could be very good for people with epilepsy 
especially because they do suffer with teeth and gums and all the rest of it. An I 
think that would definitely be a positive, an that will help a lot of people. I really do 
think that will especially if they get urm, a lot you know some people can control 
their epilepsy rather well and they don’t have fits from one year to the next which 
is brilliant, but you do obviously hear that people they have them umpteen times a 
day sometimes, at all ages urrm and I do think that something like that might help 
you know what I mean but obviously it won’t stop the fits and everything else but it 
might help the inside of the mouth and it might stop that because you know when 
you bang your teeth together the back of your neck and the, the you know on the 
base of your brain it hurts a lot and I think you know we will see anyway, I think it 
will be a good thing to go down un, and look at it era bit more about it. Surprised 
no one else has come up with that really you know, and maybe they have I don’t 
know but obviously we haven’t heard of it, uurm, I am not saying that we should 
have heard of it, but for Karl not to have heard of it, next door he seems to know 
everything else Hahahahah, and obviously people I have worked with never really 
thought about it so I do think its could be something that will be good, definitely be 
good. So yeh, that’s another good point that has come out of the RDG like you 
know. Urm, so yeh, that is another positive. 
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Extract two: Sue, Research coordinator, clinical trial (Full interview 49.34 minutes, 
conducted face to face) 
Beth  What is your understanding of the purpose of PPI in research? 
Sue Ok.. what’s my understanding erm… [pause 03] that we get input from… the 
patient, they have got the experience of what ever it is we are looking at the erm… 
the disease, the condition, so we can hear their voice to see what they feel and 
what their opinions are ((laughs)). 
Beth You would be amazed the different answers people give, 
Sue Yes is it ((laughs)).  
Beth So it’s about getting input from them? 
Sue Yes 
Beth Because they have got a different.. 
Sue Perspective, yes and they are the people with the experience aren’t they? 
Beth Yes. And, why do you think that’s important or not? 
Sue Because it’s being, it’s not being objective it is, it’s not… it’s actually being from 
within that person which we don’t always do we look at it objectively don’t we 
sometimes as researchers. Whereas we can actually get the voice of that person. 
And it just can inform us more can’t it. 
Beth And in any of your past jobs were you involved in PPI? 
Sue Erm… I did, I did erm… I was quite interested in erm… when I did my psychology 
degree my dissertation was on erm… qualitative research erm… and social 
constructionism and stuff so I was quite interested in that side of things, yes. I did 
erm… yes I did my dissertation using the internet, ((laughs)) erm… I did it on 
narratives, taking narratives off the internet that people had written then did like 
thematic analysis and all that. Yes, ((laughs)). What did you do? Sorry I am asking 
you… 
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Extract three: Fred CCRN PPI network lead (Full interview 89.26 minutes, telephone 
interview)  
Beth So if you were given the choice between a general member of the public, who 
had research experience or a person which had say experience of the disease, 
which... 
Fred Yes, well erm... the pecking order as I say top of the list is the patient themselves. 
Which is another difficult area because erm... sometimes, the Society tend to say 
no you shouldn't, erm... you shouldn't involve people with cognitive impairment in 
discussion groups, because mainly because they argue that there is a chance these 
people will get upset. They will get confused about what is being talked about they 
might think people are talking about them, they might get erm... anxious, upset, 
erm... feel that they're you know not able to follow the conversation and feel upset 
by that, whereas I agree with that but I am slightly more biased towards saying 
well, have people with, so long as it's not too advanced cognitive impairment, the 
committee should be able to cope with people who ask for things to be repeated, 
and don't understand everything and you know the committee has to change to 
match the person erm... so it is not a big disagreement but it's there is a degree of 
difference there, so patients are at the top of the list but erm... it is not as simple as 
that. There is one analogy I always use  
Beth oh? 
Fred I always use this analogy but it's a bit like blind date you know Cilla Black and blind 
date, do you remember that? Erm...there is always 3 on those panels there is 
always 3 people there is, I always say there is the strong silent type, there is the 
kind of emotional Latin lover as they would call them and then there is the hilarious 
whacky one on the end who the audience find incredibly funny erm... and it tends 
to be those 3 people chosen in blind date and I think that you get those 3 types of 
people you get as reps on committees. And I think that the Professors who chair 
some of our committees wish all the lay people were the strong silent type, you 
know maybe a patient but not someone who is going to say very much in meetings. 
Erm... and but what we tend to get, is er... more of the second category you know 
the, the kind of passionate people erm... I call them Latin Lovers but the passionate 
people who erm... who, want to say a lot and erm... say it with strength and the 
Chairs are a little bit cautious about those and then of course nobody in theory 
wants the, the so called whacky one erm... who has very unusual views and unusual 
personality, erm... and you might find that erm... patients fall, are more likely to fall 
into the first category because you know they have got the direct experience but 
when it comes to a, a research committee they don't say very much, on some of 
our committees some of them say nothing throughout most of the meetings, erm... 
whereas if they were more passionate about it they might for example, if they were 
a member of the public, they might have less direct experience of the disease but 
they might be a better advocate.  
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Appendix 3. Interview topic guides 
Draft Interview Topic Guides 20 
Introduction  
 
As outlined in the research protocol, in order to allow the individuals being interviewed an 
opportunity to discus issues that are important to them a semi-structured interview 
approach will be implemented. This will involve a combination of pre-determined questions 
and ones that are raised during the interview. Some questions will be the same for each 
informant type, with the others being group/situation specific. The nature of the research 
will result in the questions developing over time, particularly where multiple interviews are 
conducted over a time span, with new questions arising as a result of earlier data analysis.  
 
Below draft sets of possible research questions are listed, that might be asked of each of 
the informant types.  
 
Case 1: PPI leads 
In 2007 the National Institute for Health Research (NIHR) established a Comprehensive 
Clinical Research Network (CCRN) resulting in six topic-specific Clinical Research Networks 
and the Primary Care Research Network. Within these networks PPI was prioritised from 
the beginning, with designated funding attached to a PPI ‘lead’ role and mandatory in all 
networks. In order to understand the context within PPI is currently operationalised in UK 
health research, telephone interviews will be conducted with all of the PPI leads from the 
NIHR research networks. 
 
Common Questions 
 Please tell me about your current role. 
 What is your experience of implementing PPI in this network? 
 What (if anything) have you experienced to be the benefits/positive impact of PPI? 
 What (if anything) have you experienced the challenges/negative impacts of PPI to be? 
 What is your understanding of patient/ public involvement in research? 
 
Case Specific Questions  
 How does your network address PPI? 
 Please describe the process you went though to get this model of PPI in place. 
 What advice would you give to a new network developing its PPI process? 
 
 
                                                          
20
 This is the version submitted to and approved by the Universities ethics board  
 224 
 
Case 2: UKERN 
The UK Epilepsy Research Network (UKERN) was not part of the original research network 
funding and is a new network funded by the epilepsy research charities [and launched in 
Feb 2010]. The need for this network was identified from within the UK epilepsy research 
community itself, particularly as a means of facilitating large scale, multi-centre clinical 
trials. Like the other networks, one key component is that of PPI. Consequently, there is an 
opportunity to follow the process of PPI implementation within a research network from its 
inception, exploring how decisions are made around PPI and the consequences of these 
decisions.  
 
The aim is to follow the development of the network PPI initiative for approximately 24 
months. This includes (but is not limited to) attendance at full bi-yearly network meetings, 
interviews with key members of the network at multiple time points, tracking of the 
selection process, appointment and training of the PPI lay members, observation of the 
training processes and meetings of the Network management team and Clinical Study 
Groups ( each of which will include PPI representatives).  
 
Common Questions 
 
 Please tell me about your current role in the UKERN. 
 What is your understanding of patient/public involvement in research? 
 Did you have any previous research experience before joining the UKERN? 
 What (if anything) have you experienced to be the benefits/positive impacts of PPI? 
 What (if anything) have you experienced the challenges/negative impacts of PPI to be? 
 
Researcher/ clinician Specific Questions (time point one)  
 Why did you decide to join the network? 
 What is your opinion of the proposed/implemented model of PPI? 
 What do you think are/will be the benefits/challenges of operationaling PPI in the 
network? 
 
Patient/Public Specific Questions (time point one)  
 Why did you become involved in the network? 
 Have you been involved in health research before, either as a research ‘subject’ or a 
research partner? 
 What to did you expect being part of the network to be like? To what extent have your 
expectations been met so far?  
 What advice would you give to other patients/members of the public thinking about 
doing PPI? 
 
Patient/Public Specific Questions (time point two)  
 What is your opinion of the training you receive? (What if anything has been useful 
from the training? what other things if any would have been useful?) 
 Please describe your experience of being in the Network  
 Would you encourage other people you know to get involved in this way and why? 
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Case 3: Comparator Network  
The comparator network has developed its own model of PPI with members meeting once 
every three months. For the purposes of this study, observations and interviews with key 
stakeholders will be conducted over a 6-month time frame. Inclusion of comparator 
network as a case study will allow for both a disease-specific comparison with the UKERN’s 
PPI processes and insight into the operationalisation of the PPI agenda in a more developed 
and Central Government funded network.  
Common Questions 
 
 Please tell me about your current role in the WERN. 
 What is your understanding of patient/public involvement in research? 
 What is your experience of PPI?/ Did you have any previous experience before joining 
the WERN? 
 What (if anything) have you experienced to be the benefits/positive impacts of PPI? 
 What (if anything) have you experienced the challenges/negative impacts of PPI to be 
 
Researcher/ coordinator Specific Questions  
 Why did you decide to join the network? 
 How does this network address the issue of PPI? (benefits/ challenges of the model) 
 What was the process you went though to implement this model of PPI?  
 What advice would you give to a new network developing its PPI process? 
 
Patient/Public Specific Questions  
 Why did you become involved in the network? 
 Have you ever been involved in health research before, either as a research ‘subject’ or 
a research partner? (if yes, differences between being in a network and taking part in 
an individual research project?) 
 Please describe your experience of being in the Network . 
 What did you expect to happen before you joined the network? 
 What advice would you give to others thinking about doing PPI? 
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Cases 4, 5 & 6 Clinical Trials 
Within the time frame of the study it will not be possible to follow a single clinical trial from 
the application stage through to dissemination of findings. For this reason, three different 
clinical trials adopted by the UKERN will be the focus of individual case studies. Possible 
appropriate trials have been identified and their Principal Investigators (PIs) have agreed to 
the inclusion of their trials as case studies.  
 
Common Questions 
 
 Please tell me about your current role in this study. 
 What is your understanding of patient/ public involvement in research? 
 What is your experience of PPI? 
 What (if anything) have you experienced to be the benefits/positive impacts of PPI? 
 What (if anything) have you experienced the challenges/negative impacts of PPI to be? 
 
Researcher/ clinical staff in clinical trials 
 How have you tried to implement PPI in the context of this study? 
 At what stage in developing the study did you begin PPI implementation? 
 What have you found easy/difficult about involving patients/public in this study? Why? 
 
Public, Patients in clinical trials 
 Why did you decide to get involved in this research project? 
 What if any are your past experiences of health research? 
 Please tell me what it has been like to be part of this research 
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Appendix 4. Approach letter 
 
Ann Jacoby, PhD 
Professor of Medical Sociology 
 
     Email: ajacoby@liverpool.ac.uk 
Tel + 44 (0)151 794 5602  
Fax + 44 (0)151 794 5588 
 
Division of Public Health  
3rd Floor Whelan Building 
Quadrangle 
Brownlow Hill 
Liverpool L69 3GB 
United Kingdom 
5
th
 March 2010 
 
Dear  
 
Re: Request for help with PhD studies  
 
I am a PhD student working with Professor Ann Jacoby, Professor Tony Marson and 
Dr Bridget Young at the University of Liverpool within the MRC Initiative for 
Clinical Trials Methodology (see www.liv.ac.uk/nwhtmr). My PhD studies are 
focussing on the broad question of patient involvement in prioritising and designing 
research, with reference to clinical trials.  
 
I am particularly interested in the experiences of lay people involved in the research 
process and the impact their involvement has on both process and outcomes of 
research. I hope to follow the development of ‘lay (including patient) involvement’ 
in the UK Epilepsy Research Network and in a small number of clinical trials related 
to it. Taking an ethnographic approach, I plan to explore this issue from the 
viewpoints of all concerned, including not only patients and other lay members but 
also researchers and clinical staff. I will combine observations, attendance at research 
team meetings, reading of team meeting minutes, informal conversations and formal 
semi-structured interviews with a purposively selected sample of individuals, to 
develop an in-depth and holistic understanding of the issues involved.  
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Tony suggested that the bid you are currently developing would make a fascinating 
case study for my PhD, as it is at the developmental stage that lay members can, 
potentially, have the greatest impact. Should your study be subsequently funded, the 
opportunity to follow up its conduct in the early stages would also be invaluable.  
 
If you would be willing to consider your proposed project as a possible case study, I 
and my primary supervisor, Ann Jacoby, would be happy to talk to you by phone or 
Email. Please be assured that the level of your involvement would be entirely open 
for discussion. Were you to agree to your work becoming a case study for me, you 
could be cited in any publications arising from my PhD studies. Thank you for your 
time reading this letter. 
 
 
Best wishes, 
 
 
Beth Deja  
 
 
Email: E.Deja@Liv.ac.uk   Tel: 0151 795 5375 
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Appendix 5. Ethics approval  
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Appendix 6. Participant information and consent forms 
 
 
 
 
 
PARTICIPANT INFORMATION SHEET [UKERN example] 
Exploring Public and Patient Involvement in Research 
 
You are being invited to take part in a research study. Before you decide whether to 
participate, it is important for you to understand why the research is being done and what 
it will involve. 
Please take time to read the following information carefully and feel free to ask if you 
would like more information or if there is anything that you do not understand.  
Feel free to discuss this with your friends, relatives and colleagues if you wish. We would 
like to stress that you do not have to accept this invitation and should only agree to take 
part if you want to. 
Who is doing the research? 
Elizabeth Deja: PhD student in the Division of Public Health at the University of Liverpool. 
Professor Ann Jacoby: Professor at Liverpool University will be supervising the research.  
Dr Bridget Young: Reader and Director of Communication Skills at Liverpool Univeristy , will 
be supervising the research.  
What is the purpose of the study? 
The purpose of this study is to generate a detailed understating of public and patient 
involvement (PPI) in research, focusing on the experiences of the people who are involved. 
We are doing this because recent changes to government policy have led to an increase in 
PPI in research which will hopefully continue to develop. While there is now more known 
about how and why PPI should happen, less is known about how it does happen. We feel 
that it is important to understand the experiences of those involved to help future 
researchers and participants who will engage in PPI. This study will run until October 2012. 
Why have I been chosen to take part?  
 
You have been asked to take part in this study because you are involved in research 
involving patients or public as research partners and actively contributing to the process of 
doing health research. Your experiences are therefore very important to us. 
Do I have to take part? 
 
It is completely up to you. You only take part if you decide you want to. If you do decide 
you would like participate in the study you will be asked to sign a consent form to say that 
you agree to take part. If you decide later on that you wish to withdraw then you can leave 
the study at any time and you do not have to give a reason.  
 
What will happen if I take part?  
 
This research study will be asking you to be involved in a few ways and you can be involved 
as much or as little as you feel comfortable with: 
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In-depth interviews: You will be asked to take part in an interview, with the possibility of a 
follow-up interview if appropriate. You can choose to be interviewed on your own, or with 
your family/a friend present. 
  
The interviews will involve you talking to the researcher about your experiences of being 
part of the UKERN. These interviews will last for as long as you would like to talk about your 
experiences- though it is expected that they will last approximately 45mins / 1hour. With 
your permission, these interviews will be audio-recorded.  
Fieldwork and informal interviews: If you agree to it, the researcher may spend some time 
observing meetings you attend, such as the Patient Research and Development Group; and 
may chat informally with you about your experiences in general. From your conversations, 
she will take fieldnotes (a kind of research diary), which will be used to inform the research 
findings. 
Feedback on findings: A selection of participants from across the research project will be 
asked to give their feedback on preliminary research findings to ensure that the 
information given is accurately represented. If you are happy to do this you may be 
contacted regarding this at a later time point.  
Where will the research take place? 
The interview(s) will be carried out at a time and place of your choice. You may like this to 
be your home, a public setting (e.g. a cafe), or Swansea University. It is up to you to decide. 
Also if you would feel more comfortable/ if it is more convenient telephone interviews can 
be arranged.  
Are there any risks in taking part? 
 
We do not expect there to be any risks or discomfort to be associated with participating in 
this research study. However, if you feel uncomfortable or distressed then you can stop the 
interview. You can leave the study without having to give a reason. 
 
Are there any benefits in taking part? 
 
You will be helping with a new area of research. Your experiences will help us to better 
understand how PPI happens and is experienced by those involved helping to improve the 
process in the future  
 
What if I am unhappy or if there is a problem? 
 
If you are unhappy or there is a problem, please feel free to let us know by contacting the 
lead researcher, Elizabeth Deja on 0151 795 5375 or by email: e.deja@liv.ac.uk, who will try 
to help. If you are still unhappy or have a complaint which you feel you cannot come to us 
with, then you should contact the Research Governance Officer, at Liverpool University on 
0151 794 8290 (ethics@liv.ac.uk). If you contact the Governance officer please provide 
details of the name or description of the study (so that it can be identified), the 
researcher(s) involved, and the details of the complaint you wish to make. 
 
Will my participation be kept confidential? 
 
All the information that you give us will be kept strictly confidential. The procedures for 
handling, processing, storing and destroying the data will comply with the Data Protection 
Act of 1998.  
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This means that only the researchers will see what you have said. All the information which 
you provide us with during the study will be stored in locked filing cabinets or password 
protected computers. Anything about you, including any quotes which are used in the 
write-up of the study, will have your name removed and a different one put in place, so 
that you will remain anonymous.  
 
At the end of the study the research data (consent forms, anonymised interview 
transcripts, fieldnotes, and your contact details) will be kept in locked filing cabinets and/or 
password protected university computers. The data will be kept for ten years.  
 
Please note that if you did tell us something that meant you were in danger or could come 
to any harm, the researcher would have a duty to tell her supervisor about this.  
What will happen to the results of the study? 
 
After the study has finished, the results will be put together as part of the researcher’s 
postgraduate research thesis and submitted for examination. The research material will be 
stored at the University of Liverpool. The research will also be published in academic 
journals and presented at conferences. 
 
During the study we will ask you about your opinions on its findings, to get your ideas, 
comments and criticisms of what the research has found. If you wish you will be provided 
with a summary of the findings at the end of the study and you can have a copy of the final 
research report if you would like it.  
 
What will happen if I want to stop taking part? 
 
If you decide at any point that you no longer wish to be part of the study, then you can stop 
and do not have to give a reason for this. You can also ask for your data to be destroyed if 
you decide to stop being in the study.  
 
How can I find out more? 
Just get in touch with the researcher, Elizabeth Deja (PhD student) she will be happy to 
answer any questions you might have: 
Tel: 0151 795 5375 
Email: e.deja@liv.ac.uk  
 
Thank you for reading this 
This information sheet is for you to keep 
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CONSENT FORM 
  
     
Participant Name  Date Signature 
 
 
      
 Name of Person taking consent Date Signature 
 
 
   
 Researcher Date Signature 
 
Exploring Public and Patient Involvement in Research 
 
Researcher: Elizabeth Deja 
 
Please 
initial box 
1. I confirm that I have read and have understood the information sheet dated 
[DATE] for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
  
 
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my rights being affected.   
3. I understand that, under the Data Protection Act, I can at any time ask for 
access to the information I provide and I can also request the destruction of 
that information if I wish. 
 
 
4. I understand that quotes from what I say during the study may be used where 
necessary, on the condition that my identity will remain anonymous. 
 
 
 
5. I agree to being audio- recorded during the study interviews. 
 
 
 
 
6. I agree to the research data being stored. I understand the the anonymised 
data (interview trascripts and notes) may be shared with other researchers in 
the future. 
 
 
7. I agree to the researcher taking my contact details (name, telpehone number 
ect) in order to contact me during the study to arange interview times, ask for 
clarification or feedback.  
 
 
8. I agree to take part in the above study  
 
 
 
 
 
 
 
 
 
 
 
 
[V2]   1 for Researcher, 1 for Participant (If required) 
[20 July.10] 
[ED] 
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Appendix 7. Documents re. PPI in this thesis  
      
 
 
 
University of Liverpool 
Waterhouse Building 
Block B, Second Floor 
1-5 Brownlow Street   
          Liverpool   
                  L69 3GL     
 
Dear EARN Member, 
 
I am a PHD student at the University of Liverpool looking at Patient and Public 
involvement (PPI) in Epilepsy research. My supervisors are Professor Ann Jacoby 
and Dr Bridget Young. We feel that with the increasing emphasis on PPI in research, 
it is important to understand how the process happens and the experiences of 
those involved. This will help facilitate useful and constructive partnerships 
between patients, the public and researchers. 
 
As some of you might be aware, a UK Epilepsy Research Network (UKERN) was 
launched in February 2010, to help ensure that researchers across the UK are 
working together and looking at the important questions in epilepsy. Over the last 
year I have been working with Margaret Rawnsley and Monica Cooper from 
Epilepsy Action as they have been supporting the development of PPI in the 
Network. They have been kind enough to let me attend training events, meetings 
and interviews and have contributed to the design of my study.  
 
For my study I am looking at the development of PPI in UKERN along with four other 
epilepsy- related research projects. I am doing this by looking at the documents 
produced, conducting interviews with everyone involved and observing meetings. In 
order to provide individuals being interviewed an opportunity to discuss issues that 
are important to them, I am using a combination of predetermined questions and 
ones that are raised during the interview. Some questions are the same regardless 
of the person being interviewed; while others are group/situation specific.  
 
At this time, I am mainly writing to you to introduce myself as I am hoping that 
when I start to analyse the information people give me (in late 2011/early 2012), 
you might be willing to help me to develop interpretations of the data, given your 
own experiences of being involved in the research process. Separate to this (as the 
project is still developing) I would be grateful if you could let me know what you 
think of who I am interviewing, the questions I am asking and if my ’Plain English’ 
summary of the project is clear (please see attached feedback sheet).  
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If you could please send any thoughts or comments back to Margaret Rawnsley by 
the 4th of January 2011 that would be really helpful. If you would prefer not to be 
involved please ignore this letter. Thank you for taking the time to read this. If you 
would like more information on this project please feel free to email or ring me.  
 
Yours sincerely 
 
 Elizabeth Deja  
 
 
Email: e.deja@liverpool.ac.uk   Telephone:0151 795 5375 
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Feedback Sheet 
There are four sections to this feedback sheet and a total of 13 questions. Please 
read over each section and give your feedback. Your responses will be combined 
with everyone else’s and will be kept anonymous. 
 
Section One 
The ‘Plain English Abstract’ is a brief summary that I will use to help inform people 
who know nothing about this area, what the project is about. As such, it needs to be 
both clear and detailed, while still being concise.  
 
Plain English Abstract 
Since the early 1990s there has been a drive to increase the roles of patients as 
advisors in research. Over time this has become formalised into policy (DOH, 2001) 
resulting in a growth of interest into public, patient involvement in research (PPI). 
While there seems to be strong support for PPI in principle, implementing patient 
involvement in practice raises numerous questions. These questions include: what 
is meant by ‘involvement’ and ‘patient’; what are the benefits, challenges and 
impacts of involvement on both the research process and outcomes, and for the 
people within it? Using an in-depth qualitative approach (observations, interviews & 
fieldnotes) this project aims to generate a detailed understating of PPI in research 
through eight separate case studies. 
 
How easy do you think this abstract is to understand? 
 
Very Easy  Easy   A little bit hard   Very hard 
 
How appropriate do you think the language is? 
 
Not very appropriate  Appropriate  Very Appropriate 
 
Please comment on any sections that you feel are unclear (and why) or need to be 
expanded 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
 
 
 
 
 
 
 238 
 
Please comment on what information (if any) you feel is missing: 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
 
Section Two 
 
During this project I will be interviewing 
 Patients and public involved in the UK Epilepsy research network (UKREN) or 
one of its linked projects.  
 The researchers conducting the different projects 
 Some of the Epilepsy specialists in the UK Epilepsy research network  
 Coordinators of the research network and projects.  
 A small selection of people working in the Epilepsy Drug industry  
 
Do you think there are any other important groups of people that I need to talk to 
ensure that I have everyone’s point of view (please circle)  
Yes No.   
 
If yes please say which group(s) you feel I am missing: 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
___________________________________________________________________ 
 
Please use the space below to make any other comments you have on the groups of 
people I will be interviewing:  
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
 
 
 
 239 
 
Section Three 
Researcher Questions Patient and Public Questions 
 
1) Please tell me about your current role. 
2) What is your understanding of patient/ 
public involvement in research? 
3) Do you have any previous experience of 
PPI? (if yes please discuses)  
4) How does your current research project 
address PPI? 
5) What is your experience of 
implementing PPI in this research 
project? 
6) What (if anything) have you experienced 
to be the benefits/positive impacts of 
PPI? 
7) What (if anything) have you experienced 
the challenges/negative impacts of PPI 
to be? 
8) What advice would you give to a new 
research project developing its PPI 
process? 
 
 
9) Why did you become involved in the 
network? 
10) Have you been involved in health 
research before, either as a research 
‘participants’ or a research partner? 
11) What to did you expect being part of the 
network to be like? To what extent have 
your expectations been met so far?  
12) What advice would you give to other 
patients/members of the public thinking 
about doing PPI? 
13) What (if anything) have you experienced 
to be the benefits/positive impact of 
PPI? 
14) What (if anything) have you experienced 
the challenges/negative impacts of PPI 
to be? 
 
 
 
In the above table are examples of the questions that I have been asking the 
researchers/ professionals and the Patient and Public involved in PPI in Epilepsy 
research about their experience of patient and pubic involvement in research. As 
you can see many of the questions are similar as I hope to compare across the 
different groups of people.  
 
 
Do you think the wording of the questions make them easy to understand? Yes/ No.  
If ‘no’’ please state the number(s) of the question and why you think it is not clear: 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
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Do you think that these are useful questions to ask? Yes/ No. Please explain your 
answer 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
 
 
Please state any other questions that you feel it would be important to ask 
everyone about PPI? 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
 
Please state any other questions that you feel it would be important to ask ether 
the researchers or patient and public about PPI (please say which group you are 
referring to) 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
 
Please use the space below to make any other comments you have on the 
questions being asked: 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
 
 
 
 
 
 
 241 
 
Section Four 
 
Please indicate if you would be potentially interested in being involved further in 
this project by (for example) helping to develop the interpretations of the data and 
if you would mind being contacted about this at a later date   
 
Yes, I would be interested to be involved in the future 
No, I am not interested  
  
If yes please give your name/ contact details (these will only be used for this reason 
and no other): 
 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
 
 
